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Thesis introduction 
Losses in crop yields due to disease need to be reduced to meet increasing global food 
demands associated with growth in the human population. There is a well-recognised 
need to develop new environmentally-friendly control strategies to combat bacterial 
crop diseases. There are several crop diseases for which no effective bactericidal 
agents are currently available, such as potato blackleg and soft rot disease caused by 
Pectobacterium atrosepticum and other members of soft rot Enterobacteriaceae 
(Czajkowski et al., 2011). Furthermore, current control measures involving the use of 
traditional chemicals or antibiotics are losing their efficacy due to the natural 
development of bacterial resistance to these agents, as seen for fire blight of the pear 
and apple tree caused by Erwinia amylovora (de León Door et al., 2013; Mayerhofer et 
al., 2009; Ordax et al., 2006; Russo et al., 2008). Bacteriophages (phage), the viruses of 
bacteria, have received increased research interest in recent years as an 
environmentally friendly means of controlling bacterial diseases. However, not all 
phages possess the features that would enable them to be effective bactericidal 
agents. To this end, this thesis provides a detailed study of phages that infect 
Pectobacterium atrosepticum and Erwinia amylovora. The knowledge gained in the 
execution of this PhD thesis contributes to the pool knowledge about the lifestyles of 
the phages examined thus enabling a more informed choice with regard to the 
selection of suitable phages for biocontrol applications for the relevant 
phytopathogens. 
Chapter 1 is a review of phages and their application as a biocontrol against bacterial 
plant diseases in broad terms. The literature shows that phages for biocontrol 
applications should have a number of features such as strictly lytic lifestyles, suitable 
host range and genomes that possess no toxins and other virulence factors. 
Additionally, it indicates that phage biocontrol possesses several advantages over 
chemical controls in that tailor-made phage cocktails can be adapted to target specific 
disease-causing bacteria. Unlike chemical control measures, phage mixtures can be 
easily adapted for bacterial resistances that may develop over time. Phages have also 
been deemed suitable for organic growers for the control of crop disease. However, 
there exist some disadvantages to their use as bactericidal agents such a limited host 
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range, biostability and physical access to their host bacterial strain. But the use of UV 
protective agents and the timing of phage application can overcome some of these 
shortcomings. Nevertheless, this chapter shows that phage-based products against 
phytopathogens are starting to become available on the market.  
In Chapter 3, stem samples of potato crops exhibiting blackleg were taken from three 
farms in Co. Cork, Ireland, and were found to be infected with P. atrosepticum. Three 
closely related phages specific to this phytopathogen were isolated and characterised, 
namely vB_PatP_CB1, vB_PatP_CB3 and vB_PatP_CB4 (abbreviated as CB1, CB3 and 
CB4). Both CB1 and CB3 were determined to infect 12 strains and CB4 10 strains of the 
19 strains of P. atrosepticum tested. Morphology, latent periods, burst sizes and their 
stability at various temperatures and pHs were also examined. Genome sequencing of 
the three phages revealed that they shared a minimum nucleotide identity of 93% with 
each other. Their genomes exhibited an Enquartavirinae genome organization, 
possessing several conserved proteins associated with phages of this group, like the 
type species Escherichia virus N4. Tandem electrospray ionization-mass spectrometry 
(ESI-MS/MS) allowed the identification of ten structural proteins that form the virion 
of CB1, six which are conserved in phage N4. In vitro experiments demonstrated that 
the phages suppress soft rot formation upon co-inoculation with P. atrosepticum on 
whole tubers. Results of this study indicate that CB1 related phages could be good 
candidates for phage-based control. 
Chapter 4, describes Pectobacterium phage vB_PatP_CB5 (abbreviated as CB5) which 
specifically infects the bacterium. The phage was characterized in detail and 
transmission electron microscopy (TEM) micrographs indicated that it belongs to the 
Podoviridae family. CB5 has significant pairwise nucleotide identity (≥80%) to P. 
atrosepticum phages φM1, Peat1 & PP90 and shares common genome organization. 
Phylograms constructed using conserved proteins and whole-genome comparison 
based amino acid sequences show that these phages form a distinct clade within the 
Autographivirinae. They also possess conserved RNA polymerase recognition and 
specificity loop sequences. Their lysis cassette resembles that of KP34virus, containing 
in sequential order, a U-spanin, a holin and a SAR endolysin. However, they possess 
low pairwise nucleotide identity to the type phage of the KP34virus genus, Klebsiella 
15 
 
phage KP34. In addition, phage KP34 does not possess several conserved proteins 
associated with these P. atrosepticum phages. As such, we propose the allocation of 
phages CB5, Peat1, φM1 and PP90 to a separate new genus designated ‘Phimunavirus’.  
 
Chapter 5, provides a detailed description of Pectobacterium phage vB_PatM_CB7 
(abbreviated as CB7), which specifically infects P. atrosepticum.  This phage can be 
placed with the genus Cr3virus, the only genus of phage currently defined by the 
International Committee on Taxonomy of Viruses (ICTV) with phages infecting P. 
atrosepticum. Host range, morphology, latent periods, burst sizes, and stability at 
different conditions of temperature and pH were examined.  Analysis of its genome 
shows that it shares features with other Cr3-like phages, highlighting conservation 
within the genus. Conserved elements include a putative early promoter possessing 
elements like that of the Escherichia coli sigma70 promoter, which was shared with 
other genus members. A number of dissimilarities also exist regarding DNA 
methylation and nucleotide metabolism with some members not possessing homologs 
of a putative cytosine methylase and anaerobic nucleotide reductase subunits NrdD 
and NrdG respectively. Furthermore, the genome of CB7 was identified to have 
possibly the largest number of homing endonucleases in the literature to date, having 
23 from both the HNH and LAGLIDADG families. Examination of the HNH homing 
endonuclease residing within introns of genes of the large terminase, DNA polymerase, 
ribonucleotide reductase subunits NrdA and NrdB showed that they are splicing-
competent but dissimilar to the nicotinamide phosphoribosyltransferase intron. ESI-
MS/M was also performed on the virion of CB7, allowing the identification of 26 
structural proteins, 20 of which were found to be shared with the type phages of the 
genera of V5virus and SE1virus. Phylogenetic analysis conducted on Vequintavirinae in 
this study indicated the existence of a novel clade represented by Klebsiella phages 
vB_KpnM_KB57. The results of this study provide greater insights into the phages of 
the Cr3virus genus as well as the subfamily Vequintavirinae. 
 
Chapter 6, examines Pectobacterium phage vB_PcaM_CBB (abbreviated as CBB) is a 
‘jumbo’ phage belonging to the family Myoviridae. It possesses highly atypical whisker-
like structures along the length of its contractile tail. It has a broad host range with the 
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capability of infecting species of the genera Erwinia, Pectobacterium and Cronobacter. 
With a genome of 355,922 bp, excluding a predicted terminal repeat of 22,456 bp, 
phage CBB has one of the largest genomes sequenced to date. Its genome was 
predicted to encode 554 open reading frames (ORFs) with 33 tRNAs. Using a 
combination of BLASTP, Interproscan, HHpred and virion proteome analysis, 29% of its 
predicted ORFs could be assigned functions, involved in DNA replication, nucleotide 
metabolism, virion structure and peptidoglycan degradation. Putative endolysin 
CBB_187 was demonstrated to possess signal-arrest-release (SAR) activity and putative 
virion-associated lysin CBB_239 shown to be capable of peptidoglycan degradation. 
Protein comparison shows that CBB shares between 33-38% of its proteins with 
Cronobacter phage GAP32, coliphages PBECO4 and 121Q as well as Klebsiella phage 
vB_KleM_Rak2. This work presents a detailed and comparative analysis of phage CBB, 
a highly atypical jumbo Myoviridae phage, contributing to a better understanding of 
phage diversity and biology.  
 
Chapter 7, examines Erwinia amylovora phage vB_EamM_Y3 (abbreviated as Y3), 
another example of a jumbo myoviruses with whisker-like structures along the surface 
of its contractile tail. It possesses a genome of 261,365 kbp with 333 predicted ORFs.  
Using a combination of BLASTP, Interproscan and HHpred, about 21% of its putative 
proteins could be assigned functions involved in nucleotide metabolism, DNA 
replication, virion structure and cell wall degradation. The phage was found to have a 
SAR endolysin (Y3_301) possessing a soluble lytic transglycosylase domain. Like other 
SAR endolysins, inducible expression of Y3_301 caused Escherichia coli lysis, which is 
dependent on the presence of an N-terminal signal sequence. Phylogenetic analysis 
showed that its closest relatives are other jumbo phages including Pseudomonas 
aeruginosa phage PaBG and P. putida phage Lu11, sharing 105 and 87 homologous 
proteins, respectively.  Like these phages, Y3 also shares a distant relationship to 
Ralstonia solanacearum phage ΦRSL1 (sharing 55 homologous proteins). As these 
phages are unrelated to the Rak2-like group of hairy phages, Y3 along with Lu11 
represent a second lineage of hairy myoviruses.  
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1.1. Importance of crop diseases 
The human population is expected to reach 9.6 billion by 2050 and this will result in 
increased demands for food. It has been estimated that the global food supply may 
need to grow by as much as 70% in order to meet these demands (UN, 2013). For such 
growth, it has been predicted that crop supply may have to increase as much as 80-
110% (Ray et al., 2013). To achieve these yields, the impact of crop disease has to be 
reduced. It has been estimated that at least 10% of global food production is lost to 
plant diseases (Strange and Scott, 2005). The major pathogens of plants are parasitic 
plants, oomycetes, nematodes, viruses, fungi and bacteria. Among the latter, there are 
over 200 plant pathogenic bacterial species (Considine and Considine, 1995). Those 
considered to be the most important belonging to the genera of Pseudomonas,  
Ralstonia, Agrobacterium, Xanthomonas, Erwinia, Xylella, Pectobacterium and Dickeya 
(Mansfield et al., 2012).  
1.2. Bacteriophages, their life cycles and their morphology 
Bacteriophages (phages) are the most abundant biological entity in the biosphere with 
an estimated number of  1031, as total prokaryotic cell numbers are understood to be 
around 1030 in the biosphere and phage numbers are  believed to be at least 10 times 
greater than this value  (Whitman et al., 1998; Wommack and Colwell, 2000). Phages 
are specific viruses of bacteria that subvert the metabolism of their bacterial hosts in 
order to replicate. Of the phages that have been identified, the majority belong to the 
tailed phages; and these form the Taxonomic Order: Caudovirales (Ackermann, 2007). 
These phages possess icosahedral heads containing genomes comprised of double-
stranded DNA. The order Caudovirales is made up of three phage families; Myoviridae 
which have rigid contractile tails, Podoviridae with short, non-contractile tails and 
Siphoviridae with long flexible tails. Phages belonging to other families have highly 
variable morphologies with genomes of varying nucleic acid composition.  
1.3. History of bacteriophages and their use as antibacterial agents towards plant 
diseases 
The discovery of bacteriophages is credited to Frederick Twort (Twort, 1915) and Felix 
d’Herelle (d’Herelle 1917). Similar findings of antibacterial agents that hinted on the 
existence of phage had been made prior to that of Twort and d’Herelle (Abedon et al., 
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2011).  However, they were the first to suggest this phenomenon as being viral in 
origin. The potential of phages as antibacterial agents was quickly recognised, with 
d’Herelle in 1919 demonstrating the capability of his phage preparations to treat 
dysentery patients in the Hôpital des Enfants-Malades in Paris (Wilkinson, 2001). 
Following this work, many early studies and attempts were made to use phages to 
treat staphylococcal infections, cholera and bubonic plaque of humans (Sulakvelidze et 
al., 2001). This pre-antibiotic era approach became known as bacteriophage therapy. 
Studies were also initiated with the aim of using phages to control plant diseases. 
Mallmann and Hemstreet in 1924 showed that the filtrate of decomposing cabbage 
could be used to inhibit the “cabbage-rot organism” Xanthomonas campestris pv. 
campestris. In 1925, Kotila and Coons demonstrated with bioassays that they could use 
phage to prevent soft rot by Pectobacterium atrosepticum and Pectobacterium 
carotovorum subsp carotovorum on slices of potato tuber and carrot respectively  
(Coons and Kotila, 1925; Kotila and Coons, 1925). The first field trials were also done 
by Thomas (1935), who showed that he could reduce the incidence of Stewart’s wilt 
disease by treating seeds with phage against the phytopathogen Pantoea stewartii 
from 18% (untreated) to 1.5% (treated). However this type of research became 
neglected as an understanding of the nature of phage was poor at the time, and data 
on their efficacy was limited (Okabe and Goto, 1963).  
1.4. Bacteriophage types used for therapy/biocontrol 
From a terminology perspective, the term bacteriophage therapy is usually reserved 
for human and animal applications. For plants, the term bacteriophage biocontrol is 
more often used. In recent years, several studies have been published on phage 
biocontrol on a number of important bacterial plant pathogens, with many very 
promising results (Table 1.1). The main deciding factor whether a phage is applicable 
for biocontrol (and also therapy in humans or animals) is whether a phage is 
exclusively lytic (virulent) or instead temperate in nature. Virulent phages are those 
which conduct infections that ultimately result in lysis of their host bacterium with the 
release of progeny phage particles. Temperate phages can follow the lytic route of 
infection but also follow the route of lysogeny, where the phage genome integrates 
into the bacterial chromosome or persists as a plasmid. In this form, the phage is 
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known as a prophage (Łobocka et al., 2004). With this strategy, the phage genome 
replicates as part of the bacterial genome of its host until a trigger switches it into the 
lytic cycle. These triggers can be chemical or physical (UV light or heat) in nature 
(Brunner and Pootjes, 1969; Müller et al., 2012). It is interesting to note that certain 
plant extracts can also trigger these events (Sato, 1983). Often, prophage DNA can 
increase the fitness of the bacterial host due to genes present on prophage genome. 
For example, in the case of plant pathogens, the P. atrosepticum prophages ECA41 and 
ECA29 both improve the motility of the bacterial host (Evans et al., 2010). Prophages 
may also harbour genes for toxins, e.g. shiga, cholera and diphtheria toxins (Abedon 
and Lejeune, 2005). Another concern with these phages is the spread of virulence 
genes by transduction (specialised), where these phages can excise themselves from 
their host genomes incorporating host DNA into their own genomes facilitating the 
horizontal transfer of genetic material among bacteria (Griffiths et al., 2000). Also, 
some lytic bacteriophages are capable of transduction (generalised), where they 
accidentally pack bacterial DNA into their own capsid heads during the later stages of 
the lytic cycle (Klumpp et al., 2008). There is also a third mechanism of phage-host 
interaction identified in filamentous phages (Inovirus family). Here, phages form a non-
lethal chronic infection with continuous production of progeny phages. However, 
suitability of these phages for biocontrol is questionable as their infection can have 
varying effects on host virulence, as shown with phytopathogen Ralstonia 
solanacearum with its phage ϕRSS1 causing increased virulence (Yamada, 2013), 
although it has been shown possible to isolate virulent filamentous phage (Kuo et al., 
1994).  Another undesirable property in a phage intended for biocontrol is the ability 
to bring about superinfection exclusion to its host during infection. This prevents 
secondary infection of the host by another phage (Lu and Henning, 1994).  
Ideally, a phage for biocontrol applications should be exclusively lytic and possess a 
host range which allows productive infection on all strains of the pathogen 
genus/species being targeted.  Also, current opinion is that phages should be able to 
lyse the host quickly while producing high numbers of progeny phage and diffuse easily 
through the environment to which they are being applied. However, there was a 
report of a phage (φRSL1) of the phytopathogen R. solanacearum which was described 
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as not to be highly lytic but still exhibited great biocontrol effect. The current standing 
theory of this phage’s disease prevention ability is that it is capable of co-existing 
without complete removal of its host from the soil surrounding crop roots, forming an 
equilibrium of infection that maintains the phage’s population but yet suppresses 
bacteria pathogenicity (Fujiwara et al., 2011). 
While a given phage’s infection properties may appear to have great potential with in 
vitro studies, this does not necessarily translate into biocontrol potential in the field. 
Balogh showed in a study of three phages of X.citri pv citri exhibiting lytic activity in 
overlay plate assays that two of these phages were unable to lyse their host bacterium 
on grapefruit leaves, and indeed were later shown to be ineffective for the suppression 
of citrus canker in greenhouse trials (Balogh, 2006). Attention should also be paid to 
the receptors that a given phage recognises on a bacterial target. This can aid in the 
creation of phage mixtures with a reduced likelihood of host resistance (Frampton et 
al., 2014), and as such can lead to the development of phage combinations where 
individual members work in synergy to eliminate the target bacterium (Born et al., 
2011).  
1.5. Advantages of phage biocontrol over other strategies 
Unlike chemical biocides, phages occur naturally in the environment and humans are 
thus exposed to them on a daily basis without any harm. After application, their 
numbers increase if their target bacterial host species are accessible to them. 
However, they tend to persist in high numbers in any environment only as long as the 
host is present (Iriarte et al., 2012). Thus, phages are unlike copper-based pesticides 
which can potentially accumulate in the soil (Hirst et al., 1961; Pietrzak and McPhail, 
2004). Phages generally have a narrow host range, typically being limited to strains 
within a particular species of bacteria. This can allow the creation of phage mixtures 
which can target bacterial species within a given genus of bacteria only. This could be a 
specific bacterial phytopathogen or it could be a particular bacterium in a microbial 
community whose suppression could help improve crop growth. Basit et al (1992) for 
example, isolated a phage which was unable to infect the desired strain of 
Bradyrhizobium japonicum which could aid soybean crop growth due to its nitrogen 
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fixation properties but could inhibit competing bacteria which did not possess this 
feature, thus allowing enhanced nitrogen fixation to occur.  
Biofilm formation is an important factor in the virulence of phytopathogens such as E. 
amylovora (Koczan et al., 2011; Li and Wang, 2014). It is an attribute which has been 
shown to be involved in bacterial phytopathogen resistance to copper bactericides 
(Rodrigues et al., 2008). Phages have evolved to overcome this biofilm barrier through 
the use of depolymerase enzymes on their virions but can also be released on host 
lysis, which allows them to degrade biofilm material, allowing the phage anti-receptor 
to gain access to the receptors on the surface of their host bacterium (Born et al., 
2013). There is a growing demand by consumers for food produce that is free from 
chemicals biocides and preservatives. This has resulted in the restricted use of 
chemicals to produce “Organic label” crops. The requirements of such food require the 
absence of chemical residues in crop production and processing (Lohr, 2001).  Since 
phages are naturally occurring in the environment, they can be registered as 
biopesticides, making them suitable for more consumer-friendly organic farming 
(OmniLytics, 2006).  
1.6. Potential issues concerning the use of phage in biocontrol 
The main limitation for the application of phages in biocontrol in most settings is 
bacterial host-range. While this can be an advantage in certain circumstances, 
developing a phage-biocide that eliminates every member of a particular bacterial 
genus or species can be a challenge. Frequently the development of phage mixtures 
(cocktails) overcomes this disadvantage. Occasionally (but nevertheless, rarely) a 
phage is isolated which has an unexpectedly broad-host-range.  One example of this is 
a phage isolated from sewage and shown to target Pectobacterium and also enteric 
bacteria associated with humans (Pirhonen and Palva, 1988). Thus, careful attention 
should be given to ensure full understanding of likely host-range of a phage to avoid 
inefficacy or indeed to avoid the elimination of non-target potentially beneficial 
bacteria. In the latter context, instances of phage infecting beneficial bacteria resulting 
in reduced crop yield have been reported (Ahmad and Morgan, 1994; Basit et al., 
1992).  
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It is believed that phages do not directly interact with plants. However, a number of 
phage-like genes have been identified in wheat, corn and Arabidopsis cress (Chang et 
al., 1999; Hedtke et al., 1997; Ikeda and Gray, 1999) which would suggest 
incorporation of phage DNA into the genomes of these crops and thus a possible a role 
in their evolution.  
1.7. Advantages of bacteriophages in the context of host resistance 
Like antibiotics and copper sprays, for which resistance has been reported, there is 
also the possibility of bacteria becoming resistant to phage infection following 
constant exposure. However, unlike chemicals, phages are biological entities which can 
evolve and overcome these biological alterations in their hosts. There has always been 
a constant race between phage and bacteria in nature. This is indicated by the fact that 
up 10-20% of bacterial populations in certain habitats are lysed daily because of phage 
infection (Suttle, 1994). In the context of phage resistance, Qiao et al (2010) found that 
Pseudomonas syringae phage phi2954 was dependent on a host protein glutaredoxin 3 
for successful infection. Mutant host strains without this protein were shown to be 
resistant to the phage. Nevertheless, these authors showed it was possible to isolate 
mutants of the phage that had become independent of this host protein for infection 
and this observation has been developed and employed in certain phages aimed at 
biocontrol. Flaherty et al (2001) also showed that phages could evolve to overcome 
phage resistance in target bacteria and these were referred to as H-mutants. This 
allowed the development of phages with broader host ranges.  
In addition to simple mutation-based phage resistance, bacterial phytopathogens can 
also possess other more complex resistance mechanisms such as the altruistic abortive 
infection (Abi) systems which give a bacterial host population immunity against a 
phage by causing phage-infected cells to commit suicide in order to prevent phage 
reproduction (Parma et al., 1992). While a number of these systems have been 
identified in Lactococcus starter culture strains found in dairy fermentations (Chopin et 
al., 2005; Coffey and Ross, 2002), recently such a system was identified in the 
phytopathogen P. atrosepticum and was termed ToxIN. This was characterised as a 
plasmid-encoded Type III protein-RNA toxin-antitoxin system. The toxic protein ToxN is 
bound to RNA antitoxin ToxI in its inactive form. However, when phage infection 
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occurred, ToxI RNA antitoxin became unbound from ToxN causing the death of the 
bacterial host cell (Fineran et al., 2009). Indeed, Blower et al (2012) also showed using 
phage phiTE, that the phage was capable of creating mutants that could overcome this 
system by producing a pseudo ToxI RNA antitoxin preventing ToxN toxic activity  
Another mode of phage resistance is CRISPR/Cas systems, which are used by bacteria 
as well as archaea to form an immunity to protect from infection by foreign DNA such 
as phage. These systems are comprised of clustered regularly interspaced short 
palindromic repeat (CRISPR) arrays and CRISPR associated (Cas) proteins. In a recent 
study of 1,724 bacterial and archaeal genomes, it was found that these systems were 
present in 10% of studied genomes. Previous studies had estimated CRISPR/Cas 
prevalence values of 40% and 80% of studied bacteria and archaeal genomes, 
respectively (Burstein et al., 2016). These have been detected in phytopathogens such 
as  P.atrosepticum (Przybilski et al., 2011), E.amylovora  (Rezzonico et al., 2011) and 
Xanthomonas oryzae (Semenova et al., 2009). CRISPR arrays are comprised of short 
stretches of DNA (termed spacers), which are transcribed into short RNAs which 
interact with Cas proteins to detect and cut foreign DNA that match the sequence of 
the spacer (protospacer). Spacer sequences are acquired during exposure to foreign 
DNA in phage or plasmids, and thus they provide a genetic immunity from invasion by 
foreign DNA due to previous encounters (Marraffini and Sontheimer, 2008). However, 
it is also possible for phages to evolve to overcome these systems. Indeed, Semenova 
et al (2009) detected a spacer in X.oryzae which matched a protospacer of phage 
Xop411. However, the phage was still able to infect this bacterium, due to a mutation 
having occurred in the protospacer sequence.  
Bacteria developing resistance against phage infection is not necessarily a negative 
development in the context of phage biocontrol. Phage-resistance mutations in 
bacteria frequently are accompanied by a fitness cost, one example being a reduction 
in virulence, resulting in reduced disease severity. This results from the fact that 
molecules involved in phage attachment are frequently also involved in the virulence 
process. Examples include lipopolysaccharide (LPS) (Evans et al., 2010a), extracellular 
polysaccharide (EPS) (Ayers et al., 1979),  flagella (Addy et al., 2012; Evans et al., 
2010b) and pili (Ahern et al., 2014). Thus, mutations leading to resistance frequently 
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compromise virulence. There are, however, a few examples where these mutations in 
bacteria surface structures did not lead to reduced virulence as seen with LPS 
production mutants of Pectobacterium and Dickeya  (Pirhonen et al., 1988; 
Schoonejans et al., 1987).  
1.8. Bacteriophage and chemicals  
Phages have been shown to be stable in certain agrichemicals (Ravensdale et al., 
2010). However, precautions need to be taken with some chemicals being combined 
with phage. Chemical biocides typically contain a range of phage inactivating 
substances such as surfactants and chelators  (Chattopadhyay et al., 2002; Yamamoto 
et al., 1968).  Also, copper-based bacteriocides have been shown to inactivate phage, 
but this inactivation can be avoided with the delayed application of phage (4-7 days) 
after initial application of copper-based bactericide (Iriarte et al., 2007).  
1.9. The complexity of bacteriophage interaction with soil 
The rhizosphere is the area of soil which is in close proximity to the roots of a plant. 
There are a number of factors which can affect phage activity in this environment such 
as pH, moisture levels, the presence of organic matter and soil type. A number of these 
factors either individually or in combination can cause phage inactivation. Different soil 
types affect the survival of phage. For example, clay loam soils appear better at 
maintaining phage at low soil moisture levels and high soil temperatures than that of 
sandy loam soils (Straub et al., 1992) As well, low soil pH can also negativity affect 
phage survivability  (Sykes et al., 1981). 
Levels of adsorption of phage are affected differently in differing soil types, with levels 
of hindrance varying from one phage type to another (Goyal and Gerba, 1979). Phage 
can become bound to soil components such as clays (kaolinite and montmorillonite) as 
these minerals possess positively and negatively charged surfaces to which phage can 
adsorb (Schiffenbauer and Stotzky, 1982). Such adsorption can be influenced by pH 
(Goyal and Gerba, 1979; Loveland et al., 1996) as well as the presence of organic 
materials (Zhuang and Jin, 2003). Under favourable conditions, phages have been 
identified that persist at relatively stable concentrations for several weeks in soil 
(Fujiwara et al., 2011). 
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1.10. Bacteriophage in the phyllosphere 
The phyllosphere is the portion of the plant which is above the ground and phages can 
readily be isolated from this location. How phages get there naturally has not been 
defined precisely, although it is possible that they originate in the soil from which the 
plant germinated or alternatively get deposited by insect vectors. Indeed, phages for 
the phytopathogens Pantoea stewartii and Erwinia herbicola var. herbicola have been 
isolated from corn flea beetles (Woods et al., 1981). Another route is the translocation 
of phage from the roots to leaves of plants through the plant vascular system. And it 
has been shown that phages of R. solanacearum, Xanthomonas 
perforans and Xanthomonas euvesicatoria can translocate though tomatoes plants, 
phage of Xanthomonas oryzae through the rice seedlings and phages of E. amylovora 
though apple seedlings and firethorn (Iriarte et al., 2012; Kolozsváriné Nagy et al., 
2015; Rao and Srivastava, 1973). However, this translocation may be influenced by the 
phage type, plant age, plant size, plant species, plant health and possibly soil type in 
which the plant is growing (Iriarte et al., 2012). It has also been reported that E. 
amylovora phages could pass from the leaves to the roots of apple seedlings 
(Kolozsváriné Nagy et al., 2015). The phyllosphere is nevertheless a harsh environment 
for phages to survive and it has been reported that their numbers can rapidly decline 
during daylight hours  (Balogh et al., 2003; Iriarte et al., 2007). The destructive 
influence of UV light from the sun has been reported to be a limiting factor for the 
application of phages for successful biocontrol. The radiation causes the formation of 
lesions in DNA which can block DNA replication and transcription. An in vivo study with 
phage phiXV3-16, Iriarte et al demonstrated a direct relationship between phage 
reduction on tomato leaves and increasing UVA+B dose. They also showed in an in 
vitro study that UV was capable of inactivating phage used against Xanthomonas 
campestris pv. vesicatoria, preventing it from exerting a biocontrol effect (Iriarte et al., 
2007). Phage sensitivity against UV light has been shown to occur also with phage of 
Dickeya solani and  E. amylovora phages (Born et al., 2015; Czajkowski et al., 2014). 
However, there have been phages isolated against the phytopathogen Pseudomonas 
syringae pv. actinidiae which can tolerate extended UV-B doses (Yu et al., 2015). Other 
potential factors that could cause phage decline on the phyllosphere are desiccation, 
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temperature, pH as well as certain chemicals produced by plants (Delitheos et al., 
1997; Erskine, 1973; Iriarte et al., 2007). 
1.11. Bacteriophage application methods for optimal biocontrol performance on 
plants 
One of the limitations to effective phage biocontrol on crops is the possibility of poor 
persistence on the phyllosphere due to the factors discussed in the previous section. 
However, a number of methods have been found to reduce this problem. Survival of 
phage can be improved in the phyllosphere and rhizosphere if they are accompanied 
by a viable host. This can be an avirulent strain of the pathogen being targeted or 
indeed another species of bacteria which occurs naturally in that environment (Bae et 
al., 2012; Iriarte et al., 2012; Svircev et al., 2006).  It has also been found that avoiding 
daylight during application can improve phage-based biocontrol. Indeed it has been 
demonstrated that applying phage to tomato leaves in the evening resulted in longer 
phage persistence in the phyllosphere, giving phage more time to infect and kill their 
bacterial targets (Balogh et al., 2003; Iriarte et al., 2007). 
Born et al conducted studies with a number of substances to investigate if they gave 
phage protection against UV and reported that natural extracts from carrot, red 
pepper, and beetroot all gave protection as did casein, soy peptone and also purified 
aromatic amino acids, astaxanthin and Tween 80. None of these substances had a 
compromising effect on phage infection and stability (Born et al., 2015). Thus, it 
appears that a wide range of substances can enhance phage performance in the 
phyllosphere with the main requirement being that they need to absorb UV thus 
limiting phage exposure. Biodegradable polymers have also been shown to give these 
protective effects (Khalil et al., 2016). In addition, Balogh et al also showed an 
enhanced phage activity by combining the following preparations with phage, namely 
(i) 0.5% pregelatinized corn (PCF) and 0.5% sucrose, (ii) 0.5% Casecrete NH400, 0.5% 
sucrose and 0.25% PCF and (iii) 0.75% skim milk and 0.5% sucrose. These tests were 
performed in greenhouse trials and in field trials on tomato plants with phages against 
Xanthomonas campestris pv. vesicatoria. All formulations were used under a variety of 
different conditions, but generally demonstrated enhanced disease protection (Balogh 
et al., 2003).  
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Soil-based phage delivery is another approach that has been looked at to improve 
phage persistence in the phyllosphere. Iriarte et al showed that a proprietary mixture 
of phage (OmniLytics Inc.) active against X. perforans strain 97-2 could translocate to 
the upper leaves of a tomato plant from its roots. They demonstrated that these 
phages which were applied to soil at levels of 108PFU/mL could be detected at titres of 
104 PFU/g in leaf tissue for 7 days, whereas with a direct foliar application of the same 
phage mix, phages were undetectable 1 to 2 days after application (Iriarte et al., 2012). 
This work would suggest that the phage control of foliar plant diseases could be 
controlled by applying the phages to surrounding soil of a plant rather than by foliar 
spraying.   
1.12. Combination of protective methods appear to be the best direction for 
bacteriophage biocontrol 
There is evidence to support that combining phage with a number of methods used to 
control crop disease results in better control. The bacterium Pantoea agglomerans has 
been used as a biocontrol agent to suppress the growth of the agent of fire blight E. 
amylovora and is being sold under the band name Bloomtime® (Mikiciński et al., 2016). 
However, it has been reported that combining this bacterium with phage biocontrol 
can give enhanced protection that is comparable to that achieved with the antibiotic 
streptomycin (Boulé et al., 2011; Svircev et al., 2006). A similar observation of 
enhanced control was seen using a bacteriocin-producing strain of R. solanacearum 
with a phage to combat tobacco bacterial wilt (Tanaka et al., 1990). In another study, 
combining phage with Acibenzolar-S-methyl (ASM) was shown to have improved 
protection against bacterial spot of tomato in the field (Obradovic et al., 2004). 
However, combinations of phage with copper-based pesticides do not appear to 
produce synergistic effects. Treatment with copper-mancozeb as seen with citrus 
canker and bacterial spot of citrus fruits did not produce synergy against Xanthomonas 
axonopodis pv.citri or Xanthomonas axonopodis pv. citrumelo, respectively (Balogh et 
al., 2008). As mentioned previously, this could be due to phage sensitivity to the 
components of these copper-based sprays.  
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1.13. Improved understanding of bacterial host diversity should aid phage biocontrol 
and improve its success in the future  
Recent years have seen recognition of the increasing diversity and complexity of 
bacterial phytopathogens mainly due to advances in molecular techniques (16S rRNA 
sequencing). For example, X. campestris pv. vesicatoria, which was previously a single 
species has since been divided into four (Jones et al., 2004). Another example is of the 
soft rot Erwinia group which has undergone a significant taxonomic reshuffle with the 
creation of novel species and genera (Gardan, 2003; Hauben et al., 1998; Samson et 
al., 2005). These developments are very important, as while the afflictions caused by 
these bacteria may appear identical on their respective crop targets, the phage 
sensitivities of the pathogens are likely to differ significantly, but nevertheless are 
likely to have some correlation with their taxonomic groupings. For example, the soft 
rot Erwinia group, which affects potato crops, has more recently been reclassified into 
two new bacterial genera (Pectobacterium and Dickeya), and these are relatively 
distinct from the point of view of phage susceptibilities (Czajkowski, 2016). 
1.14. Phytopathogens targeted for phage biocontrol and how they are currently 
managed 
There are a number of important bacterial plant pathogens that have received 
attention for phage biocontrol in recent years (Table 1.1) as existing approaches are 
having limited efficacy or their use is restricted in certain regions of the world. The 
following section discusses selected crop pathogens where phage biocontrol has been 
evaluated and is showing promise. 
1.14.1. Dickeya and Pectobacterium  
Both Dickeya and Pectobacterium belong to the family of Enterobacteriaceae, which 
collectively can be referred to as the soft rot Enterobacteriaceae (SRE). Both genera 
characteristically produce several cell-wall-degrading enzymes that allow them to 
infiltrate and macerate the plant tissue on which they feed (Pérombelon, 2002). The 
plant host range of both bacterial genera is very broad: species belonging to Dickeya 
have been reported to infect ten monocot and eleven dicot families, while those of 
Pectobacterium are reported to infect eleven monocot and sixteen dicot families (Ma 
et al., 2007).  
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P. carotovorum subsp. carotovorum has a wide host range and global distribution, 
while P. atrosepticum is primarily found in temperate climates with a host range 
mainly limited to the potato (Pérombelon, 2002). P. wasabie and P. carotovurum 
subsp. brasilensis are also found to infect potato in a number of regions worldwide 
(Lee et al., 2014; Waleron et al., 2013). In Europe, Dickeya dianthicola is reported to be 
very important in potato disease, although more recently, a new Dickeya species called 
D. solani is being more frequently identified. Both also cause disease in other regions 
of the world (Toth et al., 2011). The economic impact of these potato infections can be 
severe. In the Netherlands, they cause annual losses in the seed potato sector of as 
much €30 million per year and in Israel, potato yield losses due to Dickeya have been 
as much as 20-25% (Prins and Breukers, 2008; Tsror (Lahkim) et al., 2008). In Ireland, 
blackleg has been reported to be one of the top causes for ware potato losses along 
with blight (MacConnell, 2002).  
With regard to the potato, there are no effective bactericides to protect against SRE 
and the most effective approach has been through careful culturing practices, 
involving avoidance of contamination and the removal of diseased plants and/or 
diseased tissue. Certification systems are also employed. These involve the 
propagation of seed plants using healthy tissue culture plantlets followed by 
propagation in greenhouses, and then open field grow-out production. It is 
accompanied by careful monitoring and removal of diseased plants before releasing 
for general production. The generation number of these crops is also kept low to limit 
bacterial build up. However, the success of these certification schemes has been 
variable and heavily weather dependent (Czajkowski et al., 2011; De Boer, 2004).  
1.14.2. Erwinia amylovora 
E. amylovora, a member of the family of Enterobacteriaceae, is the causative agent of 
fire blight which is a destructive disease that occurs to species of the plant family 
Rosaceae. The disease has been reported in 40 countries across North America, 
Europe, the Pacific Rim and the Middle East  (Bonn and van der Zwet, 2000). It heavily 
affects apple and pear production in a number of regions, with costs estimated as 
much as $100 million per year in the USA due to production losses and control 
measures  (Norelli et al., 2003). It is considered to be a quarantine concern in countries 
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belonging to plant protection agencies of APPPC (Asia and Pacific Plant Protection 
Commission), COSAVE (Comite Regional de Sanidad Vegetal para el Cono Sur), EPPO 
(Europe and Mediterranean Plant Protection Organisation) and IAPC (Inter-African 
Phytosanitary Council) (CABI, 2016). 
Pathogenesis typically involves the bacterium entering a susceptible plant host 
through the nectarthodes of its flowers, but it may also enter the plant through other 
openings such as wounds (Bubán and Orosz-Kovács, 2003). Once in the plant, it is 
capable of moving through the intracellular space of parenchyma, where at the latter 
stages it may reach the xylem vessels. Under favourable conditions, the disease can 
present itself as wilting, necrosis of tissue and dieback of the plant (Vanneste and 
Eden-Green, 2000). The bacterium does not produce cell-wall-degrading enzymes but 
the exopolysaccharide amylovoran, biofilm formation capacity, motility, a type III 
secretion system and quorum sensing are all understood to be features in its virulence 
(Piqué et al., 2015).    
Traditionally, control of fire blight relies on cultural practices involving the removal of 
diseased tissue as well as preventative sprays containing copper or antibiotics (Norelli 
et al., 2003). However, issues with these chemical controls is copper tolerance of the 
pathogen and also the long term of use antibiotics (such as streptomycin) as a control 
strategy may be limited in the future, with growing concern of antibiotic resistance and 
the resulting restricted used of antibiotics for agriculture in certain regions of the 
world such as EU countries (de León Door et al., 2013; Mayerhofer et al., 2009; Ordax 
et al., 2006; Russo et al., 2008). As mentioned, biological controls using antagonistic 
bacteria have shown a capacity for controlling the disease (Mikiciński et al., 2016) 
1.14.3. Ralstonia solanacearum 
R. solanacearum is a Gram-negative soil-borne bacterium.  It is considered to be one of 
most destructive phytopathogens with a host range of up to 200 plant species from 
over 50 families (Denny, 2007).  The bacterium is highly heterogeneous, historically 
being divided into five races (based on plant host range) and five biovars (based on 
carbon utilisation) (Denny, 2007). It causes diseases of economically important crops, 
such as bacterial wilt of tobacco, banana and tomato as well as brown rot of the 
potato (Sanchez Perez et al., 2008). The bacterium has global distribution (Sanchez 
32 
 
Perez et al., 2008), and with regard to tomato and potato production, has quarantine 
status in the EU (Anonymous, 2000). The species has a considerable economic impact: 
for example, brown rot of the potato has been estimated to exceed more than €950 
million in losses per year worldwide (Scherf et al., 2010). Infection begins by the 
bacterium entering the host plant through its roots where it will then colonise the 
xylem. Infection typically leads to the development of yellowing of the plant, stunted 
growth, wilting and death, although the bacterium is also capable of asymptomatic 
infections (Sanchez Perez et al., 2008). Typical methods of control include the use of 
cultural practices such as selection of planting time, crop rotation, using clean 
seedlings and the use of resistant cultivars (Mariano et al., 1998). However, the use of 
such cultivars has shown a negative correlation between resistance and yields (Yuliar 
et al., 2015). Also, resistance possessed by these cultivars tends to be strain specific 
(Wang et al., 2000).   
1.14.4. Pseudomonas syringe 
The bacterial phytopathogen P. syringea belongs to the class of Gammaproteobacteria 
(Hirano and Upper, 2000). The species is currently subdivided into more than 50 
pathovars, with different pathovars representing different strains with differing plant 
host ranges (Hirano and Upper, 1990; Parkinson et al., 2011). Strains of most pathovars 
typically exhibit narrow host ranges, with pathovar P. syringea pv. syringea being an 
exception, having been reported to infect more than 80 plant species  (Hirano and 
Upper, 2000).  
P. syringea pv. tomato causes necrotic lesions surrounded by a yellow chlorotic halo on 
tomato, a disease known as bacterial speck (Cruz et al., 2010). The pathovar can also 
infect members of genera of Arabidopsis and Brassica in a laboratory setting (Elizabeth 
and Bender, 2007). The disease reduces yields while also affecting fruit quality (Fatmi, 
2003).  Pathogenesis by the bacterium involves the invasion of plant tissue from 
natural openings, such as stomata, where a type III secretion system plays a major role 
in its virulence with the release of effectors to overcome the plant immune system (Xin 
and He, 2013). It is spread by contaminated tomato seeds but can also survive as an 
epiphyte for extended periods on tomato plant surfaces and is dispersed in windblown 
rain (McCarter, 1983; Preston, 2000; Smitley and McCarter, 1982). Control of the 
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organism typically involves the use of uncontaminated seeds and the use of 
bactericides  (copper and streptomycin) to limit its spread (Fatmi, 2003; Preston, 
2000). However, copper tolerant strains of the bacterium have been reported 
(Alexander et al., 1999). 
1.14.5. Xanthomonas species 
Xanthomonas is a large genus, which belongs to the class of Gammaproteobacteria, 
containing at least 27 official species, many of which also possess a number of 
pathovars. Collectively, the genus host range is broad: infecting around 400 plant 
hosts, a number of which are important crops such as rice, banana, tomato and citrus 
fruits. Species and pathovars of this genus typically exhibit a high degree of host- as 
well as tissue-specificity, invading either the xylem or intercellular spaces of the 
mesophyll parenchyma tissue  (Ryan et al., 2011).  
X. campestris pv. vesicatoria is the causative agent of bacterial spot disease of tomato 
and pepper, with the disease having been identified in many countries worldwide 
(Jones et al., 2005).  This tomato disease can be very severe with yield losses of up to 
50% reported for tomatoes, grown both in greenhouses and fields in the USA and 
Caribbean (Camesano, 2015). The disease is caused by the bacterium entering the 
plant through stomata or wounds. The bacteria then colonise the intercellular space of 
the plant, inducing water-soaked lesions that later become necrotic, which can result 
in defoliation and severely spotted fruit (Thieme et al., 2005). Control of the disease 
has involved preventative cultural practices such as avoiding unnecessary crop damage 
and using uncontaminated seed, but also includes the use of resistant cultivars as well 
as chemical controls with copper or streptomycin (Goode and Sasser, 1980). However, 
the use of resistant cultivars has not always been successful and there have been 
reports of bacteria developing resistance to the above two agents (Goode and Sasser, 
1980; McDonald and Linde, 2002; Ritchie and Dittapongpitch, 1991).  
1.14.6. Xylella fastidiosa 
Xylella fastidiosa belongs to the class of Gammaproteobacteria. It is a xylem-limited 
phytopathogen that requires insect vectors (such as sharpshooters) for its distribution 
and infection of its host plants (Chatterjee et al., 2008). It causes disease on a number 
of crops such as the grape, citrus, almond, peach and coffee (Hopkins and Purcell, 
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2002). While it has primarily been contained in the Americas, it has been identified in 
Europe in recent years causing disease on olive trees (Hopkins and Purcell, 2002; 
Loconsole et al., 2014). Disease caused by the bacterium is believed to be induced by 
the formation of biofilm aggregates in the vascular system, which restricts the 
movement of nutrients and water throughout the plant (Chatterjee et al., 2008). It 
causes Pierce disease of the grapevine, a highly destructive infection, which heavily 
affects grape production in the USA, and has been estimated to cost as much as $104.4 
million annually to the state of California (Tumber et al., 2014). Existing control 
methods have been limited in their management of the disease and include removal of 
infected plants and control of the infected insect vector populations with 
neonicotinoid-based insecticides (Janse and Obradovic, 2010). However, the use of 
these insecticides has seen restrictions in recent years due to their possible effects on 
honey bee populations (Anonymous, 2013; Lu et al., 2014). 
1.15. A critical summary of recent phage biocontrol studies on crops  
There is growing evidence showing that phages have promising biocontrol applications 
for a number of plant diseases in different crops. The following section describes 
recent studies that have been conducted since the year 2000 and the findings from 
these are summarised in Table 1.1. 
The most common crops that appear to benefit from the application of phages for 
biocontrol in the recent scientific literature are the potato and the tomato, as both 
have been the focus of numerous recent studies. The bacterial pathogens in the case 
of the potato are predominantly the SRE. As mentioned above, one of the most 
important SREs in Europe is D. solani; and the potential of phage to control this 
phytopathogen have been assessed indicating strong potential for disease control. For 
example, Adriaenssens et al (2012) conducted a bioassay and a field trial using phage 
(LIMEstone1). The bioassay involved the incubation of seed tubers (cultivar Bintje), 
which had either been inoculated with the bacteria or co-inoculated with the bacteria 
and the phage (multiplicity of infection [MOI] of 100). They showed that tubers 
inoculated with the bacteria alone would experience 40% maceration of tuber tissue, 
while those co-inoculated with the phage and bacteria exhibited no more than 10% 
maceration of tuber tissue. Similar results were observed with the seed tuber cultivar 
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Kondor. The field trial using the same phage against the same pathogen also suggested 
it was capable of exerting this biocontrol effect in-planta, as phage treated infected 
seed potatoes resulted in higher crop yields than those without phage treatment. 
Similar findings were reported by Czajkowski et al (2014) who also isolated phages 
specific for D. solani. These workers conducted bioassays with tuber slices incubated 
with the bacterial pathogen with or without phages (MOI of 0.01) and showed that the 
application of phages could prevent potato tuber tissue maceration by up to 70%. SREs 
other than D. solani were also studied for their susceptibility to phages by the same 
group. They found that the application of phages (MOI of 0.01) to control P. 
carotovorum subsp carotovorum and P. wasabie destruction could prevent damage of 
up to 80% on tuber slices and up to 95% on whole tubers against tissue maceration 
from a mixed bacterial infection (Czajkowski et al., 2015). Such data is highly 
encouraging as many SRE infections tend to result for a mixture of genera/species. 
Aside from potato, SRE infections have also been controlled by phage in lettuce, with 
high levels of disease prevention being reported (Lim et al., 2013). Aside from the SRE 
problem, potato infections from the Gram-positive bacterium Streptomyces scabies 
result in the formation of a corky lesion (known as common scab) on the tuber and 
indeed other root vegetables also, as well as causing the reduced growth of seedlings 
(Lerat et al., 2009). This pathogen has also been successfully treated in potato by 
phage biocontrol and thus has implications for other crops also as demonstrated by 
Goyer (2005). In conclusion, the above studies indicate strong potential for phage-
based control of these diseases. 
Another crop which the focus of several studies in the context of phage therapy has 
been the tomato, which is commonly infected by R. solanacearum (also causes brown 
rot in the potato) and X. campestris pathovars. Again, phage biocontrol approaches 
have been demonstrated to give a significant reduction in bacterial wilt (Ralstonia) and 
leaf spot caused by Xanthomonas. Indeed, the successful trials against R. 
solanacearum reported by Mansfield et al (2012) are significant considering the wide 
host range of the bacterium. Similarly, in the case of Xanthomonas, the observed 
beneficial effect of the application of phages can also be extrapolated to other plants 
affected by pathogens belonging to the same genus. Indeed studies on the elimination 
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of Xanthomonas using phage have been conducted with successful outcomes on both 
grapefruit and orange (Balogh et al. 2008) as well as onion (Lang et al. 2007). A variety 
of other crop infections have also been reduced in severity in other phage biocontrol 
studies. These include Pseudomonas infections of mushrooms (brown blotch) and 
leeks (bacterial blight) and infection of the grapevine by Xylella (Das et al., 2015). 
1.16. The commercialisation of phage for biocontrol in crop disease 
In recent years a number of phage biocontrol products have reached the market. A 
USA based company Omnilytics was the first company to receive registration (from the 
US Environmental protection agency) for their phage-based biopesticide product 
Agriphage. The product is designed for the control of bacterial spot or speck of 
tomatoes and peppers (specific for X. campestris pv. vesicatoria, or P. syringae pv. 
tomato). This product has also received an OMRI listing making it suitable for use by 
commercial organic growers (OmniLytics, 2006). A Hungarian company Enviroinvest 
was the second company to receive registration for their biopesticide named 
Erwiphage for the control of fire blight of apple trees (specific for Erwinia amylovora) 
(Enviroinvest, n.d.). There is also a Scottish company, APS biocontrol, which has 
developed a bacteriophage-based wash solution (Biolyse) for potatoes tubers, which is 
to be used for prevention of soft rot disease (specific against soft rot 
Enterobacteriaceae) during storage (APS Biocontrol Ltd, n.d.). Interestingly this product 
has been reported to be used by the Tesco supermarket chain (Branston, 2012).  
However, there are delays in some regions of the world with phage biocontrol due to 
legislation that hinders the use of phage biocontrol approaches for the of control of 
bacterial plant diseases. A problem with phage-mediated biocontrol is that phage 
mixtures/cocktails need to be updated constantly in order to lyse as many newly 
emerging strains of the target bacterium as possible. This approach is used by 
Omnilytics (OmniLytics, 2004). This allows a phage cocktail to be adapted to the 
relevant disease-causing bacterial strains in a given situation, also facilitating 
counteraction of any phage resistance development during the phage application. 
However, EU regulations (1107/2009 EC) require that any change to one of the 
components of a phage cocktail would require reregistering which requires time and 
expense, making the US approach currently unfeasible in the EU (Doffkay et al., 2015). 
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Legislation governing phage biocontrol may need to become more malleable in the EU 
for the best application and performance of phage products as biopesticides.   
1.17. Other phage applications of the past and possible future with regards to 
phytopathogens 
Phage typing schemes have been employed for a number of phytopathogens for 
epidemiology studies (Ahmad et al., 2014; Toth et al., 1999). These systems allow the 
identification of a particular strain of a species based on their susceptibility to series of 
phages. The downfall of this method, however, is that it depends on the isolation of 
pure cultures for identification as well as the maintenance of stocks of typing phage as 
well as host strains for which to propagate them. Nowadays, studies of 
phytopathogens have moved away from phage typing due to its tendency to generate 
false positives and false negatives results as well as its low resolution and the 
development of new and improved molecular techniques (Czajkowski, 2016) 
A number of phage-based detection systems have been developed for human and 
animal pathogens (van der Merwe et al., 2014).  Recently, however, work has been 
published on the promising application of these methods for the detection of plant 
pathogens. Such a detection system has been developed for R. solanacearum, which is 
based on detection of the bacterium by phage propagation followed with quantitative 
PCR (qPCR). Samples that contain the bacterium will cause added phage titres to 
increase, these titre increases can then be detected using qPCR. This method was 
found to be faster than conventional methods with greater sensitivity allowing 
detection of 102 CFU/g of soil, 103 CFU/ml from drainage water from potted plants and 
102 CFU/g in 0.1 g of leaf tissue. The method also doesn‘t require the destruction of a 
plant for the detection of bacterium unlike those currently used to detect R. 
solanacearum  (Kutin et al., 2009). It is possible to engineer phage of phytobacteria 
into reporter systems that can emit a detectable bioluminescent signal during 
infection. A “luxAB-tagged” reporter phage was developed for Pseudomonas 
cannabina pv. alisalensis (agent of bacterial blight of crucifers) which was shown 
capable of detecting the bacteria within minutes. This phage was also capable of 
emitting a detectable signal during infection of both cultures and diseased plant 
samples (Schofield et al., 2013). Both mentioned systems have advantages over other 
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molecular detection methods, in that phage propagation requires active metabolism, 
conveniently limiting it to viable bacterial cells. 
1.18. Discussion  
Effective control of plant disease typically calls for a disease control strategy that 
involves a number of integrated approaches. Currently, the use of phage biocontrol is 
emerging, but as yet uncommon practice. However, phages do possess several 
properties which can add to the arsenal of controls for crop diseases. They are natural, 
making them suitable for organic farming. They can be used to create phage cocktails 
with tailored host ranges. Also, phages naturally have the potential to evolve to adapt 
to overcome phage-resistance or overcome new strains of bacteria. They can be 
combined with other chemical or biocontrol agents.  A possible limitation to their use 
is their sensitivity to UV light and to certain soil conditions. However, approaches have 
been found to overcome some of these limitations with the use of UV protectant 
formulas and timing of the application of phage to crops to avoid interaction with 
chemical pesticides and exposure to UV light.  In addition to biocontrol applications, 
there is also good potential for phage-based diagnostics for plant pathogenic bacteria 
with a high sensitivity aimed specifically at viable bacteria. 
Many pesticide companies are moving away from investment in chemical pesticides 
and increasingly directing their attention to biopesticides. The pesticide market is 
worth $56 billion with the biopesticides forming only $2-3 billion of this. However, the 
growth of the biopesticide sector is expected to outpace chemical pesticides in the 
future (Marrone, 2014). This change is believed to be due to increasing customer 
demand for chemical residue free foods and increasing legalisation on the use of 
synthetic pesticides in certain regions in the word. In addition, many biopesticide 
products are potentially cheaper to develop and quicker to bring to the market 
(Marrone, 2014). With this economic environment, one can expect to see increased 
activity in the development of phage biocontrol as a viable approach for crop disease 
control in the future. 
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Table 1.1. Summary of bacteriophage biocontrol experiments which have been conducted 
since the year 2000 to the present.  
Pathogen Host Disease Information   Reference 
Streptomyces 
scabies  
Potato Common 
scab 
Seed tubers treated with 
phage ΦAS1 resulted in 
producing tuber progeny with 
reduced levels of surface 
lesion of scab (1.2%) 
compared with tubers 
harvested from non -treated 
seed tubers (23%).  
McKenna et 
al., 2001 
Xanthomonas 
campestris pv. 
vesicatoria 
Tomato Bacterial spot Greenhouse experiments with 
formulated phage cocktails 
could reduce disease severity 
with formulated phage 
cocktails providing better 
protection in comparison to 
unformulated. A similar effect 
was found in three 
consecutive field trials.  
Balogh et al. 
2003 
Xanthomonas 
campestris pv. 
vesicatoria 
Tomato Bacterial spot In field experiments, phage 
treatment was comparable to 
disease control with copper-
mancozeb. Combination of 
phage and plant activator 
(ASM) resulted in enhanced 
control. 
Obradovic et 
al., 2004 
Streptomyces 
scabies 
Radish Common 
scab 
Phages Stsc1 and Stsc3 could 
prevent disease development 
by treating radish seedlings. 
Non-treated radishes had 30% 
less weight than negative 
control, with phage treated 
radishes having masses similar 
to the negative control.  
Goyer 2005 
Xanthomonas 
axonopodis pv. allii 
Onion Xanthomonas 
leaf blight of 
onion 
Field trial showed that weekly 
and biweekly applications of 
phage could reduce disease 
severity, a result which was 
comparable to treatments of 
weekly applications of copper-
mancozeb. 
Lang et al., 
2007 
Xanthomonas 
axonopodis pv. citri  
Grapefruit Asiatic citrus 
canker 
Five greenhouse experiments 
utilising phage treatment 
could reduce disease severity 
by 59%. However, using a skim 
milk formulation of phage did 
not have increased disease 
control. Phage treatment was 
also capable of reducing 
Balogh et al. 
2008 
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disease occurrence in a citrus 
nursery.  Control was less 
effective than copper-
mancozeb. The combination 
did not give increased disease 
control. 
Xanthomonas 
axonopodis pv. 
citrumelo 
Orange Citrus 
bacterial spot 
Phage treatments reduced 
citrus spot occurrence by 35% 
and 48% in two trials in a 
commercial citrus nursery. 
Control was equal or less 
effective than copper-
mancozeb. The combination 
did not give increased disease 
control   
Balogh et al. 
2008 
Ralstonia 
solanacearum  
Tomato Bacterial wilt Tomato plants treated with 
phage ΦRSL1 showed no 
symptoms of bacterial wilt 
during the experimental 
period; whereas all untreated 
plants showed wilting 18 days 
post infection. 
Fujiwara et 
al., 2011 
Pseudomonas 
tolaasii 
Mushrooms Brown blotch 
Disease 
The formation of blotches was 
completely blocked by co-
incubation of phages with the 
pathogen. 
Kim et al. 
2011 
Erwinia amylovora  Pear, apple 
trees 
Fire blight Phages ΦEa1337-26 and ΦEa 
2345 reduced infection of 
detached pear tree blossoms 
by 84% and 96%, respectively 
with Pantoea agglomerans as 
a carrier. Also, infection of 
potted apple tree blossoms 
could be reduced by 54% with 
phage ΦEa1337-26 and P. 
agglomerans. Control 
achieved was comparable to 
streptomycin. 
Boulé et al. 
2011 
Ralstonia 
solanacearum  
Tomato Bacterial wilt Simultaneous treatment of 
phage PE204 with R. 
solanacearum of the 
rhizosphere of tomato 
completely inhibited bacterial 
wilt. However, pre-treatment 
with phage before the 
inoculation of the pathogen 
was not effective with control 
of bacterial wilt, whereas 
post-treatment of PE204 
delayed disease development. 
 
Bae et al., 
2012 
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Dickeya solani Potato Soft rot/ 
Blackleg 
Phage vB_DsoM_LIMEstone1 
and vB_DsoM_LIMEstone2 
reduced soft rot of inoculated 
tubers in bioassays and in field 
trials which produced a potato 
crop with higher yields. 
Adriaenssens 
et al., 2012b 
Pectobacterium 
carotovorum subsp. 
carotovorum 
Lettuce Soft rot Greenhouse trials showed that 
phage PP1 could significantly 
reduce disease development 
on lettuce plants. 
Lim et al., 
2013 
Dickeya solani Potato Soft rot Bioassays with phage ΦD1, 
ΦD2, ΦD3, ΦD4, ΦD5, ΦD7, 
ΦD9, ΦD10, ΦD11 could 
reduce the incidence of soft 
rot by up to 30–70% on co-
inoculated potato slices with 
pathogen and phage. 
Czajkowski 
et al., 2014 
Xylella fastidiosa Grapevines Pierce's 
Disease 
X. fastidiosa levels in 
grapevines were significantly 
reduced on pre and post 
inoculation of a four phage 
(Sano, Salvo, Prado and Paz) 
cocktail. Pierce disease 
symptoms could be stopped 
using phage treatment post 
infection as well as applying 
phage prophylactically to 
grapevines. 
Das et al., 
2015 
Pectobacterium 
carotovorum subsp. 
carotovorum, 
Pectobacterium 
wasabiae, 
Dickeya solani 
Potato Soft rot Bioassays with phage ΦPD10.3 
and ΦPD23.1 could reduce the 
severity of soft rot of tubers 
by 80% on potato slices and 
95% with whole tubers from a 
mixed pathogen infection. 
Czajkowski 
et al., 2015 
Pseudomonas 
syringae pv. porri 
Leek Bacterial 
blight 
Specific-bio-assays 
demonstrated the in-
planta efficacy of phages KIL1, 
KIL2, KIL3, and KIL3b. 
However, phage cocktail of six 
phages (KIL1, KIL2, KIL3, KIL4, 
and KIL5 and KIL3b), were 
tested with two parallel field 
trial experiments in three 
locations which showed 
variable results. In one trial, 
symptom development was 
attenuated. 
Rombouts et 
al., 2016 
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Chapter 2. Materials and methods 
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2.1. Bacterium isolation, bacteriophage isolation and cultivation conditions 
2.1.1. Cultivation conditions of bacteria and phages 
For chapters 3, 4, 5 and 6, all bacteria cultures were grown at 25°C unless stated 
otherwise, using Lysogeny broth (LB) medium (Sigma- Aldrich, St. Louis, MO, USA). For 
chapter 7, all Erwinia and Pantoea strains were grown in LB medium at 28°C.  
 
Phages CB1, CB3, CB4, CB5 and CB7 were routinely cultivated at 25°C with LB agar 
(1.5% w/v agar) and LB overlays (0.4% w/v agar) using P. atrosepticum strains DSM 
18077 (for phage CB1) and DSM 30186 (for phages CB3, CB4, CB5, CB7). Phage CBB 
was routinely cultivated at 25°C with LB overlays using 0.2% w/v agarose as described 
by Serwer et al (2007), on LB agar (1.5% w/v agar) and using P. carotovorum subsp. 
carotovorum  CB BL19-1-37 as the host strain. Stocks of phage were produced 
according to the plate lysis method as previously described (Sambrook and Russell, 
2001a). Additionally, phages were also propagated by lysis in broth, a volume of LB 
broth was inoculated with 1% overnight culture, this was grown with agitation to an 
OD600 of ca. 0.2. To this, phage was added to a final concentration of ca. 1x109   plaque 
forming units (PFU)/mL and further grown with agitation until complete clearing of 
broth was observed. The lysate was then filter sterilised (0.45 µm pore-size filter, 
Sarstedt, Nümbrecht, Germany) or underwent CsCl gradient purification (as described 
in section 2.2.4.). To determine phage titre, a 10-fold dilution series of phage stock was 
tested using the double overlay method as previously described  (Sambrook and 
Russell, 2001b).  
Phage Y3 was routinely cultivated at 28°C with the soft agar overlay method (Adams, 
1959) using LB plates and LC soft agar (LB supplemented with 10 mM CaCl2 and 2 mM 
MgSO4; 0.4% agar), and E. amylovora 1/79 as the host strain.  
2.1.2. Isolation of Pectobacterium 
Crystal violet pectate (CVP) agar was used to isolate Pectobacterium strains from stems 
of potato plants presenting symptoms of blackleg (Hélias et al., 2012). Bacterial 
identification was achieved by using biochemical and physiological tests (Perombelon 
and Van Der Wolf, 2002), genus and species-specific PCRs (Darrasse et al., 1994; De 
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Boer and Ward, 1995; Kang et al., 2003) and MALDI-TOF mass spectrometry (Bruker 
Daltonics Biotyper, Billerica, MA, USA).  
2.1.3. Bacteriophage isolation 
Five grams of soil (for the isolation of CB1, CB3, CB4, CB5 and CB7) or 5ml of activated 
sludge (for the isolation of CBB) was enriched with 30 mL of LB broth, followed by the 
addition of 300 µL of an overnight culture of P. atrosepticum (DSM 18077, DSM 30184, 
DSM 30185 and DSM 30186) or P. carotovorum subsp. carotovorum (CB BL19-1-37). 
After incubation for 18 h at 25ᵒC, this was centrifuged to pellet solid matter with 
supernatant then being filtered (0.45 µm pore-size filter, Sarstedt, Nümbrecht, 
Germany). The supernatant was spotted (10 µL) onto LB overlays seeded with different 
strains of Pectobacterium. Phages were isolated by picking individual plaques and then 
re-plating and re-isolating to ensure purity(Sambrook and Russell, 2001c). 
 
Erwinia phage Y3 was originally isolated from soil as described previously (Born et al., 
2011). Briefly, 10 g of soil was enriched in 200 mL SM-buffered (50 mM Tris, 100 mM 
NaCl, 8 mM MgSO4, pH 7.4) LB broth, which had been inoculated 1:20 with an 
overnight culture of E. amylovora 1/79. After overnight incubation at 28°C, filtered 
supernatants were spotted onto a freshly growing lawn of E. amylovora 1/79 and 
plaques were picked with a Pasteur pipette. After isolation, Y3 was propagated to high 
titres with the soft agar overlay method. 
2.2. Bacteriophage manipulations 
2.2.1. Host range 
Host range of phages was tested by spotting (µL) a serial dilution (neat to 10-9) of a 
phage suspension onto LB overlays seeded with bacteria of interest. The efficiency of 
plaquing (EOP) values was determined for sensitive strains by dividing phage titre on 
target bacterium by phage titre on host bacterium. In the case of the CB1-like phages, 
the determination of EOP values employed the use of a phage lysate with a titre of 
1x107 PFU/mL. Bacterial strains used in host range study of Pectobacterium phages 
CB1, CB3, CB4, CB5, CB7 and CBB are listed in Appendix, Table S2.1. 
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2.2.2. Single step growth curve assay 
The single step growth curve assay was conducted in a similar manner as described 
previously (Park et al., 2012; Yang et al., 2010). The host bacteria (strain DSM 30186) 
were grown to an OD600 of 0.20-0.23 (c. 1x108 colony forming units (CFU)/mL), 
followed by centrifugation of 2 mL in a microfuge to pellet bacteria. The pellet was 
resuspended in 1 mL of LB broth phage suspension to yield an approximate multiplicity 
of infection (MOI) of 5x10-4 following incubation at 25 °C for one min. This was then 
centrifuged to pellet bacteria, and the supernatant was removed, thus separating 
bound from unbound phages. The bacterial pellet with bound phage was then 
resuspended in 10 mL of LB and incubated aerobically in a water bath at 25 °C with 
agitation at 60 rpm. At five-min intervals, aliquots were removed to measure phage 
titre by the overlay method. Based on the number of PFU/mL of each replicate, the 
latent period and the burst size were determined, by dividing the average PFU/mL of 
the latent period by the average PFU/mL of the last four time points of the 
experiment. 
2.2.3. Biophysical stability 
Phage stability was tested by incubating phage suspension of 106 PFU/mL in SM buffer 
(50 mM Tris.HCl pH 7.5, 100 mM NaCl, 8 mM MgSO4) at different temperatures for one 
hour and incubating phage suspension in pH buffer ranging from 2 to 12 (10 mM 
trisodium citrate, 10 mM boric acid, and 150 mM KCl, adjusted with NaOH or HCl) for 
24 h (Adriaenssens et al., 2012b). 
2.2.4. CsCl gradient purification 
Isopycnic centrifugation through CsCl gradients was performed on phage Y3, as 
previously described (Sambrook and Russell, 2001d). However, for phages CB1, CB3, 
CB4, CB5, CB7 and CBB, this was conducted with a number of modifications. A high 
titre phage lysate (>1 × 109 PFU/mL), was precipitated using polyethylene glycol (15% 
w/v PEG8000, 1 M NaCl) at 4 °C overnight and centrifuged, after which the pellet was 
resuspended in TMN buffer (10 mM Tris-HCl pH 7.4, 10 mM MgSO4·7H2O, 0.5 M NaCl), 
and where necessary a chloroform phase separation step (1:1) was conducted to 
remove debris. The resulting phage preparation was placed onto a CsCl step gradient 
composed of 1.3, 1.5, and 1.7 g/mL layers and spun in a 100 Ti rotor (Beckman Coulter, 
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Brea, CA, USA) at 200,480 g for 3 h at 4 °C. Resulting phage bands were collected and 
subjected to dialysis with two changes of Tris-HCl buffer (10 mM, pH 7.5) at 4 °C. 
2.2.5. Transmission electron microscopy  
CsCl purified phages were absorbed onto freshly prepared ultra-thin carbon films.  
Negatively staining of phages CB1, CB3, CB4 involved the use of 2% (w/v) uranyl 
acetate and 1% phosphotungstic acid, for phages CB5 and CB7 the use of 1% (w/v) 
uranyl acetate and for phage CBB the use of 2% (w/v) uranyl acetate. Micrographs 
were taken using a Tecnai 10 transmission electron microscope (FEI Thermo Fisher, 
Eindhoven, the Netherlands) at an acceleration voltage of 80 kV with a MegaView G2 
CCD-camera (EMSIS, Muenster, Germany).  
For transmission electron microscopy of phage Y3, CsCl-purified phages were 
negatively stained with 2% ammonium molybdate and then analysed as previously as 
described (Klumpp et al., 2008). 
2.3. Bacteriophage genome and proteome analysis 
2.3.1. Genomic DNA isolation and restriction digestion 
Genomic DNA was extracted from phages CB1, CB3, CB5, CB7 as previously described 
(Pickard, 2009). CsCl purified phage particles were treated with DNase and RNase, 
followed by treatment with 10% SDS and proteinase K followed by DNA extraction with 
phenol: chloroform: isoamyl alcohol (25:24:1 v/v) and chloroform: isoamyl alcohol 
(24:1 v/v).   
For the extraction of genomic DNA from phage Y3, CsCl-purified phage particles had 
free nucleic acids degraded with treatment of 15 min at 37°C by DNase I (final 
concentration: 1 U/ml) and RNase A (50 µg/ml). Nucleases were inactivated and phage 
capsids degraded 1 h at 56°C with EDTA (20 mM, pH 8.0), proteinase K (50 μg/ml), and 
SDS (0.5% [w/v]). DNA was then purified using a phenol-chloroform extraction 
followed by ethanol precipitation (Sambrook and Russell, 2001e) 
DNA samples were digested with BamHI, Ssp1 and ClaI according to manufacturer’s 
protocols (New England BioLabs, Ipswich, MA, USA). The digested DNA was analysed by 
agarose gel electrophoresis.  
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2.3.2. Genomic DNA sequencing 
Prior to sequencing, DNA quality and quantity were estimated using both a Nanodrop 
(ND-1000, Thermo Fisher, Waltham, MA, USA) and by visualisation after agarose gel 
electrophoresis.  
 
For phages CB1, CB3, CB4 and CB7, genomic sequencing was outsourced to the Centre 
for Genomic Research at the University of Liverpool, UK. Illumina MiSeq system, with a 
TruSeq DNA Nano LT library sample preparation kit for library preparation. Library 
quality was assessed using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, 
CA, USA) and Qubit measurements prior to being sequenced with paired-end reads of 
2 ×250 bp. De novo assembly was conducted using Spades genome assembler v.3.10 
(St. Petersburg, Russia). 
 
The genome of phage CBB was sequenced with a high throughput Illumina MiSeq 
System outsourced at Nucleomics Core (VIB, Belgium). Libraries were processed with a 
custom NEBNext® Ultra™ DNA Kit to generate 500-bp fragments with individual 
barcodes. The quality of each library preparation was controlled using an Agilent 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and Qubit measurements, 
before being pooled together with a non-homologous genome and sequenced with 
2x150 bp paired-end reads. Demultiplex, quality controlled (above Q30) and trimmed 
reads were de novo assembled using CLC Bio Genomics Workbench v7.0 (Aarhus, 
Denmark) into a single contig.  
Genome sequencing of phages CB5 and Y3 was outsourced to GATC Biotech (Konstanz, 
Germany). To conduct sequencing DNA libraries were first created by DNA 
fragmentation, adapter ligation followed by a size selection and amplification. DNA 
libraries were then measured and quantified on a fragment analyser before 
sequencing with 2 x 300 bp paired-end reads using the Illumina Hiseq system (Illumina, 
San Diego, CA, USA). The de novo assembly was performed using default parameters 
with CLC Genomics Workbench v8.0 (Aarhus, Denmark). 
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2.3.3. BAL-31 nuclease treatment of genomic DNA 
A total of 40 μg of phage genomic DNA was digested with BAL-31 (0.5 units per μg) 
(New England BioLabs, Ipswich, MA, USA) at 30°C. Over a series of time intervals, 
aliquots were taken, treated with EGTA for BAL-31 deactivation and then subjected to 
digestion with restriction enzyme BglII at 37°C (New England BioLabs, Ipswich, MA, 
USA) (Klumpp et al., 2008). Resulting genomic DNA was visualised by agarose gel 
electrophoresis. 
2.3.4. Pulsed-field gel electrophoresis 
Pulsed-field gel electrophoresis (PFGE) was conducted as described by Lingohr et al. 
(2009). A CsCl purified phage suspension was mixed with an equal volume of low-
melting-point agarose (Bio-Rad Laboratories, Hercules, CA, USA). Prepared plugs were 
placed in lysis buffer (50mM Tris, 50mM EDTA, 1% SDS) and digested with proteinase K 
for 2 h at 54 ˚C. Plugs were then washed twice with TE buffer (10mM Tris, 1mM EDTA 
[pH8.0]) and subjected to electrophoresis on a 1% agarose gel using Bio-Rad CHEF-DR® 
II PFGE apparatus (Bio-Rad Laboratories, Hercules, CA, USA) at 6V/cm (200V) with 60-
120 switch time ramp for 24 h. Yeast chromosome PFGE markers (Bio-Rad 
Laboratories, Hercules, CA, USA) were used to allow estimation of phage genome size.  
2.3.5. Bioinformatic analysis  
2.3.5.1. Identification of ORFs, tRNA genes, putative protein function, promoters and 
terminators and the creation of circular genomic maps. 
Open reading frames (ORFs) of CB1, CB3, CB4, CB5, CB7 and CBB were predicted with 
GLIMMER (Delcher et al., 1999) and GenmarkS (Besemer et al., 2001). The RAST server 
(http://rast.nmpdr.org/; (Becker et al., 2005))  was employed with GLIMMER (Delcher 
et al., 1999) to predict ORFs of Y3.   
 
Further analysis of predicted ORF gene products was conducted with BLASTP 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins), Pfam 
(http://pfam.xfam.org/search#tabview=tab1; (Finn et al., 2015)), InterProScan 
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998142/;(Mitchell et al., 2014)) and 
HHpred (https://toolkit.tuebingen.mpg.de/#/tools/hhpred; (Söding et al., 2005)).  With 
the detection of ORFs with transmembrane domains and lipoprotein cleavage signal 
49 
 
being identified with the use of TMHMM v.2 
(http://www.cbs.dtu.dk/services/TMHMM/; (Krogh et al., 2001)) and LipoP v.1 
(http://www.cbs.dtu.dk/services/LipoP/; (Juncker et al., 2003)), respectively.  The 
molecular weights of the predicted ORFs were estimated using the batch protein 
molecular weight determination of the sequence manipulation suite 
(http://www.bioinformatics.org/sms2/protein_mw.html). The presence of transfer 
RNA genes was investigated with the use of tRNAscan-SE 
(http://lowelab.ucsc.edu/tRNAscan-SE/; (Lowe and Eddy, 1997)) and ARAGORN 
(http://130.235.46.10/ARAGORN/; (Laslett and Canback, 2004)). Potential Rho-
independent terminators in were identified using ARNold (http://rna.igmors.u-
psud.fr/toolbox/arnold; (Naville et al., 2011)) with Mfold QuikFold 
(http://unafold.rna.albany.edu/?q=DINAMelt/Quickfold; (Zuker, 2003)) using RNA 
energy rules 3.0 to verify predictions, with putative single-stranded hairpin promoters 
identification being assisted with Mfold QuikFold using DNA energy rules. 
 
Putative promotors of phages CB7, CBB and Y3, were determined by the submission of  
100bp of DNA sequence upstream of each gene to MEME (Multiple Em for Motif 
Elicitation) (http://meme-suite.org/tools/meme) (Bailey et al., 2009). Codon usage of 
CBB was analysed using the University of Georgia’s amino acid and codon usage 
statistics services (http://www.cmbl.uga.edu/software/codon_usage.html). Circular 
genome maps of CB7 and Y3 were drawn using GCview   
(http://stothard.afns.ualberta.ca/cgview_server/  ; (Grant and Stothard, 2008)).  
 
2.3.5.2. Comparative genomics of Pectobacterium CB1-like phages  
The linear genomic comparison maps of CB1 and other N4-like phages was created 
with the use of either BLASTN or TBLASTX to determine genome homology and was 
visualised with Easyfig (Sullivan et al., 2011).  Artemis Comparison Tool (ACT) was used 
for the identification of feature variations between the genomes of the CB1-like 
phages, with homology being assessed with BLASTN (Carver et al., 2005). Phylogenetic 
analysis employed the use of the DNA polymerase and vRNA polymerase proteins of 
38 N4-like phages as well as those of CB1-like phages (Appendix, Table S2.2) using 
MEGA7 (Kumar et al., 2016), involving the use of MUSCLE for sequence alignment 
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(Edgar, 2004), with the construction of phylograms using the maximum likelihood (ML) 
method based on the Jones–Thornton–Taylor model (Jones et al., 1992), with the 
robustness of the trees being assessed with bootstrapping (1000). The heat map 
comparing the genomes of 38 N4-like phages and CB1-like phages was generated using 
Gegenees, using accurate parameters (fragment length: 200 bp; step size: 100 bp; 
threshold: 0%) (Ågren et al., 2012). 
 
2.3.5.3. Comparative genomics of Pectobacterium phage CB5 
To determine shared proteins among phiM1-like phage proteomes Coregenes 3.5 
(http://gateway.binf.gmu.edu:8080/CoreGenes3.5/custdata.html; (Turner et al., 
2013)) was used. Translated ORFs from phage φM1 were searched against hidden 
Markov model profiles downloaded from the prokaryotic Virus Orthologous Groups 
(pVOGs) database (PMID: 27789703, (Grazziotin et al., 2017)) using hmmscan (PMID: 
22039361, (Eddy, 2011)) with an E-value cutoff of 1 x 10-3. Matches to pVOG profiles 
were considered significant at an E-value of ≤1 x 10-15 and ≥35% coverage of the profile 
HMM. The linear genomic comparison maps were created with the use of either 
BLASTN or TBLASTX, to determine similarity, and then visualised with Easyfig (Sullivan 
et al., 2011). Phylograms were generated based on the amino acid sequence of the 
major capsid protein of phage CB5 and 52 members of Autographivirinae (Appendix, 
Table S2.3) using MEGA7 (Kumar et al., 2016), applying MUSCLE for sequence 
alignment (Edgar, 2004) with the construction of phylograms using the maximum 
likelihood (ML) method based on the Whelan and Goldman substitution model 
(Whelan and Goldman, 2001), with the robustness of the trees was assessed by 
bootstrapping (1000). VICTOR was employed using all pairwise comparisons of the 
amino acid sequences (same phages as described previously) which employs the 
Genome-BLAST Distance Phylogeny (GBDP) method (Meier-Kolthoff et al., 2013) under 
settings recommended for prokaryotic viruses (Meier-Kolthoff and Göker, 2017). The 
resulting intergenomic distances (including 100 replicates each) were used to infer a 
balanced minimum evolution tree with branch support via FASTME including SPR 
postprocessing (Lefort et al., 2015) for each of the formulas D0, D4 and D6, 
respectively. The trees were rooted at the midpoint (Farris, 1972) and visualised with 
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FigTree (Rambaut, 2006). Taxon boundaries at the species, genus, subfamily and family 
level were estimated with the OPTSIL program (Göker et al., 2009), the recommended 
clustering thresholds (Meier-Kolthoff and Göker, 2017) and an F value (fraction of links 
required for cluster fusion) of 0.5 (Meier-Kolthoff et al., 2014). The heat map 
comparing the genomes of phage CB5 and 31 phages of Autographivirinae was 
generated using Gegenees utilising TBLASTX, using accurate parameters (fragment 
length: 200 bp; step size: 100 bp, threshold set to 5%) (Ågren et al., 2012). Alignment 
of the RNAP proteins for the examination of catalytic active residues and residues of 
the recognition and specificity loop was conducted using MUSCLE on MEGA7. 
2.3.5.4. Comparative genomics of Pectobacterium phage CB7 
To determine shared proteins among phage proteomes of Cr3virus Coregenes 3.5 
(http://gateway.binf.gmu.edu:8080/CoreGenes3.5/custdata.html; (Turner et al., 
2013)) was used. The linear genomic comparison maps were created with the use of 
either BLASTN or TBLASTX, to determine homology, and then visualised with Easyfig 
(Sullivan et al., 2011). Artemis Comparison Tool (ACT) was used for identification of 
feature variations between phage genomes of Vequintavirinae, with homology being 
assessed with TBLASTX (Carver et al., 2005). Phylograms were generated based on the 
amino acid sequence of the major capsid protein, larger terminase and DNA 
polymerase of phage CB7 and 17 members of Vequintavirinae were created using 
MEGA7 (Kumar et al., 2016), applying MUSCLE for sequence alignment (Edgar, 2004) 
with the construction of phylograms using the maximum likelihood (ML) method based 
on the Whelan and Goldman substitution model (Whelan and Goldman, 2001), with 
the robustness of the trees was assessed by bootstrapping (1000). VICTOR was 
employed using all pairwise comparisons of the amino acid sequences (same phages as 
described previously) which employs the Genome-BLAST Distance Phylogeny (GBDP) 
method (Meier-Kolthoff et al., 2013) under settings recommended for prokaryotic 
viruses (Meier-Kolthoff and Göker, 2017). The resulting intergenomic distances 
(including 100 replicates each) were used to infer a balanced minimum evolution tree 
with branch support via FASTME including SPR postprocessing (Lefort et al., 2015) for 
each of the formulas D0, D4 and D6, respectively. The trees were rooted at the 
midpoint (Farris, 1972) and visualised with FigTree (Rambaut, 2006). Taxon boundaries 
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at the species, genus, subfamily and family level were estimated with the OPTSIL 
program (Göker et al., 2009), the recommended clustering thresholds (Meier-Kolthoff 
and Göker, 2017) and an F value (fraction of links required for cluster fusion) of 0.5 
(Meier-Kolthoff et al., 2014). The heat map comparing the genomes of phage CB7 and 
17 members of Vequintavirinae was generated using Gegenees utilising TBLASTX, using 
accurate parameters (fragment length: 200 bp; step size: 100 bp, threshold set to 0%) 
Ågren et al., 2012). 
2.3.5.5. Comparative genomics of Pectobacterium phage CBB 
Coregenes (Turner et al., 2013) was used for total proteome comparisons between 
phages, with the BLASTP threshold set at 75% (excluding phage CBB terminal repeat 
ORFs CBB_555 to CBB_605). Genome comparison of the Rak2-like phages was 
visualised using Easyfig (Sullivan et al., 2011) with comparison of genome sequences 
facilitated by TBLASTX (excluding  phage CBB terminal repeat ORFs CBB_555 to 
CBB_605 of CBB) and reorientation of genomes such that the largest ORF was set to 
the first position to improve visual understanding (as starting point among Genbank 
files was not uniform). Phylograms were generated using MEGA7 (Kumar et al., 2016) 
involving the use of MUSCLE for sequence alignment (Edgar, 2004), with the 
construction of phylograms using the maximum likelihood (ML) method based on the 
Jones–Thornton–Taylor model (Jones et al., 1992). Analysis using the portal vertex 
protein of phage CBB was conducted as described previously (Brewer et al., 2014). The 
full-length protein was used in the BLASTP search to find phages with homologous 
portal proteins. A conserved internal region from 100 different portal vertex proteins 
from different phages was then extracted and aligned with MUSCLE. The resulting 
alignment was then used to create a phylogram based on the Maximum likelihood 
method (Jones et al., 1992), with the robustness of the trees being  assessed by 
bootstrapping (100) 
2.3.5.6. Comparative genomics of Erwinia phage Y3 
Genome comparisons between phages were performed using TBLASTX and visualised 
using Easyfig (Sullivan et al., 2011). Multiple sequence alignments were created with 
MEGA7 (Kumar et al., 2016) using MUSCLE. Phylograms were constructed using the 
portal vertex (Y3_003), large terminase (Y3_004), DNA polymerase (Y3_173) and ATP 
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dependent DNA helicase (Y3_176) among phages possessing homology to ΦRSL1, with 
the large terminase and portal vertex protein being used among jumbo myoviruses of 
E. amylovora. To estimate the robustness of the phylograms, the maximum-likelihood 
algorithm (Jones et al., 1992) based on the Whelan and Goldman substitution model 
(Whelan and Goldman, 2001), was conducted with bootstrap support (1000).  A total 
proteome comparison between phages was conducted using Coregenes 3.5 with the 
BLASTP threshold set at 75% 
(http://gateway.binf.gmu.edu:8080/CoreGenes3.5/custdata.html; (Turner et al., 
2013)).  
2.3.6. Bacteriophage virion ESI-MS/MS proteome analysis 
Phage capsid proteins were extracted from high titre CsCl purified phage (>1x109 
PFU/mL) using chloroform:methanol extraction (1:1:0.75, v/v/v). The resulting protein 
pellet was resuspended in loading buffer (1% SDS, 6% sucrose, 100 mM dithiothreitol, 
10 mM Tris pH 6.8, 0.0625% w/v bromophenol blue) and heated to 95˚C for 5 min to 
resuspend the pellet. This was subsequently loaded onto a 12% SDS-PAGE gel after 
which gel electrophoresis was conducted. The resulting gel was then stained using 
Gelcode™ Blue Safe Protein Stain (Thermo Scientific, Waltham, MA, USA) to visualise 
virion proteins. Gel fragments were extracted and subjected to trypsinisation which 
were analysed using tandem electrospray ionisation-mass spectrometry (ESI-MS/MS) 
exactly as described previously (Van den Bossche et al., 2014).  
2.3.7. Determination of HNH endonuclease splicing 
A similar approach was taken as previously described (Ceyssens et al., 2008; Landthaler 
et al., 2002). Freshly grown host bacteria (strain DSM 30186) at an OD600 of 0.20-0.23 
was infected with phage at an MOI of 5x10-4, in the same manner as described for 
single-step growth curve assay as previously described (as described in section 2.2.2.). 
At 15 min, 30 min and 45 min, 1 mL of infected cells were pelleted and then 
resuspended in phosphate buffer saline (PBS). Total RNA was then extracted using the 
High Pure RNA Roche extraction kit (Roche, Basel, Switzerland) and subsequently 
reverse transcription PCR (RT-PCR) was performed using the cDNA synthesis kit 
(Bioline, London, UK) according to manufactures protocol. PCRs were performed to 
amplify products using primers specific to regions situated at 5’ and 3’ ends of HNH 
54 
 
endonucleases being examined (Table 2.1), using RedTaq Readymix (Sigma-Aldrich, St. 
Louis, MO, USA) with cDNA and a control using CB7 genomic DNA. These products 
were then inspected by agarose gel electrophoresis and Sanger sequencing for the 
presence of splicing.  
 
Table 2.1. Primers used for the creation of PCR products from cDNA and genome DNA of 
Pectobacterium phage CB7 for the examination of HNH endonuclease splicing.  
HNHs being examined Primer name Primer sequence 5'-3' 
CB7_2 
CB7_F CGTTGCTTCAGTTCTTCC 
CB7_R ATCGTAGACGATCCACG 
CB7_50 and CB7_52 
CB7_50-52F ACGACTACGTATTGACG 
CB7_50-52R CCTTCCATGACCATACC 
CB7_54 
CB7_54F CGACACAGCGACTTATCC 
CB7_54R GACATTGACAGAGTGTCG 
CB7_196 
CB7_196F CAACATCAACGCACTGG 
CB7_196R TTCAGCCGACATAGAGG 
CB7_202 
CB7_202F CAAGGTAAGTATGCTGC 
CB7_202R TTCTTCGCCACAGAAGG 
CB7_245 
CB7_245F CGCAGATGATGTCTTCC 
CB7_245R AACATTGTGAGCATTACC 
 
2.3.8. Accession number of phage genomes 
All phage genomes examined in this thesis were submitted to Genbank (Table 2.2). 
Table 2.2. Genbank accession number of phages genomes  
Phage Genbank accession no. 
Pectobacterium phage vB_PatP_CB1 KY514264 
Pectobacterium phage vB_PatP_CB3 KY514265 
Pectobacterium phage vB_PatP_CB4 KY549659 
Pectobacterium phage vB_PatP_CB5 KY953156 
Pectobacterium phage vB_PatM_CB7 KY514263 
Pectobacterium phage vB_PccM_CBB KU574722 
Erwinia phage vB_EaM_Y3 KY984068 
 
55 
 
2.4. Cloning, recombinant protein expression and purification 
2.4.1. Cloning of putative peptidoglycan degrading proteins of Pectobacterium phage 
CBB and Erwinia phage Y3 
For the cloning of protein CBB_187, its gene was amplified using forward primer 
CBB_187-PciI and reverse primer CBB_187-XhoI. The truncated version of CBB_187, 
namely rTM-CBB_187 without the transmembrane domain, was amplified using 
forward primer rTM-CBB_187 and the reverse primer CBB_187-XhoI (Table 2.3).  For 
the cloning of protein CBB_239, its gene was amplified using forward primer CBB_239-
PciI and reverse primer CBB_239-XhoI (Table 2.3). All PCR reactions were conducted 
using Velocity DNA polymerase (Bioline, London, UK), using CBB genomic DNA as a 
template. Resulting PCR products were digested (NcoI and XhoI) and ligated in-frame 
into vector pET28a, in a manner that would allow Induced proteins to possess a 6 x 
Histidine tag at the N-terminus. The pET28a vector with the insert of CBB_187 and the 
transmembrane tunicated version of this  protein (rTM-CBB_187 ) were chemically 
transformed into E.coli Lemo21 (DE3) (New England Biolabs, Ipswich, MA, USA ), while 
the insert of the CBB_239, in pET28a, was transformed into E.coli BL21 (DE3) (New 
England Biolabs, Ipswich, Massachusetts), following the manufacturer's  standard 
protocol.   
For the cloning of protein Y3_301, its gene was amplified using forward primer 
Y3_301-PciI and reverse primer Y3_301-Xho1. The truncated version of Y3_301, 
namely rTM-Y3_301 without the transmembrane domain was amplified using forward 
primer rTM-Y3_301-PciI and the above reverse primer Y3_301-XhoI (Table 2.3). All 
amplifications were conducted with High Fidelity PCR Master mix (Roche, Basel, 
Switzerland) using genomic DNA as a template. The resulting PCR product was digested 
and ligated in-frame into vector pET28a, with the resulting construct transformed in E. 
coli Lemo21 (DE3) (Schlegel et al., 2012), following the manufacturer’s standard 
protocol (New England Biolabs, Ipswich, MA, USA).  
DNA sequencing was performed on purified plasmid to ensure the integrity of all 
constructs.  
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Table 2.3. List of primers used for the cloning of CBB_187/ rTM-CBB_187, CBB239 and 
Y3_301/rTM-Y3_301. Primer overhangs, restriction sites and coding sequences are indicated 
by uppercase, underlined and lowercase letters, respectively. 
Product Primer 
name 
Primer sequence 5’-3’ Restriction 
enyzme 
CBB_187 CBB_187-
PciI 
CATACAtgtataaagcgatacaagaactc PciI 
CBB_187-
XhoI 
AAGCTTCTCGAGaagactactcaataataagtcaacacg XhoI 
rTM-
CBB_187 
rTM-
CBB_187-
Pci1 
CATACATGtcacatgatcgtactacatcattagt PciI 
CBB_239 CBB_239-
BspH1 
CATCatgagcaattgggttttaac BspHI 
CBB_239-
Xho1 
AAGCTTCTCGAGtagagattctacaatacgtgc XhoI 
Y3_301 Y3_301-PciI CATACatgttagttatcatcaacaatcg PciI 
Y3_301-
XhoI 
AAGCTTctcgagggaagaaggagtatgct XhoI 
rTM-
Y3_301 
rTM-
Y3_301-PciI 
CATACATgttacgcatttcgccgtc PciI 
 
2.4.2. Overexpression of protein CBB_239 
Recombinant CBB_239 was overexpressed in the pET28a/E.coli BL21 (DE3) expression 
system by growing in LB broth containing kanamycin (40 µg/mL) with a 1% inoculum of 
an overnight culture. This culture was incubated at 30 ᵒC (150 rpm.) to an optical 
density (600nm) of 0.2-0.4, after which the culture was induced with IPTG (400 μM) 
and incubation at 30°C for a further 4 h. Cells were harvested by centrifugation (14,534 
g for 20 min) and the resulting cell pellet was resuspended in a buffer of 20mM sodium 
phosphate (pH7.4), 0.5 M NaCl, 40 mM imidazole. At this point in the procedure cells 
could be stored at -80ᵒC or lysed using Bugbuster lysis mastermix reagent (Merck 
Millipore, Billerica, MA, USA) with agitation at 120 rpm. at room temperature for 20 
min. Soluble and insoluble protein fractions were separated by centrifugation at 7,085 
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g for 20 min. Protein fractions were examined by using SDS-PAGE (Sambrook et al., 
2001).  
2.4.3. Purification and quantification of protein CBB_239 
The soluble fraction of lysate was applied to an ÄKTA pure chromatography system (GE 
Healthcare, Little Chalfont, UK) using a sample pump S9-S (GE Healthcare, Little 
Chalfont, UK). A Histrap FastFlow crude 1 mL column (GE Healthcare, Little Chalfont, 
UK) was used for selective protein binding, using a running buffer of 10mM sodium 
phosphate (pH 7.4), 0.5M NaCl, 20 mM imidazole and an elution buffer of 10mM 
sodium phosphate (pH 7.4), 0.5M NaCl, 500 mM imidazole. Factions that contained the 
purified protein of interest were pooled and desalted by loading onto a 5 mL HiTrap 
desalting column (GE Healthcare, Little Chalfont, UK) using a desalting buffer of 10mM 
sodium phosphate (pH 7.4), 150 mM NaCl. The resulted purified protein was quantified 
using a Pierce BCA protein assay kit (Thermo Scientific, Waltham, MA, USA) following 
the manufacturer's standard protocols  
2.5. Lytic activity tests 
2.5.1. Demonstrate signal-arrest-release (SAR) activity  
SAR endolysin activity of CBB187/rTM-CBB_187 or Y3_301/rTM-Y3_301 in pET28a/E. 
coli Lemo21 (DE3) expression system was determined by using 40mL liquid cultures 
(triplicate) in LB both using selective markers kanamycin (40 µg/mL) and 
chloramphenicol (40 μg/mL) with 1% inoculum of an overnight culture.  Cultures were 
agitated (150 rpm) at 30 ᵒC with the optical density (600nm) being measured at 1 h 
intervals. At hour 4 (OD600~0.4) half the cultures were induced with IPTG (400 μM) and 
readings were continued up to hour 8. Averages and standard deviations were 
determined using Microsoft Excel. 
2.5.2. Zymogram analysis  
The assay involved the preparation of a 12% SDS-PAGE gel but with the addition of 
autoclaved bacterial cells to the separation gel. A purified putative peptidoglycan 
degrading protein sample was mixed with an equal volume of protein gel loading dye 
(1% [w/v]SDS, 6% [w/v] sucrose, 100 mM 1,4 dithiothreitol, 10 mM Tris-HCl pH6.8, 
0.0625% [w/v] bromophenol blue), this was then heated to 95ᵒC for 5 min, after which 
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the sample was applied to the gel and put running at 200 V for 40 – 60 min. The gel 
was then soaked in distilled water at room temperature with gentle agitation for 30-60 
min before being transferred into renaturation buffer (25mM Tris-HCl, pH 8.0, 1% 
Triton X100). This was then again incubated at room temperature with gentle 
agitation, after 15 min the gel was checked every five min for the presence of clearing.  
2.5.3. Turbidity reduction assay  
Turbidity reduction assay was conducted as previously described by Lavigne et al 
(2004). Briefly, P. carotovorum subsp. carotovorum BL19-1-37 was grown to an OD600nm 
of 0.6 which was pelleted by centrifugation at 7,085 g for 10 min. The resulting pellet 
was resuspended in chloroform-saturated 50 mM Tris-HCl (pH 8), incubated at room 
temperature and agitated at 200 rpm for 45 min. Cells were then again pelleted and 
washed twice with and resuspended in 50 mM Tris-HCl (pH 8) to a final OD600nm of 0.1. 
Fifty microliters of purified protein were added to 150 μL of treated cells in triplicate. 
For a negative control 50 uL of a buffer of 10mM sodium phosphate (pH 7.4), 150 mM 
NaCl was added to 150 μL of treated cells. The OD600nm was then read every min for 10 
min. 
2.6. Assessing biocontrol potential 
2.6.1. Tuber rot assay to determine biocontrol potential of CB1, CB3 and CB4 mixture 
The potato whole tuber rot assay was used to assess the potential of a phage mixture 
comprised of phages CB1, CB3 and CB4 to prevent infection of potato tissue by P. 
atrosepticum and was conducted in a similar manner as previously described 
(Czajkowski et al., 2015). The phage mixture was made by adding an equal number of 
phages to a total titre approx. 1x107 PFU/mL to SM buffer. P. atrosepticum strains, 
DSM 18077 and DSM 30186, were resuspended in deionised water with cell numbers 
of approx. 1x107 CFU/mL and mixed in equal quantities. Ware potato tubers were 
obtained at a local supermarket, these were first washed with tap water, then surface 
sterilised for 10 min in 70% isopropanol, then again washed with tap water and 
allowed to dry on tissue paper at room temperature.  
Whole tuber assay involved tubers being incised at the rose end (opposite the stolon 
end) to remove a 0.5 cm transverse slice. To which 100 µL of either bacteria or water 
was added, left to absorb and then followed with the addition of 100 µL of SM buffer 
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or phage mixture. These were then allowed 30 min to sit at room temperature before 
the detached potato slices were reattached using sterile toothpicks to tubers. Tubers 
were then incubated or 72 hrs at 25ᵒC in a humid box.  To assess the protective effect 
of the phage mixture the weight of rotten tissue was determined for each tuber. 
 
2.6.2. Statistical analysis of data from tuber rot assay 
Figure 3.7 was generated with Excel. Statistical analysis was performed with IBM SPSS 
Software (version 24). Normality of data was assessed with the Shapiro-Wilks test at a 
significance level of 0.05. Non-parametric tests were chosen for data not normally 
distributed. Comparison of the weight of soft rot tissue of infected potatoes, phage 
treated and untreated, were performed with the Mann-Withney U test. 
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Chapter 3. Novel N4-like bacteriophage of 
Pectobacterium atrosepticum 
 
A manuscript based upon this chapter has been published in Pharmaceuticals. 
Buttimer, C., Hendrix, H., Lucid, A., Neve, H., Noben, J.-P., Franz, C., O’Mahony, J., 
Lavigne, R., Coffey, A. (2018). Novel N4-like bacteriophages of Pectobacterium 
atrosepticum. Pharmaceuticals 11. https://doi.org/10.3390/ph11020045 
 
Transmission electron microscopy was conducted by Horst Neve. 
Mass spectrometry analysis of phage virion proteins was conducted by Hanne Hendrix. 
Genome sequencing of CB1-like phages was outsourced to the University of Liverpool, 
UK. 
Statistical analysis of the biocontrol experiment was assisted by Kate Hayes. 
MALDI-TOF analysis was assisted by Monika Koziel. 
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3.1. Introduction 
The genera of Pectobacterium and Dickeya, often referred to collectively as the soft rot 
Enterobacteriaceae (SRE), are phytopathogens that cause economically important 
losses in a wide range of arable and ornamental crops. These bacteria are all Gram-
negative, non-spore forming, facultative anaerobic rods that are typified by the 
production of extracellular pectinolytic enzymes during plant infection (Pérombelon, 
2002; Toth et al., 2011). Both genera are considered to be among the top ten most 
important plant pathogens (Mansfield et al., 2012). To date, the predominant SRE 
species and subspecies which cause blackleg and soft rot of the potato crop in Europe 
are Pectobacterium atrosepticum, Pectobacterium carotovorum subsp. carotovorum, 
Pectobacterium parmentieri (formally Pectobacterium wasabiae), Dickeya dianthicola 
and Dickeya solani (Khayi et al., 2016; Toth et al., 2011; van der Wolf et al., 2017; 
Waleron et al., 2013). P. atrosepticum is traditionally believed to be one of the more 
important causative agents for blackleg in temperate climates (Toth et al., 2003), and 
the dominant blackleg causative agent in Scotland (van der Wolf et al., 2017). 
Strategies for the control of potato soft rot and blackleg are limited, whether they be 
physical, chemical or biological. In addition, no blackleg resistant potato cultivars are 
available. The current approach to disease control is the use of cultivation practices to 
minimise levels of infection, including contamination avoidance and the removal of 
diseased plants and/or tissue. Seed certification schemes are also employed. However, 
the success of these schemes vary and are highly weather dependent (Czajkowski et 
al., 2011; De Boer, 2004).  
Phages, the viruses of bacteria, are being investigated as a potential biocontrol 
strategy for many problematic bacteria, including phytopathogens. Indeed, phages of 
Erwinia amylovora, Xanthomonas campestris pv. vesicatoria, Agrobacterium 
tumefaciens and many others have been investigated for their disease control 
potential (Buttimer et al., 2017b; Frampton et al., 2012).  In addition, a number of SRE 
phages have also been recently isolated and characterized (Czajkowski, 2016), some of 
these having also been assessed for their potential as biocontrol agents of their 
respective phytopathogenic hosts with promising results.  
Proof of concept experiments using SRE phages on potato whole tubers has 
demonstrated that phage biocontrol has the capability to inhibit soft rot caused by P. 
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carotovorum subsp. carotovorum, P. parmentieri and D. solani (Adriaenssens et al., 
2012b; Czajkowski et al., 2015; Smolarska et al., 2018).  A field trial was conducted by 
Adriaenssens et al. (2012) using phage vB_DsoM_LIMEstone1 against D. solani and 
showed that phage treatment against blackleg resulted in decreased disease severity 
and improved yields.  However, SRE species causing disease that were not sensitive to 
the phage limited the success of the overall outcome. Investigation of phage biocontrol 
of SRE also has not been limited to the potato. Phage biocontrol was shown, for 
example, to reduce the incidence of soft rot by 50% on tuber plugs of Calla lily due to 
P. carotovorum subsp. carotovorum infection in greenhouse trials (Ravensdale et al., 
2010). Promising results were also demonstrated using phage against this species 
infecting Chinese cabbage (Lim et al., 2013).   
We here report the isolation and characterisation of P. atrosepticum phages 
vB_PatP_CB1, vB_PatP_CB3 and vB_PatP_CB4. To the author's knowledge, this is the 
first report of N4-like phages to be identified infecting bacteria belonging to SRE. 
Escherichia phage N4 is a lytic podovirus, which was isolated in the 1960s from sewers 
in Genoa, Italy (Molina et al., 1965). The phage is typified by the possession of a virion-
associated RNA (vRNA) polymerase, which it injects along with its genome into its host 
Escherichia coli at the beginning of infection to initiate transcription of its DNA and an 
overall conserved transcriptional scheme (Glucksmann et al., 1992). To date, Genbank 
contains at least 56 genome sequences of N4-like phages infecting hosts belonging to 
the classes of Alpha-, Beta- and Gamma-proteobacteria, with each phage genome 
encoding the hallmark feature of a vRNA polymerase. Six phage genera have been 
defined among these so far, these being G7cvirus, Lit1virus, Ea92virus, Luz7virus and 
N4virus (Adriaenssens et al., 2017; Wittmann et al., 2016b, 2016a, 2015) with another 
two genera (Sp58virus and Dss3virus) having been proposed (Wittmann et al., 2015). 
Furthermore, using these newly isolated N4-like phages, we demonstrated their 
potential for biocontrol with the suppression of soft rot formation with their co-
inoculation with P. atrosepticum on potato tubers. 
 
63 
 
3.2. Results 
3.2.1. Isolation of SRE from potato crops symptomatic of blackleg 
In 2013, nineteen potato stem samples symptomatic for blackleg, each representing a 
crop, were collected from three distinct farms in Co. Cork, Ireland. Isolate identification 
was based on cavity formation on crystal violet pectate (CVP) medium, production of 
reducing substances from sucrose, acid production from α-methyl-glucoside, 
Pectobacterium genus-specific along with P. atrosepticum and P. carotovorum subsp. 
carotovorum species-specific PCRs and MALDI-TOF mass spectrometry. Based on these 
results, fourteen plants were found to be infected with P. atrosepticum with a 
remaining plant found to be infected with both P. atrosepticum and P. carotovorum 
subsp. carotovorum (Appendix, Table S3.1).  
 
3.2.2. Isolation of bacteriophages, host range and general characteristics 
Thirteen phage isolates were obtained from soil samples that were collected from 
potato grading machinery and potato fields from two of the three farms mentioned 
above. These were subjected to genomic DNA comparison. Restriction digestion 
analysis, employing BamH1, allowed the identification of ten isolates that produced 
three similar band patterns (Figure 3.1). Phages producing these patterns were found 
in both the grading machinery and the field soils. An example of each was taken for 
further study, namely CB1, CB3 and CB4. These isolates produced clear plaques with an 
approximate diameter of 2-3 mm (overlay concentration 0.4% w/v agar in LB) on their 
respective host strains of P. atrosepticum, with narrow halos occasionally being 
observed to be surrounding plaques.  
The host ranges of these phages were examined using 31 bacterial strains (local Irish 
isolates and reference strains) from five different species belonging to SRE, namely P. 
atrosepticum (19 strains), P. carotovorum subsp. carotovorum (4 strains), D. 
chrysanthemi bv. chrysanthemi (1 strain), D. dianthicola (3 strains) and D. solani (4 
strains). These phages were able to form plaques on 15 strains of their host species, P. 
atrosepticum, with no plaque formation or inhibition of growth being observed on the 
other species. Slight variations in lytic ability were found among the three phages, with 
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CB1 and CB3 determined to form plaques on 12 strains, while CB4 was only found to 
infect 10 of the 19 strains tested (Table 3.1).  
 
 
Figure 3.1. Genomic DNA of Pectobacterium phages CB1, CB3 and CB4, BamHI-digested 
(lane 3, 5 and 7, respectively) and undigested (lane 2, 4 and 6, respectively). Lane 1; DNA 
marker (Hyperladder 1kb, Bioline).  Gel concentration 1 % w/v agarose. 
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Table 3.1. Host range of Pectobacterium phages CB1, CB3 and CB4 on 31 strains of various 
members of the soft rot Enterobacteriaceae determined by spot testing with serial 
dilutions of phage suspensions. The efficiency of plating (EOP) values were determined for 
sensitive strains. Results recorded as −, no infection; CS, the presence of clear spot with 
no plaque formation; number, EOP value; *, host strain of phage. EOP values determined 
by spot testing in triplicate. 
Bacteria Bacteriophage infection 
Species Strain CB1 CB3 CB4 
Pectobacterium atrosepticum DSMZ  18077 (type strain) 1.000* 2.263 0.909 
DSMZ 30184 2.00E-05 CS CS 
DSMZ 30185 0.371 0.126 0.136 
DSMZ 30186 0.003 1.000* 1.000* 
CB BL1-1 CS CS CS 
CB BL2-1 0.571 0.737 0.336 
CB BL3-1 0.529 0.605 0.218 
CB BL4-1 0.571 0.789 0.245 
CB BL5-1 CS 0.158 CS 
CB BL7-1 CS CS CS 
CB BL9-1 0.027 0.007 0.164 
CB BL11-1 CS 0.279 0.127 
CB BL12-2 2.86E-06 0.079 0.255 
CB BL13-1 1.71E-05 0.063 0.436 
CB BL14-1 CS CS CS 
CB BL15-1 - - - 
CB BL16-1 0.005 CS CS 
CB BL18-1 CS 0.037 CS 
CB BL19-1 0.005 CS CS 
Pectobacterium carotovorum 
subsp. carotovorum 
DSMZ 30168 (type strain) - - - 
DSMZ 30169 - - - 
DSMZ 30170 - - - 
CB BL19-1-37 - - - 
Dickeya chrysanthemi bv 
chrysanthemi 
LMG 2804 - - - 
Dickeya dianthicola PD 482  - - - 
PD 2174   - - - 
GBBC 1538 - - - 
Dickeya solani sp. PRI 2222  - - - 
LMG 25865  - - - 
GBBC 1502 - - - 
GBBC 1586  - - - 
 
 
Examination of the morphology of the three phages by transmission electron 
microscopy showed that they can be classified as members of the Podoviridae family 
(Ackermann, 2001). They featured a C1 morphotype with isometric capsids (ca. 70 nm) 
and short non-contractile tails (length: ca. 25 nm) (Figure 3.2, Table 3.2). Head and tail 
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measurements are consistent with previously reported N4-like phages (Wittmann et 
al., 2015). Additionally, a set of (putatively six) short whiskers (length: ca. 25 nm) 
attached to a collar structure (width: ca. 19 nm) were observed.  At their distal ends, 
the whiskers terminate with elongated globular appendices (ca. 12 nm x 7 nm). 
(Wittmann et al., 2015). The three phages were named in accordance with the 
nomenclature set out by Kropinski et al. (2009).  
 
Figure 3.2. Transmission electron micrographs of negatively stained Pectobacterium 
phages CB1, CB3 and CB4 using 2% (w/v) uranyl acetate (top) and 1% (w/v) 
phosphotungstic acid (bottom). 
Table 3.2. Dimensions of Pectobacterium phage CB1, CB3 and CB4 negatively stained with 
2% (w/v) uranyl acetate (head sizes) or with 1% phosphotungstic acid (all other 
measurements). *Whisker length from collar to distal end of the whisker ball. 
 Head 
(nm) 
Tail length 
(nm) 
Collar 
width (nm) 
Whisker 
length* (nm) 
Whisker ball 
length (nm) 
Whisker ball 
width (nm) 
CB1 67.8±4.4 
(n=19) 
23.9±1.7 
(n=8) 
18.5±1.3 
(n=8) 
23.4±3.0 
(n=14) 
12.3±1.4 
(n=16) 
6.3±0.7 
(n=17) 
CB3 71.8±1.7 
(n=6) 
25.8±2.3 
(n=8) 
19.6±0.8 
(n=7) 
25.6±1.7 
(n=7) 
12.0±1.5 
(n=9) 
7.4±0.9 
(n=9) 
CB4 70.4±2.5 
(n=12) 
25.5±1.0 
(n=5) 
19.3±0.8 
(n=6) 
23.5±1.6 
(n=3) 
11.8±0.9 
(n=5) 
6.6±0.6 
(n=5) 
 
 
The one-step-growth curve assay, under standard conditions using LB medium, 
showed that the latent period of CB1 was 60 min with an approximate burst size of 
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207 plaque forming units (PFU)/cell. For CB3, a latent period of 65 min with an 
approximate burst size of 246 PFU/cell observed. For CB4, a latent period of 65 min 
with an approximate burst size of 158 PFU/cell observed (Appendix, Figure S3.1). 
Phage viability under different environmental conditions was also examined. Over a 
duration of one hour all phages were found to be stable between -18°C and 50 °C. 
They were also found to be stable between pH 5 and 11 for 24 hrs (Appendix, Figure 
S3.2, S3.3). 
 
3.2.3. Genome and proteome analysis 
3.2.3.1. Genomes of phages CB1, CB3 and CB4 show an N4virus organisation 
The genome sequences obtained for phages CB1, CB3 and CB4 were 75,394 bp, 75,522 
bp and 75,973 bp with coverage of 2057x, 1882x and 1765x, respectively. The 
genomes of these phages are likely linear with direct terminal repeats (DTRs) with 
estimated sizes of 647 bp (for CB1 and CB3) and 648 bp (for CB4). This estimation is 
based on the identification of a localised region with roughly double the read depth in 
comparison to average read depth across the whole genome of each phage, a similar 
finding to previously reported N4-like phages (Fouts et al., 2013; Li et al., 2014). 
However, it is noteworthy that termini at the ends of the DTRs for these phages can be 
asymmetric, as seen in the case of Escherichia phage N4 itself (Ohmori et al., 1988). It 
is not known whether DTR asymmetry exists in phages CB1, CB3 and CB4. As well as 
this, the average GC content of these genomes was found to be 49%, just below the GC 
content associated with the host bacterium P. atrosepticum at 50-51%  (Bell et al., 
2004; Nikolaichik et al., 2014).  
The number of predicted open reading frames (ORFs) determined on the non-
redundant genome of these phages were 97, 102 and 100 for CB1, CB3 and CB4, 
respectively (Appendix, Table S3.2, S3.3, S3.4). Proteins predicted to play roles in 
transcription, DNA replication, virion morphogenesis and host lysis were identified in 
all three phages as well as putative genes for homing endonucleases (Figure 3.3). No 
integrase, excisionase or repressor genes were detected suggesting that all three 
phages have an exclusively lytic lifecycle. Moreover, no ORFs were identified for 
pathogenicity or known toxins. 
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Figure 3.3. Comparison of the genomes of Pectobacterium phages CB1, CB3 and CB4 
employing BLASTN and visualised with Easyfig. Genome maps comprise of arrows 
indicating locations of ORFs among the different phage genomes. Arrows have been 
colour-coded describing their predicted roles (see key), and lines between genome maps 
indicate levels of homology. 
Phages CB3 and CB4 exhibited a 97% genome-wide nucleotide identity (BLASTN 
algorithm) and can thus be considered different isolates of the same phage species 
(Adriaenssens and Brister, 2017). The major feature variations found between them 
being their ORFs for thymidylate synthase and N4 gp32-like protein (Appendix, Table 
S3.5). The only major difference identified with host range between these phages was 
the ability of CB3 to infect two extra P. atrosepticum strains (CB BL5-1 and CB BL18-1) 
(Table 3.1). In addition, phage CB4 also possessed two genes for tRNAs (for asparagine 
& glutamine). In contrast, phage CB1 was only 95% similar to CB3 and 93% similar to 
CB4. This places CB1 on the boundary of speciation with the other two phages. CB1 
possesses the same predicted thymidylate synthase gene and has no tRNA genes like 
CB3. However, the predicted early gene region possesses variations in its ORF content 
not shared with CB3 and CB4. These differences include the presence of different 
hypothetical proteins and the presence of two additional HNH endonucleases. There is 
also a notable sequence variation of the rIIB protein of CB1 to that of the other two 
phages. Interestingly, CB1 shares its N4 gp32-like gene with CB4 (Appendix, Table 
S3.5).  
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The overall genomic architecture of the CB1-like phages resembles those belonging to 
the N4-like group (Figure 3.4), possessing all 18 core proteins of these phages 
identified by Li et al (Li et al., 2016) (Appendix, Table S3.6), thus allowing the N4-like 
designation. When comparing these phages to Escherichia phage N4, the gene order of 
most structural proteins is well conserved with major variations associated with the 
genes involved in host lysis and genes for structural proteins believed to play roles in 
tail morphogenesis. This observation has been noted among other N4-like phages 
(Ceyssens et al., 2010; Kulikov et al., 2012). These phages do not fall within any genera 
currently defined in the N4-like group to date. Phylograms based on the vRNA and 
DNA polymerase proteins show that they form their own distinct clade among these 
phages (Figure 3.5), with their closest evolutionary relationship appearing to be with 
the phages of the genera of Lit1virus and Luz7virus. Additionally, when protein 
homology was calculated with Gegenees analysis (TBLASTX), they show limited identity 
to other N4-like members (Figure 3.6).  
 
Figure 3.4. Comparison of the genomes of Pectobacterium phage CB1 with those phages 
representing the genera of N4virus, G7cvirus, Ea92virus, Lit1virus and Luz7virus employing 
TBLASTX and visualised with Easyfig. Genome maps comprise of arrows indicating 
locations of genes on the different phage genomes, and lines between genome maps 
indicate the level of homology. 
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Figure 3.5. Phylogenetic analysis using the (A) DNA polymerase (log likelihood = -
16535.57) and (B) vRNA polymerase (log likelihood = -103761.67) protein sequences of 
Pectobacterium phages CB1, CB3 and CB4 and 38 other N4-like phages. Phages belonging 
to the genera of G7cvirus, Lit1virus, Ea92virus, Luz7virus and N4virus and proposed 
genera Sp58virus and Dss3virus are highlighted. The amino acid sequences were 
compared using MUSCLE. The tree was constructed using the maximum likelihood 
algorithm. The percentages of replicate trees were assessed with the bootstrap test 
(1000). 
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Figure 3.6 TBLASTX heat map generated using Gegenees with accurate parameters – fragment length: 200 bp; and step size: 100 bp; threshold: 
0%. The map includes the genomes of 38 N4-like phages with phages representing the genera G7cvirus (red), Lit1virus (brown), Ea92virus (green), 
Luz7virus (pink) and N4virus (yellow) and proposed genera Sp58virus (orange) and Dss3virus (grey), with the Pectobacterium phages CB1, CB3 
and CB4 coded in blue. 
Organism 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41
1: Ea9-2 100 90 86 31 31 31 32 32 31 31 31 25 20 22 22 22 19 19 19 19 18 18 18 18 18 18 23 23 21 22 21 22 22 20 20 20 20 20 21 21 21
2: Rexella 90 100 91 31 31 31 32 32 31 31 31 25 20 22 23 22 19 19 19 19 18 18 18 18 18 18 23 23 21 22 21 22 22 20 20 20 20 20 21 21 21
3: vB_EamP_Gutmeister 91 96 100 32 32 32 33 33 32 32 32 25 20 22 23 23 19 19 19 19 19 18 18 18 18 18 23 23 22 22 22 22 22 20 20 20 20 20 21 21 21
4: JWAlpha 31 31 31 100 94 55 45 36 34 34 34 24 20 21 21 21 19 19 19 19 19 18 18 18 18 18 23 23 21 21 21 22 22 20 20 21 21 21 21 21 21
5: JWDelta 31 31 30 92 100 54 44 35 34 34 34 23 20 20 21 21 19 19 19 19 18 18 18 18 18 18 23 23 21 21 21 22 22 20 20 21 21 21 20 20 20
6: phiAxp-3 31 31 31 54 54 100 49 39 34 34 34 23 20 21 21 21 19 19 19 19 18 18 18 18 18 18 23 23 21 21 21 22 22 20 20 21 21 21 20 20 20
7: inbricus 33 33 33 46 46 51 100 42 37 37 36 25 20 21 22 22 20 20 20 19 19 18 18 18 18 18 24 24 22 22 22 22 22 21 21 21 21 21 21 21 21
8: N4 34 34 33 38 38 41 43 100 48 48 47 25 21 22 22 23 20 20 20 20 19 19 19 19 19 19 25 24 22 22 22 23 23 20 20 21 21 21 22 22 22
9: ECBP1 33 33 33 36 37 37 38 48 100 79 74 24 22 23 23 23 20 20 20 20 20 19 19 19 19 19 24 24 22 22 22 22 22 21 20 21 21 21 21 21 21
10: vB_EcoP_PhAPEC7 32 32 32 36 36 36 37 47 77 100 76 24 21 23 23 23 20 20 20 20 19 19 19 19 19 19 24 24 22 22 22 22 22 20 20 20 20 21 21 21 21
11:  vB_EcoP_G7C 32 32 32 35 35 36 37 46 72 76 100 24 21 23 23 23 20 20 20 20 19 19 19 19 19 19 24 24 22 22 22 22 22 20 20 20 20 20 21 21 21
12: vB_EamP-S6 24 25 24 24 24 24 24 24 23 23 23 100 22 24 24 24 20 20 20 20 19 18 18 18 18 18 21 21 20 21 21 21 21 20 20 20 20 20 20 20 20
13: EcP1 23 23 22 23 23 23 23 23 23 24 24 25 100 31 31 31 22 22 22 22 21 21 21 21 21 21 22 22 21 21 21 21 21 21 21 21 21 21 22 21 21
14: Pollock 24 24 23 22 22 22 23 23 24 24 24 26 29 100 67 66 22 23 23 23 21 22 21 21 21 21 21 21 21 21 20 21 21 22 22 22 22 22 22 21 21
15: FSL SP-058 23 23 23 22 22 22 22 22 23 23 23 25 28 63 100 87 22 22 22 22 21 21 21 21 21 21 21 21 20 20 20 20 20 21 22 21 21 22 21 21 21
16: FSL SP-076 23 23 23 22 22 22 22 23 23 24 24 25 28 62 87 100 22 22 22 22 21 21 21 21 21 21 21 21 20 20 20 20 20 21 21 21 21 21 21 21 21
17: pVa5 19 19 19 20 20 20 20 20 20 20 20 20 20 21 21 21 100 34 34 33 20 19 19 19 19 19 19 19 18 19 19 19 19 20 20 20 20 20 20 20 20
18: VBP47 19 19 19 20 20 20 20 19 20 20 20 20 20 22 22 22 34 100 99 56 20 20 20 20 20 20 19 19 18 18 18 19 19 21 21 20 21 21 21 21 21
19: VBP32 19 19 19 20 20 20 20 20 20 20 20 20 20 22 22 22 34 99 100 57 20 20 20 20 20 20 19 19 18 18 18 19 19 21 21 21 21 21 21 21 21
20: pYD6-A 19 19 19 19 20 19 20 20 20 20 20 20 20 22 22 22 33 57 57 100 20 20 20 20 20 20 19 19 18 18 18 18 18 20 20 20 20 20 20 21 21
21: Presley 19 19 18 19 19 19 19 19 19 19 19 19 19 20 20 20 20 20 20 19 100 18 18 18 18 18 18 18 18 18 18 18 18 20 20 20 20 20 22 22 22
22: pVco-5 19 19 19 19 19 19 19 19 19 19 19 19 20 21 21 21 20 20 20 20 19 100 37 36 36 36 19 19 18 18 18 18 18 19 19 19 19 19 19 19 19
23: phi 1 19 19 19 20 20 19 19 20 20 20 20 20 20 22 21 21 20 21 21 21 19 40 100 78 78 78 20 20 19 18 18 18 18 20 20 20 20 20 20 20 20
24: JSF3 19 19 19 19 19 19 19 19 19 19 19 20 20 22 21 22 20 21 21 21 19 38 76 100 97 98 19 19 18 18 18 18 18 20 20 20 20 20 20 19 20
25: VCO139 19 19 19 19 19 19 19 19 19 19 19 19 20 22 21 21 20 21 20 21 19 38 76 98 100 99 19 19 18 18 18 18 18 19 19 19 20 20 19 19 19
26: JA-1 19 19 19 19 19 19 19 19 19 19 19 19 20 22 21 21 20 20 20 21 19 38 76 98 98 100 19 19 18 18 18 18 18 19 19 19 19 19 19 19 19
27: ZC08 24 24 24 24 24 24 24 24 24 24 24 22 20 21 21 21 19 19 19 19 19 19 19 19 19 19 100 91 21 21 21 21 21 19 19 19 19 19 19 19 19
28: ZC03 24 24 24 24 24 24 25 25 24 24 24 22 20 21 21 21 19 19 19 19 19 19 19 19 19 19 92 100 21 21 21 21 21 19 19 19 20 19 20 20 20
29: phiCB2047-B 22 22 22 22 22 22 22 22 21 22 21 21 19 20 20 20 18 18 18 18 18 18 18 18 18 18 20 20 100 39 39 40 40 19 19 19 19 19 19 19 19
30: EE36P1 22 22 22 22 22 22 22 22 21 21 22 21 19 19 20 20 18 18 18 18 18 17 17 17 17 17 20 20 39 100 79 55 55 18 19 19 19 19 19 19 19
31: DSS3P2 21 22 21 21 21 22 22 21 21 21 21 21 19 19 19 19 18 18 18 18 18 17 17 17 17 17 20 20 38 78 100 55 54 18 18 19 19 19 19 19 19
32: DFL12phi1 21 21 21 22 22 22 22 21 21 21 21 21 19 19 19 19 18 18 18 18 18 17 17 17 17 17 20 20 39 53 54 100 93 18 18 19 19 19 18 18 18
33: vBDshPR2C 21 21 21 22 22 22 22 22 21 21 21 21 19 19 19 19 18 18 18 18 18 17 17 17 17 17 20 20 39 53 53 94 100 19 19 19 19 19 19 18 18
34: LUZ7 20 20 19 20 20 20 20 19 19 20 20 20 19 20 20 20 20 20 20 20 20 18 18 18 18 18 18 18 18 18 18 18 18 100 80 40 40 41 22 22 22
35: KPP21 20 20 19 20 20 20 20 19 19 19 20 20 19 20 20 20 20 20 20 20 20 18 18 18 18 18 18 18 18 18 18 18 18 80 100 40 40 41 22 22 22
36: LIT1 20 20 20 21 21 21 21 20 20 20 20 20 19 20 20 20 20 20 20 20 20 18 18 18 18 18 19 18 19 18 19 19 19 40 40 100 88 88 22 22 22
37: RWG 20 20 20 21 21 21 21 20 20 20 20 20 19 20 21 20 20 20 20 20 20 18 18 18 18 18 19 19 19 19 19 19 19 41 41 88 100 90 22 22 22
38: vB_Pae575P-3 20 20 20 21 21 21 21 20 20 20 20 20 19 20 21 20 20 20 20 20 20 18 19 19 19 18 19 19 19 19 19 19 19 42 42 88 90 100 23 22 22
39: vB_Pat_CB4 21 21 20 21 21 20 21 21 21 21 21 20 19 20 20 20 20 20 20 20 22 19 18 18 18 18 19 19 19 19 19 19 19 22 22 22 22 22 100 96 92
40: vB_Pat_CB3 21 21 20 21 21 21 21 21 21 21 21 20 19 20 20 20 20 20 20 20 22 19 18 18 18 18 19 19 19 19 19 19 19 22 22 22 22 22 97 100 94
41: vB_Pat_CB1 21 21 20 20 20 20 21 21 21 21 21 20 19 20 20 20 20 20 20 20 22 19 18 18 18 18 19 19 19 19 19 19 19 22 22 22 22 22 92 94 100
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3.2.3.2. Transcription 
Transcription of the CB1-like phage genomes likely happens in a similar manner to that 
of Escherichia phage N4. All three phages possess a vRNA (CB1_77, CB3_82, CB4_81), 
which conducts transcription of single-stranded DNA that is initiated at hairpin 
promotors located within the early gene region. These promoters are composed of a 5 
nucleotide hairpin with a 3 nucleotide loop possessing a central purine (Glucksmann et 
al., 1992). Inspection of the early gene region of phages CB1, CB3 and CB4 reveal the 
presence of three potential hairpin loops for all three, which appear analogous to 
hairpin loops in phage N4 (Appendix, Table S3.7). Middle gene transcription in phage 
N4 is conducted by a heterodimeric RNA polymerase related to the T7-like RNA 
polymerase family (Carter et al., 2003), with the CB1-like phages also possessing 
homologs (CB1_22, 23, CB3_24, 25 and CB4_24, 25). Finally, late gene transcription of 
phage N4 involves its ssDNA-binding protein activating the E. coli sigma 70 RNA 
polymerase directing it towards the N4 late promotors (Choi et al., 1995), with the 
ssDNA-binding protein also having homologs among the CB1-like phages (CB1_72, 
CB3_77 and CB4_76). Within the non-redundant parts of the genomes of the CB1-like 
phages, 18 putative rho-independent terminators were identified for CB1 and CB3 with 
17 identified for CB4 (Appendix, Table S3.8, S3.9, S3.10). Comparison between these 
phages showed that 16 of these terminators were located at similar locations among 
their respective genomes. (Appendix, Table S3.11).  
 
3.2.3.3. DNA replication, metabolism and methylation 
The CB1-like phages have several components of a DNA replication system including a 
DNA polymerase I (CB1_46, CB3_50, CB4_49), a helicase (CB1_40, CB3_42, CB4_42) 
and a primase (CB1_67, CB3_72, CB4_71). Their ability to alter the nucleotide pool of 
their host exploiting a thymidylate synthase (CB1_63, CB3_68, CB4_67) allows the 
conversion of dUMP to dTMP and a putative nucleoside triphosphate 
pyrophosphohydrolase (CB1_87, CB3_92, CB4_91), which allows conversion of 
nucleoside triphosphates to their monomer form. These phages also possess a DNA 
adenine methylase (CB1_53, CB3_57, CB4_56) (IPR012327). Indeed, restriction 
digestion patterns of the genomic DNA of CB1, CB3 and CB4 using ClaI indicate that 
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their DNA is likely deoxyadenosine-methylated (Appendix, Figure S3.4, S3.5, S3.6). 
Such methylation is known to occur on the DNA of a number of other phages such as 
P1 and T4 of E. coli. It can have regulatory functions involved in phage DNA packaging 
and transcription but additionally can provide resistance against host restriction 
endonucleases (Murphy et al., 2013). 
 
3.2.3.4. Cell lysis 
Escherichia phage N4 possesses a signal-arrest-release (SAR) endolysin (N-
acetylmuramidase, pfam05838) (Stojković and Rothman-Denes, 2007). Such endolysins 
are transported to the inner membrane by the host sec system and depend on pin 
holins to cause the collapse of membrane potential to induce their cell wall degrading 
activity (Savva et al., 2014). A typical feature of such endolysins is the possession of an 
N-terminal transmembrane domain. However, the CB1-like phage endolysin (Endolysin 
lambda type, IPR034691) (CB1_60, CB3_64, CB4_63) lacks this feature, thus indicating 
that their endolysin likely depends on the predicted class II holin (CB1_59, CB3_63, 
CB4_62) for release into the host cell periplasm to reach cell wall peptidoglycan (Savva 
et al., 2014). Situated next to these predicted ORFs for the endolysin and holin of the 
CB1-like phages are two overlapping ORFs (CB1_58, 58a, CB3_62, 62a, CB4_61, 61a), 
which possess one of the typical gene arrangements of a spanin rz and rz1 pair (Young, 
2014). In this spanin pair arrangement, the gene for the rz protein is the larger of the 
two, encoding a protein with a transmembrane domain. The smaller gene encodes a 
lipoprotein. However, in the CB1-like example, the ORF predicted to encode the 
lipoprotein is the larger of the two with the smaller protein lacking the predicted 
transmembrane domain.  
 
3.2.3.5. Structural proteome of phage CB1 
There is a minimum of ten proteins that have been identified to form the virion of 
Escherichia phage N4 (Choi et al., 2008), with in silico analysis showing six to be shared 
with phage CB1. These six are the vRNA polymerase (CB1_77), the major capsid 
(CB1_83), the portal protein (CB1_86) and structural proteins of unknown function 
resembling those of gp52 (CB1_79), gp54 (CB1_81) and gp67 (CB1_90) of N4. Those 
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not found to be shared with CB1 were the tail sheath (gp65), the tail appendage 
(gp66), the head decorating protein (gp17) and one other structural protein (gp51) 
that has previously been suggested to be an internal virion protein (Hardies et al., 
2016). Using in silico analysis, three proteins were identified to play potential roles in 
the morphogenesis of the tail structure of CB1 not shared with N4, namely CB1_57, 61 
and 62. The CB1_61 ORF is likely to encode a tail spike given that it possesses an SGNH 
hydrolase-type esterase domain (IPR013830), suggesting enzymatic activity like the tail 
spike (gp63.1) of N4-like Escherichia phage G7C, which deacetylates host surface 
polysaccharides (Prokhorov et al., 2017). Mass spectrometry (ESI-MS/MS) conducted 
on the structural proteome of CB1 verified the presence of the shared N4 structural 
proteins along with the three identified putative tail proteins and one hypothetical 
protein (CB1_78) (Table 3.3). This latter protein of the CB1 virion mirrors the position 
of gp51 of phage N4 but shares no homology. All CB1 structural proteins identified 
possess homologs in phages CB3 and CB4, with the putative tail spike protein CB1_61 
being split into two ORFs on the genome of CB4 (CB4_64, 65). Furthermore, the large 
terminase responsible for virion DNA packaging was identified for all three phages 
(CB1_91, CB3_97, CB4_95).  
Table 3.3. Results of tandem mass spectrometry of proteins of the Pectobacterium phage 
CB1 virion. 
ORF Predicted function 
Molecular 
mass (kDa) 
No. of unique 
peptides 
Sequence 
coverage % 
CB1_57 Putative tail protein 15.59 6 71 
CB1_61 Putative tail spike protein 104.98 19 29 
CB1_62 Putative tail protein 26.01 10 55 
CB1_77 
Virion associated RNA 
polymerase (N4 gp50-like) 
399.92 37 13 
CB1_78 Unknown structural protein 41.64 15 52 
CB1_79 
Structural protein (N4 gp52-
like) 
14.2 3 19 
CB1_81 
Structural protein (N4 gp54-
like) 
28.82 9 53 
CB1_83 
Major capsid protein (N4 
gp56-like) 
43.33 33 75 
CB1_86 Portal protein (N4 gp59-like) 83.31 27 45 
CB1_90 
Structural protein (N4 gp67-
like) 
33.72 9 40 
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3.2.3.6. Selfish genetic elements 
Homing endonucleases are mobile genetic elements with endonuclease activity that 
only promote the spread of their own encoding gene (Stoddard, 2005). Several homing 
endonucleases of the HNH family (IPR003615) have been identified on the genomes of 
the three CB1-like phages. Phage CB1 itself was found to possess six homing 
endonucleases (CB1_24, 33, 39, 43, 52, 71), whereas phages CB3 (CB3_36, 47, 56, 76) 
and CB4 (CB4_36, 46, 55, 75) both possess four. Such genes have also been identified 
among other N4-like phages (Fouts et al., 2013; Kulikov et al., 2012). 
 
3.2.4. Bacteriophage biocontrol on whole tubers 
The phage mixture consisting of phages CB1, CB3 and CB4 was assessed for its ability 
to suppress soft rot caused by a mixed infection of by their host P. atrosepticum 
strains, DSM 18077 and DSM 30186, using whole tuber rot assays. The potato cultivar 
Rooster was selected for these experiments, given that it is the predominant variety 
grown in the Republic of Ireland (it comprised 60% of the Irish crop in 2014) (Bord Bia 
the Irish Food Board, 2015). 
The whole tuber rot assay was carried out independently in triplicated and results 
were averaged. The assay involved two sets of ten tubers being treated with bacteria 
(designated sets (a) and (b), 100 µL at approx.1.0x107 CFU/mL), which were allowed to 
absorb into the tuber tissue. A third set (c) was treated with water. Sets (a) and (c) 
were treated with SM while (b) was treated with the phage mixture (100 µL at 1x107 
PFU/mL). Following incubation, the average weight of rotten tissue from each set of 
tubers was recorded. Set (a) (bacteria + SM buffer) was 5.39 ± 3.121 g; Set (b) (bacteria 
+ phage) was 0.311 ± 0.498 g, thus the average weight of infected tubers treated with 
phage was less than that treated without phage, with this result being statistically 
significant (p<0.0005). Indicating phage treatment limited soft rot formation. No rot 
was observed for set (c) (Figure 3.7). Look to Appendix, Figure S3.7 for the visual 
outcome of treated tuber sets (a), (b) and (c).  
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Figure 3.7. Protective effective effect of a phage mixture containing Pectobacterium 
phages CB1, CB3 and CB4 on whole tubers against a mixed infection of Pectobacterium 
atrosepticum strains DSM 18077 and DSM 30186. The assay [n=10] was carried out 
independently in triplicate and results were averaged.  
 
3.3. Discussion 
Of the sixteen samples of potato crops symptomatic of blackleg obtained from three 
potato farms in Co. Cork from which pectolytic isolates were found, fifteen were 
identified to be infected with P. atrosepticum with the remaining infection identified to 
be caused by a mixture of P. atrosepticum with P. carotovorum subsp. carotovorum. 
This study focused on the identification and isolation of exclusively lytic phages of P. 
atrosepticum from the potato crop environment, followed by an assessment of their 
potential for biocontrol applications against soft rot and/or blackleg disease. P. 
atrosepticum is highly relevant to Irish potato horticulture, and to date, relatively few 
reports focusing on phage biocontrol of this pathogen have appeared in the scientific 
literature.   
During an enrichment screening for P. atrosepticum phages, three closely related 
phage isolates were obtained, namely CB1, CB3 and CB4. Genome sequencing revealed 
them to be N4-like, sharing a similar gene order and possessing all 18 core genes found 
among all N4-like members. For phage therapy applications involving the treatment of 
Pseudomonas aeruginosa murine infections, N4-like phages have been deemed to be 
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safe and effective (Shigehisa et al., 2016). This suggested that the three identified 
phages could be good candidates for biocontrol applications.  
Phages CB1, CB3 and CB4 appear to possess relatively broad host ranges within their 
host species, collectively spanning 15 of the 19 tested P. atrosepticum strains (Table 
3.1). By comparison, among the other members of the N4-like phages (infecting 
Escherichia, Pseudomonas, Vibrio and Roseovarius), many have been found to 
propagate only on the strain used in the original isolation (Chan et al., 2014; Katharios 
et al., 2017; Kulikov et al., 2012). The relative broad host range observed is desirable 
for their use in biocontrol applications. Nevertheless, the application of these phages 
would have limited biocontrol potential where other SRE species may be involved in 
disease. Additionally, P. atrosepticum strains tested consisted predominantly of those 
from an Irish environment. It is unknown if strains from a different geographical 
location would have a similar susceptibility to these phages.  However, resistance 
could be overcome by supplementing the phage mixture with additional phages 
targeting resistant P. atrosepticum strains as well as other SRE species. The generation 
of phage cocktails is an important approach being adopted for phage preparations for 
use in the food industry and veterinary medicine as it ensures the widest possible host 
range against the targeted bacteria (Chan et al., 2013; García et al., 2008). Phages with 
host ranges limited within their respective host species have been observed for a 
number of other studies focusing on SRE phage biocontrol (Adriaenssens et al., 2012b; 
Lim et al., 2013; Smolarska et al., 2018). Nevertheless, a few notable exceptions have 
been described such as Dickeya phages D4 and D5 being able to infect several Dickeya 
species and Dickeya phages ϕPD10.3 and ϕPD23.1 being able to infect D. solani, P. 
carotovorum subsp. carotovorum and P. parmentieri (Czajkowski, 2016; Smolarska et 
al., 2018). To date, no broad host range phage infecting multiple SRE species including 
P. atrosepticum has been described.  
The tuber rot assay in this study indicated that phages CB1, CB3 and CB4 appeared to 
possess some potential for the inhibition of soft rot formation of potato tubers (Figure 
3.7). A similar finding was previously demonstrated using phages against P. 
carotovorum subsp. carotovorum, D. solani and P. parmentieri (Adriaenssens et al., 
2012b; Czajkowski et al., 2015; Smolarska et al., 2018). An approximate multiplicity of 
infection (MOI) of 1 was used in our experiments to achieve this effect, lower than that 
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reported with Dickeya phage vB_DsoM_LIMEstone1 at an MOI of 10 and 100, 
(Adriaenssens et al., 2012b) but higher than that with Dickeya phages ΦPD10.3 and 
ΦPD23.1 against P. carotovorum subsp. carotovorum, D. solani and P. parmentieri at 
an MOI of 0.01 (Czajkowski et al., 2015). However, further work is necessary to 
examine the inhibitory effect of soft rot on potato tubers by the CB1-like phages in 
more detail as well as additional studies to explore if the phages could inhibit blackleg 
formation on whole plants. Obviously, other environmental conditions that could 
potentially affect the viability of these phages in field applications such as UV light, 
salinity, soil composition, agrochemical factors (including fertilisers, copper based 
compounds, etc.) would also require investigation.    
Of the ten structural proteins identified to form the CB1 virion (Table 3.4), four were 
not shared with that of Escherichia phage N4 (CB1_57, 61, 62 and 78). These proteins 
appear to be associated with tail components of the CB1 virion. Their lack of homology 
is likely due to their adaption to allow recognition of its host bacterium and enable 
subsequent DNA injection. For N4-like Escherichia phage G7C to recognise its host, its 
tail spike esterase domain must first deacetylate the O-antigen of its host 
lipopolysaccharide (Prokhorov et al., 2017). This may also be the case for the CB1-like 
phages with their putative tail spike (CB1_61, CB3_66 and CB4_75, 76) possessing an 
SGNH hydrolase-type esterase domain (IPR013830). 
Phylogenetic analysis (based on phylograms and Gegenees (TBLASTX) of CB1-like 
phages show that they are distinct members within the N4-like group, with their 
closest evolutionary relationship being found with phages of the genera Lit1virus and 
Luz7virus. This analysis also indicates the existence of higher-order taxonomic 
relationships between genera of the N4-like phages. Such relationships are becoming 
apparent due to the increasing number of N4-like genomes being added to public 
databases. Such a relationship was identified between the phages belonging to the 
genera of N4virus, G7cvirus and Ea92virus with Achromobacter phage JWAlpha, which 
has been proposed to form the subfamily Enquartavirinae (Wittmann et al., 2015). A 
similar connection was also found with the genera of Luz7virus and Lit1virus (Figure 
3.5, Table 3.3). These relationships are indicated with clades that are closely situated 
within phylograms and the sharing of protein sequence identity of ~30-40% in 
Gegenees analysis.  
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A taxonomy proposal describing the CB1-like phages as a new genus has been 
submitted to the International Committee for the Taxonomy of Viruses (ICTV), 
proposing the genus of Cbunavirus. 
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Chapter 4. Pectobacterium atrosepticum phage 
vB_PatP_CB5; a member of the proposed genus 
‘Phimunavirus’ 
 
A manuscript based upon this chapter has been published in Viruses 
Buttimer, C., Lucid, A., Neve, H., Franz, C., O’Mahony, J., Turner, D., Lavigne, R., Coffey, 
A. (2018). Pectobacterium atrosepticum Phage vB_PatP_CB5: A member of the 
proposed Genus “Phimunavirus.” Viruses 10, 394. https://doi.org/10.3390/v10080394 
 
Transmission electron microscopy was conducted by Horst Neve. 
Genome sequence of phage CB5 was outsourced to GATC Biotech, Germany. 
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4.1. Introduction 
In the post-genomic era, the number of bacteriophage (phage) genomes being 
deposited into public databases, such as NCBI GenBank, has substantially increased 
due in part to the ever-decreasing cost of DNA sequencing. This growing quantity of 
genomic data has led to increasing insights into the evolutionary relationships 
between phages. Originally, phage taxonomic classification was based on morphology, 
nucleic acid composition and physicochemical characteristics (Calendar, 2006). More 
recently, classification has developed to the point where nucleotide and protein 
homology can be usefully employed to tease out phylogenetic relationships. This has 
led to the creation of subfamilies within of the Myoviridae, Siphoviridae and 
Podoviridae, such as the subfamily Autographivirinae. This subfamily encompassed 
what was previously known as the T7 supergroup (Lavigne et al., 2008). Key defining 
features of the subfamily Autographivirinae include the presence of a single RNA 
polymerase (RNAP) gene and a typical genomic organisation with genes positioned on 
the Watson strand  (King et al., 2012). To date, this subfamily currently encompasses 
seven genera: T7virus, SP6virus, Phikmvvirus, Fri1virus, KP32virus, Pradovirus and 
KP34virus (Adriaenssens et al., 2017; Lavigne et al., 2008). 
The bacterial genera Pectobacterium and Dickeya, often referred to collectively as the 
soft rot Enterobacteriaceae, are phytopathogens that cause economically important 
losses in a wide range of arable crops, thus potentially impacting food biosecurity. 
They are Gram-negative, facultative anaerobic rod-shaped cells that are typified by the 
production of extracellular pectinolytic enzymes during infection of plants 
(Pérombelon, 2002; Toth et al., 2011). Within the last two years, a limited number of 
Pectobacterium and Dickeya phages have been reported whose genome sequences 
have been described to resemble phages of KP34virus and Phikmvvirus. The first of 
these to have their genome described was Pectobacterium atrosepticum phage Peat1 
(accession no. KR604693) by Kalischuk et al. (Kalischuk et al., 2015). Phage φM1 
(accession no. JX290549) was subsequently described by Blower et al. (Blower et al., 
2017), after isolation and characterisation by Toth et al. (Toth et al., 1997). Related 
phages have also been described for Pectobacterium carotovorum subsp. carotovorum 
(namely phage PPWS1, accession no. LC063634.2) and Dickeya (phage BF25/12, 
accession no. KT240186.1) (Alič et al., 2017; Hirata et al., 2016). In addition, a P. 
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atrosepticum phage, PP90 (accession no. KX278419.1), has been deposited to the 
public databases as well as P. carotovorum subsp. carotovorum phage PP16 (accession 
no. KX278418). The latter two display high level of amino acid sequence similarity and 
possess a similar genomic organisation of genes to phages of KP34virus.  
In this study, we describe the newly isolated P. atrosepticum phage vB_PatP_CB5. 
Phylogenetic analysis of its genome shows a close evolutionary relationship with P. 
atrosepticum phages φM1, Peat1 and PP90 (termed the PhiM1-like phages from here 
onwards in this article). Based on these findings, we propose the formation of the 
bacteriophage genus ‘Phimunavirus’ to formally classify these phages, with 
Pectobacterium phage φM1 designated as the type phage.  
 
4.2. Results 
4.2.1. Isolation, host range, growth characteristics and morphology 
Phage CB5 was isolated from soil samples collected from potato grading machinery on 
a farm in Co. Cork, Ireland, during the year 2013, as mentioned previously (Buttimer et 
al., 2018a). Host range was determined on 31 bacterial strains from five different 
species belonging to soft rot Enterobacteriaceae, namely P. atrosepticum (19 strains), 
P. carotovorum subsp. carotovorum (4 strains), D. chrysanthemi bv. chrysanthemi (1 
strain), D. dianthicola (3 strains) and D. solani (4 strains). The phage possesses a 
narrow host range, in that it is only capable of forming plaques on the phage’s host 
strain (DSM 30186) and two other strains of P. atrosepticum (Table 4.1). Additionally, 
spot tests showed that the phage had an inhibitory effect on 15 of the other 16 strains 
of P. atrosepticum tested with the observation of zones of clearing at high phage titres 
despite the absence of distinct plaques. No plaque formation or inhibition was 
detected for any other bacterial species tested. A similar narrow host range has also 
been reported for PhiM1-like Pectobacterium phage φM1, with an infectivity range 
confined to a small number of P. atrosepticum strains (Toth et al., 1997). This limited 
host range has also been observed among phages of KP34virus and Phikmvvirus 
(Ceyssens et al., 2006; Eriksson et al., 2015). On the propagating host strain DSM 
30186, CB5 was found to produce clear plaques with an approximate diameter of 3 
mm (Appendix, Figure S4.1). One-step-growth curve assay, under standard conditions 
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using LB medium, demonstrated that phage CB5 possessed a latent period of 45 mins 
with an approximate burst size of 43 PFU/cell (Figure-4.1).  
 
Table 4.1. Host range of Pectobacterium phage vB_PatP_CB5 (CB5) on 31 strains of the soft rot 
Enterobacteriaceae determined by spot testing with serial dilutions of phage. 
Species Strain Sensitivity  
Pectobacterium atrosepticum 
DSM 18077 (type strain) ++ 
DSM 30184 + 
DSM 30185 + 
DSM 30186 ++* 
CB BL1-1 + 
CB BL2-1 + 
CB BL3-1 + 
CB BL4-1 + 
CB BL5-1 + 
CB BL7-1 + 
CB BL9-1 + 
CB BL11-1 + 
CB BL12-2 ++ 
CB BL13-1 + 
CB BL14-1 + 
CB BL15-1 - 
CB BL16-1 + 
CB BL18-1 + 
CB BL19-1 + 
Pectobacterium carotovorum subsp. 
carotovorum 
DSM 30168 (type strain) - 
DSM 30169 - 
DSM 30170 - 
CB BL19-1-37 - 
Dickeya chrysanthemi bv chrysanthemi LMG 2804 - 
Dickeya dianthicola 
PD 482 - 
PD 2174  - 
GBBC 1538 - 
Dickeya solani 
sp. PRI 2222 (D36) - 
LMG 25865 (D10) - 
GBBC 1502 - 
GBBC 1586 - 
Results recorded as ++, sensitive; +, the presence of clear spot with no plaque formation; −, no 
infection; *host strain of phage. 
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Figure 4.1. Single-step growth curve of Pectobacterium phage vB_PatP_CB5 infection of 
host bacterium DSM 30186. The assay was independently repeated in triplicate and the 
results were averaged. 
 
Examination of the morphology of the phage by transmission electron microscopy 
(Figure 4.2), shows it can be classified as a member of the Podoviridae family, featuring 
a C1 morphotype (Ackermann, 2001) with an icosahedral head (63.1 ± 3.6 nm in 
diameter, n=25) with clearly distinguishable hexagonal outlines and a short non-
contractile tail (13.1 ± 1.8 nm, n=11), and short appendices (length: ca. 10.1 ± 1.7 nm, 
n=10) visible at the head/tail connection site. These head and tail dimensions are 
consistent with previously reported phages of KP34virus and Phikmvvirus (Eriksson et 
al., 2015; Lavigne et al., 2003). The phage was formally named in accordance with the 
nomenclature set out by Kropinski et al. (2009). 
  
 
 
86 
 
 
Figure 4.2. Transmission electron microscopy of negatively stained Pectobacterium phage 
CB5 using 1% (w/v) uranyl acetate. Triangle indicates the short conical tail structure, and 
arrows indicate short appendages (whiskers) beneath the capsid.  Scale bars represent 50 
nm.  
 
4.2.2. General genome information of CB5 
The genome sequence size obtained for phage CB5 is 44,262 bp (coverage >1000x) and 
examination of sequence reads indicated the presence of direct terminal repeats 
(DTRs) with an estimated size of 287 bp. This estimation is based on the identification 
of a localized region with more than double the read depth compared to average read 
depth across the whole genome (Appendix, Figure S4.2). This approach to detecting 
DTRs has also been applied to a number of other phages (Buttimer et al., 2017a; Fouts 
et al., 2013; Li et al., 2014). Additionally, the average G+C% content of its genome was 
found to be 49%: close to the range that is typically expected for its host bacterium, P. 
atrosepticum at 50-51% (Bell et al., 2004; Nikolaichik et al., 2014).  
The genome of CB5 was predicted to contain 60 ORFs. These, apart from one, were 
found to read in the 5’ to 3’ direction, with GC skew correlating well with transcription 
(Marín and Xia, 2008). Based on analysis using a combination of BLASTP, InterProScan 
and HHpred, putative functions to 33 of the 60 predicted ORFs (55%) were assigned. 
These gene products can be categorized into DNA replication, virion structure and host 
lysis functions (Appendix, Table S4.1). Of the assigned ORFs, five are predicted to 
encode homing endonucleases of the HNH family (CB5_17, 23, 29, 41, 48) (IPR003615). 
No integrase, excisionase nor repressor genes were detected suggesting the phage has 
an exclusively lytic lifecycle. Furthermore, no tRNA genes were identified.  
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4.2.3. Comparative genomics of PhiM1-like phages 
The four phages within the proposed genus ‘Phimunavirus’ possess genomes of similar 
size that share a high degree of sequence similarity and share a large number of 
conserved proteins (Table 4.2). Genome sizes (excluding DTRs) range from 43,534 bp 
(φM1) to 45,633 bp (Peat1), with nucleotide pairwise identity between the four phages 
ranging from 82 to 86% (BLASTN). Total ORF numbers range from 52 (φM1) to 61 
(Peat1), with Coregenes analysis showing that they collectively share a minimum of 39 
proteins, including 32 which were affiliated to a known pVOG (Table 4.3). These coding 
sequences are spread across the entire genome and are not associated/limited to 
particular genomic modules. Of the four phages, only φM1 possesses a tRNA gene (for 
isoleucine). G+C content among the four phages is highly similar, ranging from 48.7 to 
49.2%. Additionally, these phages show limited similarity to Klebsiella phage KP34 (7 to 
9% identity). Indeed, Coregenes shows that phage KP34 shares 29 proteins with the 
PhiM1-like phages (Table 4.3). The major variations of conserved proteins of phage 
KP34 with these phages are five hypothetical proteins located in the DNA replication 
and nucleotide metabolism region. Also, additional hypothetical proteins were 
identified immediately downstream of the genes encoding the RNAP and large 
terminase proteins, as well as the ORFs for their predicted holin and tail spike.  
 
Table 4.2. Properties of the seven phages belonging to the proposed genus of 
‘Phimunavirus’. 
Phag
e 
Genome 
size (bp) 
DTRs 
(bp) 
G+C 
content
, % 
ORFs tRNA DNA identity, 
%* 
Homologous 
proteins, 
%** 
φM1 43,534 293 49.18 52 1 100 100 
CB5 44,262 287 48.98 60 0 84 73 
Peat1 45,633 NA 48.86 61 0 86 87 
PP90 44,570 NA 48.89 56 0 86 80 
* DNA identity in comparison to φM1 using BLASTN. 
**Number of homologous proteins in comparison to φM1 using Coregenes. 
NA, not available.  
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Table 4.3. Thirty-nine conserved genes among phages (φM1, Peat1, CB5, PP90) of the 
proposed genus ‘Phimunavirus’, as determined by Coregenes, and their details in regard 
to the type phage φM1. Conserved proteins of these phages shared with Klebsiella phage 
KP34 are highlighted in bold with italics. Additionally, pVOGs determined from translated 
ORFs of φM1 of these conserved proteins are presented. 
no. Product 
φM1 
Accession 
no. 
φM1 locus 
tag 
pVOG 
1 hypothetical protein AFQ22488.1  PhiM1_03 VOG6006 
2 hypothetical protein AFQ22489.1  PhiM1_04 VOG1073 
3 hypothetical protein AFQ22493.1  PhiM1_08 VOG5528 
4 hypothetical protein AFQ22494.1  PhiM1_09 - 
5 putative peptidase AFQ22495.1  PhiM1_10 VOG5332 
6 hypothetical protein AFQ22496.1  PhiM1_11 VOG5704 
7 putative DNA primase AFQ22497.1  PhiM1_12 VOG4551 
8 putative DNA helicase AFQ22499.1  PhiM1_14 VOG0025 
9 hypothetical protein AFQ22501.1  PhiM1_16 - 
10 hypothetical protein AFQ22503.1  PhiM1_18 - 
11 DNA polymerase AFQ22505.1  PhiM1_20 VOG0026 
12 hypothetical protein AFQ22506.1  PhiM1_21 VOG1076 
13 DNA exonuclease AFQ22507.1  PhiM1_22 VOG0028 
14 hypothetical protein AFQ22508.1  PhiM1_23 - 
15 DNA endonuclease VII AFQ22510.1  PhiM1_25 VOG8238 
16 putative metallophosphoesterase AFQ22512.1  PhiM1_27 VOG1606 
17 hypothetical protein AFQ22514.1  PhiM1_29 VOG1254 
18 hypothetical protein AFQ22515.1  PhiM1_30 VOG9679 
19 putative RNA polymerase AFQ22516.1  PhiM1_31 VOG0019 
20 hypothetical protein AFQ22517.1  PhiM1_32 VOG1406 
21 hypothetical protein AFQ22518.1  PhiM1_33 VOG9202 
22 putative structural protein AFQ22519.1  PhiM1_34 VOG8332 
23 
putative head-tail connector 
protein AFQ22520.1  PhiM1_35 
VOG0030 
24 putative scaffolding protein AFQ22521.1  PhiM1_36 VOG0031 
25 putative endonuclease AFQ22522.1  PhiM1_37 - 
26 putative capsid protein AFQ22523.1  PhiM1_38 VOG4572 
27 putative tail tubular protein A AFQ22524.1  PhiM1_39 VOG4592 
28 putative tail tubular protein B AFQ22525.1  PhiM1_40 VOG0034 
29 putative internal core protein A AFQ22526.1  PhiM1_41 VOG1080 
30 putative internal core protein B AFQ22527.1  PhiM1_42 VOG3794 
31 putative internal core protein C AFQ22528.1  PhiM1_43 VOG0038 
32 putative tail fiber protein AFQ22529.1  PhiM1_44 - 
33 putative DNA maturase A AFQ22530.1  PhiM1_45 VOG0041 
34 putative DNA maturase B AFQ22531.1  PhiM1_46 VOG4544 
35 hypothetical protein AFQ22532.1  PhiM1_47 - 
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36 putative Rz1A protein AFQ22534.1  PhiM1_49 VOG1082 
37 putative holin AFQ22535.1  PhiM1_50 VOG0765 
38 endolysin AFQ22536.1  PhiM1_51 VOG4565 
39 phage tail spike protein AFQ22537.1  PhiM1_52 VOG4640 
 
 
The gene order is highly conserved among the PhiM1-like phages (Figure 4.3). Their 
genome architecture is arranged so that the predicted early and middle gene regions 
end with an RNAP gene (CB5_39), with ORFs within these regions involved in DNA 
replication and nucleotide metabolism, but also expected to be involved in host take-
over. The position of ORFs for RNAP in the PhiM1-like phages is shared with phages of 
the genera KP34virus, Fri1virus and KMVvirus, but not with those of the genera 
T7virus, SP6virus and KP32virus where the RNAP is situated at the early gene region 
(Figure 4.4). The late gene region of the PhiM1-like phages is associated with virion 
morphogenesis and host lysis roles. Gene order between PhiM1-like phages and KP34-
like phages is highly conserved apart from the position of an ORF encoding a conserved 
protein (CB5_36, PhiM1_27, AXI77_gp27, PP90_28) possessing a calcineurin-like 
phosphoesterase domain (IPR004843) (Figure 4.4).  
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Figure 4.3. Comparison of the genomes of the phages that form the proposed genus of 
‘Phimunavirus’; Pectobacterium phages CB5 and Pectobacterium phages φM1, Peat1 and 
PP90 using currently available annotation from Genbank, employing BLASTN and 
visualised with Easyfig. The genome maps comprise of arrows indicating locations and 
orientation of ORFs among different phage genomes. Arrows have been colour-coded 
describing their predicted roles (see key), and shading between the genome maps 
indicate the level of identity. 
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Figure 4.4. Pairwise comparison of the type phages representing six genera of the 
subfamily Autographivirinae; KP34virus, Phikmvvirus, Frivirus, SP6virus, T7virus and 
against Pectobacterium phage φM1. Maps were created using currently available 
annotation from Genbank with comparisons employing TBLASTX and visualised with 
Easyfig. The genome maps comprise of arrows indicating locations and orientation of 
ORFs. Lines between genome maps indicate the level of identity. ORF of a conserved 
protein shared between φM1 and KP34 that does not mirror genomic position is colour-
coded green. The ORF encoding the RNAP shared between genera of Autographivirinae 
has been colour-coded red. 
 
4.2.4. Phimunavirus evolutionary position the Autographivirinae  
To determine the PhiM1-like phages’ evolutionary relationship to other phages within 
the Autographivirinae, a phylogenetic analysis was conducted using the amino acid 
sequence of the major capsid protein (Figure 4.5). The resulting phylogram showed 
that the PhiM1-like phages form their own clade on a branch containing an additional 
clade representing the P. carotovorum subsp. carotovorum phages PP16 and PPSW1 
and Dickeya phage BF25/12. The branch that these phages form, was found to be 
positioned close to phages of the KP34virus genus along with sister groups consisting 
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of Vibrio phage VP93 and the Pantoea phage LIMElight, which have previously been 
described to possess a close evolutionary relationship to the KP34virus  members 
(Eriksson et al., 2015). This analysis was performed with the head-tail connector 
protein, large terminase subunit, and tail tubular proteins A and B. These analyses 
produced tree exhibiting similar relationships, albeit with weaker bootstrap support 
values (Appendix, Figure S4.3). Whole-genome comparison based on amino acid 
sequences was performed using VICTOR and the resulting phylogram (formula D4, 
yielding average support of 71 %) presented a similar conclusion like that based on 
major head protein sequence (Figure 4.6). Additionally, analysis using VICTOR could 
cluster these 53 phage genomes into 13 genera and four subfamilies, with PhiM1-like 
phages being placed in their own genera with P. carotovorum subsp. carotovorum 
phages PP16 and PPSW1 and Dickeya phage BF25/12 (Appendix, Table S4.2). Further 
analysis using Gegenees (TBLASTX) based on protein similarity, indicate the PhiM1-like 
phages form a clade with high identity values of ≥80%. Additionally, as seen in the 
phylograms, it was observed that P. carotovorum subsp. carotovorum phages PP16 and 
PPSW1 and Dickeya phage BF25/12 share an evolutionary relationship with PhiM1-like 
phages (identity values ≥54%) (Figure 4.7).  
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Figure 4.5. Phylogenetic analyses of amino sequences of the major capsid (log likelihood = 
13809.83) of Pectobacterium phage CB5 and 52 members of the Autographivirinae 
subfamily using maximum likelihood (Whelan and Goldman substitution model), with 
1000 bootstrap replicates. Members of the T7virus, SP6virus, KP34virus, Frivirus, 
Pradovirus, KP32virus are illustrated. 
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Figure 4.6. VICTOR generated phylogenomic GBDP trees of Pectobacterium phage CB5 
and 52 members of the Autographivirinae subfamily inferred using the formula D4 and 
yielding average support of 71 %. The numbers above branches are GBDP pseudo-
bootstrap support values from 100 replications. Members of the T7virus, SP6virus, 
KP34virus, Frivirus, Pradovirus, KP32virus are illustrated. 
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Figure 4.7. TBLASTX heat map generated using Gegenees with accurate parameters – fragment length: 200 bp; and step size: 100 bp with the 
threshold set to 5%. The map includes the genomes of 32 phages of Autographivirinae with phages representing the genera Fri1virus (yellow), 
KP34virus (brown), Phikmvvirus (green) and the proposed genus of ‘Phimunavirus’ (blue). 
Phage 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
1: Acinetobacter  phage Abp1 100 86 80 80 34 20 19 19 19 18 18 20 20 20 20 20 20 21 21 21 22 21 21 21 18 18 18 18 18 18 18 18
2: Acinetobacter  phage phiAB1 87 100 81 80 34 20 20 19 19 18 18 20 20 20 20 20 20 21 21 21 21 21 21 20 18 18 18 18 18 18 18 18
3: Acinetobacter  phage vB_ApiP_P2 81 81 100 80 33 20 20 19 19 18 18 20 20 20 20 20 20 20 21 20 21 21 21 20 18 18 18 18 18 18 18 18
4: Acinetobacter  phage Fri1 81 80 80 100 33 19 20 19 19 18 18 20 20 20 20 20 20 21 21 21 21 21 21 21 18 18 18 18 18 18 18 18
5: Acinetobacter  phage Petty 34 35 34 33 100 20 20 19 19 18 18 20 20 20 20 20 20 21 21 21 21 21 21 21 18 18 19 18 18 18 18 18
6: Ralstonia  virus phiAp1 18 18 18 18 18 100 42 22 22 20 20 20 20 20 20 20 20 20 21 20 20 20 20 20 22 22 22 22 22 22 22 22
7: Ralstonia  phage RSB3 19 19 19 19 19 42 100 23 23 21 21 20 20 20 20 20 20 21 21 21 21 21 21 21 23 23 22 22 22 22 23 23
8: Pseudomonas  phage LKA1 18 18 18 18 18 23 23 100 31 20 20 20 20 20 20 20 20 21 21 21 21 21 21 21 28 28 28 28 28 28 28 28
9: Pseudomonas  phage phi-2 18 18 18 18 18 22 23 30 100 20 19 20 20 20 19 20 20 21 21 21 20 20 21 21 29 29 29 29 29 29 29 29
10: Enterobacteria phage J8-65 17 17 17 17 17 21 21 21 20 100 47 20 19 18 18 19 19 21 21 21 20 20 20 21 20 20 20 20 20 20 20 20
11: Pantoea  phage LIMEzero 17 17 17 17 17 20 20 20 19 46 100 19 18 18 18 18 18 20 20 20 19 19 20 20 19 19 19 19 19 19 19 19
12: Pantoea  phage LIMElight 19 19 19 19 19 20 20 20 20 19 19 100 30 30 31 31 30 24 24 24 23 23 23 23 20 20 20 20 20 20 20 20
13: Klebsiella  phage NTUH-K2044-K1-1 19 19 19 19 19 20 20 20 20 18 18 31 100 76 75 76 73 25 25 25 25 25 25 25 20 20 20 20 20 20 20 20
14: Klebsiella  phage vB_KpnP_SU503 19 19 19 19 19 20 20 20 20 18 18 31 77 100 77 76 73 25 25 25 25 25 25 25 20 20 20 20 20 20 20 20
15: Klebsiella  phage KP34 19 19 19 19 19 20 20 20 20 18 18 31 76 76 100 78 74 25 25 25 25 25 25 25 20 20 20 20 20 20 20 20
16: Klebsiella phage vB_KpnP_SU552A 19 19 19 19 19 20 20 20 20 19 18 32 76 75 77 100 75 26 26 25 25 25 25 26 20 20 20 20 20 20 20 20
17: Klebsiella  phage F19 19 19 19 19 19 20 20 20 20 18 18 31 74 73 74 76 100 25 25 25 25 25 25 25 20 20 20 20 20 20 20 20
18: Dickeya  phage BF2512 19 20 19 19 19 21 21 21 21 21 20 24 25 25 25 25 25 100 61 60 57 56 55 56 21 21 21 21 21 21 21 21
19: Pectobacterium  phage PP16 20 20 20 20 20 21 21 21 21 21 20 24 25 25 25 26 25 61 100 72 55 55 54 55 21 21 21 21 21 21 21 21
20: Pectobacterium  phage PPWS1 20 20 19 19 20 21 21 21 21 20 20 24 25 25 25 25 24 59 71 100 55 55 54 54 20 21 21 21 21 21 21 21
21: Pectobacterium  phage PP90 21 21 20 20 20 20 21 21 21 20 20 24 25 25 25 25 25 56 55 55 100 85 82 80 20 20 20 20 20 20 20 20
22: Pectobacterium  phage vB_PatP_CB5 20 20 20 20 20 21 21 21 21 20 19 23 25 25 25 25 25 56 56 56 84 100 85 83 21 21 20 20 20 20 20 21
23: Pectobacterium  phage Peat1 20 20 20 20 20 21 21 21 21 20 20 23 25 25 25 25 25 55 54 54 81 86 100 86 20 20 20 20 20 20 20 20
24: Pectobacterium  phage PhiM1 20 20 20 20 20 21 21 21 21 21 20 24 25 25 25 26 25 57 55 55 82 83 87 100 21 21 21 21 21 21 21 21
25: Pseudomonas  phage LKD16 17 17 17 17 17 22 22 27 29 19 19 19 19 19 19 19 20 20 20 20 20 20 20 20 100 79 79 79 77 78 78 80
26: Pseudomonas  phage phikF77 17 17 17 17 17 22 22 27 29 19 19 19 20 20 19 20 20 21 20 20 20 20 20 20 79 100 85 84 81 81 82 84
27: Pseudomonas  phage LUZ19 17 17 17 17 17 22 22 27 29 19 19 19 20 20 19 19 19 20 20 20 20 20 20 20 78 85 100 90 85 86 84 86
28: Pseudomonas  phage MPK6 17 17 17 17 17 22 22 27 29 19 19 19 20 20 19 19 20 21 20 20 20 20 20 20 79 85 91 100 88 86 84 87
29: Pseudomonas  phage MPK7 17 17 17 17 17 22 22 28 29 19 19 19 20 19 19 20 20 21 20 20 20 20 20 20 77 81 86 88 100 87 86 84
30: Pseudomonas  phage PT2 17 17 17 17 18 22 22 27 29 19 19 19 19 20 19 20 20 21 20 20 20 20 20 20 78 82 86 85 87 100 95 91
31: Pseudomonas  phage phiKMV 17 17 17 18 18 22 22 27 29 19 19 20 20 20 20 20 20 21 21 20 20 20 20 20 79 83 85 85 86 96 100 94
32: Pseudomonas  phage PT5 17 17 17 17 17 22 22 27 29 19 19 19 19 19 19 19 19 20 20 20 20 20 20 20 80 84 87 87 84 92 93 100
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4.2.5. RNAP of the PhiM1-like phages 
The RNAP protein has been used as a feature to establish genera within the subfamily 
of Autographivirinae. Within the amino acid sequence of the RNAP of phage T7, the 
key catalytic residues Asp537, Lys631, Tyr639 and Asp812; and the regions of 
functional importance, namely the recognition loop (93-101 aa) and the specificity 
loop (739-770 aa) are generally well conserved among different clades within 
Autographivirinae (Ceyssens et al., 2006; Eriksson et al., 2015). Analysis of PhiM1-like 
phages shows that they all have the catalytic residues Asp537, Lys631 and Asp812. 
Comparisons of the recognition loop and specificity loop of these phages show that 
they are vastly different to that of φKMV, with the recognition loop of KP34 and Fri1 
possessing a small resemblance to that of these phages (Table 4.4). Furthermore, 
sequence variation is evident between the PhiM1-like phages and the closely related P. 
carotovorum subsp. carotovorum phages PP16 and PPSW1 and Dickeya phage 
BF25/12. 
Table 4.4. Alignment of the recognition and specificity loops of the RNAP of PhiM1-like 
phages to phages φKMV and KP34. Underlined amino acids/residues show sites of 
substitutions in comparison to φM1. 
Phage Recognition loop Specificity loop 
φKMV HQEAKAAGPAAKL EEVRVRLRAEAVEYVTLYEAK-DE 
KP34 MRNVKAPGIGGKY EEVRVRIDCMNLSAVLVHNRDFKT 
Fri1 VKKQKIRGVGGKY VTKTVAIRSMGINNIAYRYPD-NQ 
φM1 ICSKGTRGVGGKY SITRVSLKALGVALNMRVFDD-HS 
CB5 ICSKGTRGVGGKY SITRVSLKALGVALNMRVFDD-HS 
Peat1 ICSKGTRGVGGKY SITRVSLKALGVALNMRVFDD-HS 
PP90 ICSKGTRGVGGKY SITRVSLKALGVALNMRVFDD-HS 
BF25/12 MCSTGSRGLGGKY DSTRINLNALGTQLVMRTFND-HL 
PP16 ICTTGNRGLNGKY DSTRIELRSLGIKLVMRTFDD-TQ 
PPWS1 ICTTGNRGLNGKY DSTRIELRSLGIKLVMRTFDD-TQ 
 
4.2.6. Early gene region 
Early region ORFs are those that are expected to be transcribed immediately upon 
internalisation of phage DNA within the host. In silico analysis of ORFs for hypothetical 
proteins within this region is typically limited (in the context of determining their 
functions) for the majority of phages due to their vast diversity. However, it can be 
expected that these ORFs are involved in the redirection of host proteins to a role in 
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the phage infection cycle through stimulation or inhibition of protein-protein 
interactions  (Roucourt and Lavigne, 2009). Here, we define the early genes among the 
PhiM1-like phages as those positioned before the DNA primase ORF (Figure 4.3). Six 
ORFs were found to be conserved within this region using Coregenes (Appendix, Table 
S4.3). Of these six ORFs, only one could be assigned the putative function of a 
peptidase (IPR007484).  
4.2.7. DNA replication, repair and related metabolism 
PhiM1-like phages encode ORFs for proteins involved in the replication and repair of 
DNA (Appendix, Table S4.4), including a primase, helicase, DNA polymerase, 
endonuclease VII and a putative 5’ exonuclease. The order of these ORFs is conserved 
among the genomes of these phages with variation existing in the context of the 
presence of ORFs for hypothetical proteins and homing endonucleases among the 
primase, helicase, DNA polymerase and endonuclease VII. Additional variations 
identified were that CB5 possesses an ORF encoding a putative nucleatidyl transferase, 
which is absent among other PhiM1-like phages; and that CB5 and Peat1 lack an ORF 
encoding a putative polynucleotide 5' kinase / 3'phosphatase that is shared between 
PP90 and φM1.  
4.2.8. Structure related genes 
Discussion of these genes also includes those specifying large and small terminase 
(maturase) proteins which play a role in the packaging of DNA into the phage capsid. A 
total of 12 ORFs predicted to be involved in virion morphogenesis are shared among 
the PhiM1-like phages (Appendix, Table S4.5). These include a head-tail connector 
protein, a virion scaffolding protein, major capsid protein, tail tubular proteins A and B, 
internal virion proteins A, B and C, a tail fibre and a tail spike. The order in which the 
ORFs for these proteins occur in the genomes of these phages is highly conserved. 
Minor differences within this syntenic region were due to the presence of homing 
endonucleases among the ORFs or in some cases splitting ORFs, for example, the head-
tail connector protein of PP90 (PP90_39, 40). Additionally, it was noted that some 
structural proteins were encoded by split ORFs without the presence of homing 
endonucleases, as seen for the major capsid protein (AX177_gp38, 39), tubular protein 
A (AX177_gp41, 42) and internal virion protein C of Peat1 (AX177_gp46, 47).  
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The predicted tail spike protein of these phages possesses the P22 tail spike domain 
(IPR015331). The P22 tail spike is characterised by the right-handed beta-helix 
architecture first observed for pectate lyase (Jenkins et al., 1998). This protein is 
capable of breaking down saccharides upon binding to host cell surface (Andres et al., 
2010), which may be the case also for the PhiM1-like tail spike. The internal virion 
protein B of these phages may also possess enzymatic activity, with HHpred analysis 
indicating homology to phage proteins with lysozyme activity (best hit against 
PhiM1_42; Escherichia phage P1 endolysin Lyz, PDB accession no. 1XJU_A). This 
suggests that this protein may play a role in the breakdown of cell wall peptidoglycan 
during injection of phage genomic DNA into its host cell, like Gp16 of phage T7 (Moak 
and Molineux, 2000).  
4.2.9. Lysis cassette of PhiM1-like phages that of KP34virus 
The PhiM1-like phages possess three proteins predicted to cause host lysis. These are 
arranged in a conserved order: a spanin, a holin and an endolysin (Appendix, Table 
S4.6). The endolysins of these phages are predicted to possess an N-terminal 
transmembrane domain with lysozyme domain (IPR023347), indicating a likely 
function as a signal-arrest-release (SAR) endolysin, similar to that described for 
Pseudomonas phage φKMV (Briers et al., 2011). SAR endolysins use the host sec 
translocon system to enable their transport to the cell’s inner membrane. The most 
likely holin of these phages is the pin-hole holin variety. These can provide narrow 
channels for ion movement causing membrane depolarization and activation of the 
SAR endolysin resulting in the degradation of cell wall peptidoglycan (Briers et al., 
2011; Pang et al., 2009). Spanins are proteins responsible for the destruction of the 
outer membrane of Gram-negative hosts allowing phage progeny release. The 
predicted spanin of these phages is comprised of a single protein with an N-terminal 
outer-membrane lipoprotein signal and a C-terminal transmembrane domain, 
classifying them of the u-spanin variety (Young, 2014). The lysis cassette configuration 
of the PhiM1-like phages resembles that of Klebsiella phage KP34, sharing the same 
gene variations to the type phage φKMV of Phikmvvirus. The spanin of φKMV is 
composed of a two protein component system, an i-spanin integral cytoplasmic 
membrane protein (Rz) and an o-spanin outer membrane lipoprotein (Rz1) (Berry et 
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al., 2013; Young, 2014). Variation also exists with the order of occurrence of the genes 
for these proteins (holin, SAR endolysin, Rz and Rz1) in the lysis cassette of φKMV in 
comparison to the PhiM1-like phages and phage KP34 (Figure 4.8). 
 
Figure 4.8. Lysis cassette scheme of (A) Klebsiella phage KP34 and PhiM1-like phages 
compared to (B) Pseudomonas phage φKMV. 
 
4.3. Discussion 
In silico analysis shows that the Pectobacterium phage CB5 belongs to a distinct group 
of phages (φM1, Peat1 and PP90) that infect P. atrosepticum and that can be classified 
as members of the subfamily Autographivirinae. In this article, we propose the 
creation of the genus ‘Phimunavirus’ to encompass these phages, the genus name is 
derived from the allocated type phage φM1, the first representative of these phages to 
be described. This proposal is supported due to these phages sharing a high DNA 
pairwise identity of ≥80% (BLASTN), with a highly conserved gene order (Figure 4.3) 
and a shared protein content of ≥60% (Coregenes). They also form a distinct clade 
when compared to other phages of Autographivirinae on phylograms based on their 
major capsid protein sequence (Figure 4. 5) and whole-genome comparison based on 
amino acid sequences employing VICTOR (Figure 4.6). Furthermore, Gegenees analysis 
(TBLASTX) based on amino acid sequence also indicates the existence of this clade 
(Figure 4.7). Additionally, the recognition and specificity loop of the RNAP between 
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these phages is highly conserved (Table 4.4). These phages share a number of 
characteristics with members of the KP34virus genus. Such as a similar arrangement of 
genes (Figure 4.4) like that of the lysis cassette, arranged sequentially in the order of a 
u-spanin, holin and SAR endolysin (Figure 4.8). However, DNA pairwise identity of 
these phages with the type phage, Klebsiella phage KP34, is low at 7-9%. In addition, 
Coregenes analysis showed that the PhiM1-like phages also possess a number of 
conserved proteins not shared with KP34 (39 vs 29 proteins, respectively) (Table 4.3). 
Furthermore, the amino acid sequence of the recognition and specificity loop of the 
RNAP of KP34 differs with that of PhiM1-like phages (Table 4.4). Interestingly, 
phylograms of the conserved proteins (Figure 5 and Appendix, Figure S4.3) and whole-
genome comparison based on amino acid sequence (Figure 4.6) show a more closely 
placed evolutionary relationship of Vibrio phage V93 and Pantoea phage LIMElight 
with the KP34virus genus than with the PhiM1-like phages. Features that exclude these 
phages from being incorporated into KP34virus genus were that phage V93 possesses a 
distinct lysis cassette and encodes two tail proteins, while phage LIMElight encodes a 
tail fibre protein with greater similarity to phages of SP6virus than to that of KP34 
(Eriksson et al., 2015).   
It is clear that P. carotovorum subsp. carotovorum phages PP16 and PPSW1 and 
Dickeya phage BF25/12 share a close evolutionary relationship with PhiM1-like phages, 
sharing DNA pairwise identity between 47% and 55%. They also form a clade that sits 
on the same branch with that of PhiM1-like phages on phylograms comparing the 
major capsid protein and whole-genome comparison based on amino acid sequences 
of phages of Autographivirinae (Figure 4.5, 4.6). Furthermore, Gegenees analysis 
(TBLASTX) shows an identity of between 54% and 60% (Figure 4.7). However, the 
relationship is more distant than that between phages of the suggested  
‘Phimunavirus’ genus. Thus casting doubt if they should be placed in the genus, 
therefore we have chosen to exclude phages PP16, PPSW1 and BF25/12 from the 
genus at this point in time until the availability of more data on related phages.  
Not all Pectobacterium phages reported to date that have been classified as belonging 
to Autographivirinae resemble phage φM1. For example, Pectobacterium carotovorum 
subsp. carotovorum phage PP2 possesses homology to Cronobacter phage 
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vB_CsaP_Gap277, a phage that has been identified to represent a distinct genus within 
Autographivirinae (Abbasifar et al., 2013; Lim et al., 2017). 
Finally, It has been commented that the split of the Phikmvvirus genus into genera 
better reflecting evolutionary relationships is to date incomplete (Nowicki et al., 2017). 
This concern was highlighted in phylograms constructed in this study with the 
observation of phage LIMElight, which is currently classified as a member of the 
Phikmvvirus, is in fact placed between the genera Fri1virus and KP34virus (Figure 4.5, 
4.6). Since the creation of the Autographivirinae subfamily, many more phages related 
to it have been sequenced. It is clear from the phylograms constructed in this study 
that a taxonomic reassessment of these phages is required to adequately reflect their 
genomic diversity.  
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Chapter 5. Isolation and characterisation of 
Pectobacterium phage vB_PaM_CB7; further 
insights into the genus Cr3virus 
 
Genome sequence of phage CB7 was outsourced to the University of Liverpool, UK. 
Transmission electron microscopy was conducted by Horst Neve. 
Mass Spectrometry analysis of phage proteins was conducted by Hanne Hendrix. 
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5.1. Introduction 
Soft Rot Enterobacteriaceae (SRE) is a group of economically important 
phytopathogenic bacteria that consist of the genera of Pectobacterium and Dickeya, 
both typified by the production of extracellular pectinolytic enzymes upon plant 
infection (Pérombelon, 2002; Toth et al., 2011, 2003). Of these, Pectobacterium 
atrosepticum has traditionally been the most dominant SRE affecting the potato crop 
in temperate climates, causing potato blackleg and soft rot disease (Pérombelon, 2002; 
Toth et al., 2003), infections for which there are no effective bactericides. Control 
strategies used to date are mainly culturing approaches such as the removal of 
diseased tissues and/or plants and the implementation of seed certification schemes 
(Czajkowski et al., 2011).  
Examination of the phages of several well studied SRE members have shown a good 
potential of phages to be exploited for biocontrol (Adriaenssens et al., 2012b; 
Czajkowski et al., 2015; Smolarska et al., 2018). The phages of P. atrosepticum have 
also received this attention (Buttimer et al., 2018a). Currently, it is known that there 
are at least three kinds of phages from the order Caudovirales that infect this 
bacterium (Blower et al., 2012; Buttimer et al., 2018a, 2018b). Of these groups, one 
has been recently formally established as a genus by the ICTV, namely Cr3virus 
(Krupovic et al., 2016). This genus and the genera of V5virus and Se1virus form the 
subfamily Vequintavirinae, which falls within the Myoviridae family (Krupovic et al., 
2016). Before the establishment of the Cr3virus genus, members of this group had 
often been described as being rV5-like, referring to the closely related Escherichia 
phage rV5, the type phage of V5virus (Blower et al., 2012). The type phage of Cr3virus 
is Cronobacter phage CR3 (accession no. JQ691612), the first representative of the 
Cr3virus to have its genome described (Shin et al., 2012), with information on 
Pectobacterium phage ΦTE (accession no. JQ015307) and Cronobacter phage PBES 02  
(accession no. KT353109) becoming available later (Blower et al., 2012; Lee et al., 
2016). These three phages and Cronobacter phage CR8 (accession no. KC954774) and 
CR9 (accession no. JQ691611), for which genome sequences are available on public 
databases (Genbank), officially form the Cr3virus genus. Furthermore, genomes of 
Pectobacterium phages DU_PP_I (accession no. MF979560) and DU_PP_IV (accession 
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no. MF979563) have come available on public databases within the last year and both 
of these share high pairwise nucleotide identity with phage CR3 (>70%), with a similar 
gene arrangement and so they can, therefore, be described as additional members 
within this genus.  
This study reports the analysis of the newly-isolated Pectobacterium phage CB7. 
Phylogenetic analysis of its genome shows that it can be placed within the genus 
Cr3virus. Analysis of this phage provides greater insights into phages of Cr3virus, 
regarding transcription, HNH endonuclease gene splicing, DNA related metabolism and 
virion structure.  
5.2. Results 
5.2.1. Isolation of CB7, host range and general characteristics 
Phage CB7 was isolated from a soil sample collected from potato grading machinery on 
a farm in Co. Cork, Ireland, during the year 2013. The phage was differentiated from 
other phage isolates based upon band patterns observed after restriction digestion 
analysis of its genomic DNA using BgII and SspI (Figure 5.1). Its host range was 
examined using 31 bacterial strains from five different SRE species, namely P. 
atrosepticum (19 strains), P. carotovorum subsp. carotovorum (four strains), D. 
chrysanthemi bv. chrysanthemi (one strain), D. dianthicola (three strains), and D. solani 
(four strains). The phage was found to possess a narrow host only exhibiting activity 
against its host strain P. atrosepticum (DSM 30186) and four other strains of the same 
species (Table 5.1). It produced clear plaques with an approximate diameter of 1-2 mm 
(0.4% LB agar overlay) on the host strain (Appendix, Figure S5.1).  
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Figure 5.1. Genomic DNA of Pectobacterium phage CB7 digested with restriction enzyme BglII 
(A) and SspI (B). Lane 1; DNA marker (Hyperladder 1kb, Bioline), Lane 2; undigested CB7 
genomic DNA, Lanes 3 and 4; digestion of CB7 genomic DNA with BglII and SspI respectively. 
The gel concentration was 0.8 % (w/v).  
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Table 5.1. Host range of Pectobacterium phage vB_PatM_CB7 (CB7) on 31 strains of soft rot 
Enterobacteriaceae as determined by spot testing with a serial dilution of phage.  
Species Strain Sensitivity 
Pectobacterium atrosepticum DSMZ  18077 (type strain) - 
DSMZ 30184 - 
DSMZ 30185 + 
DSMZ 30186 +* 
CB BL1-1 - 
CB BL2-1 + 
CB BL3-1 + 
CB BL4-1 + 
CB BL5-1 - 
CB BL7-1 - 
CB BL9-1 - 
CB BL11-1 - 
CB BL12-2 - 
CB BL13-1 - 
CB BL14-1 - 
CB BL15-1 - 
CB BL16-1 - 
CB BL18-1 - 
CB BL19-1 - 
Pectobacterium carotovorum subsp. carotovorum DSMZ 30168 (type strain) - 
DSMZ 30169 - 
DSMZ 30170 - 
CB BL19-1-37 - 
Dickeya chrysanthemi bv. chrysanthemi LMG 2804 - 
Dickeya dianthicola PD 482  - 
PD 2174   - 
GBBC 1538 - 
Dickeya solani sp. PRI 2222 (D36) - 
LMG 25865 (D10) - 
GBBC 1502 - 
GBBC 1586  - 
Erwinia amylovora LMG 2024  - 
GBBC 403 - 
Erwinia mallotivora LMG 1271 - 
Results recorded as +, sensitive; −, no infection; * host strain of phage 
The one-step growth curve assay, using standard growing conditions with LB medium, 
showed that CB7 possesses a latent period of 55 min with an approximate burst size of 
154 PFU/cell (Figure 5.2). This differs to the CR3-like phage Cronobacter phage PBES 02 
which has a latent period of 30 min and a burst size of 250 PFU/cell, the only 
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representative for which such data is available (Lee et al., 2016). The stability of the 
phage was also examined under different conditions of temperature and pH. Over one 
hour, the phage was found to be stable between the temperatures of -18 ºC and 55 ºC 
(Figure 5.3), and over a period of 24 h was stable between a pH of 5 and 11 (Figure 
5.4). Temperature stability of CB7 is similar to that of phage PBES 02, but its pH 
stability range appears to be slightly wider (Lee et al., 2016).  
 
 
Figure 5.2. Single step growth curve analysis of Pectobacterium phage CB7 on P. atrosepticum 
strain DSM 30186. The assay was performed in triplicate and the results were averaged.  
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Figure 5.3. Stability of Pectobacterium phage CB7 to various temperatures upon one-hour 
exposures. Error bars represent the standard deviation of biological repeats (n=3). 
 
 
Figure 5.4. Stability of Pectobacterium phage CB7 to various pH values upon 24 hours of 
exposure. Error bars represent the standard deviation of biological repeats (n=3). 
 
Transmission electron microscopy showed that CB7 possesses an A1 morphotype 
(Figure 5.5), allowing it to be classified as a member of the family of Myoviridae  
(Ackermann, 2001). The phage possesses an icosahedral head (84.05 ± 3.88 nm in 
diameter, n=11), with clearly distinguishable hexagonal outlines, and a contractile tail 
(123.39 ± 2.63 nm x 20.18 ± 1.05 nm, n=8) possessing tail fibres (length: 42.40 ± 3.68 
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nm, n=6). The phage was named in accordance with the nomenclature set out by 
Kropinski et al. (2009).  
 
 
Figure 5.5. Transmission electron micrographs of negatively stained Pectobacterium phage CB7 
with 1% (w/v) uranyl acetate. Scale bar represents 100 nm. 
5.2.2. General genome characteristics of CB7 
Genome sequencing of CB7 revealed a size of 142,778 bp (coverage 2554x) and 
examination of sequence reads indicated that its genome is likely circular permuted 
like that of Coliphage T4 (Casjens and Gilcrease, 2009) due to there being no region 
possessing significantly higher read depths than that of the average read depth across 
the entire genome. BAL-31 exonuclease time course treatment of the genome 
followed by restriction digestion with BglII agrees with the above finding with no bands 
found to be preferentially degraded following examination by agarose gel 
electrophoresis (Figure 5.6). A similar result was obtained with the closely related 
Pectobacterium phage ΦTE (Blower et al., 2012). Therefore, since the genome is 
believed to be circularly permuted the start position of its Genbank file was matched 
to that of Cronobacter phage CR3. Additionally, the  G+C content of its genome was 
found to be 50.1%, a value similar to what would be typically expected for its host 
species, P. atrosepticum (50-51%) (Bell et al., 2004; Nikolaichik et al., 2014).  
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Figure 5.6. Treatment of Pectobacterium phage CB7 genomic DNA with BAL-31 for 60 min 
(Lane 1), 80 min (Lane 2), 100 min (lane 3), 120 min (Lane 4), 140 min (Lane 4), 160 min (Lane 
5), 180 min (Lane 6) and (Lane 7) 200 min followed with restriction digestion with BglII. 
Molecular weight marker (Hyperladder 1kb, Bioline) (lane 8). Gel concentration 1% (w/v) 
agarose. 
 
The genome of CB7 was determined to contain 253 ORFs (Figure 5.7 and Appendix, 
Table S5.1). Based upon the orientation of these ORFs the genome can be divided into 
four regions, namely region 1 (CB7_241 - 37), region 2 (CB7_38 - 103), region 3 
(CB7_104 - 143) and region 4 (CB7_144 - 240). ORF orientation correlates well with GC 
skew (Marín and Xia, 2008). Using in silico analysis based on protein sequence 
homology, protein structure homology, lipoprotein and transmembrane analysis, and 
as well as ESI-MS/MS spectrometry, it was possible to identify a role for 81 (32%) of 
these putative proteins. The remaining proteins could be categorised as either 
hypothetical proteins (9), conserved hypothetical proteins (143), putative lipoproteins 
(3), conserved (4) and hypothetical (13) transmembrane proteins. Additionally, one 
tRNA gene for tyrosine was identified. No ORFs were identified to encode integrase, 
excisionase nor repressor proteins, indicating that the phage likely follows an 
exclusively lytic lifestyle.  
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Figure 5.7. Summary of the 
genomic organisation of the 
142,778 bp genome of 
Pectobacterium phage CB7. On 
the outer ring, putative ORFs 
are represented by purple 
arrowheads labelled with 
predicted function where 
possible. On the middle ring is 
shown GC content relative to 
the mean GC content of the 
genome. On the inner ring, GC 
shew is illustrated where green 
represents a positive skew and 
purple a negative skew. 
Created using GCview. 
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5.2.3. Phylogenetic analysis; CB7 is a member of Cr3virus and the status of 
Vequintavirinae 
Examination of the genome of CB7 with the BLASTN algorithm showed that the phage 
has significant homology with phages of the genus Cr3virus (≥60% identity), sharing a 
similar arrangement of genes (Table 5.2, Figure 5.8). Coregenes analysis also showed a 
large number of shared proteins (Table 5.2), confirming CB7 to be a member of the 
genus Cr3virus. Furthermore, construction of phylograms (with confident bootstrap 
values) using the large terminase, major head and DNA polymerase proteins of phages 
within the subfamily of Vequintavirinae placed CB7 within a clade that represents the 
genus of Cr3virus (Figure 5.9). This was further supported by the creation of a GBDP 
phylogram using VICTOR (Figure 5.10) and Gegenees analysis (TBLASTX) where CB7 
was shown to possess 55% to 86% identity within a clade representing Cr3virus (Figure 
5.11).  
 
Table 5.2. Properties of the five phages of Cr3virus and Pectobacterium phages DU_PP_I, 
DU_PP_V and CB7 and comparison of all seven with the type phage CR3 
*DNA identity in comparison to CR3 using BLASTN., **Number of homologous proteins in 
comparison to CR3 using Coregenes. 
Phage Accession 
no. 
Genome 
size (bp) 
G+C 
content, 
% 
ORFs tRNA Identity 
(%)* 
Shared 
proteins 
(%)** 
Cronobacter phage CR3 JQ691612 149,273 50.9 265 18 100 100 
Cronobacter phage CR8 KC954774 149,162 50.8 269 17 94 80 
Cronobacter phage CR9 JQ691611 151,924 50.6 281 17 70 89 
Cronobacter phage 
PBES 02 
KT353109 149,732 50.7 270 14 64 90 
Pectobacterium phage 
DU_PP_I 
MF979560 144,959 50.1 267 8 73 80 
Pectobacterium phage 
DU_PP_IV 
MF979563 145,233 50.3 268 8 73 80 
Pectobacterium phage 
vB_PatM_CB7 
KY514263 142,778 50.1 253 1 64 70 
Pectobacterium phage 
ΦTE 
JQ015307 142,349 50.1 242 2 62  63 
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Figure 5.8. Comparison of the genome of Pectobacterium phage CB7 to other CR3-like phages 
(Pectobacterium phage ΦTE and Cronobacter phages PBES 02, CR3, CR8 and CR9) using 
currently available annotations employing TBLASTX and visualised with Easyfig. A bar chart 
shows the G+C skew of the CB7 genome, genome maps comprise of orange arrows indicating 
locations of genes among the different phage genomes; and lines between genome maps 
indicate the level of identity (blue/turquoise; genes sharing orientation, red/orange; genes 
with inverted orientation). The large terminase was set as the first gene among all genomes. 
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Figure 5.9. Phylograms constructed using the large terminase (A), major head (B) and DNA 
polymerase (C) of Pectobacterium phage CB7 and homologs of 17 phages of the subfamily of 
Vequintavirinae analysed using maximum likelihood (Whelan and Goldman substitution 
model), with 1000 bootstrap replicates using MEGA7. Members of the genera of Se1virus, 
V5virus and Cr3virus are illustrated. 
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Figure 5.10. VICTOR generated phylogenomic GBDP tree of Pectobacterium phage CB7 and 17 
members of Vequintavirinae subfamily inferred using the formula D4 and yielding average 
support of 87%. The numbers above branches are GBDP pseudo-bootstrap support values 
from 100 replications. Members of the genera of Se1virus, V5virus and Cr3virus are illustrated. 
 
 
Figure 5.11. TBLASTX heat map generated using Gegenees with accurate parameters - 
fragment length: 200 bp; and step size: 100 bp; threshold: 0%. The map includes the genomes 
of Pectobacterium phage CB7 and 17 members of Vequintavirinae subfamily. Members of the 
genera of the Se1virus (brown), Cr3virus (blue), and V5virus (pink) are illustrated. 
 
Analysis performed in this work showed that there are currently eight phage genomes 
in the public databases that can be classified as Cr3virus. New additions to the genus 
other than CB7, are Pectobacterium phages DU_PP_I and DU_PP_IV (Table 5.2). 
Generally, phages within the Cr3virus genus possess genome sizes that range between 
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142,349 bp (φTE) and 151,924 bp (CR9) and possess an average G+C content of 
50±0.34%. Total ORF number range from 242 (φTE) to 281 (CR9), with Coregenes 
showing that they share a minimum of 166 proteins in comparison to phage CR3. 
However, there is a large variation in tRNA gene content among these phages. Those 
infecting Cronobacter possess between fourteen (PBES 02) and eighteen (CR3) tRNA 
genes, while those infecting Pectobacterium is much lower: one (CB7) to eight 
(DU_PP_I and DU_PP_IV) tRNA genes.  
5.2.4. Transcription, promoters and terminators 
Phage CB7 does not contain an RNA polymerase suggesting that it is totally dependent 
on host-encoded RNA polymerase for transcription. However, no proteins that could 
potentially play a role in the takeover of host RNA polymerase causing its redirection 
to host promoters were identified, as seen in Escherichia phage T4 (Hinton, 2010). 
A putative promoter with the consensus of AAAA(N3)TGTTGAC(N19)TATAAT was 
identified at 13 sites on the genome of CB7 (Appendix, Table S5.2). The sequence of 
this putative promoter resembles the consensus sequence of the sigma70 promoters 
of E. coli, possessing -10, -35 and the UP elements (Hinton, 2010). The locations of this 
promoter are heavily concentrated within a region containing a large number of ORFs 
encoding short hypothetical proteins (likely early gene region), with some located 
within a region possessing genes for a DNA helicase, DNA methylase and DNA 
polymerase (Figure 5.12). Based on the gene products downstream of these promoter 
sites, it would suggest the promoter may play a role in early and possibly middle phase 
transcription. Moreover, analysis of genomes of Cronobacter phages CR3, CR8 and CR9 
showed that this putative promoter is also present among their genomes, with 21, 21 
and 13 sites being identified respectively (Appendix, Table S5.3, S5.4 and S5.5, Figure 
S5.2, S5.3 and S5.4). Like CB7, the promoter is concentrated within a localised region 
containing a large number of ORFs encoding short hypothetical proteins (likely early 
gene region), as well as also being located near a small number of ORFs with gene 
products involved in DNA replication and nucleotide metabolism (likely middle gene 
region). Identification of this promoter among these additional phages suggests it may 
represent part of a conserved transcription strategy being employed among members 
 
 
117 
 
of Cr3virus. Furthermore, 27 putative rho-independent terminators were also 
identified on the genome of CB7 (Appendix, Table S5.6).   
 
 
Figure 5.12. Genome map of Pectobacterium phage CB7 showing locations of a putative 
sigma70-like promoter with the consensus sequence AAAA(N4)TGTTGAC(N17)TATAAT. The 
map comprises of arrows indicating the location of ORFs. Arrows have been colour-coded 
describing their predicted role (see key). The genome map was created with Snapgene. 
 
5.2.5. DNA replication, methylation and nucleotide metabolism 
Within the genome of CB7, ORFs for proteins associated with functions related to DNA 
replication were mostly found within gene region 2 while those for nucleotide 
metabolism were mostly found within gene region 4 (Figure 5.7). The phage was 
identified to have several proteins that would be involved in DNA replication such as a 
DNA polymerase (CB7_49, 51, 53), DNA ligase (CB7_234), helicase (CB7_80) and a 
putative primase (CB7_73). There is also a homolog of recombination endonuclease VII 
of Escherichia phage T4 (CB7_214). In phage T4, this protein is involved in DNA 
mismatch repair and assists in DNA packaging by removing branched replicative DNA 
(Shcherbakov et al., 2011).  
The phage genome also encodes proteins involved in nucleotide metabolism, such as 
aerobic class I ribonucleotide reductase (RNR) subunits NrdA (CB7_195, 197) and NrdB 
(CB7_201, 203) with the role of deoxynucleoside triphosphates (dNTP) synthesis during 
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aerobic conditions. In addition, it also encodes anaerobic class III ribonucleotide 
reductase subunits NrdG (CB7_187) and NrdD (CB7_188), which enable dNTP 
production during anaerobic conditions. These classes of RNRs have been identified 
among a number of phage genomes on Genbank (Lundin et al., 2009). Additionally, the 
RNR class I function of CB7 can potentially be supported by glutaredoxin (CB7_189) 
allowing RNR reduction through acting as an electron carrier (Feeney et al., 2012). The 
phage is also capable of influencing the deoxythymidine monophosphate (dTMP) pool 
of the host by using deoxyuridine monophosphate (dUMP) with its thymidylate 
synthase (CB7_206) (IPR003669). It also has a ribose-phosphate pyrophosphokinase 
(CB7_242) (IPR005946) which forms the precursor phosphoribosyl pyrophosphate 
(PRPP) which can be used in the biosynthesis of purine and pyrimidine nucleotides. 
PRPP can also be used by CB7 with its nicotinamide phosphoribosyltransferase 
(CB7_244, 246) to produce nicotinamide mononucleotide, an intermediate in the 
production of coenzyme nicotinamide adenine dinucleotide (NAD).  
The phage is also capable of influencing the tRNA pool of the host with a tRNA 
nucleotidyltransferase (CB7_179) (IPR012006) which synthesises or repairs the 3' 
terminal CCA sequence of tRNA molecules. 
The identification of two kinds of DNA methylase enzymes on phage CB7 (CB7_63, 183) 
indicates that its genome is likely to be adenine and cytosine methylated, given that it 
has a putative N-6 adenine-specific DNA methylase (DAM) (IPR002052) and DNA 
cytosine methylase (HHpred analysis: best hit; 5-cytosine DNA methyltransferase of 
Entamoeba histolytica, PDB accession no. 3QV2_A). Indeed, restriction digestion 
patterns of the genomic DNA of CB7 using ClaI does indicate that its DNA is likely to be 
DAM methylated (Figure 5.13).   
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Figure 5.13. (A) Genomic DNA of Pectobacterium phage vB_PatM_CB7, which had been 
digested with restriction enzyme ClaI (Lane 1), with DNA marker (Hyperladder 1kb, Bioline) 
(Lane MW).  (B) In silico digest of CB7 genomic DNA with ClaI with DAM methylation (Lane 2); 
without DAM methylation (Lane 3); DNA marker (Hyperladder 1kb, Bioline) (Lane MW). Gel 
concentration 1% (w/v) agarose. Image B was generated using Snapgene. 
Comparison of CB7 to other members in Cr3virus genus using ACT (TBLASTX) showed 
that the majority of the previously discussed proteins involved in DNA replication, 
methylation and nucleotide metabolism are shared across the genus (Appendix, Table 
S5.7). The exceptions to this are a homolog of the putative DNA cytosine methylase 
not shared with Pectobacterium phages ΦTE, DU_PP_I and DU_PP_IV. Another 
variation identified was that NrdD and NrdG of CB7 were only shared with ΦTE among 
the genus. These gene product variations suggest that there may be small differences 
between members of Cr3virus regarding DNA methylation and nucleotide metabolism; 
unless proteins for which a function could not be defined among these phages perform 
a similar role. Additional comparison (using ACT with TBLASTX) between CB7 and type 
phages rV5 and PVP-SE1 revealed differences in gene product content. (Appendix, 
Table S5.8). Both type phages were found not to share a homolog of CB7 DNA ligase. 
Furthermore, phage rV5 was identified to not have homologs of the CB7 tRNA 
nucleotidyltransferase and nicotinamide phosphoribosyltransferase.  
5.2.6. Selfish genetic elements within the genome of CB7 
Homing endonucleases are mobile genetic elements consisting of genes that encode a 
protein with endonuclease activity that promotes the lateral transfer of their own 
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encoding gene. These endonucleases can recognise specific DNA sequences at which 
they initiate catalysis causing DNA strand breakage resulting in the insertion of a 
homing endonuclease encoding gene, due to DNA cellular mechanisms that rely on 
homologous recombination (the process being termed homing). Introns are segments 
of DNA that are removed from a mature mRNA post-transcription, while inteins are 
self-splicing protein elements that self-excise from a protein precursor with the 
concomitant post-translation ligation of C- and N-terminal segments called exteins. 
Homing endonucleases can be found associated with these elements but can simply 
exist as a free-standing gene (Chevalier and Stoddard, 2001). A significant number of 
homing endonucleases have been characterised among phages and shown to have 
recognition sites that lie within genes related to DNA  replication and metabolism 
(Edgell et al., 2000), but they have also been identified  to target genes related to 
virion structure  (Kala et al., 2014; Pope et al., 2013).   
On the genome of CB7, twenty-one homing endonucleases of the HNH family 
(IPR003615, IPR029471) were identified (twenty HNHs confirmed with Interproscan, 
and one HNH identified with HHpred). Five of these HNH homing endonucleases were 
associated with an intron, with the remaining identified as free-standing genes (Table 
5.3). ORFs for these homing endonucleases were found to cover approximately 7 % of 
the genome of CB7. 
A single intron with an HNH gene was found to be interrupting ORFs for the large 
terminase (CB7_1,3), ribonucleotide-diphosphate reductase (CB7_195, 197) and 
nicotinamide phosphoribosyltransferase (CB7_144, 246), with two introns with an HNH 
gene, found to be interrupting ORFs of the DNA polymerase (CB7_49, 51, 53), with an 
additional HNH gene at the 5’ end of this gene product. These can be categorised as 
being group 1 introns as they possess homing endonucleases of the HNH family 
(Chevalier and Stoddard, 2001).  
RT-PCR was performed to investigate splicing of the previously described introns at the 
mRNA level. Total RNA was extracted from cells of P. atrosepticum strain DSM 30186 
infected with phage CB7 at different time points (15 min, 30 min and 45 min). The 
resulting cDNA was then investigated for splicing using PCR with primers 
complementary to the 5’ and 3’ ends of the HNH endonuclease genes being examined 
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and using CB7 genomic DNA as a control. The size of the resulting PCR product was 
then compared to that obtained from CB7 genomic DNA (Figure 5.14). Splicing was 
shown to occur for introns containing an HNH for gene products of the large terminase 
(CB7_3), ribonucleotide reductase NrdB (CB7_196), nicotinamide 
phosphoribosyltransferase (CB7_202) and DNA polymerase (CB7_50,51). This was 
supported by the appearance of PCR products derived from cDNA that were smaller 
than that those obtained from CB7 genomic DNA, indicating that splicing had occurred 
at the mRNA level causing the removal of HNH ORF sequences, thus resulting in 
smaller PCR products.  
No splicing occurred for DNA polymerase HNH CB7_54, situated at the 5’ end of ORF 
CB7_53. This is likely to be due to the likely free-standing nature of this HNH and not 
being part of an intron. However, HNH CB7_245 is associated with an intron that 
interrupts the ORFs of nicotinamide phosphoribosyltransferase and was not found to 
be removed by splicing at the mRNA level. The existence of introns with an HNH that 
do not splice post-transcription (like that of the intron with HNH CB7_245) has been 
previously described. Aeromonas phage Aeh1 anaerobic ribonucleotide reductase 
subunit NrdA is split by an intron that contains an HNH endonuclease (mobE) and does 
not splice post-transcription. This intron causes NrdA to be translated as two separate 
peptides that associate with each other post-translation along with ribonucleotide 
reductase NrdB subunit while still retaining activity (Friedrich et al., 2007). This may 
also be the case for the nicotinamide phosphoribosyltransferase of CB7. The above 
HNH splicing results of CB7 were further confirmed by performing Sanger sequencing 
on the PCR products derived from cDNA. 
Three inteins were identified among the ORFs of CB7, namely the putative helicase 
(CB7_80), the ribonucleotide reductase NrdB (CB_197) and NrdA (CB7_201) (Table 
5.3). Furthermore, the inteins of ORFs CB7_80 and CB7_201 were found to contain the 
homing endonuclease of the LAGLIDADG family (IPR004860). Experiments were not 
conducted to determine the splicing nature of these elements within the time-frame of 
this study. 
In total, twenty-three homing endonucleases were identified to be present on the 
genome of CB7. This is one of the largest quantities of homing endonucleases 
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identified on a phage genome examined in literature to date, greater than that 
described for Escherichia phage T4, which possesses fifteen homing endonucleases - 
one of the highest known among T4-like phages (Edgell et al., 2010). Most of the 
homing endonucleases of CB7 are shared with Pectobacterium phage ΦTE, and less so 
with the Cronobacter phages of the Cr3virus genus (Table 5.3). Cronobacter phage CR3 
is only predicted to possess two HNH homing endonucleases. The presence of a high 
number of homing endonucleases appears to be a common trend among many phage 
types infecting bacteria of SRE group (Adriaenssens et al., 2012b;-Buttimer-et-al.,-
2018b,-2018a).
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Table 5.3. Inteins and homing endonucleases (free-standing or intron-associated) identified in the genome of Pectobacterium phage CB7, using ACT 
(TBLASTX) for comparison with Pectobacterium phage ΦTE and Cronobacter phage Cr3. 
ORF/associated 
ORF 
Selfish genetic element Homing 
endonuclease 
family 
Gene product function of the 
targeted gene 
Does splicing 
occur (mRNA 
level)? 
Shared 
with ΦTE 
Shared with 
Cr3 
CB7_2 intron associated with 
homing endonuclease 
HNH large terminase (CB7_1,3) Yes Shared No 
CB7_38 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_48 free-standing homing 
endonuclease 
HNH _ _ No No 
CB7_50 intron associated with 
homing endonuclease 
HNH DNA polymerase (CB7_49, 51) Yes Shared No 
CB7_52 intron associated with 
homing endonuclease 
HNH DNA polymerase (CB7_51, 53) Yes Shared No 
CB7_54 free-standing homing 
endonuclease 
HNH _ No shared No 
CB7_62 free-standing homing 
endonuclease 
HNH _ _ No No 
CB7_80 intein associated with 
homing endonuclease 
LAGLIDADG putative helicase (CB7_80) _ Shared _ 
CB7_109 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_143 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_180 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_182 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_196 intron associated with 
mobile genetic element 
HNH ribonucleotide reductase NrdB, 
part 1 & 2 (CB7_195, 197) 
Yes No No 
CB7_197 intein with no homing _ ribonucleotide reductase NrdB, _ Shared _ 
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endonuclease part 2 (CB_197) 
CB7_201 intein associated with 
homing endonuclease 
LAGLIDADG ribonucleotide reductase NrdA, 
part 1 (CB7_201) 
_ Shared _ 
CB7_202 intron associated with 
homing endonuclease 
HNH ribonucleotide reductase NrdA 
(CB7_201, 203) 
Yes Shared No 
CB7_212 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_219 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_220 free-standing homing 
endonuclease 
HNH _ _ Shared Shared 
CB7_221 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_230 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_243 free-standing homing 
endonuclease 
HNH _ _ Shared No 
CB7_245 intron associated with 
homing endonuclease 
HNH nicotinamide 
phosphoribosyltransferase 
(CB7_245) 
No Shared No 
CB7_249 free-standing homing 
endonuclease 
HNH _ _ No No 
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Figure 5.14. Gel images showing PCR products demonstrating splicing of intron-associated 
homing endonucleases associated with Pectobacterium phage CB7 using primers 
complementary to the 5’ and 3’ ends of the ORFs. (A) CB7_2; HNH endonuclease situated 
between ORFs encoding the large terminase (CB7_1,3),  (B) CB7_50 and CB7_52; two HNH 
endonucleases situated between the ORFs encoding the DNA polymerase (CB7_49, 51, 53), (C) 
CB7_54; HNH endonuclease situated between the ORFs encoding the DNA polymerase 
(CB7_53) and a structural protein (CB7_55), (D) CB7_196; HNH endonuclease situated between 
the ORFs encoding the ribonucleotide-diphosphate reductase (CB7_195, 197), (E) CB7_202; 
HNH endonuclease situated between the ORFs encoding the ribonucleoside triphosphate 
reductase (CB7_201, 203), (F) CB7_245; HNH endonuclease situated between the ORFs 
encoding the nicotinamide phosphoribosyltransferase (CB7_244, 246). First and last lanes in 
each gel contain DNA marker (Hyperladder 1kb, Bioline), the molecular mass of bands is 
illustrated. Images A & B: PCR products using cDNA (Lanes 2, 4 & 6) and genomic DNA of 
Pectobacterium phage CB7 (Lane 8) and negative controls with water (Lanes 3, 5, 7 & 9). Lanes 
2, 4 & 6 used cDNA from phage host infections times points of 15 min and 30 min and 45 min, 
respectively. Images C, D, E & F: PCR products using cDNA (Lanes 2 & 4) and genomic DNA of 
Pectobacterium phage CB7 (Lane 6) and negative controls with water (Lanes 3, 5 &7). Lanes 2 
& 4 used cDNA derived from RNA from phage host infections times points of 15 and 30 min, 
respectively. 
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5.2.7. Structural proteome of CB7 
The majority of ORFs identified to encode proteins involved in the morphogenesis of 
the virion of CB7, including the large terminase (CB7_1, 3) which plays a role in the 
capsid packaging of genomic DNA, are located within gene region 1 of the CB7 
genome. One exception was the ORF of structural protein CB7_55, which is situated in 
gene region 2 (Figure 5.7). ESI-MS/MS analysis was conducted on the virion of CB7, and 
this is the first phage of the Cr3virus genus to have such analysis described. A total of 
twenty-six proteins were identified to form its virion (Table 5.4). Those for which a 
function could be inferred were putative tail proteins (CB7_17, 18, 23, 26, 31), tail fibre 
proteins (CB7_10, 36), tail baseplate proteins (CB7_27, 28, 29, 30) and capsid proteins 
(CB7_4, 5, 7, 8). In silico analysis of the other eleven structural proteins identified 
failed to find a putative role.   
Putative structural protein CB7_32 was identified to encode a tail assembly protein 
due to it possessing a phage T4 gp38 tail assembly domain (IPR003458). This was not 
detected by mass spectrometry (MS) analysis. Protein gp38 of phage T4 acts as a 
chaperone protein in the assembly of the long tail fibre and is not present in the 
mature phage particle. This may also be the case for the gene product of CB7_32. 
Proteins that may be involved in host recognition are CB7_10 and CB7_36 as they may 
play a role in the structure of phage tail fibres. Gene product CB7_10 possesses a 
collagen domain (IPR008160); and such domains are commonly associated with phage 
tail fibre proteins (Ghosh et al., 2012). Additionally, the putative tail collar protein 
CB7_31 may also play a role in host cell attachment given that it possesses an Ig-
domain (IPR003343). Such domains commonly occur on several phage virion proteins 
such as the tail fibre, the baseplate wedge initiator, the major tail and major capsid 
proteins. It is believed that this domain may interact weakly with carbohydrates 
present on the host cell surface (Fraser et al., 2006). 
Comparison between phages of the Cr3virus genus shows that the majority of the 
identified structural proteins of phage CB7 are shared among members. Exceptions to 
this are CB7_55, with homologs of this protein only shared with phages outside the 
Cr3virus genus, such as Erwinia phages PhiEaH1 (accession no. YP_009010139) and 
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vB_Eam_Stratton (accession no. ANZ50590). In addition, the structural protein 
CB7_251 only has a homolog on phage ΦTE (Appendix, Table S5.9).  
When type phages rV5 and PVP-SE1 were first described, the number of proteins that 
were identified to form the virion of these phages were sixteen and thirty-six proteins 
respectively. MS analysis of both of these virions allowed the confirmation of six (for 
rV5) and twenty-five (for PVP-SE1) of these proteins (Kropinski et al., 2013; Santos et 
al., 2011). Comparisons of these two phages with CB7 show that they share twenty 
structural proteins, with highly limited homology occurring between several proteins 
predicted to play roles in tail fibre structure (Appendix, Table S5.10).  
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Table 5.4. Results of tandem mass spectrometry of proteins of the Pectobacterium phage CB7 
virion. 
ORF Predicted function Protein molecular 
weight (kDa) 
No. of 
unique 
peptides 
Sequence 
coverage % 
CB7_4 putative portal protein 55.37 36 76 
CB7_5 putative prohead core protein 
protease 
21.35 2 18 
CB7_6 unknown structural protein 40.57 3 15 
CB7_7 putative head 
stabilization/decoration protein 
15.6 16 97 
CB7_8 putative major head protein 37.6 30 93 
CB7_10 putative tail fibre protein 111.95 38 46 
CB7_11 unknown structural protein 24.54 7 37 
CB7_12 unknown structural protein 17.19 9 48 
CB7_13 unknown structural protein 20.14 4 32 
CB7_15 unknown structural protein 16.58 5 44 
CB7_16 unknown structural protein 26.47 3 16 
CB7_17 putative tail sheath protein 50.69 26 89 
CB7_18 putative tail tube protein  17.2 6 45 
CB7_23 putative tape measure protein  87.72 30 40 
CB7_24 unknown structural protein 31.67 5 25 
CB7_25 unknown structural protein 14.38 1 15 
CB7_26 putative tail protein 36.5 1 5 
CB7_27 putative baseplate protein  26.42 9 65 
CB7_28 putative tail lysozyme 20.45 1 11 
CB7_29 putative baseplate wedge protein 54.37 9 23 
CB7_30 putative baseplate protein 24.2 11 57 
CB7_31 putative tail collar protein 59.21 19 47 
CB7_36 putative tail fibre protein 81.89 19 34 
CB7_37 unknown structural protein 43.48 1 21 
CB7_55 unknown structural protein 26.53 4 24 
CB7_251 unknown structural protein 19.68 1 10 
 
5.2.8. Cell wall degrading enzymes and cell lysis proteins 
Peptidoglycan degrading enzymes are used during the initial steps of phage infection 
to penetrate the host cell wall during injection of phage DNA (virion-associated lysins). 
They are also employed during host cell lysis at the end of the phage lytic cycle 
(endolysins) (Oliveira et al., 2018). Three potential peptidoglycan-degrading enzymes 
were identified in the genome of CB7 (Appendix, Table S5.11). CB7_28 is a putative 
virion-associated lysin and HHpred analysis of this protein and its homologs among 
Cr3virus and phages rV5 and PVP-SE1 showed that they are homologous to gp25 of 
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Escherichia phage T4 (using CB7_28; best hit gp25-like lysozyme of Geobacter 
sulfurreducens, PDB accession no. 2IA7_A). This protein of phage T4 forms part of the 
phage’s baseplate and possesses acidic lysozyme activity (Szewczyk et al., 1986). 
CB7_83 is predicted to be a putative cell wall hydrolase (N-acetylmuramyl-L-alanine 
amidase) resembling SleB, a protein in Bacillus subtilis responsible for hydrolysis of the 
spore cortex during germination (IPR011105). Homologs of CB7_83 were identified 
among members of all genera within the Vequintavirinae subfamily. A homolog of this 
protein in Cronobacter phage CR3 (namely, CR3_087) has been implicated in host lysis 
(Shin et al., 2012). Additionally, analysis of this protein with SignalP predicts the 
presence of a putative N-terminal peptide signal. This feature is recognised by the cell 
secretary system allowing transport of the protein across the inner membrane into the 
periplasm of the cell or to the extracellular space, with proteolytic cleavage of the 
signal peptide sequence (Ivankov et al., 2013). CB7_190 is a potential peptidase 
(IPR009045) with HHpred analysis showing homology to the endolysin of Escherichia 
phage T5 (L-alanyl-D-glutamate peptidase, PDB accession no. 2MXZ). This putative 
peptidoglycan degrading enzyme has only been identified in Pectobacterium phages 
CB7 and ΦTE (phiTE_147) within the CR3virus genus with the other genus members 
having a putative peptidoglycan degrading enzyme of different origin and possibly 
enzymatic activity (IPR023346). 
A putative Rz/Rz1 spanin pair (CB7_252/253) was also identified: these proteins are 
shared among members of the Cr3virus genus as well as phages rV5 and PVP-SE1 
(Appendix, Table S5.11). They play a role in the destruction of the outer membrane of 
Gram-negative cells during host cell lysis allowing progeny phage release at the end of 
infection. Like other spanin proteins, the CB7_252/25 products are typical examples, 
one possessing an N-terminal transmembrane domain and the other possessing a 
lipoprotein signal sequence (Summer et al., 2007). The ORFs of these consist of 
separate coding sequences where the stop codon of the Rz gene overlaps with the 
start codon of the Rz1 gene. This gene arrangement is in common with Escherichia 
phage T4 (Summer et al., 2007). For CB7, rV5 and PVP-SE1, this spanin protein pair is 
not associated with a classic lysis cassette as their genes are located next to those of 
the large terminase. A similar gene arrangement has also been seen in a number of 
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Podoviruses such as Vibrio phage VP4 and Enterobacteria phage SP6 (Summer et al., 
2007).  
Another class of proteins associated with host lysis are holins. These create openings in 
the host cell periplasm allowing the phage endolysin to access cell wall peptidoglycan 
(Barenboim et al., 1999). As CB7 (including other members of Cr3virus) does not 
appear to have a classic lysis cassette, where all the lysis genes are in proximity to each 
other, this makes the identification of candidate holins difficult. However, in the case 
of CB7, a hypothetical membrane protein (65 amino acid residues in length) was 
observed, whose ORF overlaps that of its putative SleB-like protein CB7_83. This 
protein is predicted to possess two transmembrane domains where its N - and C - 
termini are situated in the host cell cytoplasm, making it a strong candidate for a class 
two holin (CB7_82) (Barenboim et al., 1999). A similar protein is found among a 
number of other phages of the Cr3virus genus (phage CR9 being an exception) 
downstream of their SleB-like protein (Appendix, Table S5.11). 
Phage CB7 does not appear to have homologs of rIIA and rIIB, which are present in rV5 
and PVP-SE1. The function of these proteins are not well understood but they are 
thought to have an influence on the regulation of host lysis relating to membrane 
integrity and energetics (Paddison et al., 1998) 
5.3. Discussion 
The Cr3virus ICTV-defined genus is the first to date, which includes phages that infect 
P. atrosepticum. However, the coming years should see the creation of additional 
genera with at least two other phage types known which infect that bacterial species 
(Buttimer et al., 2018a, 2018b). The categorisation of phage within defined genera 
should assist in understanding their biology and indeed in their selection as biocontrol 
agents by knowing more about their various shared properties.  
Phylogenetic analysis in this study allowed the positioning of Pectobacterium phage 
CB7 within Cr3virus (Table 5.2, Figure 5.9, 5.10, 5.11). Examination of this phage and 
comparative analysis with other phages within the genus show they possess a 
conserved transcriptional strategy, involving the use of a promoter with elements 
resembling that of the E. coli sigma70 promoter (Appendix, Tables S5.2.-S5.5.). 
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Moreover, these phages appear to possess conserved strategies of DNA replication, 
DNA metabolism, host lysis and virion structure as indicated by their shared protein 
content associated with these processes. However, there also appears to be limited 
diversity within the genus, such as members not sharing homolog proteins involved in 
DNA methylation, nucleotide metabolism, virion structure and those involved in 
peptidoglycan degradation (Appendix, Table S5.7, S5.9, S5.11).  
Of the twenty-six structural proteins identified to form the virion of phage CB7 (Table 
5.4), twenty were found to be shared with the type phages rV5 and PVP-SE1 of V5virus 
and SE1virus, respectively (Appendix, Table S5.10). The differences within protein 
content among these phages are concentrated within those proteins predicted to form 
the tail fibre. Such differences likely reflect the adaption of the tail fibre of these 
phages to allow the recognition of their respective host cell receptors. 
Both Pectobacterium phage ΦTE and Cronobacter phage CR3 are flagellum-dependent 
for the recognition of their respective host bacterium and the feature is likely shared 
among all the Cr3virus members (Blower et al., 2012; Shin et al., 2012). 
Pectobacterium phage ΦATI described by Evans et al. (Evans et al., 2010b) shares this 
flagellum receptor specificity and is likely a Cr3virus, with currently available partial 
genome sequences of this phage (Genbank accession nos. FN396585, FN396583 and 
FN396595) possessing significant homology to that of Cr3virus phages. It was reported 
that mutants of P. atrosepticum resistant to phage ΦATI infection due to defective 
flagella had reduced virulence in potato tuber rot assays (Evans et al., 2010a).  Such 
reduced virulence resulting from phage application would be a desirable outcome 
were host resistance to develop.  
However, a closely related phage of the same genus, Pectobacterium phage ΦTE has 
been shown to be capable of causing generalised transduction (Blower et al., 2012). 
Both phages CB7 (Figure 5.6) and ΦTE have been identified to possess circularly 
permuted genomes and the feature is likely shared with other members of Cr3virus  
(Blower et al., 2012). Due to the physical nature of these phage genomes, it is likely 
they employ a headful packaging strategy. Such strategies are known to have a high 
occurrence of generalised transduction (Casjens and Gilcrease, 2009; Thierauf et al., 
2009). Such a genomic feature could hypothetically contribute to the spread of 
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pathogen virulence factors among different strains of the bacterial host, were 
transduction to occur after application of the phages for biocontrol strategies 
(Buttimer et al., 2017b). On the other hand, T4-like phages with similar packaging 
strategies have been deemed suitable for biocontrol applications suggesting that it’s 
not a major consideration (Bruttin and Brüssow, 2005; Denou et al., 2009). 
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Chapter 6. Things are getting hairy; 
Pectobacterium phage vB_PcaM_CBB 
 
A manuscript based upon this chapter has been published in Frontiers in Microbiology 
Buttimer, C., Hendrix, H., Oliveira, H., Casey, A., Neve, H., McAuliffe, O., Ross, R.P., Hill, 
C., Noben, J.-P., O’Mahony, J., Lavigne, R., Coffey, A. (2017). Things are getting hairy: 
Enterobacteria bacteriophage vB_PcaM_CBB. Frontiers in Microbiology. 8, 44. 
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6.1. Introduction  
Bacteriophages (phages) the viruses of bacteria are the most abundant biological 
entities in the biosphere with an estimated number of 1031 (Hendrix, 2002; Whitman 
et al., 1998). The order Caudovirales (the tailed phages) make up the greatest majority 
of the phages types that have been studied and within this order are the phage 
families of Myoviridae, Siphovirdae and Podoviridae (Ackermann, 2001). Myoviridae 
have the most sophisticated virion design, possessing a tail capable of contracting on 
infection and generally having the largest genomes when compared to the other 
families (Hatfull, 2008). However, only a small number of the known Myoviridae 
phages have genomes greater than 200 kbp; these are often referred to as ‘giant’ or 
‘jumbo’ phages  (Hendrix, 2009). The largest of these isolated to date are Bacillus 
phage G (498 kbp, accession no. JN638751.1), Cronobacter phage GAP32 (358 kbp, 
accession no. NC_019401), Escherichia phage PBECO4 (348 Kbp, accession no. 
NC_027364) and Klebsiella phage Rak2 (345 kbp, accession no.  NC_019526). The 
former three phages, GAP32, PBECO4 and Rak2 are recent discoveries, and their 
genomes have only been presented within the last three years (Abbasifar et al., 2014; 
Kim et al., 2013; Šimoliūnas et al., 2013). These phages share a number of protein 
homologs with the T4-like phages, but they lack a number of universal core proteins 
found among the Myoviridae subfamily of Tevenvirinae. Due to the lack of sequence 
identity, the lack of an even distribution of homologs among their genomes with the 
T4-like phages and the possession of their own species-specific proteins, it has been 
proposed that these phages should be placed within a new subfamily (Abbasifar et al., 
2014). More recently, there have been two additional phages that share homology to 
this subfamily (termed the Rak2-like phages from here onwards in this chapter) these 
are Escherichia phage 121Q (348 kbp, accession no. NC_025447.1) and Klebsiella phage 
K61-1 (346 kbp, accession no. AB897757).  
This article presents morphological, genomic and structural proteomic findings on 
another newly isolated Rak2-like phage, Pectobacterium phage vB_PcaM_CBB. This is a 
broad host range Enterobacteriaceae infecting jumbo phage which possesses highly 
atypical whisker-like structures along its contractile tail surface, a feature which has 
not been described in any of the other Rak2-like phage published to date.   
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6.2. Results  
6.2.1. Growth parameters, morphology and host range 
Pectobacterium phage vB_PcaM_CBB was isolated from activated sludge from a 
wastewater treatment plant in Little Island, Co. Cork, Ireland. The bacterial host used 
was Pectobacterium carotovorum sbp. carovotorum strain CBBL19-37-1 which had 
previously been isolated from blackleg-infected potato crop from Co. Cork. When the 
phage was plated and examined by plaque assay utilising a 0.4% agar overlay, 
pinpoint-sized plaques were observed with inconsistent formation across replicate 
experiments. This problem was overcome by using a 0.2% agarose overlay as described 
by Serwer et al. (2007). The host range of the phage was examined using a number of 
bacterial genera and species within the family Enterobacteriaceae which showed it was 
capable of forming plaques on strains of Pectobacterium carotovorum, Pectobacterium 
atrosepticum, Erwinia mallotivora, Cronobacter muytjensii and Cronobacter 
malonaticus. The phage was also found to inhibit the growth of Dickeya dianthicola, 
Dickeya solani, Pantoea agglomerans and Erwinia amylovora, as lysis was observed on 
low dilutions (neat, 10-1) of tested phage lysate with no plaque formation observed at 
subsequent higher dilutions (up to 10-8) (Table 6.1).   
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Table 6.1. Host range of Pectobacterium phage CBB on 35 strains of various members of the 
bacterial family of Enterobacteriaceae as determined by spot testing with serial phage 
dilutions (the experiment was done twice: on separate days).  Results were recorded as 2 
(plaque formation), 1 (growth inhibition) and 0 (no sensitivity). Host strain marked with *. 
Bacteria Strain Sensitivity 
Cronobacter muytjensii  ATCC 51329 (type strain) 2 
Cronobacter malonaticus DPC 6531 2 
Cronobacter sakazakii  ATCC 29004 0 
Dickeya chrysanthemi biovar 
chrysanthemi 
LMG 2804 (type strain) 0 
Dickeya dianthicola PD 482  0 
PD 2174   1 
GBBC 1538 1 
Dickeya solani sp. PRI 2222  1 
LMG 25865  1 
GBBC 1502 1 
GBBC 1586  1 
Enterobacter cloacae  NCTC 11590 0 
Enterobacter gergoviae  NCTC 11434 (type strain) 0 
Erwinia amylovora LMG 2024 (type strain) 0 
GBBC 403 1 
Erwinia mallotivora LMG 1271 2 
Pantoea agglomerans LMG 2660 1 
LMG 2570 0 
Pantoea stewartii LMG 2713 0 
LMG 2714 0 
LMG 2712 0 
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Pectobacterium atrosepticum DSM  18077 (type strain) 0 
DSM30186 2 
CB BL5-1 1 
CB BL7-1 1 
CB BL11-1 1 
CB BL12-2 1 
CB BL13-1 1 
CB BL14-1 1 
CB BL15-1 1 
CB BL16-1 2 
Pectobacterium carotovorum 
subsp. carovotorum  
DSM 30168 (type strain) 0 
DSM 30169 0 
DSM 30170 0 
CB BL19-1-37* 2 
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Examination of the morphology of CBB by transmission electron microscopy showed it 
belonged to the family of Myoviridae with an A1 morphotype (Ackermann, 2001), 
displaying a large icosahedral head presenting hexagonal and pentagonal outlines in 
micrographs  (Figure 6.1) from which estimations were made on its dimensions (Table 
6.2). Capsids had a height of 126.9 ± 4.9 nm and a width of 128.0 ± 6.2 nm. Tails 
displayed transverse striations with dimensions of 123.0 ± 2.6 nm x 27.1 ± 1.8 nm with 
a base plate with dimensions of 36.4 ± 2.3 nm x 14.7 ± 1.2 nm. Phage CBB also 
possesses a neck passage structure (see triangle in Figure 6.1.) and beneath the base 
plate a set of six short tail fibres (length 28.6 ± 2.7nm) could also be visualised (see 
arrow in Figure 6.1). Phage particles with contracted tail sheaths were only rarely 
found indicating high structural stability of the phage. The contractile tail of CBB was 
found to be highly unusual as it possesses hair-like appendages (whiskers) covering its 
surface (see open arrows in Figure 6.1). These hairs are highly stable, as they did not 
dissociate from the phage tails during a 1½ year of storage at 4 ˚C.  Only two other 
phages have been reported to possess these hairy features; these being Escherichia 
coli phage PhAPEC6 (Tsones, 2014) and an unpurified phage observed in a preparation 
of crushed silkworm larvae referred to as X particle (Ackermann et al., 1994). Other 
than CBB having the whiskers, its morphology is typical of the Rak2-like phages in that 
it has a very large head with a comparatively short tail (Drulis-Kawa et al., 2014).  
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Figure 6.1. Electron micrographs of Pectobacterium phage CBB with black arrows indicating 
baseplate fibres, open arrows indicating hair-like appendages (whiskers) and triangles 
indicating neck passage structure. (A) CBB virion base plate tail fibres are indicated. (B-D) Fully 
intact virions with atypical whisker-like structures on the contractile tail surface. (E) CBB virion 
contractile tail missing a capsid. (F) CBB virion with a contracted tail.  
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Table 6.2. Estimations of the dimensions of Pectobacterium phage CBB derived from 
micrographs obtained from transmission electron microscopy 
Head Tail NPS Baseplate Tail hairs Baseplate fibres 
height width length  width width height width height length length 
n=16 n=16 n=16 n=16 n=16 n=16 n=16 n=16 n=29 n=33 
126.9 128.0 123.0 27.1 21.8 7.4 36.4 14.7 119.3 28.6 
± 4.9 ± 6.2 ± 2.6 ± 1.8 ± 1 .4 ± 0.7 ± 2.3 ± 1.2 ± 10.4 ± 2.7 
Tail length: incl. NPS (collar) structure and incl. baseplate (but without baseplate fibres) 
Tail hairs: measured from flanking tail sheath surface and incl. tiny terminal globular structures 
Baseplate fibres: measured incl. terminal globular structures 
 
6.2.2. General genome features 
Phage CBB was found to possess a very large genome of 355,922 bp with predicted 
terminal repeats of 22,456 bp (resulting in total genome size of 378,378 bp).  The 
contig representing its genome was resolved with 1,044,532 reads and with an average 
coverage of 401x. The existence of terminal repeats was suggested during sequence 
analysis by the identification of a localised area in the genome which had twice the 
read depth compared with the rest of the genome. Identification of phage genome 
ends by this approach has been reported for other phages (Fouts et al., 2013; Li et al., 
2014). The existence of the terminal repeats was verified by pulsed-field gel 
electrophoresis, which indicated that the size of the genome obtained from 
sequencing is within the correct range (Figure 6.2). However, even when terminal 
repeats are excluded, the genome is one of the largest published phage genomes to 
date, behind Bacillus megaterium phage G (498 kbp) and Cronobacter sakazakii phage 
vB_CsaM_GAP32 (358,663 bp) (Abbasifar et al., 2014).  
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Figure 6.2. PFGE of Pectobacterium phage CBB genomic DNA; lanes 1, 3 and 5 yeast 
chromosome PFG marker (Bio-Rad Laboratories) and lane 2 and 4 genomic DNA of phage CBB.  
 
The average G+C content of the genome of CBB is 36% with below-average skews 
appearing around ORFs on the minus strand (Figure 6.3). The average G+C content is 
much lower than that typically found in its hosts species namely, Pectobacterium 
atrosepticum at 50-51% (Bell et al., 2004; Nikolaichik et al., 2014), P. carotovorum 
subsp carotovorum at 52.2% (Park et al., 2012) and Erwinia mallotivora at 52.4% 
(Redzuan et al., 2014). This observation is not as unusual, as virulent phages will 
usually deviate from their host G+C content having a higher A+T. It has been suggested 
that this is due to energy and metabolism cost limitations (Rocha and Danchin, 2002). 
However, the G+C content is quite similar to other Rak2-like phages (35.5%, 34.09% 
and 35.5% for GAP32, PBECO4 and Rak2, respectively).   
The genome of CBB has 554 predicted open reading frames (ORFs) (excluding 51 ORFs 
within the predicted terminal repeat), of which only 34 are encoded on the minus 
strand. Putative proteins of twenty-two ORFs were found to share sequence homology 
with each other, suggesting that their genes may have arisen from duplication events 
(paralogs) (Appendix, Table S6.1). On the basis of i) observed protein sequence 
homologies, ii) protein structure homology, iii) lipoprotein and iv) transmembrane 
analysis it was possible to predict the possible role for 162 of these proteins (Appendix, 
Table 6.2) with several others being categorised as hypothetical proteins (47), 
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conserved hypothetical proteins (291), putative lipoproteins (4), and putative 
membrane proteins (7) or conserved putative membrane proteins (43). No integrase, 
excisionase or repressor genes were detected in the genome which suggests that this 
phage follows an exclusively lytic lifestyle.   
It is understood that virulent phages can overcome codon utilisation differences from 
their hosts by using encoded tRNAs, a feature often observed in large genomes 
(Mesyanzhinov et al., 2002). Phage CBB has a large number of predicted tRNA genes 
with a possible 33 being identified and concentrated within a   5̴1Kbp region within the 
genome. Thirty-one of these genes appear to encode functional tRNA genes, with 
many of the tRNAs being for amino acids with codons which are highly utilised by the 
phage (Appendix, Table S6.3, S6.4). 
6.2.3. Bacteriophage CBB: a Rak2-like phage and its distant relationship to the 
Tevenvirinae subfamily 
Initial BLASTP searches with the predicted ORFs of phage CBB showed that it shared 
strong homology with the Rak2-like phages. Comparisons among these phages showed 
that the closest relative to CBB is Cronobacter sakazaki phage GAP32 (358,663 bp; 545 
ORFs), with 479 homolog proteins followed by Escherichia coli 121Q (348, 532; 611 
ORFs) with 239 homolog proteins, E. coli PBECO4 (348,113 bp; 551 ORFs) with 230 
homolog proteins and Klebsiella phage RAK2 (345,809 bp; 554 ORFs) with 230 homolog 
proteins. Phage CBB also shares strong homology with Klebsiella phage K64-1 (346,602 
bp), however, at present its Genbank file contains an incomplete annotation. This 
protein homology is illustrated in Figure 6.3. Comparison between the proteomes of 
these phages shows that they share between 33-38% of their proteins (204 
homologous proteins). These shared proteins likely represent the core genome of the 
Rak2-like phages, given that they appear to be resistant to sequence deviation due to 
their likely importance for successful phage infection. Nucleotide pairwise comparison 
(BLASTN) of these phages with CBB show that Cronobacter phage GAP32 is the most 
closely related with 65% identity, followed by Escherichia phages 121Q and PBECO4 
with 4-5% and with Klebsiella phages Rak2 and K64-1 being the least related with 1% 
identity.  
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It has been reported that the Rak2-like phages possess a number of proteins that are 
homologous to those found within the superfamily of T4-like phages (Abbasifar et al., 
2014; Šimoliūnas et al., 2013). Phage T4 is the type phage of the genera of T4virus, 
while phage KVP40 is the type phage of Schizot4virus. Total protein comparisons of 
phages CBB, GAP32, PEBEC04, RAK2 with phage T4 (NC_000866) and phage KVP40 
(NC_005083.2) show that they share 41 homologous proteins with T4 (14.75% of the 
total proteins of T4) and 46 homologous proteins with KVP40 (12.07% of the total 
proteins of KVP40) using Coregenes (BLASTP cut value of 75%). However, despite this 
correlation to the Tevenvirinae subfamily, it is clear that the vast differences suggest 
these phages should be grouped separately. Nevertheless, a clear evolutionary link is 
present. There are 38 proteins which are considered to be the core proteins of the T4-
like viruses. These proteins range in function from DNA replication, repair and 
recombination, auxiliary metabolism, gene expression and phage morphogenesis 
(Petrov et al., 2010). Examination of the CBB genome revealed that it has ORFs for 
proteins that appear to be homologs to these core proteins, with 21 being identified 
with functions involved in DNA replication and recombination, auxiliary metabolism as 
well as phage morphogenesis proteins with homology to those of T4 and KVP40 
(reference strains for T4virus and Schizot4virus, respectively). However, large 
divergence was observed, especially with morphologically-related proteins, with some 
having very little homology to those of the type strains (Table 6.3). As well as T4-like 
core genes, there are a number of genes that have been designated at T4-like quasi-
core genes. These are genes whose presence will vary from phage to phage as it is 
believed that they are not necessary for certain genetic backgrounds (Petrov et al., 
2010). In the genome of CBB, it was also possible to identify 12 ORFs specifying 
putative homologs of these quasi-core proteins (Appendix, Table S6.5).   
To further investigate the relationship between CBB and the other Rak2-like phages 
and the T4-like phages, the amino acid sequence of portal vertex protein (CBB_252) of 
CBB was used to construct a phylogenetic tree using the top BLASTP hits against 
CBB_252 (Appendix, Table S6.6). The portal vertex protein has been used as a marker 
in a number of phylogenetic studies of the T4-like phages (Brewer et al., 2014; Sullivan 
et al., 2008; Zhong et al., 2002).  This tree placed CBB and the other Rak2-like portal 
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proteins within a well-supported clade showing large divergence from clades 
representing the Tevenvirinae genera of T4virus, Schizot4virus and clades representing 
other unclassified T4-like phages. The result suggests that the Rak2-like phages are 
highly distinct from T4-like phages for which sequence data is available in the public 
databases (Figure 6.4). The major capsid protein has also been used to conduct similar 
phylogenetic studies within the T4-like phages (Comeau and Krisch, 2008). A similar 
phylogenetic study was done with the major capsid protein of CBB (CBB_257) which 
also suggested the same conclusion to that obtained with the portal vertex protein 
(Appendix, Figure S6.1). 
 
 
Figure 6.3. Comparison of the genomes of Pectobacterium phage CBB (without predicted 
terminal repeat region) to other potential Rak2-like phages (Cronobacter sakazakii phage 
vB_CsaM_ GAP32,  Escherichia coli phage 121Q, E. coli phage PBECO4, Klebsiella phage 
vB_KleM_RAK2, Klebsiella phage K64-1) using currently available annotations employing 
TBLASTX and visualised with Easyfig  (Sullivan et al., 2011). A bar chart shows the G+C skew of 
the CBB genome, genome maps comprise of orange arrows indicating locations of genes 
among the different phage genomes; and lines between genome maps indicate the level of 
homology (blue/turquoise – genes sharing orientation, red/orange – genes in an inverted 
orientation). To assist in the comparison between genomes the largest gene of each of the 
phages was positioned as the first gene for each genome.  
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Table 6.3. Core proteins of T4-like phages identified within the genome of Pectobacterium phage CBB with a comparison to homologs in Enterobacter 
phage T4 and Vibrio phage KVP40 (type strains of T4virus and Schizot4virus, respectively) using BLASTP.  
Function T4 like core protein CBB 
homolog 
Accession 
no.  of T4 
protein 
Identity  E-value Accession no. 
of KVP40 
protein 
Identity E-value 
DNA 
replication, 
repair and 
recombination 
gp43 - DNA polymerase CBB_263  NP_049662.1 28% 4.00E-26 NP_899330.1 29% 4.00E-37 
gp44 - sliding clamp complex CBB_332 NP_049665.1 30% 6.00E-28 NP_899326.1 27% 5.00E-25 
gp41 - helicase-primase complex CBB_291 NP_049654.1 25% 1.00E-21 NP_899258.1 25% 4.00E-28 
gp32 - single strand binding protein CBB_277  NP_049854.1 29% 3.00E-08 NP_899253.1 23% 0.005 
gp46 - subunits of recombination nuclease CBB_246 NP_049669.1 31% 1.00E-23 NP_899322.1 30% 3.00E-21 
gp47 - subunits of recombination nuclease CBB_245 NP_049672.1 25% 6.00E-17 NP_899320.1 24% 8.00E-14 
UvsW protein - recombination DNA-RNA 
helicase 
CBB_281 NP_049796.1 23% 3.00E-29 NP_899623.1 27% 6.00E-46 
Auxiliary 
metabolism 
NrdA - ribonucleotide reductase  CBB_303 NP_049845.1 46% 0 NP_899523.1 47% 0 
NrdB - ribonucleotide reductase  CBB_305 NP_049841.1 40% 3.00E-105 NP_899524.1 45% 9.00E-122 
Phage 
morphogenesis 
gp4 - head completion protein CBB_208  NP_049755.1 34% 1.00E-21 NP_899577.1 42% 2.00E-25 
gp6 - baseplate wedge component CBB_237  NP_049764.1 42% 0.098 NP_899587.1 27% 3.00E-05 
gp13 - neck protein CBB_201 NP_049772.1 31% 1.00E-06 NP_899596.1 21% 3.00E-07 
gp15 - tail completion protein CBB_233 NP_049774.1 20% 3.00E-07 NP_899598.1 21% 2.00E-05 
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gp17 - large terminase CBB_275  NP_049776.1 28% 8.00E-29 NP_899601.1 25% 2.00E-42 
gp18 - tail sheath subunit CBB_204  NP_049780.1 36% 2.00E-27 NP_899602.1 39% 4.00E-32 
gp20 - head portal vertex protein CBB_252 NP_049782.1 29% 2.00E-36 NP_899604.1 31% 2.00E-35 
gp21 - prohead core protein CBB_255  NP_049785.1 31% 2.00E-10 NP_899607.1 37% 1.00E-25 
gp23 - precursor to major head protein CBB_257  NP_049787.1 35% 3.00E-36 NP_899609.1 34% 8.00E-37 
gp25 - base plate wedge subunit CBB_238  NP_049800.1 31% 2.00E-10 NP_899586.1 28% 1.00E-08 
gp53 - baseplate wedge component CBB_242 NP_049756.1 38% 1.00E-04 NP_899579.1 35% 5.00E-07 
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Figure 6.4. Maximum likelihood tree created from the alignment of the conserved region of the portal vertex region of 100 homologous sequences 
from different T4-like phage to that of the portal vertex protein of Pectobacterium phage CBB, found using a BLASTP search. 100 bootstrap replicates 
were conducted.
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6.2.4. Transcription 
Within the genome of CBB, 18 sigma70-like promoters were predicted with a 
consensus sequence preceded by an UP-like element (Estrem et al., 1998) (Appendix, 
Table S6.7). Eleven of these promoters were concentrated in a region upstream of 
ORFs CBB_390 to CBB_546, with the majority of ORFs within this region encoding short 
hypothetical proteins (Figure 6.5, part A). Of the few ORFs for proteins of known 
function, two are most likely to be involved in overriding of the host transcription: the 
transcriptional regulator (CBB_511) and RNA polymerase sigma factor (CBB_513). The 
RNA polymerase sigma factor contains an RNA polymerase -70 like domain 
(IPR014284) containing sigma factor region 2 (IPR013325), region 3 and region 4 
(IPR013324). Protein CBB_476 may also have a role in overriding host transcription due 
to a PrlF antitoxin family domain (IPR031848).  It is suspected that the mentioned 
region CBB_390 to CBB_546 represents the early genes which are expressed in the 
very early stages of infection and are involved in host take over. It should also be noted 
that three of the other seven sigma70-like promoters lie on the terminal repeat 
downstream of this region and could possibly be a continuation of the early gene 
region with the remaining promoters being located on the opposite end of the genome 
(Figure 6.4, part B).   
Aside from this sigma70-like promoter, a second possible promoter was detected 
which shows resemblance to a classic sigma70-like promoter with a classic -10 element 
(TATA). However, it differs with its -35 element with a consensus sequence of 
TGAAACG instead of TTGACA (Appendix, Table S6.8). This motif was also identified in 
the GAP32 genome (Abbasifar et al., 2014). Of the 18 examples of this detected motif, 
11 were upstream of ORFs CBB_258 to CBB_329 (Figure 6.5, part B), with many of the 
ORFs within this region found to encode proteins with functions related to DNA 
synthesis (CBB_263, 280, 328, 290, 291, 315, 277, 324 and 325). There was also a T4-
like gp55-like sigma factor (PHA02547, 4.69e-08) predicted for possible late 
transcription (CBB_244) just downstream of one of these promoters (Porf_244). 
However, no homologs for the other associated late transcription proteins of phage 
T4, namely gp33 and gp45, were detected (Geiduschek and Kassavetis, 2010). 
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A third potential promoter was found by analysing the upstream sequences of ORFs 
that had been predicted to encode structure-related proteins of CBB in a single 
submission to MEME.  Analysis showed the presence of a consensus sequence of 
ATAAATA with a concentration of A and T downstream of this motif. This hypothetical 
promoter was found to be present in 35 locations and has also been predicted to 
precede structurally related genes in GAP32. It is expected that this sequence plays a 
role in late gene expression (Appendix, Table S6.9). This motif resembles that of the T4 
late promoter sequence, namely TATAAATA (Geiduschek and Kassavetis, 2010).  
Apart from the above-mentioned promoters, 74 potential rho factor independent 
terminators were identified in the CBB genome (Appendix, Table S6.10)  
 
Figure 6.5. Genome maps of Pectobacterium phage CBB showing locations of sigma70-like 
promoters (A) and CBB divergent sigma70-like promoters (B) created using SnapGene. 
 
6.2.5. DNA replication, DNA modification and nucleotide metabolism 
There are eight proteins which form the T4 DNA replisome these being DNA 
polymerase (gp43), clamp loaders (gp44, gp62, gp45), single strand DNA binding 
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protein (gp32), primase (gp61), helicase (gp41) and loading protein (gp59) (Nelson et 
al., 2009). CBB was found to have homologs to five of the eight proteins (CBB_263, 
332, 277, 290 and 291), but lacks the clamp loaders (gp62, gp45) and loading protein 
(gp59). Interestingly, the phage possesses a bacterial DNA polymerase III epsilon 
subunit (CBB_280) with a DnaQ domain (COGO847, 4.32e-21). There was also a protein 
which resembles the bacterial DNA polymerase III alpha subunit (CBB_328). However, 
this protein appears to be truncated, being much smaller in size to its closest bacterial 
hits on BLASTP (172aa vs c.1120aa) such as those from Oceanobacillus massiliensis 
(WP_010651140.1) and Bacillus megaterium (WP_026681428.1). 
The phage also has T4 homologs for helicase uvsw (CBB_281) and dda (CBB_315), 
topoisomerase gp52 (CBB_325), RNA ligase rnlA (CBB_83) and DNA ligase gp30 
(CBB100), while one of its two ribonuclease H enzymes (CBB_272, 314) is related to T4 
rnh. In addition, an array of T4 homologs involved in DNA repair and recombination 
were identified, including gp46 and gp47 (CBB_246,267), endonuclease VII (CBB_248), 
uvsX (CBB_278), uvxW (CBB_281) and UV repair endonuclease V (CBB_519). CBB also 
has other DNA-replication proteins that have no counterpart to phage T4 such as 
primase-helicase (CBB_291) and gyrase subunit (CBB_324).  
Like the other Rak2-like phages, CBB has ORFs coding for a number of enzymes 
apparently involved in nucleotide metabolism including the aerobic class I NrdA-NrdB 
(CBB_303, 305) and anaerobic class III NrdD-NrdG (CBB_141, 145) ribonucleotide 
reductase (RNR) enzymes for the conversion of ribonucleotides to 
deoxyribonucleotides (Dwivedi et al., 2013). There is also a glutaredoxin (CBB_194) to 
potentially support with class I RNR function (Sengupta and Holmgren, 2014). CBB has 
two CMP/dCMP deaminases (CBB_110,135). These generate dUMP, which is a 
substrate for its thymidylate synthase (CBB_223, T4 homolog td) which generates 
dTMP. The thymidylate synthase is supported by a dihydrofolate reductase (CBB_313, 
T4 homolog Frd), which provides the intermediate metabolite tetrahydrofolate. The 
phage has a thymidine kinase (CBB_203, T4 homolog tk) for the production of TMP, 
and such dNMPs may potentially be utilised by its deoxynucleoside-monophosphate 
kinase (CBB_203) for the production of dNDP derivatives. There is also a putative 5’, 3’ 
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deoxyribonucleotidase (CBB_380), an enzyme in humans and mice involved in the 
dephosphorisation of dNMP  (Walldén et al., 2007).   
Like GAP32, CBB has genes that appear to encode possible nicotinamide-nucleotide 
adenylyltransferases (CBB_113, 361) as well as a gene encoding nicotinamide 
phosphoribosyltransferase (CBB_115). These enzymes are involved in the de novo 
synthesis of coenzyme NAD+ (Schweiger et al., 2001) and their function is supported by 
a nicotinamide mononucleotide transporter [PnuC] (CBB_361), a membrane-bound 
protein involved in the uptake of the NAD+ precursor nicotinamide mononucleotide 
(Zhu et al., 1991).  
DNA methylation and glycosylation are strategies used by phages to provide protection 
against host restriction (Samson et al., 2013). CBB possesses DNA methylation enzymes 
for both adenine and cytosine (CBB_72, 157, 399). However, unlike GAP32, CBB lacks a 
second copy of DNA N-6-adenine methyltransferase (GAP32_519). No enzymes were 
identified in the CBB genome related to the production of 
glycosylated hydroxymethylcytosine which are found in the T-even phages (Petrov et 
al., 2010).  
6.2.6. tRNA gene and tRNA related proteins  
Phage CBB has a large number of tRNA genes and it appears that in two cases (tRNA 
gene 13 and 22), correct formation and function of their tRNA gene products is 
assisted by tyrosyl tRNA synthetase (CBB_132) and tRNAHis guanylyltransferase 
(CBB_152) respectively, both of which are also encoded on the CBB genome. The 
phage also appears to assist in tRNA turnover with the capability of releasing tRNA 
molecules from newly formed peptides by a tRNA peptidyl-tRNA hydrolase (CBB_392). 
All three gene products have homologs present in GAP32 with just CBB_132 and 
CBB_392 being shared with Rak2 also. As mentioned CBB has two RNA ligase enzymes 
(CBB_83, 181) of these CBB_83 may be involved in tRNA repair (Wang et al., 2006). 
6.2.7. Translation and post-translation 
The phage also appears to be able to assist in the formation of the bacterial translation 
initiation complex (ribosome, mRNA and tRNA) by possessing its own translation 
initiation factor IF-3 (CBB_318), with homologs of this protein also being identified in 
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GAP32, 121Q, PBECO4 and Rak2. In addition, CBB has two ORFs encoding for GroES-
like proteins (CBB_131,268). Large phages such as T4 and Enterobacter phage RB49 can 
use host-encoded co-chaperonin GroES to assist in the correct folding of their own 
structural proteins. However, these two phages also possess their own phage-encoded 
GroES-like proteins that likely mimic bacterial host GroES proteins (Keppel et al., 2002), 
this may also be the case for CBB  
6.2.8. Terminase and DNA packing 
The packaging of bacteriophage T4 DNA into its capsid requires two proteins; the small 
terminase (gp16) and the large terminase (gp17). Phage CBB has two proteins which 
possess the 17 terminase domain (PHA02533), namely CBB_274 (E-value 1.28e-09) and 
CBB_275 (E-value 5.47e-79). However, in the case of CBB_274, this domain is 
incomplete suggesting it to be a truncated form of a large terminase. This feature was 
also found to be present with the other Rak2-like phages and is considered to be 
unusual and has also been identified in the T4 superfamily Sinorhizobium phages 
phiM12 (NC_027204) and phiN3 (NC_028945). 
The genomic DNA of phage T4 is packaged into its capsid with the headful packaging 
strategy, which results in a partially circularly permuted chromosome that is terminally 
repeated (Casjens and Gilcrease, 2009). The exact physical nature of the genome of 
CBB currently remains unknown; but as discussed previously, analysis of its genome 
sequence reads suggests the presence of terminal repeats.  
CBB also has an ORF for a T4 homolog to endonuclease VII (CBB_248), which in T4 is 
involved in DNA packaging as well as recombination and mismatch repair.  
6.2.9. Selfish genetic elements 
Homing endonucleases are selfish mobile genetic elements with endonuclease activity 
that only promote the spread of their own encoded gene. These can be found as self-
standing genes within introns, as fusions with host proteins or also in self-splicing 
inteins and their presence is prevalent in a number of phage genomes (Edgell et al., 
2010). In CBB, three free-standing homing endonuclease genes of the HNH family were 
identified, namely homing endonucleases CBB_420, CBB_ 528 and CBB_535 
resembling those found in bacteriophages Rak2 and GAP32. Homing endonuclease 
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CBB_420 lies at the end of tRNA gene 7A, CBB_528 sits between a hypothetical and a 
putative membrane protein and CBB_535 lies at end of virion structural protein, 
Inteins are selfish genetic elements which self-cleave from a protein posttranslation. 
These elements are typically spread by homing endonuclease elements (Tori and 
Perler, 2011). Nevertheless, no intein-related domains (hedgehog/Hint) were found in 
the genome of CBB. However, it should be mentioned that inteins can occur in the 
Rak2-like phages with hedgehog/Hint domain (smart00306) in association with the 
domain of a homing endonuclease of the LAGLIDADG family (pfam14528). Both were 
detected in the large terminase of phages Rak2 and K64-1.  
6.2.10. Cell wall degrading enzymes 
The 35.5 kDa gene product of CBB_187 is predicted to be the endolysin of CBB with 
homologs identified in GAP32 (gp180), 121Q (gp532) and RAK2 (gp506). In silco 
analysis shows that the protein is modular in structure, possessing three domains, 
these being an N-terminal transmembrane domain, a possible intermediate cell wall-
binding domain showing weak homology to the LysM domain (IPR018392), and a C-
terminus lysozyme domain (IPR023347). It is worth mentioning that the cell wall 
binding domain is very apparent in the 121Q homolog (PB1_121_532) of this protein. 
The presence of a cell binding domain is unusual in phages infecting Gram-negative 
bacteria and only a few endolysins with this feature have been reported to date, 
examples being the Pseudomonas aeruginosa phage endolysins KZ144 (phage φKZ), 
and EL188 (phage EL) (Briers et al., 2009, 2007). However, the cell-binding domains of 
these differ to those identified in the Rak2-like phages. Another feature of this 
endolysin is the presence of an N-terminal transmembrane domain, reported in 
endolysins that follow the signal-arrest-system (SAR), examples being P1 lyz and φKMV 
gp45 lysin (Xu et al. 2004).  
Three identified proteins (CBB_238,239 and 240) are possibly associated with the 
baseplate structure of the phage tail, and each has a lysozyme domain. Gene product 
CBB_238 possesses a GPW 25-like domain (PF04965), which is related to gp25 of 
phage T4. The latter forms part of the T4 baseplate and possesses acidic lysozyme 
activity (Szewczyk et al., 1986), with protein CBB_238 also being quite similar in size 
(129aa vs 132aa). CBB_240 a N-terminal gp5 domain (IPR006531) with a C-terminal 
 
 
155 
 
lysozyme (IPR002196). The gp5 N-terminal domain is an oligosaccharide-binding (OB) 
fold and is related to the tail spike (gp5) of T4. However, it is not certain if CBB_240 has 
this function as it is much larger than gp5 (894aa vs 575aa) and the domain 
architectures differ, with gp5 possessing an N-terminal OB-fold, centrally located 
lysozyme and C-terminal triple stranded-helix domains (Kanamaru et al., 2002). 
CBB_240 may also contain a centrally located M23 family peptidase domain 
(pfam01551, E-value 6.48E-4) which could be identified in homologs in other Rak2-like 
phages. Gene product CBB_239 is 18.5 kDa and possesses a T4-type lysozyme domain 
(IPR001165). 
6.2.11. Demonstration of the activity of proteins CBB_187 and CBB_239  
6.2.11.1. CBB_187 possess SAR activity 
For a number of SAR endolysins, an inducible system with E.coli has permitted the 
demonstration of SAR activity with the detection of a reduction in culture turbidity 
upon induction of the cloned gene (Briers et al., 2011; Lynch et al., 2013). A similar 
experiment was used to demonstrate this activity for CBB_187.  Expression of the 
cloned gene was observed to be lethal to cells as the addition of IPTG after four hours 
of growth caused the OD600 to drop from ~0.400 to ~0.200 (Figure 6.5). This result 
would suggest the protein is a SAR endolysin using the host sec system to translocate it 
to the inner membrane of the cell, thus allowing the lysozyme domain of the protein 
to reach the periplasm to act on the cell wall of the bacterium. No lytic activity was 
detected for the truncated transmembrane domain version of the protein (rTM-
CBB_187), with induction of the protein in E.coli not causing lysis. 
An important feature of SAR endolysins is the regulation of their lytic activity while in 
their membrane-tethered form. The two main mechanisms that have been identified 
for those with the lysozyme domain are (a) those which regulate activity by the 
formation of disulphide bridges (as seen with LyzP1 of coliphage P1) and (b) those 
which utilise steric hindrance of catalytic residues due to the proximity of the bilayer to 
which the enzyme is embedded, as seen with R21of lambdoid phage 21 (Kuty et al., 
2010).  As CBB_187 possesses only one cysteine residue (Cys 265), making the 
formation of disulphide bridges impossible, it would suggest that the mechanism of 
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enzymatic regulation of the protein is more likely to be similar to that of the latter 
mechanism.  
 
Figure 6.5. Growth curve of E. coli Lemo21 (DE3) carrying pET28a with SAR endolysin CBB_187 
and its transmembrane domain truncated derivative (rTM-CBB_187). The culture was induced 
at OD600 ~0.400 with 400 µM IPTG (indicated with an arrow). All measurements were carried 
out in triplicate and averages are represented 
 
6.2.11.2. Zymograms and turbidity reduction assays show CBB_239 can breakdown 
peptidoglycan 
The ability of CBB_239 to degrade peptidoglycan was first demonstrated by zymogram 
assay. Lysis was detected for all Gram-negative strains tested (Table 6.3), with the 
observation of a band clearing with a molecular weight between 17-20 kDa with a tail-
back of lysis above the band on the zymogram gels. However, no activity was detected 
for the Gram-positive strains.  The turbidity reduction assay also demonstrated the 
activity of CBB_239. Prior to protein exposure, cells of P. carotovorum subsp. 
carotovorum were treated with chloroform-saturated 50 mM Tris-HCl (pH 8) buffer 
causing outer membrane removal before exposure of the cell wall to the protein 
CBB_239. CBB_239 (final concentration of 0.15μg/mL) could be seen to reduce the 
OD600nm over a 10 min period, indicating the breakdown of bacterial cell wall due to 
the enzymatic activity.  
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CBB_239 is a glycoside hydrolase with its enzymatic action directed towards the glycan 
strand, the universal component of peptidoglycan among Gram-negative and positive 
bacteria.  Zymogram assays indicated that the enzyme has a wide host range, with 
activity being found against peptidoglycan of all tested strains of Gram-negative 
bacteria (Table 6.3). This level of activity is typical of lysozyme proteins of Gram-
negative infecting phages, due to the highly conserved nature of peptidoglycan among 
these bacteria, possessing the A1γ chemotype (Briers et al., 2007; Oliveira et al., 2016, 
2014). No enzymatic activity was found with the peptidoglycan of the Gram-positive 
species Listeria monocytogenes (A1γ chemotype) and Staphylococcus aureus (A3α 
chemotype). The peptidoglycan of both these bacteria is known to exhibit resistance to 
egg-white lysozyme. This resistance has been determined to be due to the presence of 
deacetylated glucosamine residues for L. monocytogenes and O-acetylated muramic 
acid residues for S. aureus on the glycan strand of the peptidoglycan of these bacteria 
(Bera et al., 2004; Kamisango et al., 1982). Such peptidoglycan modifications could 
possibly explain their resistance to CBB_239. 
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Table 6.3. Lysis spectrum of CBB_239 observed on zymograms using crude peptidoglycan from 
a number of different Gram-negative and Gram-positive bacteria.  
Strain name  Bacteria origin Peptidoglycan 
hydrolysis  
Pectobacerium atrospeticum DSM 18077 Solanum tuberosum + 
P. atrosepticum DSM 30186 Solanum tuberosum + 
P. atrosepticum CB BL 13-1 Solanum tuberosum + 
P. atrosepticum CB BL 16-1 Solanum tuberosum + 
Pectobacterium carotovorum subsp. carotovorum 
DSM 30168 
Solanum tuberosum + 
P. carotovorum subsp. carotovorum DSM 30169 Brassica 
oleracea var. capitata 
+ 
P. carotovorum subsp. carotovorum BL 30-1-37 Solanum tuberosum + 
Erwinia mallotivora LMG 1271 Mallotus japonicus + 
Cronobacter mutyjensii ATCC51329 _ + 
Cronobacter malanaticus DPC 6531 Brain tumour + 
Cronobacter sakazakii ATCC 29004 _ + 
Escherichia coli Lemo21 (DE3) _ + 
Staphylococcus aureus ATCC 6538 _ - 
Listeria monocytogenes 10403 S _ - 
Results recorded as +, peptidoglycan degrading activity observed; -, no peptidoglycan 
degrading activity observed. 
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Figure 6.6. Turbidly reduction assay of desalted his-tagged recombinant CBB_239 (final conc. 
0.15μg/mL) on Pectobacterium carotovorum subsp. carotovorum CB BL19-1-37 treated with 
chloroform saturated 10mM Tris-HCl (pH7) to remove outer membrane. The negative control 
was a desalting buffer of 10mM sodium phosphate (pH 7.4), 150 mM NaCl. All measurements 
were carried out in triplicate and averages are represented.  
 
6.2.12. Structural proteins of CBB and other Rak2-like phages 
To identify gene products involved in the maturation and structure of the capsid of 
CBB, an in-silico approach was first undertaken to identify homologs of the proteins 
with known functions. This was followed by the identification of proteins with domains 
with structure-related roles and also by protein analysis using mass spectrometry (ESI-
MS/MS). The identification of phage structural homologs was further supported by 
structural proteomic analysis data that had previously been conducted on other Rak2-
like phages, namely GAP32 and Rak2 (Abbasifar et al., 2014; Šimoliūnas et al., 2013). 
Using this approach, it was possible to predict 65 gene products with structural roles 
(excluding the terminase proteins as well as the PhoH and ssDNA binding protein of 
Rak2). Such genes were identified to have functions in the structure of the capsid 
(CBB_208, 252, 255, 257), neck (CBB_201), tail (CBB_112, 204, 233), baseplate 
(CBB_237, 238, 239, 240, 242) and tail fibres (CBB_226, 260, 261).  Next, we attempted 
an experimental verification of structural proteins using SDS-PAGE of the denatured 
virion proteins (Figure 6.7), followed by trypsin digestion and mass spectrometry (ESI-
MS/MS). From this work, 55 proteins were associated with the structure of the phage 
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capsid (Table 6.5) with sequence coverage ranging from 4.1% to 91.3% and the 
number of unique peptides ranging from 1 to 30. These results allowed the 
identification of an additional 18 structural gene products to be associated with the 
structure of the mature CBB phage particle (Appendix, Table S7.11).  
The structure of CBB is very similar to that of GAP32, sharing 76 homologs of the 83 
gene products predicted to be involved in CBB morphology. Phage Rak2 however, is 
less similar to CBB, only sharing 64 homologs of these genes. TEM images taken of 
these phages shows that tail fibres associated with the baseplates of CBB and GAP32 
are morphological very similar with both greatly differing to that of Rak2 (Abbasifar et 
al., 2014; Šimoliūnas et al., 2013). Analysis of the structural genes also indicates this. 
There are tail fibre related proteins (CBB_226, 261) in the genomes of GAP32 and CBB 
which have no homologs in Rak2 and there are also a number of tail fibre/tail spike 
gene products (RAK_527, 528, 530, 530, 532) in Rak2 which are not represented in CBB 
and GAP32. These differences most likely represent adaption of tail components 
correlating with host ranges of these phages.  
The only structural protein of GAP32 that had previously been identified by mass 
spectrometry, which was not found in the genome of CBB, was GAP_001. It resembles 
a DNA chromosome condensation protein. This protein possesses the AST1 (COG5184) 
domain of the Conserved Domain Database and the regulator of chromosome 
condensation 1/ beta-lactamase-inhibitor protein II (IPR009091) domain of 
Interproscan. Interestingly homologues of this protein were also identified in multiple 
copies in the genomes of other Rak2-like phages 121Q (121Q_234-238, 240-242 and 
244-248) and PBEC04 (ACQ_286, 289, 292 and 294-296).  
The majority of the structural genes of CBB are focused around one large region of 
approximately 70Kbp (CBB_201-261), with small clusters of genes occurring 
throughout the rest of the genome. There are six structural proteins (CBB_144, 247, 
536, 537, 551 and 552) that have been identified by mass spectrometry whose genes 
are not present on GAP32 genome, and four of these occur in a small   ̴10kb cluster 
(CBB_534 to 553).  
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One of the unusual features found with phage CBB when compared to GAP32 was a 
number of proteins containing Kelch-like domains for which there were no obvious 
homologues present in the other Rak2-like phages. These proteins were CBB_550, 
possessing a Kelch-type beta propeller (IPR015915) domain and CBB_552 and 
CBB_554, both with a Kelch-type beta propeller (IPR015915) and Kelch repeat type 1 
(IPR006652) domains. These domains are comprised of six four-stranded beta 
propellers and have been identified as important in protein-binding interactions in a 
number of non-phage-related proteins. Of the three mentioned proteins, CBB_552 has 
been identified to form part of the mature phage structure. Proteins containing Kelch-
like domains have been identified in the proteomes of eukaryotic viruses such as 
poxvirus. Their presence is unusual in phage but they have been reported in other 
giant phages that infect Pseudomonas and Yersinia (Barry et al., 2010; Hertveldt et al., 
2005; Skurnik et al., 2012) 
Given the high level of morphological and genetic similarity of phage CBB to GAP32, it 
is logical to assume that the presence of the extra morphological feature of hair-like 
structures along the tail shaft of phage CBB would be represented by morphological 
genes not present in GAP32 (other than CBB_370, a homologue of which is found in 
Rak2), if GAP32 does indeed lack these atypical whisker-like structures observed on 
CBB. However, it still possible that a number of other structural proteins of CBB may 
not have been detected in the mass spectrometry assays conducted for this article. At 
this time, it is not possible to pinpoint the exact gene products responsible for the 
atypical whisker-like structures observed in phage CBB.  
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Figure 6.7. SDS PAGE of the structural proteins of Pectobacterium phage CBB. Left lane shows 
migration patterns of molecular mass colour protein standard broad range (New England 
Biolabs) with right lanes showing that of structural proteins of phage CBB.   
Table 6.5. Details of the proteins identified from ES-MS/MS conducted on capsid proteins of 
Pectobacterium phage CBB.  
ORF Predicted function 
No. of unique 
peptides 
sequence 
coverage % 
CBB_29  unknown structural protein 8 29,55 
CBB_38  unknown structural protein 9 56,61 
CBB_104 ATP-dependent Clp protease 
proteolytic subunit 
1 4,51 
CBB_112 major tail protein 4 24,30 
CBB_118 unknown structural protein 7 60,40 
CBB_144 unknown structural protein 5 34,00 
CBB_169 unknown structural protein 3 26,30 
CBB_183 unknown structural protein 8 23,60 
CBB_201 Neck protein 5 32,60 
CBB_205 unknown structural protein 6 20,10 
CBB_207 unknown structural protein 9 37,10 
CBB_210 unknown structural protein 13 60,50 
CBB_213 unknown structural protein 5 18,93 
CBB_214 unknown structural protein 1 15,40 
CBB_224 unknown structural protein 22 47,80 
CBB_225 unknown structural protein 16 68,54 
CBB_226 long tail fibre proximal subunit 10 6,06 
CBB_227 unknown structural protein 5 32,07 
CBB_228 unknown structural protein 13 44,09 
 
 
163 
 
CBB_230 unknown structural protein 2 12,70 
CBB_231 unknown structural protein 12 53,30 
CBB_233 tail sheath stabiliser and 
completion protein 
12 31,61 
CBB_234 unknown structural protein 12 35,84 
CBB_236 unknown structural protein 21 7,72 
CBB_237 baseplate wedge 13 12,47 
CBB_240 baseplate hub subunit and tail 
lysozyme 
3 4,11 
CBB_241 unknown structural protein 12 17,10 
CBB_242 baseplate wedge protein 3 39,40 
CBB_243 unknown structural protein 8 46,20 
CBB_247 unknown structural protein 1 4,78 
CBB_251 unknown structural protein 29 50,14 
CBB_254 unknown structural protein 3 15,50 
CBB_256 unknown structural protein 4 13,23 
CBB_257 precursor of major head subunit 21 68,06 
CBB_260 putative tail fibre protein 11 24,04 
CBB_270 unknown structural protein 12 91,32 
CBB_271 unknown structural protein 9 56,40 
CBB_276 unknown structural protein 8 21,70 
CBB_286 unknown structural protein 4 29,70 
CBB_292 unknown structural protein 1 10,90 
CBB_294 unknown structural protein 4 33,10 
CBB_298 unknown structural protein 10 35,81 
CBB_299 unknown structural protein 2 20,00 
CBB_320 unknown structural protein 4 37,20 
CBB_322 unknown structural protein 30 43,57 
CBB_334 unknown structural protein 7 40,00 
CBB_494 unknown structural protein 1 5,81 
CBB_496 unknown structural protein 4 17,50 
CBB_536 unknown structural protein 8 41,40 
CBB_537 unknown structural protein 2 11,00 
CBB_548 unknown structural protein 5 25,90 
CBB_549 unknown structural protein 6 50,70 
CBB_551 unknown structural protein 4 24,10 
CBB_552 unknown structural protein 2 9,54 
CBB_553 unknown structural protein 7 34,80 
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6.3. Discussion 
A number of jumbo phages like CBB have been reported in recent years (Abbasifar et 
al., 2014; Buttimer et al., 2016; Drulis-Kawa et al., 2014; Kim et al., 2013; Šimoliūnas et 
al., 2013; Yuan and Gao, 2016). Among them, phage CBB is significant given the 
identification of atypical whisker-like structures on its contractile tail, for which a 
function has not yet been assigned. However, given that a number of proteins found 
on phage particle surfaces (such as those with Ig-like domains (Fraser et al., 2006) have 
been proposed to play a role in the interaction between the phage and the host cell 
surface other than tail fibre proteins, it is not difficult to hypothesise that the whisker-
like structures may play a similar role. However, this remains to be proven. The likely 
reason that these phages have been rarely isolated and reported may be due to the 
difficulty observed with plaque formation in standard plaque assay overlays, as 
experienced with phage CBB.  
CBB is a member of a group of phages represented by phage Rak2 (the first to have 
been reported), of which, phages PBEC03, 121Q, Gap32 and K61-1 are members. CBB, 
like the other Rak2-like phages possesses a number of homologous core proteins 
found in T4-like phages,  a number of which play crucial functions, suggesting that 
these proteins have not been acquired by horizontal gene transfer as seen with some 
phages (Petrov et al., 2010).  However, given the level of divergence and the lack of a 
number of core T4-like protein homologues, this relationship appears to be distant 
with current members of Tevenvirinae, as suggested by the phylogenetic analysis of 
portal vertex and major capsid proteins done in this study. In addition, these phages 
also possess a large number of proteins that have not been identified in other T4-like 
phages, as illustrated with total protein comparison of the Rak2-like phages to those of 
phage T4 and KVP40. The currently available sequence annotation and morphological 
data for the Rak2-like phages give merit to the proposal of placing them within a new 
subfamily, as suggested by Abbasifar et al. (2014). Furthermore, a shared nucleotide 
pairwise identity of 65%, a similar arrangement of genes and the position of phages 
CBB and GAP32 within phylograms (Figure 6.3, 6.4 and Appendix, Figure S6.1) suggest 
the allocation of their own genus within this subfamily (Adriaenssens and Brister, 
2017).   
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Chapter 7. Erwinia amylovora phage vB_EamM_Y3 
represents another lineage of hairy Myoviridea 
 
A manuscript based upon this chapter has been published in Research in Microbiology 
Buttimer, C., Born, Y., Lucid, A., Loessner, M.J., Fieseler, L., Coffey, A. (2018). Erwinia 
amylovora phage vB_EamM_Y3 represents another lineage of hairy Myoviridae. 
Research in Microbiology. https://doi.org/10.1016/j.resmic.2018.04.006 
 
Isolation, host range, TEM micrographs of Erwinia phage Y3 was conducted by Yannick 
Born. 
Genome sequencing of phage Y3 was outsourced to GATC Biotech, Germany. 
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7.1. Introduction 
The order of Caudovirales (the tailed phages) consists of three families of 
bacteriophage (phage), with about 25% consisting of members of the family 
Myoviridae (Ackermann and Prangishvili, 2012). These members possess virions with 
contractile tails and include the phages with the largest genomes sizes (Hatfull, 2008). 
Those with genomes greater than 200 kbp are typically referred to as “jumbo phages”; 
and currently, there are over ninety in the databases with most having Gram-negative 
hosts (Hendrix, 2009; Yuan and Gao, 2017). Those with the largest genomes identified 
to date are Bacillus phage G (498 kbp) and those belonging to the Rak2-like group such 
as Cronobacter sakazakii phage vB_CsaM_GAP32 (358 kbp), Serratia marcescens phage 
BF (357 kbp) and Pectobacterium phage vB_PcaM_CBB (355 kbp) (Abbasifar et al., 
2014; Buttimer et al., 2017a; Casey et al., 2017). Erwinia phages are of relevance in the 
context of alternative methods for bacterial crop disease control. Indeed, recent years 
have seen an intensive investigation into the use of these phages for biocontrol of 
contagious fire blight of apples and pears. Such research is motivated by increasing 
reports of resistance to other antibacterial agents (McManus et al., 2002; Nischwitz 
and Dhiman, 2013; Tancos et al., 2016). The search for new phages for biocontrol 
applications has resulted in the identification of a number of jumbo phages such as 
Erwinia amylovora jumbo phages Ea35-70 (accession no. NC_023557.1; (Yagubi et al., 
2014)), φEaH1 (Meczker et al., 2014),  φEaH2 (Dömötör et al., 2012), including another 
sixteen jumbo phages which have had their genome sequences only recently published 
(Esplin et al., 2017). 
Another important bacterial pathogen is Ralstonia solanacearum, which colonises the 
xylem and causes wilt in a wide range of economically important crops. Its relevance 
has resulted in the discovery of Ralstonia solanacearum phage ΦRSL1 (231 kbp, 
accession no. NC_010811.2), described in by Yamada et al (2010) and found to possess 
very little homology to known myoviruses. In recent times, a number of other jumbo 
phages have been identified with low but significant homology to phage ΦRSL1 at the 
protein level.  These are Pseudomonas phage Lu11 (280 kbp, accession no. 
NC_017972.1) and PaBG (258 kbp, accession no. NC_022096.1) as well as phage NTCB 
(258 kbp, accession no. LT598654.1), whose genome sequence was identified in a 
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metagenomic study of a decaying Trichodesmium bloom, and whose host range 
remains unknown (Adriaenssens et al., 2012a; Pfreundt et al., 2016; Sykilinda et al., 
2014). As well as the recently described RNA Erwinia amylovora phage 
vB_EamM_Yoloswag (259 kbp, accession no. KY448244), which can also be assigned to 
this group (Esplin et al., 2017).   
Here we report a newly isolated jumbo phage, vB_Eam_Y3 of E. amylovora, which 
possesses atypical whisker-like structures along the surface of its contractile tail; and 
has been found to share homology (at the protein level) to Lu11 and PaBG with distant 
homology to ΦRSL1. 
7.2. Results 
7.2.1. Growth parameters, host range and morphology 
Erwinia amylovora phage vB_EamM_Y3 was isolated from soil, which had been 
collected at an apple orchard with trees displaying fire blight symptoms in Suree 
(canton of Lucerne, Switzerland) in 2008. The bacterial host strain used for its isolation 
was Erwinia amylovora strain 1/79, which had originally been isolated from an apple 
tree in Germany in 1979 (Falkenstein et al., 1988); and its use as a host strain resulted 
in tiny clear pin-sized plaques. The phage was found to infect a number of strains of E. 
amylovora as well as strains of Pantoea agglomerans and Pantoea vagans (Table 7.1). 
Essentially, its host range was similar to other previously identified E. amylovora 
phages (Born et al., 2011).  
Examination of the morphology of Y3 (n=10) by transmission electron microscopy 
showed the phage belonged to the family of Myoviridae possessing an A1 morphotype 
(Ackermann, 2007), with an icosahedral head of 129 nm (±4 nm) in diameter and with 
a contractile tail with a length of 192 nm (±12 nm) (Figure 7.1). The phage was named 
in accordance with the bacterial virus nomenclature set out by Kropinski et al (2009). 
The most unusual feature of Y3 was the hair-like structures along the surface of its 
contractile tail, a characteristic that has only been observed on a small number of 
phages to date: these being the jumbo Pseudomonas phage Lu11 (Adriaenssens et al., 
2012a) which shares protein homology with Y3, and those belonging to jumbo phage 
Rak2-like group such as Pectobacterium phage vB_PccM_CBB (Buttimer et al., 2017a) 
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and Escherichia phage 121Q (accession no. NC_025447.1; (Hua, 2016)), and phages of 
unknown genome sizes and lineages such as X particle and Escherichia phage PhAPEC6 
(Ackermann et al., 1994; Tsones, 2014). 
Table 7.1. Host range of bacteriophage vB_EamM_Y3 tested on strains of Erwinia amylovora 
and closely related genera and species, as determined by spot testing with dilution. 
Species Strain Sensitivity 
Erwinia amylovora 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
CFBP 1430 - 
CFBP 1232 + 
Ea153 + 
 1/74 - 
 1/79 + 
ACW 38899 + 
ACW 56400 + 
ACW 44274 + 
Ea Rac 3075 + 
ACW 55500 + 
ACW 55835 + 
ACW 55955 + 
IPV 1077/7 + 
01SFR-BO - 
LA 469 - 
LA 071 + 
LA 411 + 
LA 468 + 
LA 477 + 
Erwinia persicina 
  
  
ACW 40943  - 
ACW 40560x  - 
ACW 41072 - 
Erwinia billingiae Pagg B90 - 
Pantoea agglomerans 
  
  
Eh 42 - 
Em 406 - 
Em 283 + 
Pantoea vagans C9-1 + 
Pantoea ananatis 351 Lys - 
Results recorded as +, sensitive; −, no infection.  
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Figure 7.1. Electron micrograph of Erwinia amylovora phage Y3. Phage particles were 
negatively stained with 2% ammonium molybdate. Hair-like structures are evident around the 
tails. Scale bar represents 100 nm. 
 
7.2.2. General genome features 
The genome size of Y3 (261,365 bp) places it among the double-stranded DNA jumbo 
phages. The assembly pattern of the reads obtained from sequencing indicated that its 
genome is likely to be circularly permuted with terminal repeats like that of coliphage 
T4 (Casjens and Gilcrease, 2009). Due to this observation, the start position of its 
Genbank file was set to match that of Erwinia phage Yoloswag, its closest relative 
available on public databases. The average G+C content of Y3 was found to be 47%, 
which is lower than that which would typically be found for its host chromosomal DNA 
at ca.53% (Mann et al., 2013; Powney et al., 2011).  
A total of 333 ORFs were identified with putative gene products ranging in size of 39 to 
1951 amino acids. These ORFs were largely divided into two major gene clusters 
(Figure 7.2). The largest region 1 was situated between Y3_75 to 221, with ORFs mostly 
in the anticlockwise direction and region 2 situated from Y3_001 to 74 and Y3_222 to 
333 with ORFs mostly in the clockwise direction. The GC skew correlates well with the 
ORF orientation of the proposed clusters (Marín and Xia, 2008). The ORFs were found 
to be tightly organised having little intergenic space, with a number of examples of 
neighbouring ORFs’ start and end points overlapping. Most ORFs were found to start 
with AUG, while twenty and three ORFs were predicted to start with GUG and UUG, 
 
 
170 
 
respectively. Of the gene products of the identified ORFs, seventy could be allocated a 
possible function (Appendix, Table S7.1) with others identified as putative 
transmembrane proteins (fourteen) putative lipoproteins (two) and hypothetical 
proteins (247). No tRNA genes were identified on the genome.  
In terms of lysogeny, no integrase, excisionase or repressor genes were identified. 
However, one gene product (Y3_031) was found to possess the AntA/AntB 
antirepressor domain (IPR013557), which has been associated with anti-repressor 
proteins such as that encoded by LO142 of temperate phage 993W (Sandt et al., 2002). 
These proteins are believed to be involved in the lysis/lysogenic decision-making 
process of the phage, possibly suggesting a temperate ancestry (Trotter et al., 2006), 
with a homolog of this protein also evident in Yoloswag. 
A potential promoter with a consensus sequence of CTGTAAATA was identified at 
thirty two locations in the genome of Y3 (Appendix, Figure S7.1, Table S7.2), with a 
highly similar promoter (ACTGTAAATA[N7]A) also having been predicted in the 
genome of Pseudomonas phage Lu11 (Adriaenssens et al., 2012a) and like that of Lu11, 
this promotor is mostly situated before ORFs with products predicted to play roles in 
nucleotide metabolism and DNA replication. In addition, forty-five potential rho factor 
independent terminators were located throughout the genome of Y3 (Appendix, Table 
S7.3). 
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Figure 7.2. Summary of the genomic organisation of the 261,365 bp genome of Erwinia amylovora phage Y3. On the outer ring, putative ORFs are 
represented by purple arrowheads labelled with a predicted function where possible. On the middle ring is shown GC content relative to the mean GC 
content of the genome. On the inner ring, GC skew is illustrated where green represents positive skew and purple a negative skew. 
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7.2.3. Phylogenetic position of Y3 within the family Myovirdea   
At the DNA level, Y3 was found to have little or no homology to phage genomes 
currently available on public databases, with its closest match being Yoloswag 
(coverage 6%, identity 75%) using BLASTN analysis. However, during BLASTP analysis, a 
small number of other jumbo phages were found to share a number of homologs 
(large terminase, major capsid protein, etc). These were phage NTCB, Pseudomonas 
phages Lu11 and PaBG and Ralstonia phage ΦRSL1, which hinted at a possible 
evolutionary relationship (Figure 7.3). Like Y3 at the DNA level, these five phages 
(Yoloswag, NCTB, Lu11, PaBG and ΦRSL1) also exhibited no homology to each other 
indicating that they are at most only distantly related. 
To determine the relatedness to each other among above six phages, a phylogenetic 
analysis was conducted using four shared proteins (portal vertex, DNA polymerase, 
large terminase and ATP dependent DNA helicase) to generate phylogenetic trees with 
confident bootstrap values (Figure 7.4). Similar phylogenetic markers have been used 
in studies of other jumbo phages  (Buttimer et al., 2017a; Šimoliūnas et al., 2013; Yuan 
and Gao, 2017).  These trees showed that among the six, two separate clades were 
formed: one included Y3 and Yoloswag, and the second was comprised of those 
phages infecting the genus Pseudomonas (Lu11 and PaBG). Phages NCTB and ΦRSL1 
were outliers. The NCTB position on the tree is somewhere between the Erwinia and 
Pseudomonas phages. Phage ΦRSL1 appeared on a branch that sits outside of all the 
other five phages implying a far more distant relatedness. This interpretation was 
further supported by the analysis of the phages proteomes using Coregene (Table 7.2). 
The E. amylovora phages were found to share 225 proteins with each other; the 
Pseudomonas phages shared 136; NTCB shared between 88 and 112 proteins with 
both the Erwinia clade and the Pseudomonas clade respectively. ΦRSL1 was still the 
most distantly related, sharing only 55 to 65 homologues with the other five phages.  
This distant evolutionary relationship could possibly be explained in the context of host 
range with the genera Erwinia and Pseudomonas belonging to the class of 
Gammaproteobacteria while Ralstonia belongs to the class Betaproteobacteria 
(Garrity, 2004).  
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Finally, phylogenetic analysis was performed using the large terminase and portal 
protein of all jumbo myoviruses of E. amylovora that have had their genome 
sequences submitted to Genbank to date. Both these proteins have been used as 
phylogenetic markers in such studies of distantly related phages of Enterobacteriaceae 
(Grose and Casjens, 2014). The resulting phylogram shows that there is a minimum of 
four clades of these phages infecting this bacterium. With Y3, along with phage 
Yoloswag, forming a novel clade that is highly distinct from the other three clades 
identified, as the branch that these phages reside on in phylograms sits outside of 
those representing the other clades (Appendix, Table S7.4 and Figure 7.5). 
 
 
Figure 7.3. Comparison of the genomes of phage Y3 with jumbo phages Erwinia amylovora 
phage Yoloswag, phage NCTB, Pseudomonas phages Lu11 and PaBG and Ralstonia phage 
ΦRSL1 using currently available annotations employing TBLASTX and visualised with Easyfig.  
The blue/red bar chart (top) shows the G+C skew of the Y3 genome. The genome maps 
comprise of arrows indicating locations and orientation of ORFs. Lines between genome maps 
indicate the level of homology. To assist in the comparison, the largest gene of Y3 was set to 
the first position of its map with the corresponding homologous gene being set to the first 
position for the other phage genomes. Level of amino acid identity is shown via the gradient 
scale.  
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Figure 7.4. Phylogenetic analysis using the portal vertex protein (phylogram A), DNA 
polymerase (B), large terminase (C) and ATP dependent DNA helicase (D) using the six phages 
Y3, Yoloswag, NCTB, Lu11, PaBG and ΦRSL1. The amino acid sequences were compared using 
MUSCLE. The tree was constructed using the maximum likelihood algorithm. The percentages 
of replicate trees were assessed with the bootstrap test (1000).   
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Figure 7.5.  Phylogenetic analysis using the large terminase (phylogram A) and portal protein 
(B) of jumbo Erwinia amylovora myoviruses with genome sequences submitted to Genbank to 
date. The amino acid sequences were compared using MUSCLE. The tree was constructed 
using the maximum likelihood algorithm. The percentages of replicate trees were assessed 
with the bootstrap test (1000) 
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Table 7.2. Homologous proteins shared between the phages related to Erwinia amylovora 
phage Y3 (Yoloswag, NTCB, Pseudomonas phages PaBG and Lu11 and Ralstonia phage ΦRSL1).  
  Y3 Yoloswag NCTB PaBG Lu11 ΦRSL1 
Y3 (333)   
225 
(67.57%) 
112 
(33.63%) 
105 
(31.53%) 
87 
(26.13%) 
55 
(16.52%) 
Yoloswag 
(334) 
225 
(67.37%) 
  
113 
(33.83%) 
102 
(30.54%) 
87 
(26.05%) 
53 
(15.87%) 
NCTB (301) 
112 
(37.21%) 
113 
(37.54%) 
  
95 
(31.56%) 
88 
(29.24%) 
53 
(17.61) 
PaBG (308) 
105 
(34.09%) 
102 
(33.12%) 
95 
(30.84%) 
  
136 
(44.16%) 
65 
(21.1%) 
Lu11 (391) 
87 
(22.25%) 
87 
(22.25%) 
88 
(22.51) 
136 
(34.78%) 
  
62 
(15.86%) 
ΦRSL1 (343) 
55 
(16.03%) 
53 
(15.45%) 
53 
(15.45) 
65 
(18.95%) 
62 
(18.08%) 
  
The number in bracket next phage name is total predict proteins with percentages 
representing the portion of shared proteins within the proteome of the phage in question. 
Analyses were conducted using Coregenes with the BLASTP threshold set to 75%. 
 
7.2.4. Morphogenesis proteins  
The majority of the putative structural proteins of Y3 were situated in a cluster with a 
length of 65 kbp (Y3_104 -158) within region 1, with the majority of these shared with 
phages Yolosway, NTCB, PaBG and Lu11. These putative proteins were the tail tube 
(Y3_132, 134), the tail sheath (Y3_135, 158), the baseplate (113, 114, 124), the tail 
fibres (Y3_104, 108, 109, 110), the tail-collar fibre protein (Y3_110) and the major 
capsid protein (Y3_139). A putative portal protein (Y3_006) was located outside of this 
region, being adjacent to the large terminase (Y3_004). Interestingly, the homology of 
the portal protein to that of Bacillus phage G (gp14, 5E-8, 23%) was found to be high 
when using BLASTP.  Proteins Y3_106 and Y3_143 also shared strong homology with 
gp431 (2e-9, 28%) and gp19 (3e-09, 33%) respectively of Bacillus phage G. Y3_106 is 
situated between ORFs predicted to form the tail fibres that possess collagen domains 
(Ghosh et al., 2012). This gene product was predicted to be a tail fibre hinge protein 
due to the presence of an ILEI domain (PF15711.4, 1.7E-7). This domain belongs to the 
FAM3 superfamily to which the T4-like phage tail hinge gp35 protein is distantly 
related (Guo et al., 2006).  Three of the structural proteins that have been identified in 
phage ΦRSL1 (ΦRSL1_135, 136, 140) as confirmed by N-terminal sequencing (Yamada 
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et al., 2010), were found to have homologues in phage Y3 (namely Y3_135, 139, 140, 
158) providing further evidence that they play a role in the virion structure of Y3.  
7.2.5. Nucleotide metabolism, DNA replication and modification 
Typical of large myoviruses, Y3 has a number of proteins with functions predicted to 
influence the nucleotide pool within its host (Hendrix, 2009). These include a CMP 
deaminase (Y3_035) allowing the hydrolysis of dCMP to dUMP and a putative dUTPase 
(Y3_300) allowing the conversion of dUTP to dUMP. The dUMP can then be acted upon 
by a thymidylate synthase (Y3_045), which can catalyse the methylation of dUMP to 
dTMP, which a dTMP kinase (Y3_118) can, in turn, convert to dTDP. Another feature 
typical of large phages is the possession of a number of proteins involved in DNA 
replication. It is worth mentioning that smaller phages typically use a lesser number of 
proteins to recruit the host replication machinery to carry out this role (Hendrix, 2002). 
Phage Y3 was identified to possess helicases (Y3_001, 168, 176), primases (Y3_024, 
227), a DNA ligase (Y3_148), topoisomerase subunits (Y3_327, 329), as well as class 1 
polymerases (Y3_011, 173) and the delta component (PF13177.5, 5.7E-26) of a class III 
polymerase (Y3_209). Y3 also has proteins involved in DNA repair and maintenance 
including RecA (Y3_243), UV damage endonuclease UvsE (Y3_287) and MmcB-like DNA 
repair protein (Y3_119) as well as those involved in DNA recombination (Y3_186) and 
DNA degradation (Y3_229). DNA methylation is a well-known strategy used by some 
phages to protect against host restriction endonucleases (Samson et al., 2013) and 
accordingly, Y3 appears to be able to methylate both cytosine and adenine (Y3_29, 50). 
7.2.6. Other metabolic functions of Y3 
While the genome of phage Y3 does not possess tRNA genes, it does possess proteins 
potentially involved in their maturation such as RNA 2'-phosphotransferase (Y3_272) 
and a carboxy-S-adenosyl-L-methionine synthase (Y3_017). Curiously, the phage was 
found to possess an asparagine synthase (Y3_020), which would allow the conversion 
of aspartate to asparagine.  Such auxiliary phage genes that produce proteins that 
compliment a host’s metabolism have been identified in a number phages of marine 
environments; and the role of their encoded proteins are understood to be the 
removal of potential bottlenecks in their host metabolism that could potentially hinder 
the lytic cycle (Hurwitz and U’Ren, 2016).  
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7.2.7. Selfish genetic elements 
Inteins are selfish genetic elements that self-cleave and remove themselves from a 
translated protein (Tori and Perler, 2011). Proteins identified with these elements in 
phage Y3 are the large terminase (Y3_004), C-5 cytosine methyltransferase (Y3_050) 
and one of the four predicted tail fibre proteins (Y3_110). Also identified was a homing 
endonuclease of the HNH family (Y3_179), situated between two hypothetical 
proteins. These homing endonucleases are mobile genetic elements with 
endonuclease activity that only promote the spread of their own encoding gene (Edgell 
et al., 2010). 
7.2.8. Cell wall degrading enzymes 
Analysis of the protein Y3_301 showed that it possesses an N-terminal transmembrane 
domain (12-34 aa) with a high alanine content (23%), with one basic residue (arginine), 
and a C-terminal soluble lytic transglycosylase (SLT) domain (IPR008258; 108-218 aa). 
The latter domain degrades peptidoglycan by cleavage of the β-1,4 glycosidic bond 
that results in the formation of a 1,6-anhydrobond in the muramic acid residue. A 
homolog of this protein was also found in phage Yoloswag (YOLOSWAG_297). Due to 
the composition of the domains in this protein, it was suspected to be an endolysin 
that followed the signal arrest (SAR) system like gp45 of φKMV and lyz of phage P1 
(Briers et al., 2011; Xu et al., 2004). Analysis of the protein using SignalP 3.0, showed 
that it possessed an N-terminal signal sequence with a probability of 0.729. However, 
the more recent version of SignalP did not identify this domain suggesting that the N-
terminal secretory signal is not removed after export, but rather remains tethered to 
the inner membrane after translocation by the host sec translocon system.  
For a number of these types of endolysin, an inducible system with E. coli permits 
demonstration of SAR endolysin activity using a detectable reduction in culture 
turbidity upon induction (Briers et al., 2011; Lynch et al., 2013). A similar experiment 
was conducted here for protein Y3_301. Accordingly, gene Y3_301 was cloned into 
pET28a and transformed into E coli Lemo21 (DE3). Expression of the cloned gene was 
lethal to cells, as the addition of IPTG after 4 hours of growth caused the OD600 to drop 
from ~0.480 to ~0.320 at 8 hours (Figure 7.6).  No lytic activity was detected after the 
removal of the signal sequence as seen with the induction of the truncated 
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transmembrane domain Y3_301 (rTM-Y3_301). As the toxic activity of this protein was 
found to be dependent on the presence of its transmembrane domain, it could be 
concluded that this protein behaves as a typical SAR endolysin, requiring the 
transmembrane domain to act as a signal sequence for its translocation enabling the 
catalytic domain of the protein to reach the periplasm where it acts on the 
peptidoglycan of the bacterial cell resulting in lysis.   
An important feature of SAR endolysins is the regulation of their enzymatic activity 
while in their membrane-tethered form. The two main mechanisms that have been 
identified for those with the lysozyme domain are (a) those which utilise steric 
hindrance of catalytic residues due to the proximity of the bilayer to which the enzyme 
is embedded (as seen with R21 of lambdoid phage 21) and (b) those which regulate 
activity by the formation of disulphide bridges as seen with LyzP1 of coliphage P1 (Kuty 
et al., 2010). Little is understood of how SAR endolysins with transglycosylase domains 
regulate their activity. However, the formation of disulphide bridges is a possible 
explanation of how Y3_301 might regulate itself. Five cysteine residues were identified 
in its amino acid sequence, one situated within the transmembrane domain (Cys23) 
and the four-remaining located within its catalytic domain (Cys127, 147, 182 & 188).  
A second protein, namely Y3_197 was found to possess a soluble lytic transglycosylase 
(SLT) domain (PF05838), with a peptidoglycan binding domain (IPR018537). A homolog 
of this protein was also found in phage Yoloswag (YOLOSWAG_189). To date, we have 
not succeeded in demonstrating its predicted enzymatic activity after cloning in E. coli 
(data not shown). 
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Figure 7.6. Growth curve of E. coli Lemo21 (DE3) carrying pET28a with the SAR endolysin 
Y3_301 and its truncated derivative without the transmembrane domain (rTM-Y3_301). The 
culture was induced at OD600 ~0.450 with 400 µM IPTG (indicated with an arrow). All OD 
measurements were taken in triplicate and the averages are represented.   
 
7.3. Discussion 
As mentioned above, a number of hairy Myoviridae jumbo phages to date have been 
placed in the Rak2-like group. The possession of whisker-like structures is shared with 
the unrelated E. amylovora phage Y3, suggesting that these may be more widespread 
in the Myoviridae family than previously thought.  For the Rak2-like Escherichia phage 
121Q, this feature has been linked to a protein which resembles a phage tail fibre 
(Hua, 2016).  The exact gene products responsible for the atypical whisker-like 
structures of Y3 is yet unknown. However, a few genes have been predicted to encode 
tail fibre structures (Y3_104, 106, 108, 109, 110), and any of these could potentially be 
responsible. The role of these atypical hairs of these phages is still unknown but it has 
been speculated to play a role in enhancing phage ability to detect and infect its host 
by facilitating the phage adsorption processes (Buttimer et al., 2017a; Hua, 2016).  
Phylogenetic studies show that phages Y3 and Yoloswag establish a novel clade of 
jumbo phages infecting E. amylovora (Figure 7.5). In the context of shared homologous 
proteins, Lavigne et al (2009) defined phage subfamily and genus boundaries at ≥20% 
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and ≥40%, respectively. Based on these cut-off values, it would place phages Y3 and 
Yoloswag within a genus within a subfamily to which NTCB, PaBG and Lu11 are also 
members and which is peripherally related to ΦRSL1 (Table 7.2).  
Little has been described about SAR endolysins in jumbo phages to date. However, a 
small number of jumbo phages have been predicted to possess them. These include 
members of the Rak2-like group such as Klebsiella phage vB_KleM-RaK2 (gp506), 
Pectobacterium phage CBB (CBB_187), Cronobacter phage GAP32 (gp180) and 
coliphage Q121 (gp532) (Abbasifar et al., 2014; Buttimer et al., 2016); and upon 
examination within our study, Erwinia phages Ea35-70 (Ea357_029), Deimos-Minion 
(accession no. ANH52127.1; DM_29) and Simmy50 (accession no. KU886223.1; gp_30). 
Phages Y3 and Yoloswag can be included in this group. These endolysins are known to 
be highly prevalent in phages that infect Enterobacteriaceae (Oliveira et al., 2013); and 
this may also be the case for their jumbo phages, as a number of such endolysins have 
already been identified among them. 
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Thesis summary 
Note, Table 8.1 below condenses the information in this summary. 
Pectobacterium atrosepticum and Pectobacterium carotovorum subsp. carotovorum are 
species that belong to a group of bacteria, collectively known as the soft rot 
Enterobacteriaceae (SRE). They harm production of a number of ornamental plants and 
arable crops. Both P. atrosepticum and P. carotovorum subsp. carotovorum impact potato 
production causing potato blackleg disease and tuber soft rot (Mansfield et al., 2012; 
Pérombelon, 2002). This thesis describes recently isolated bacteriophages of three distinct 
phage genera that infect P. atrosepticum, namely Cbunavirus, Phimunavirus and Cr3virus. 
Both Cbunavirus and Phimunavirus are newly established genera that were identified and 
formalised in the work of this thesis and for which taxonomy proposals have been 
submitted to the International Committee for the Taxonomy of Viruses (ICTV). This 
taxonomic classification was based on shared nucleotide identity values of ≤95% but ≥70% 
(using the BLASTN algorithm), genome synteny and their position within phylograms based 
on conserved proteins and/or total proteomes (TBLASTX) (Adriaenssens and Brister, 2017). 
Additionally, papers were also published describing these phages of Cbunavirus and 
Phimunavirus. The thesis also describes two new jumbo phages (phages CBB and Y3). The 
first was isolated against P. carotovorum subsp. carotovorum and was found to be closely 
related (at the protein level) to a group of jumbo phages that infect genera belonging to the 
family of Enterobacteriaceae, collectively named after the first described representative of 
this group, Klebsiella phage Rak2 (345 kbp, accession no. NC_019526). The second jumbo 
phage studied in the thesis infects the phytopathogen Erwinia amylovora, the causative 
agent of fire blight, a destructive disease that impacts pear and apple trees (Bonn and van 
der Zwet, 2000; Mansfield et al., 2012). This latter phage was found to be related at the 
protein level to a group of jumbo phages of Erwinia and Pseudomonas, all distantly related 
to Ralstonia phage ΦRSL1 (231 kbp, accession no. NC_017972) and collectively named after 
this phage. The significance of both jumbo phages is discussed in more detail later in this 
summary, although it’s worthy of mention at this point that each of them merited a 
published paper. 
The phages belonging to the genera of Cbunavirus, Phimunavirus and Cr3virus were isolated 
from soil obtained from potato grading machinery from two commercial potato farmers in 
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Co. Cork, Ireland in 2013. Eleven isolates were obtained and subjected to genome restriction 
digestion analysis using BamHI, SspI and BglII (Appendix, Figure S5.1 and Figures 3.1, 5.1), 
nine of these isolates were found to produce similar banding profiles. Three of these nine 
isolates, namely Pectobacterium phages vB_PatP_ CB1 (phage CB1), vB_PatP_CB3 (phage 
CB3) and vB_PatP_CB4 (phage CB4), being closely related were collectively referred to as 
the CB1-like phages and were analysed in detail. This analysis established phage CB1 as the 
type phage of the genus of Cbunavirus. The two remaining phage types isolated were 
Pectobacterium phage vB_PatP_ CB5 (phage CB5), a phage of the newly described genus of 
Phimunavirus; and Pectobacterium phage vB_PatM_CB7 (phage CB7), a phage of the genus 
Cr3virus.  
TEM analysis showed all five phages (CB1, CB3, CB4, CB5 and CB7) were of the order 
Caudovirales, possessing virions with tails (Ackermann, 2001) (Figures 3.2, 4.2, 5.5). The 
CB1-like phages and phage CB5 were identified to possess a morphology associated with the 
phage family Podoviridae, possessing icosahedral capsids with diameters of 67.8 ± 4.4 – 71.8 
± 1.7 nm and 63.1±3.6 nm, with a short non-contractile tail with a length of 23.9 ± 1.7 – 25.8 
nm and 13.1 ± 1.8 nm, respectively. The dimensions of these are similar to related phages in 
the scientific literature (Eriksson et al., 2015; Lavigne et al., 2003; Wittmann et al., 2015). 
Phage CB7 was identified to have the morphology associated with the phage family 
Myoviridae. This phage is larger than the above-mentioned Podoviridae (CB1, CB3, CB4 and 
CB5) possessing an icosahedral capsid with a diameter of 84.05 ± 3.88 nm, with a contractile 
tail with a length of 123.39 ± 2.63 nm. A similar tail length was reported for Cr3virus 
member Pectobacterium phage ɸTE, although the capsid dimensions of CB7 are somewhat 
smaller than that of ɸTE at 98.4 ± 3 nm (Blower et al., 2012). 
Given the biocontrol potential of bacteriophages, attention was devoted to defining their 
host ranges on representative phytopathogenic bacterial strains. The above five phages 
were all isolated using two strains of P. atrosepticum, namely, stain DSM 18077 (for phage 
CB1) and strain DSM 30186 (for phages CB3, CB4, CB5 and CB7). P. atrosepticum strain DSM 
18077 is the type strain of this bacterial species. Host range examination against different 
species within SRE, showed that their infection was limited to P. atrosepticum with the CB1-
like phages having the largest host range within this species, each being able to infect a 
minimum of 10 strains of P. atrosepticum while phages CB5 and CB7 could infect 3 and 5 
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strains, respectively (Tables 3.1, 4.1., 5.1). This information is important for potential 
inclusion of the phages in future bacterial phytopathogen control measures.  
Further analysis of these five phages included the examination of the latent periods and 
phage burst sizes on their respective host strains under standard conditions (LB medium, 
incubation temperature of 25 ᵒC). The CB1-like phages have the longest latent period at 60-
65 min, CB7 had an intermediate length latent period at 55 min and CB5 had the shortest at 
45 min. There was also a similar pattern with burst size among the phages, with CB1-like 
phages having the largest burst size of 158-246 PFU/cell, phage CB7 an intermediate burst 
size of 154 PFU/cell and phage CB5 the smallest at 43 PFU/cell (Appendix, Figure S3.1 and 
Figure 4.1, 5.2). Interestingly, phage CB5 was observed to be difficult to cultivate and 
propagate under laboratory conditions, and its low burst size was deemed to be likely the 
reason why it was never possible to obtain a lysate with a titre exceeding 1x109 PFU/mL 
regardless of whether harvesting phage from double agar overlay plates with SM buffer or 
standard propagating in broth. The overall data obtained was broadly similar to that 
reported for other SRE phages (Adriaenssens et al., 2012b). 
Phage virion stability should be taken into consideration when creating phage preparations 
for biocontrol applications, as it is important to understand factors that could negatively 
impact phage titre during storage but also upon application. Stability was thus established 
for the CB1-like phages and CB7. Over an incubation period of one-hour, the CB1-like 
phages were found to have no significant titre losses between -18 to 50 ᵒC, while phage CB7 
appeared to exhibit slightly greater thermal resistance, but again with no significant titre 
loss between -18 to 55 ᵒC (Appendix, Figure S3.2 and Figure 5.3). Regarding pH, incubation 
for a 24-hour period showed that for the CB1-like phages and phage CB7 no significant titre 
losses occurred between pH values of 5 to 11 (Appendix, Figure S3.3 and Figure 5.4). Phage 
CB5, on the other hand, was found to be sensitive to the universal buffer used for pH 
stability experiments. When the phage was incubated in each of the separate components 
of this buffer, significate titre losses were found to occur in 10 mM trisodium citrate (data 
not shown). Phage viability loss due to sodium citrate has been previously reported (Kuo et 
al., 1971).  
Genome sequencing was conducted on the five phages CB1, CB3, CB4, CB5 and CB7. Among 
these, the largest genome with a size of 142,778 kbp was obtained for CB7, an intermediate 
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size genome was obtained for each of the CB1-like phages between 75,394 - 75,973 kbp, 
and the smallest genome being obtained for phage CB5 at 44,262 kbp. Examination of 
genome sequence reads for both the CB1-like phages and phage CB5 revealed a location 
with a doubling of sequence reads compared to the average across their entire genome, 
indicating the presence of direct terminal repeats (DTRs). DTRs with a size of 647-648 bp 
and 287 bp were determined for the CB1-like phages and phage CB5 respectively, hinting 
their genomes to be linear. These genome properties are similar to those reported of 
related phages (Blower et al., 2017; Ohmori et al., 1988). Examination of the genome of 
phage CB7 did not reveal this feature, indicating that its genome is likely circular 
permutated. This conclusion was also indicated by a Bal-31 exonuclease time course 
treatment of the CB7 genome followed by restriction digestion with BglII, showing no bands 
to be preferentially degraded upon examination by agarose gel electrophoresis (Figure 5.6). 
Additionally, related phages of phage CB7 (those of Cr3virus) are also believed to have 
circularly permutated genomes (Blower et al., 2012). The largest number of open reading 
frames (ORFs) were identified for phage CB7 with 253 ORFs, an intermediate number 
identified for the CB1-like phages between 97 - 102 ORFs, with the smallest number 
identified for phage CB5 with 60 ORFs. Genes for tRNAs were only identified for phages CB7 
and CB4, each having one and two genes, respectively. All five phages were found to have 
no genes associated with lysogeny, indicating these phages follow a fully lytic lifestyle. 
Additionally, genes associated with virulence factors or known toxins were also not 
identified on their genomes.  
Of all the phages identified to infect P. atrosepticum in the research of this thesis, the CB1-
like phages were identified to have a number of the desirable features for biocontrol 
applications against this phytopathogen. Such as good biostability, ease at which these 
phages could be prepared in the lab (phage lysates with titres exceeding 1x109 PFU/mL 
could be routinely prepared), lack of undesirable genes (those for lysogeny and virulence 
factors) and the possession of a wide host range against P. atrosepticum, collectively being 
able to infect 15 of the 19 (79%) tested strains of the species. Thus, the disease control 
capability of a phage mixture of CB1, CB3 and CB4 was investigated by tuber rot assays. At a 
multiplicity of infection (MOI) of 1, these phages were found to suppress soft rot formation 
on tubers of the Rooster potato variety by a mixed infection using P. atrosepticum strains 
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DSM 18077 and DSM 30186 (Figure 3.7). However, further testing is warranted to 
investigate the biocontrol potential of these phages in greater detail. Such as an 
investigation of the minimum MOI which is required for these phages to inhibit disease 
formation. To investigate if these phages can inhibit soft rot formation caused by P. 
atrosepticum strains most relevant to the Irish potato industry, but additionally strains of 
this bacterium relevant to the potato industry in other parts of the world. It should also be 
investigated if these phages can suppress the formation of blackleg of potato crop in the 
field, with further testing of phage biostability to factors such as UV, agricultural chemicals 
(such as copper compounds and fertiliser) as well stability in soil; as such factors are known 
to affect phage stability (Iriarte et al., 2007; Straub et al., 1992; Sykes et al., 1981)  
The first phage of this thesis summary mentioned two jumbo phages. The first, 
Pectobacterium phage vB_PcaM_CBB (phage CBB) was isolated from activated sludge 
obtained from a wastewater treatment plant in Little Island, Co. Cork, Ireland in 2015. The 
bacterial host used was P. carotovorum subsp. carotovorum strain CB BL19-1-37 which had 
previously been isolated from a potato plant showing signs of blackleg from a commercial 
potato farm in Co. Cork, Ireland in 2013.  Examination of this phage by TEM analysis showed 
that it belongs to the family Myoviridae, possessing a large capsid with a width of 128.0 ± 
6.2 nm and a relatively short contractile tail with a length of 123.0 ± 2.6 nm (Figure 6.1). The 
length of the tail of this phage is comparable to phage CB7, but its capsid is significantly 
larger. Furthermore, this analysis revealed that this phage possesses atypical hair-like 
appendages on the surface of its contractile tail. Host range analysis showed the phage is 
not only able to infect its host species of P. carotovorum subsp. carotovorum but also P. 
atrosepticum, Cronobacter muytjensii, Cronobacter malonaticus and Erwinia mallotivora 
(Table 6.1). However (and explaining why this phage was not included in the above-
mentioned biocontrol study), the phage was found to be quite difficult to propagate under 
laboratory conditions. To allow the phage to create reproducible plaques using the double 
overlay method for enumeration, a dilute LB overlay method using 0.2% (w/v) agarose was 
developed and employed. Additionally, the phage could not be propagated in broth but only 
by harvesting phage from double agar overlay plates with SM buffer. Genome sequencing 
revealed phage CBB to have an atypically large genome of 355,922 kbp in size and is 
suspected to be linear with fixed ends with DTRs of 22,456 kbp. Furthermore, it has one of 
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the largest phage genomes sequenced to date. The largest described in the literature are 
those of Bacillus phage G (498 kbp, accession no. JN638751.1) and Cronobacter phage 
GAP32 (358 kbp, accession no. NC_019401), with phage CBB being related to the former. A 
phage with a genome greater than 200 kbp can be termed as a jumbo phage. The genome 
of phage CBB was identified to contain 554 ORFs (not taking into consideration its DTRs) 
with 33 tRNA genes. These values are significantly larger than those of any of the P. 
atrosepticum specifically infecting phages. It is tempting to speculate if a large number of 
genes encoding proteins and tRNAs of phage CBB contributes to its wide host range. 
The second jumbo phage described in this thesis is Erwinia phage vB_EamM_Y3 (phage Y3). 
This phage was isolated from soil from an apple orchard with trees displaying symptoms of 
fire blight in the canton of Lucerne in Switzerland in 2008. The TEM analysis of the phage 
showed it belongs to the family of Myoviridae (Figure 7.1), possessing a large capsid with a 
width of 129 ± 4 nm and a contractile tail with a length of 192 ± 12 nm. The capsid 
diameters of this phage are similar to that of phage CBB, but its tail is significantly longer. 
Furthermore, as seen with phage CBB, the analysis also showed this phage to possess 
atypical hair-like appendages on the surface of its contractile tail. However, the hairs 
appeared to be much thicker than those of phage CBB.  Like phage CBB, this phage is also 
capable of infecting outside of its genus E. amylovora, in that it could also lyse Panthoea 
agglomerans and Panthoea vagans (Table 7.1). Genome sequencing of this phage revealed a 
genome of 261,365 kbp, but analysis of sequence reads failed to identify DTRs as 
determined for CB1-like phages, phage CB5 and phage CBB. It is believed its genome is 
circularly permutated like that of phage CB7. The genome was identified to contain 333 
ORFs with no tRNA genes. Furthermore, phylogenetic studies with this phage and Erwinia 
phage Yoloswag (259 kbp, accession no. KY448244) showed that these phages form a newly 
identified clade of jumbo phages infecting E. amylovora (Figure 7.5). 
Detailed molecular analysis of all of the phages in this thesis revealed a variety of interesting 
properties. For example, selfish genetic elements were identified in the genomes of all 
phages examined in this thesis. The genomes of phages CB5 and CBB were identified to 
contain three HNH endonucleases with phage Y3 found to contain five and CB1-like have 
between four and six. However none of these contained inteins. In comparison to these 
phages, phage CB7 was determined to contain a significantly greater number of 
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endonucleases: twenty-one HNH and two LADLIDADG (Table 5.3). Five of the HNH 
endonucleases form introns that divide the CB7 genes encoding the helicase, 
ribonucleotide-diphosphate reductase, nicotinamide phosphoribosyltransferase and DNA 
polymerase. These, apart from the HNH associated intron of the nicotinamide 
phosphoribosyl transferase gene, were demonstrated to be splicing competent by utilising 
reverse transcriptase PCR (Figure 5.14). Furthermore, phage CB7 was found to have three 
inteins, two of which contain the LAGLIDADG homing endonucleases (Table 5.3). This 
number of endonucleases in a phage genome is one of the largest described to date. Other 
phages that have been reported to have many endonucleases are Escherichia phage T4 with 
fifteen, and Dickeya phage Limestone with fourteen (Adriaenssens et al., 2012b). 
Mass spectrometry (ESI-MS/MS) was also conducted on the virions of phages CB1, CB7 and 
CBB. This analysis revealed that the virions of these three phages are formed from a 
minimum of ten, twenty-six and fifty-five proteins, respectively (Table 3.3, 5.4, 6.5).  It is 
interesting to observe that the genome size of these phages appears to correlate with the 
complexity of the structure of their virions.  
Three of all the phage types, namely those represented by CB5, CBB and Y3 have signal 
arrest release (SAR) endolysins (ORFs CB5_59, CBB_187 and Y3_301). They have an N 
terminal transmembrane domain on their respective endolysins enabling the host sec 
system to transport the protein to the inner membrane (Briers et al., 2011; Xu et al., 2004). 
Interestingly, ORF CBB_187 of phage CBB is predicted to also have an intermediate cell wall 
binding domain. Both of the endolysins of CB5 and CBB are predicted to have lysozyme 
activity, while that of phage Y3 is unusual in that it is predicted to have lytic transglycosylase 
activity. It was possible to demonstrate the SAR activity of both CBB_187 and Y3_301 in the 
laboratory by cloning the respective ORFs into Escherichia coli and overexpressing them, 
resulting in cell lysis (Figures 6.5, 7.6). 
Similar to phages CB5 and CBB, the endolysin of the CB1-like phages (CB1_60, CB3_64, 
CB4_63) is also predicted to have lysozyme activity. However, their protein lacks the N-
terminal transmembrane domain, thus they are not likely to have SAR activity.  As for phage 
CB7, the exact protein that functions as the endolysin remains to be identified. The top two 
endolysin candidates here are CB7_83, which resembles SleB (an N-acetylmuramyl-L-alanine 
amidase), a protein responsible for hydrolysis of the spore cortex in Bacillus subtilis; and 
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CB7_190 which is predicted to be a peptidase with HHpred analysis showing homology to 
the endolysin of Escherichia phage T5. 
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Table 8.1. Feature comparison of the bacteriophages described in this thesis. 
Features CB1-like 
(Pectobacterium phages 
CB1, CB3, CB4) 
Pectobacterium 
phage CB5 
Pectobacterium phage 
CB7 
Pectobacterium phage 
CBB 
Erwinia phage Y3 
Host range Pa (infects a minimum of 
10 strains each) 
Pa (infects a 
minimum of 3 
strains) 
Pa (infects a minimum 
of 5 strains) 
Pa, Pcc, Cmu, Cma, Em Ea, Pa, Pv 
Taxonomy Podoviridae,  
CBunavirus 
Podoviridae,  
Autographivirinae, 
Phiunavirus 
Myoviridae, 
Vequintavirinae, 
Cr3virus 
Myoviridae, 
‘Rak2-like’ 
Myoviridae, 
‘ΦRSL1-like’ 
Latent period/burst size 60-65 min/ 158-246 
PFU/cell 
45 min/ 43 PFU/cell 55 min/ 154 PFU/cell - - 
Genome size 75, 394 – 75,973 kbp 44, 262 kbp 142, 778 kbp 355, 922 kbp 261,365 kbp 
DTRs 647-648 bp 287 bp - 22,456 bp - 
ORFs no.  (excluding DTRs) 97-102 60 253 554 333 
tRNA gene no. 2 identified for phage CB4  0 1 33 0 
Homing endonucleases 3-6 (HNH family) 5 (HNH family) 23 (HNH and 
LAGLIDADG family) 
3 (HNH family) 3 (HNH family) 
Endolysin Lysozyme Lysozyme (SAR) SleB or Peptidase Lysozyme (SAR) Soluble lytic 
transglycosylase (SAR) 
Minimum no. of proteins 
determined to form phage 
virion by ESI-MS/MS 
10 (determined using 
phage CB1) 
- 26 55 - 
Biocontrol potential Yes Unlikely Unlikely unlikely unlikely 
Bacteria recorded as Pa, P. atrosepticum; Pcc, P. carotovorum subsp. carotovorum; Cmu, C. muytjensii; Cma, C. malonaticus; Em, E. malotivora; Ea, E. 
amylovora; Pa, P. agglomerans; Pv, P. vagans.  
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A number of proteins identified among the phages described in this thesis merited 
further investigation due to their predicted enzymatic activity or function within the 
respective phage lifecycle (Table 8.2).  
Several peptidoglycan degrading proteins were identified among the phages and these 
have potential applications as antibacterial agents (Rodríguez-Rubio et al., 2013; Yang 
et al., 2014). Examples are those previously described of in phage CB7, namely proteins 
CB7_83 and CB7_190.  There is also a putative endolysin in phage CB5 (namely ORF 
CB_51), a predicted SAR endolysin with lysozyme activity. SAR endolysins have been 
identified in other phages of genera belonging to the subfamily of Autographivirinae, 
such as the SAR endolysin KMV45 of Pseudomonas phage ɸKMV (Briers et al., 2011). It 
would be interesting to identify if the SAR endolysin is present in the genus of 
Phimunavirus. SAR endolysin activity has been confirmed with gp61 of Escherichia 
phage N4 (Stojković and Rothman-Denes, 2007). However, for the related CB1-like 
phages (such as CB1_60 of Pectobacterium phage CB1) with predicted lysozyme 
activity, their endolysin does not have the predicted N-terminal transmembrane 
domain. It would be interesting in a future project to confirm that such SAR activity is 
not associated with phages of the genus of Cbunavirus. Furthermore, CB5_51 of phage 
CB5 was predicted (by HHpred analysis) to be a virion-associated peptidoglycan 
degrading protein with lysozyme activity. Such proteins have also been identified 
among Autographivirinae members Pseudomonas phage ɸKMV and Escherichia phage 
T7 (Briers et al., 2006; Moak and Molineux, 2000).  
Proteins with a putative role in cell surface receptor binding were also identified. Such 
proteins can potentially be exploited for the detection of problematic bacteria (Javed 
et al., 2013). Examples of these are the putative tail fibres of phage CB7 (CB7_10, 36) 
and the putative tail spike proteins CB1_61 and CB5_60 of phages CB1 and CB5, 
respectively. The latter proteins are suspected to degrade or modify surface 
polysaccharide on recognition of host cells. ORF CB5_60 encodes a P22 tail spike 
domain (IPR015331), derived from the tail spike of Salmonella phage P22 shown to 
break down saccharides on binding to host cell surface (Andres et al., 2010). In 
addition, ORF CB1_62 possesses a GDSL lipase/esterase (IPR001087), suggesting the 
protein may be like that of N4-like Escherichia phage G7C, as the tail spike of this 
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phage (gp63.1) shares this domain and has been shown to deacetylate host surface 
polysaccharides  (Prokhorov et al., 2017). Such proteins have been shown to modify 
host cell surfaces altering their susceptibility to phage infection. Indeed, the tail 
associated depolymerase of Erwinia phage L1 was shown to be capable of degrading 
saccharides associated with the EPS of E. amylovora enabling infection by Erwinia 
phage Y2 (Born et al., 2013). 
Overall, the thesis has conducted a detailed analysis of seven new and interesting 
phages that infect the soft-rot Enterobacteriaceae (SRE). At a scientific level, the study 
has led to new taxonomic designations with several interesting molecular aspects 
being identified in one or other of the phages. The various characteristics were 
compared among the phages in the thesis and also compared with phages already in 
the public domain. Properties of relevance to potential biocontrol applications of the 
phages were also described. Given their scientific interest and application potential, all 
of the phages were deposited in DSMZ (Deutsche Sammlung von Mikroorganismen 
und Zellkulturen - German Collection of Microorganisms and Cell Cultures GmbH), one 
of the top culture collections in the world.  
 
 
194 
 
Table 8.1. List of identified proteins on the of the bacteriophages described in this thesis that 
merit further investigation. 
Phage Protein 
locus 
Molecular 
mass (kDa) 
Amino 
acids 
Description 
Pectobacterium 
phage CB1 
CB1_60 17.4 158 Lysozyme 
Pectobacterium 
phage CB1 
CB1_61 105 976 tail spike (putative SGNH 
esterase - hydrolase) 
Pectobacterium 
phage CB5 
CB5_51 97.9 904 internal virion protein B 
(putative lysozyme) 
Pectobacterium 
phage CB5 
CB5_59 21.9 201 putative SAR (lysozyme) 
Pectobacterium 
phage CB5 
CB5_60 61.9 585 tail spike (putative 
pectate lysate) 
Pectobacterium 
phage CB7 
CB7_10 111.9 1099 putative fibre protein 
Pectobacterium 
phage CB7 
CB7_36 81.9 793 putative fibre protein 
Pectobacterium 
phage CB7 
CB7_83 19.9 176 SleB-like protein 
Pectobacterium 
phage CB7 
CB7_190 14.5 127 putative L-alanyl-D-
glutamate peptidase 
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Appendix 1 
Table S2.1. Bacteria strains used in the isolation and testing of host range of Pectobacterium 
phages CB1, CB3, CB4, CB5, CB7 and CBB 
Bacteria strain Isolation source 
Cronobacter  muytjensii  ATCC 51329 (type strain) Unknown 
Cronobacter malonaticus DPC 6531 Brain tumour 
Cronobacter sakazakii  ATCC 29004 Unknown 
Dickeya chrysanthemi bv. 
chrysanthemi 
LMG 2804 (type strain) 
Chrysanthemum 
Dickeya dianthicola PD 482  Solanum tuberosum cv. Ostara 
PD 2174   - 
GBBC 1538 - 
Dickeya solani sp. PRI 2222  - 
LMG 25865  Solanum tuberosum cv.  Première 
GBBC 1502 - 
GBBC 1586  - 
Enterobacter cloacae  NCTC 11590 Unknown 
Enterobacter gergoviae  NCTC 11434 (type strain) Human urinary tract 
Erwinia amylovora LMG 2024 (type strain) Pear (Pyris communis) 
GBBC 403 Crataegus sp. 
Erwinia mallotivora LMG 1271 Mallotus japonicus 
Pantoea agglomerans LMG 2660 Wisteria floribunda 
LMG 2570 Sorbus sp. 
Pantoea stewartii LMG 2713 Zea mays 
LMG 2714 Zea mays 
LMG 2712 Zea mays 
Pectobacterium atrosepticum DSM  18077 (type strain) Solanum tuberosum 
DSM 30184 Solanum tuberosum cv. Bodenkraft 
DSM 30185 Solanum tuberosum 
DSM 30186 Solanum tuberosum cv. Maritta 
CB BL1-1 Solanum tuberosum cv. British 
Queen 
CB BL2-1 Solanum tuberosum cv. British 
Queen 
CB BL3-1 Solanum tuberosum cv. British 
Queen 
CB BL4-1 Solanum tuberosum cv. British 
Queen 
CB BL5-1 Solanum tuberosum cv. British 
Queen 
CB BL7-1 Solanum tuberosum cv. Golden 
wonder 
CB BL9-1 Solanum tuberosum cv. Golden 
wonder 
CB BL11-1 Solanum tuberosum cv. Rooster 
CB BL12-2 Solanum tuberosum cv. Golden 
wonder 
CB BL13-1 Solanum tuberosum cv. Golden 
wonder 
 
 
196 
 
CB BL14-1 Solanum tuberosum cv. Golden 
wonder 
CB BL15-1 Solanum tuberosum cv. Golden 
wonder 
CB BL16-1 Solanum tuberosum cv. Golden 
wonder 
CB BL18-1 Solanum tuberosum cv. Golden 
wonder 
CB BL19-1 Solanum tuberosum cv. Golden 
wonder 
Pectobacterium carotovorum 
subsp. carotovorum 
DSMZ 30168 (type strain) Solanum tuberosum 
DSMZ 30169 Brassica oleracea var. capitate 
DSMZ 30170 Solanum tuberosum "Maritta" 
CB BL19-1-37 Solanum tuberosum cv. Golden 
wonder 
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Table S2.2. Genbank details of N4-like phages used in phylograms and Gegenees analysis of 
the CB1-like phages. 
Phage Genbank accession 
number 
DNA polymerase virion RNA 
polymerase 
Achromobacter phage JWAlpha KF787095.1 KF787095.1 YP_009004769.1 
Achromobacter phage JWDelta KF787094.1 KF787094.1 AHC56581.1 
Achromobacter phage phiAxp-3 NC_028908.1 NC_028908.1 YP_009208706.1 
Acinetobacter phage Presley KF669658.1 KF669658.1 YP_009007647.1 
Dinoroseobacter phage DFL12phi1 KJ621082.2 KJ621082.2 YP_009043702.1 
Dinoroseobacter phage vBDshPR2C KJ803031.1 KJ803031.1 AID16877.1 
Enterobacter phage EcP1 NC_019485.1 NC_019485.1 YP_007003173.1 
Erwinia phage Ea9-2 NC_023579.1 YP_009007430 YP_009007447.1 
Erwinia phage vB_EamP_Gutmeister KX098391.1 ANJ65360.1 ANJ65375.1 
Erwinia phage vB_EamP_Rexella KX098390.1 ANJ65282.1 ANJ65299.1 
Erwinia phage vB_EamP-S6 NC_019514.1 NC_019514.1 YP_007005815.1 
Escherichia phage ECBP1 JX415535.1 YP_006908814.1 YP_006908827.1 
Escherichia phage N4 NC_008720.1 YP_950517.1 YP_950528.1 
Escherichia phage Pollock NC_027381.1 NC_027381.1 YP_009152160.1 
Escherichia phage vB_EcoP_G7C HQ259105.1 YP_004782168.1 YP_004782180.1 
Escherichia phage vB_EcoP_PhAPEC7 KF562340.1 YP_009056171.1 YP_009056186.1 
Pseudoalteromonas phage pYD6-A JF974296.1  JF974296.1 YP_007674286.1 
Pseudomonas phage inbricus MG018928.1 ATW58103.1 ATW58114.1 
Pseudomonas phage KPP21 LC064302.1 LC064302.1 YP_009218950.1 
Pseudomonas phage LIT1 FN422399.1 YP_003358435.1 YP_003358468.1 
Pseudomonas phage LUZ7 FN422398.1 FN422398.1 YP_003358355.1 
Pseudomonas phage RWG KM411958.1 AIZ94788.1 AIZ94822.1 
Pseudomonas phage vB_Pae575P-3 KX171209.1 ANT44317.1 ANT44349.1 
Pseudomonas phage ZC03 KU356690.1 KU356690.1 AMD43402.1 
Pseudomonas phage ZC08 KU356691.1 KU356691.1 AMD43541.1 
Roseophage DSS3P2 FJ591093.1 FJ591093.1 YP_002899070.1 
Roseophage EE36P1 FJ591094.1 FJ591094.1 YP_002898988.1 
Salmonella phage FSL SP-058 NC_021772.1 NC_021772.1 YP_008239463.1 
Salmonella phage FSL SP-076 KC139520.1 KC139520.1 YP_008240191.1 
Sulfitobacter phage phiCB2047-B NC_020862 NC_020862 YP_007675808.1 
Vibrio phage JA-1 KC438282.1 KC438282.1 YP_008126816.1 
Vibrio phage JSF3 KY065148.1 APD18062.1 APD18049.1 
Vibrio phage phi 1 KP280062.1 KP280062.1 YP_009198592.1 
Vibrio phage pVa5 KX889068.1 KX889068.1 APC46019.1 
Vibrio phage pVco-5 KY612839.1 ARM71084.1 ARM71100.1 
Vibrio phage VBP32 HQ634196.1 HQ634196.1 YP_007676574.1 
Vibrio phage VBP47 HQ634194.1 HQ634194.1 YP_007674140.1 
Vibrio phage VCO139 KC438283.1 KC438283.1 AGI61882.1 
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Table S2.3. Details of proteins used in the phylogenetic analysis of 52 phages from the 
subfamily Autographivirinae and Pectobacterium phage CB5 
Phage Genome accession no. Major capsid accession no. 
Acinetobacter phage Abp1 NC_021316.1 YP_008058231.1 
Acinetobacter phage Fri1 NC_028848.1 YP_009203047.1 
Acinetobacter phage Petty NC_023570.1 YP_009006529.1 
Acinetobacter phage phiAB1 NC_028675.1 YP_009189372.1 
Acinetobacter phage 
vB_ApiP_P2 
MF033351.1 ASN73550.1 
Aeromonas phage phiAS7 NC_019528.1 YP_007007808.1 
Cronobacter phage 
vB_CskP_GAP227 
NC_020078.1 YP_007348355.1  
Dickeya phage BF25/12 KT240186.1 ALA46504.1  
Enterobacteria phage J8-65 NC_025445.1 YP_009101383.1 
Enterobacteria phage K30 NC_015719.1 YP_004678755.1 
Enterobacteria phage T7 NC_001604.1 NP_041997.1 
Erwinia amylovora phage Era103  NC_009014.1 YP_001039668.1 
Escherichia phage phiKT NC_019520.1 YP_007006600.1 
Escherichia virus K1-5 NC_008152.1 YP_654132.1 31 
Escherichia virus K1E NC_007637.1 YP_425009.1 
Klebsiella phage F19 NC_023567.2 YP_009006057.1 
Klebsiella phage K11 NC_011043.1 YP_002003823.1 
Klebsiella phage KP32 NC_013647.1 YP_003347548.1 
Klebsiella phage KP34 NC_013649.2 YP_003347636.1 
Klebsiella phage NTUH-K2044-
K1-1 
NC_025418.1 YP_009098373.1 
Klebsiella phage vB_KpnP_SU503 NC_028816.1 YP_009199922.1 
Klebsiella phage 
vB_KpnP_SU552A 
NC_028870.1 YP_009204828.1 
Kluyvera phage Kvp1 FJ194439.1 ACJ14590.1 
Pantoea phage LIMElight NC_019454.1 YP_007002894.1 
Pantoea phage LIMEzero NC_015585.1 YP_004539113.1 
Pectobacterium phage PhiM1 JX290549.1 AFQ22523.1 
Pectobacterium phage PP16 NC_031068.1 YP_009286812.1 
Pectobacterium phage PP90 NC_031096.1 YP_009289647.1 
Pectobacterium phage PPWS1 LC063634.2 BAS69556.1 
Pectobacterium_phage_Peat1 NC_029081.1 YP_009224669.1+YP_00922467
0.1 
Pseudomonad phage gh-1 AF493143.1 AAO73167.1 
Pseudomonas phage Bf7 NC_016764.1 YP_005098192.1  
Pseudomonas phage LKA1 NC_009936.1 YP_001522884.1 
Pseudomonas phage LKD16 NC_009935.1 YP_001522824.1 
Pseudomonas phage LUZ19  NC_010326.1 YP_001671977.1 
Pseudomonas phage MPK6 NC_022746.1 YP_008766800.1 
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Pseudomonas phage MPK7 NC_022091.1 YP_008431345.1 
Pseudomonas phage phi-2 NC_013638.1 YP_003345495.1 
Pseudomonas phage phikF77 NC_012418.1 YP_002727855.1 
Pseudomonas phage phiKMV NC_005045 NP_877471.1  
Pseudomonas phage PT2 NC_011107.1 YP_002117817.1 
Pseudomonas phage PT5 EU056923.1 ABW23115.1 
Ralstonia phage RSB1 NC_011201.1 YP_002213721.1 
Ralstonia phage RSB3 NC_022917.1 YP_008853924.1 
Ralstonia virus phiAp1 KY117485.1 APU03181.1 
Salmonella phage SP6 NC_004831.2 NP_853592.1 
Vibrio phage VP93 NC_012662 YP_002875653.1 
Xanthomonas phage f20-Xaj KU595432.1 AMM44667.1 
Xanthomonas phage f30-Xaj KU595433.1 AMM44714.1 
Xylella phage Prado NC_022987.1 YP_008859419.1 
Yersinia phage phi80-18 HE956710.2 CCI88880.2 
Yersinia phage phiR8-01 HE956707.2 CCI88417.2 
Pectobacterium phage 
vB_Pat_CB5 
KY953156 ARW59018 
 
 
 
200 
 
Table S3.1. Results of physiological, biochemical, Pectobacterium genus (pel gene) specific and Pectobacterium atrosepticum and Pectobacterium 
carotovorum subsp. carotovorum species-specific PCRs and MALDI-TOF mass spectrometry on isolates obtained from potato stem samples 
symptomatic for blackleg from farms in Co. Cork, Ireland. 
Strains Isolation source Cavity 
formation 
on CVP 
medium 
(27 °C, 48 
h) 
Growth 
on NA at 
37 °C 
Production 
of reducing 
substances 
from 
sucrose 
Acid 
production 
from 
alpha-
methyl 
glucoside 
PCR - Pel 
gene 
(Darrasse 
et al 
1994) 
PCR - P. 
atrosepticum 
(De Boer & 
Ward 1995)  
PCR - P. 
carotovorum 
subsp. 
carotovorum 
(Kang et al 
2003) 
MALDI-
TOF MS 
Identity 
CB BL1-1 Co. Cork, 
Clonakilty, 
cultivar British 
queens 
+ - + + + + NA Pa Pa 
CB BL2-1 + - + + + + NA Pa Pa 
CB BL3-1 + - + + + + NA Pa Pa 
CB BL4-1 + - + + + + NA Pa Pa 
CB BL5-1 + - + + + + NA Pa Pa 
CB BL7-1 Co. Cork, 
Dunmanway, 
cultivar Golden 
wonders 
+ - + + + + NA Pa Pa 
CB BL9-1 + - + + + + NA Pa Pa 
CB BL11-1 Co. Cork, 
Dunmanway, 
cultivar Roosters 
+ - + + + + NA Pa Pa 
CB BL12-2 Co. Cork, 
Skibbereen, 
cultivar Golden 
wonders 
+ - + + + + NA Pa Pa 
CB BL13-1 + - + + + + NA Pa Pa 
CB BL14-1 + - + + + + NA Pa Pa 
CB BL15-1 + - + + + + NA Pa Pa 
CB BL16-1 + - + + + + NA Pa Pa 
CB BL18-1 + - + + + + NA Pa Pa 
CB BL19-1 + - + + + + NA Pa Pa 
CB BL19-1-37 + + - - + - + NA Pcc 
Results recorded as +, positive; −, negative; NA, not available; Pa, P. atrosepticum; Pcc, P. carotovorum subsp. carotovorum 
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(C) 
 
Figure S3.1. Single step growth curve growth analysis of phage vB_PatP_CB1 infection of P. atrosepticum strain DSM 18077 (A), phage vB_PatP CB3 
infection of P. atrosepticum strain DSM 30186 (B) and phage vB_PatP CB4 infection of P. atrosepticum DSM 30186 (C). Each assay was 
independently repeated in triplicate and the results were averaged. 
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Figure S3.2. Stability of Pectobacterium phages CB1, CB3 and CB4 to various pH values upon 24 
hours of exposure. Error bars represent the standard deviation of biological repeats (n=3). 
 
 
Figure S3.3. Stability of Pectobacterium phages CB1, CB3 and CB4 to various temperatures 
upon one-hour exposures. Error bars represent the standard deviation of biological repeats 
(n=3).  
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Table S3.2. Genomic annotation of Pectobacterium phage CB1 
ORF Start 
(bp) 
Stop 
(bp) 
Length 
(aa) 
Molecular 
mass (kDa) 
Function 
CB1_01 141 389   8.64 putative membrane protein 
CB1_02 915 1196 93 10.69 conserved hypothetical protein 
CB1_03 1262 1762 166 18.74 hypothetical protein 
CB1_04 1831 2070 79 9.32 hypothetical protein 
CB1_05 2140 2247 35 3.77 putative membrane protein 
CB1_06 2244 2594 116 13.7 hypothetical protein 
CB1_07 2738 2908 56 6.31 putative membrane protein 
CB1_08 2954 3229 91 10.11 hypothetical protein 
CB1_09 3232 3447 71 8.08 hypothetical protein 
CB1_10 3444 3758 104 12.06 hypothetical protein 
CB1_11 3755 4246 163 19.11 conserved hypothetical protein 
CB1_12 4239 4619 126 14.04 N4 gp14-like protein 
CB1_13 4790 4906 38 4.49 hypothetical protein 
CB1_14 4910 5179 89 10.22 hypothetical protein 
CB1_15 5176 5469 97 11.28 hypothetical protein 
CB1_16 5469 5792 107 12.57 hypothetical protein 
CB1_17 5789 6094 101 11.33 hypothetical protein 
CB1_18 6094 6390 98 11.29 hypothetical protein 
CB1_19 6463 6744 93 10.61 hypothetical protein 
CB1_20 6823 7119 98 10.45 conserved hypothetical protein 
CB1_21 7165 7608 147 16.98 hypothetical protein 
CB1_22 7618 8601 327 37.78 RNAP1 
CB1_23 8612 9892 426 47.79 RNAP2 
CB1_24 9937 10470 177 20.81 HNH endonuclease 
CB1_25 10473 10715 80 8.96 hypothetical protein 
CB1_26 10718 10960 80 9.1 hypothetical protein 
CB1_27 11206 11415 69 7.99 hypothetical protein 
CB1_28 11402 11989 195 22.06 hypothetical protein 
CB1_29 11970 12164 64 7.58 hypothetical protein 
CB1_30 12161 12475 104 11.72 hypothetical protein 
CB1_31 12731 12949 72 8.82 hypothetical protein 
CB1_32 13011 13112 33 3.97 hypothetical protein 
CB1_33 13109 13471 120 13.67 HNH endonuclease 
CB1_34 13468 13854 128 13.59 putative lipoprotein 
CB1_35 13944 15014 356 40.03 N4 gp24-like protein 
CB1_36 15057 15665 202 22.06 hypothetical protein 
CB1_37 15680 16267 195 22.92 hypothetical protein 
CB1_38 16236 17387 383 43.01 N4 gp25-like protein 
CB1_39 17389 17856 155 17.27 HNH endonuclease 
CB1_40 17874 19229 451 51.51 helicase 
CB1_41 19299 19753 174 20.01 hypothetical protein 
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CB1_42 19750 20088 112 12.45 N4 gp32 like 
CB1_43 20347 20853 168 19.19 HNH endonuclease 
CB1_44 20850 23276 808 92.07 rIIA-like protein 
CB1_45 23273 25108 611 65.39 rIIB-like protein 
CB1_46 25120 27901 903 101.88 DNA polymerase I 
CB1_47 27902 28087 61 6.7 putative membrane protein 
CB1_48 28116 28307 63 7.47 hypothetical protein 
CB1_49 28285 28758 157 18.56 conserved hypothetical protein 
CB1_50 28766 29113 115 13.14 hypothetical protein 
CB1_51 29172 29492 106 11.65 putative membrane protein 
CB1_52 29530 30042 170 19.21 HNH endonuclease 
CB1_53 30039 30845 268 30.4 DNA adenine methylase  
CB1_54 30852 31037 61 6.87 hypothetical protein 
CB1_55 31034 31303 89 10.04 hypothetical protein 
CB1_56 31527 31760 77 8.8 hypothetical protein 
CB1_57 32260 31805 151 15.59 putative tail protein 
CB1_58a 32722 32321 133   putative Rz 
CB1_58 32840 32343 165 18.21 putative Rz1  
CB1_59 33051 32815 78 9.19 holin 
CB1_60 33524 33048 158 17.45 lysozyme 
CB1_61 36651 33721 976 104.98 putative tail spike protein 
CB1_62 37382 36663 239 26.01 putative tail protein 
CB1_63 38247 37480 255 28.66 thymidylate synthase 
CB1_64 38255 38422 55 6.27 conserved hypothetical protein 
CB1_65 38448 38972 174 19.82 conserved hypothetical protein 
CB1_66 38972 39961 329 37.92 N4 gp42-like protein 
CB1_67 39972 42134 720 82.1 primase 
CB1_68 42142 42693 183 20.51 ryanodine receptor like protein 
CB1_69 42793 43005 70 7.94 hypothetical protein 
CB1_70 43005 43742 245 27.72 N4 gp44-like protein 
CB1_71 43729 44250 173 20.22 HNH endonuclease 
CB1_72 44268 45032 254 27.69 ssDNA binding protein 
CB1_73 45096 45431 111 12.06 hypothetical protein 
CB1_74 45424 45987 187 20.22 putative holiday junction resolvase 
CB1_75 45993 46781 262 27.45 hypothetical protein 
CB1_76 46791 46970 59 6.36 putative membrane protein 
CB1_77 58065 46984 3693 399.92 virion associated RNA polymerase (N4 
gp50-like) 
CB1_78 59234 58068 288 41.64 unknown structural protein 
CB1_79 59647 59234 137 14.2 structural protein (N4 gp52-like) 
CB1_80 62430 59656 924 101.4 N4 gp53-like protein  
CB1_81 63282 62494 262 28.82 structural protein (N4 gp54-like) 
CB1_82 63875 63294 193 21.85 N4 gp55-like protein 
CB1_83 65136 63964 390 43.33 major capsid protein (N4 gp56-like) 
CB1_84 66365 65151 163 44.18 tail measure protein (N4 gp57-like) 
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CB1_85 66782 66456 404 12.29 conserved hypothetical protein 
CB1_86 69087 66850 745 83.31 portal protein (N4 gp59-like) 
CB1_87 69155 69703 182 20.23 putative nucleoside triphosphate 
pyrophosphohydrolase 
CB1_88 70214 70459 81 9.33 conserved hypothetical protein 
CB1_89 70648 71040 130 14.12 N4 gp48-like 
CB1_90 71977 71072 301 33.72 structural protein (N4 gp67-like) 
CB1_91 73599 71986 537 61.46 large terminase subunit 
CB1_92 73765 73592 57 6.43 hypothetical protein 
CB1_93 74444 73758 228 25.42 N4 gp69 -like 
CB1_94 74500 74760 86 9.56 conserved hypothetical protein 
CB1_95 75086 74781 101 10.91 hypothetical protein 
CB1_96 75191 75295 34 3.74 putative membrane protein 
CB1_97 75385 75783 132 14.17 hypothetical protein 
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Table S3.3. Genomic annotation of Pectobacterium phage CB3 
ORF start stop Length 
(aa) 
Molecular 
weight (kDa) 
Function 
CB3_01 45 443 132 14.17 hypothetical protein 
CB3_02 1011 1292 93 10.68 conserved hypothetical 
protein 
CB3_03 1341 1841 166 18.69 conserved hypothetical 
protein 
CB3_04 1874 2011 45 4.87 putative membrane protein 
CB3_05 2008 2358 116 13.7 hypothetical protein 
CB3_06 2355 2501 46 5.58 hypothetical protein 
CB3_07 2502 2672 56 6.31 putative membrane protein 
CB3_08 2718 2960 90 9.04 hypothetical protein 
CB3_09 2957 3250 97 10.95 conserved hypothetical 
protein 
CB3_10 3228 3470 80 9.34 hypothetical protein 
CB3_11 3470 4123 217 25.81 hypothetical protein 
CB3_12 4120 4491 123 13.7 hypothetical protein 
CB3_13 4476 4778 100 11.71 hypothetical protein 
CB3_14 4782 5051 89 10.26 hypothetical protein 
CB3_15 5048 5341 97 11.22 hypothetical protein 
CB3_16 5341 5664 107 12.57 hypothetical protein 
CB3_17 5661 5951 96 10.99 hypothetical protein 
CB3_18 5930 6250 106 11.96 hypothetical protein 
CB3_19 6250 6546 98 11.43 hypothetical protein 
CB3_20 6619 6900 93 10.61 hypothetical protein 
CB3_21 6979 7275 98 10.48 conserved hypothetical 
protein 
CB3_22 7321 7599 92 10.71 conserved hypothetical 
protein 
CB3_23 7609 8022 137 16.09 hypothetical protein 
CB3_24 8032 9015 327 37.71 N4 RNAP1-like protein 
CB3_25 9026 10306 426 47.83 N4 RNAP2-like protein 
CB3_26 10309 10500 63 7.7 hypothetical protein 
CB3_27 10547 10822 91 10.88 hypothetical protein 
CB3_28 10870 11064 64 7.14 hypothetical protein 
CB3_29 11067 11312 81 9.37 hypothetical protein 
CB3_30 11558 11767 69 8.04 hypothetical protein 
CB3_31 11754 12341 195 22.06 hypothetical protein 
CB3_32 12322 12516 64 7.58 hypothetical protein 
CB3_33 12513 12821 102 11.48 hypothetical protein 
CB3_34 13087 13302 71 8.69 hypothetical protein 
CB3_35 13364 13465 33 3.97 hypothetical protein 
CB3_36 13462 13824 120 13.67 HNH endonuclease 
CB3_37 13821 14207 128 13.59 putative lipoprotein 
CB3_38 14297 15367 356 39.98 N4 gp24-like protein 
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CB3_39 15410 16018 202 21.99 hypothetical protein 
CB3_40 16069 16620 183 21.54 hypothetical protein 
CB3_41 16571 17740 389 43.76 N4 gp25-like protein  
CB3_42 17758 19053 431 48.93 DNA helicase 
CB3_43 19034 19240 68 8.01 DNA helicase 
CB3_44 19240 19764 174 20.01 hypothetical protein 
CB3_45 19761 20129 122 13.59 N4 gp32-like protein 
CB3_46 20129 20320 63 7.13 hypothetical protein 
CB3_47 20392 20898 168 19.19 HNH endonuclease 
CB3_48 20895 23321 808 91.86 rIIA-like protein 
CB3_49 23318 25417 699 74.58 rIIB-like protein 
CB3_50 25499 28210 903 101.89 DNA polymerase I 
CB3_51 28211 28396 61 6.76 putative lipoprotein 
CB3_52 28425 28616 63 7.47 conserved hypothetical 
protein 
CB3_53 28594 29067 157 18.53 nucleotidase 
CB3_54 29075 29422 115 13.16 hypothetical protein 
CB3_55 29481 29801 106 11.65 putative membrane protein 
CB3_56 29839 30351 170 19.16 HNH endonuclease 
CB3_57 30348 31154 268 30.28 DNA adenine methylase  
CB3_58 31161 31346 61 6.87 putative HNN endonuclease 
CB3_59 31343 31612 89 10.04 conserved hypothetical 
protein 
CB3_60 31836 31069 77 8.87 hypothetical protein 
CB3_61 32569 32114 151 15.59 tail protein 
CB3_62a 33031 32630 133 15.1 putative rz 
CB3_62 33149 32652 165 18.27 putative rz1 
CB3_63 33360 33124 78 9.19 holin 
CB3_64 33833 33357 158 17.45 lysozyme 
CB3_65 33877 33975 32 3.31 hypothetical protein 
CB3_66 34020 36960 976 105.02 putative tail spike protein 
CB3_67 37691 36972 239 26.02 tail fiber protein 
CB3_68 37789 38556 255 28.66 thymidylate synthase 
CB3_69 38564 38731 55 6.27 conserved hypothetical 
protein 
CB3_70 38757 39281 174 19.82 conserved hypothetical 
protein 
CB3_71 39281 40270 329 37.94 N4 gp42-like protein 
CB3_72 40281 42443 720 82.1 primase 
CB3_73 42451 43002 183 20.55 Ryanodine receptor Ryr-like 
protein 
CB3_74 43102 43314 70 7.94 hypothetical protein 
CB3_75 43314 44051 245 27.72 N4 gp44-like protein 
CB3_76 44038 44559 173 20.22 Putative HNH homing 
endonuclease 
CB3_77 44577 45341 254 27.69 ssDNA binding protein 
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CB3_78 45405 45740 111 11.99 hypothetical protein 
CB3_79 45733 46296 187 20.22 putative holiday junction 
resolvase 
CB3_80 46302 47090 262 27.41 hypothetical protein 
CB3_81 47100 47279 68 6.36 putative membrane protein 
CB3_82 11082 47293 3693 400.09 virion associated RNA 
polymerase 
CB3_83 59543 58377 373 41.67 Structural protein 
CB3_84 59956 59543 137 14.22 N4 gp52-like protein 
CB3_85 62739 59965 924 101.53 N4 gp53-like protein  
CB3_86 63591 62803 262 28.82 N4 gp54-like protein 
CB3_87 64184 63603 193 21.85 N4 gp55-like protein 
CB3_88 65445 64273 390 43.33 major virion protein 
CB3_89 66641 65460 394 42.85 tape measure protein 
CB3_90 66964 66638 108 12.29 conserved hypothetical 
protein 
CB3_91 69269 67032 745 83.31 N4 gp59-like protein 
CB3_92 69337 69885 182 20.23 putative nucleoside 
triphosphate 
pyrophosphohydrolase 
CB3_93 70397 70311 28 3.24 hypothetical protein 
CB3_94 70396 70641 81 9.33 conserved hypothetical 
protein 
CB3_95 70830 71222 130 14.12 N4 gp48-like protein 
CB3_96 72159 71254 301 33.72 putative structural protein 
CB3_97 73781 72168 537 61.45 terminase large subunit 
CB3_98 73947 73774 57 6.43 putative membrane protein 
CB3_99 73940 74626 228 25.42 N4 gp69-like protein 
CB3_100 74682 74942 86 9.56 conserved hypothetical 
protein 
CB3_101 75268 74963 101 11.02 hypothetical protein 
CB3_102 75567 75965 132 14.17 hypothetical protein 
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Table S3.4. Genomic annotation of Pectobacterium phage CB4 
ORF Start 
(bp) 
Stop 
(bp) 
Length 
(aa) 
Molecular 
weight (kDa) 
Function 
CB4_001 141 389 82 8.6 putative membrane protein 
CB4_002 958 1239 93 10.68 conserved hypothetical 
protein 
CB4_003 1288 1788 166 18.69 conserved hypothetical 
protein 
CB4_004 1851 1958 35 3.77 putative membrane protein 
CB4_005 1955 2305 116 13.7 hypothetical protein 
CB4_006 2302 2448 48 5.58 hypothetical protein 
CB4_007 2449 2619 56 6.31 putative membrane protein 
CB4_008 2665 2907 80 9.04 hypothetical protein 
CB4_009 2904 3197 97 10.95 conserved hypothetical 
protein 
CB4_010 3175 3417 80 9.34 hypothetical protein 
CB4_011 3417 4070 217 25.81 hypothetical protein 
CB4_012 4067 4438 123 13.7 N4 gp14-like protein 
CB4_013 4423 4725 100 11.71 hypothetical protein 
CB4_014 4729 4998 89 10.26 hypothetical protein 
CB4_015 4995 5288 97 11.22 hypothetical protein 
CB4_016 5288 5611 107 12.57 hypothetical protein 
CB4_017 5608 5898 96 10.99 hypothetical protein 
CB4_018 5877 6197 106 11.96 hypothetical protein 
CB4_019 6197 6493 98 11.43 hypothetical protein 
CB4_020 6566 6847 93 10.61 hypothetical protein 
CB4_021 6926 7222 98 10.48 hypothetical protein 
CB4_022 7268 7546 92 10.71 conserved hypothetical 
protein 
CB4_023 7556 7969 137 16.09 hypothetical protein 
CB4_024 7979 8962 327 37.71 N4 RNAP1-like protein 
CB4_025 8973 10253 426 47.83 N4 RNAP2-like protein 
CB4_026 10256 10447 63 7.7 hypothetical protein 
CB4_027 10494 10769 91 10.88 hypothetical protein 
CB4_028 10769 11011 90 8.94 hypothetical protein 
CB4_029 11014 11259 81 9.37 hypothetical protein 
CB4_030 11505 11714 69 8.04 hypothetical protein 
CB4_031 11701 12288 195 22.06 hypothetical protein 
CB4_032 12269 12463 64 7.58 hypothetical protein 
CB4_033 12460 12768 102 11.48 hypothetical protein 
CB4_034 13034 13249 71 8.69 hypothetical protein 
CB4_035 13311 13412 33 3.97 hypothetical protein 
CB4_036 13409 13771 120 13.67 HNH endonuclease 
CB4_037 13768 14154 128 13.59 putative lipoprotein 
CB4_038 14244 15314 356 40.03 N4 gp24-like protein 
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CB4_039 15357 15965 202 22.14 hypothetical protein 
CB4_040 15980 16567 195 23.01 hypothetical protein 
CB4_041 16518 17687 289 43.71 N4 gp25-like protein 
CB4_042 17705 19060 451 51.55 DNA helicase 
CB4_043 19060 19584 174 19.98 hypothetical protein 
CB4_044 19581 19919 112 12.45 N4 gp32-like protein 
CB4_045 19919 20107 62 7.04 hypothetical protein 
CB4_046 20178 20684 168 19.17 HNH endonuclease 
CB4_047 20681 23107 808 91.81 rIIA-like protein 
CB4_048 23104 25203 699 74.58 rIIB-like protein 
CB4_049 25354 27996 880 99.26 DNA polymerase I 
CB4_050 28033 28182 49 5.28 putative membrane protein 
CB4_051 28211 28402 63 7.47 conserved hypothetical 
protein 
CB4_052 28380 28853 157 18.48 nucleotidase 
CB4_053 28861 29208 115 13.13 hypothetical protein 
CB4_054 29267 29587 106 11.65 putative membrane protein 
CB4_055 29625 30137 170 19.16 HNH endonuclease 
CB4_056 30134 30940 268 30.28 DNA adenine methylase  
CB4_057 30947 31132 61 6.87 hypothetical protein 
CB4_058 31129 31398 89 10.04 conserved hypothetical 
protein 
CB4_059 31622 31855 77 8.85 hypothetical protein 
CB4_060 32355 31900 151 15.59 tail protein 
CB4_61a 32817 32418 133 15.1 putative rz 
CB4_061 32935 32438 165 18.27 putative rz1 
CB4_062 33146 32910 78 9.19 holin 
CB4_063 33619 33143 158 17.45 lysozyme 
CB4_064 33816 35627 603 65.39 putative tail spike protein 
CB4_065 36873 35611 420 44.3 conserved hypothetical 
protein 
CB4_066 37604 36885 239 25.98 tail protein 
CB4_067 38194 38814 206 23.46 thymidylate synthase 
CB4_068 38819 38986 55 6.32 hypothetical protein 
CB4_069 39012 39536 174 19.88 N4 gp41-like protein 
CB4_070 39536 40525 329 37.93 N4 gp42-like protein 
CB4_071 40536 42698 720 82.1 primase 
CB4_072 42706 43257 183 20.55 conserved hypothetical 
protein 
CB4_073 43357 43569 70 7.95 hypothetical protein 
CB4_074 43569 44306 245 27.71 N4 gp44-like protein 
CB4_075 44293 44814 173 20.2 HNH endonuclease 
CB4_076 44832 45596 245 27.69 ssDNA binding protein 
CB4_077 45660 45995 111 11.95 hypothetical protein 
CB4_078 45988 46551 187 20.23 putative holiday junction 
resolvase 
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CB4_079 46557 47345 262 27.45 hypothetical protein 
CB4_080 47355 47534 59 6.36 putative membrane protein 
CB4_081 58629 47548 3693 400.08 virion associated RNA 
polymerase 
CB4_082 59798 58632 388 41.73 structural protein 
CB4_083 60211 59798 137 14.23 N4 gp52-like protein 
CB4_084 62994 60220 924 101.39 N4 gp53-like protein 
CB4_085 63846 63058 262 28.82 N4 gp54-like protein 
CB4_086 63858 64439 193 21.85 N4 gp55-like protein 
CB4_087 65700 64528 390 43.33 major capsid protein 
CB4_088 66896 65715 393 43.03 tape measure protein 
CB4_089 67219 66893 108 12.29 conserved hypothetical 
protein 
CB4_090 69524 67287 745 83.26 portal protein 
CB4_091 69593 70162 189 21.22 putative nucleoside 
triphosphate 
pyrophosphohydrolase 
CB4_092 70768 71013 81 9.33 conserved hypothetical 
protein 
CB4_093 71203 71595 130 14.12 N4 gp48-like protein 
CB4_094 72532 71627 301 33.57 putative tail protein 
CB4_095 74154 72541 537 61.46 terminase large subunit 
CB4_096 74344 74147 65 7.53 hypothetical protein 
CB4_097 75023 74337 228 25.45 N4 gp69-like protein 
CB4_098 75079 75339 86 9.56 conserved hypothetical 
protein 
CB4_099 75665 75360 101 10.96 hypothetical protein 
CB4_100 76114 76362 82 8.6 putative membrane protein 
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Table S3.5. Identified ORFs and tRNA gene variations between the genomes of Pectobacterium 
phages CB1, CB3 and CB4. With genome comparisons made using BLASTN with ACT. Bold with 
italics (shared feature), without bold with italics (unique feature to phage in question). 
CB1 CB3 CB4 Variation 
CB1_4 
(hypothetical) 
_ _ CB1_4 has no homolog in 
CB3+CB4 
CB1_8 
(hypothetical) 
_ _ CB1_8 has no homolog in 
CB3+CB4 
CB1_10 
(hypothetical) 
CB3_9 
(hypothetical) 
CB4_9  ORFs of CB1 not shared with 
CB3 +CB4 
CB1_11 
(hypothetical) 
CB3_10 
(hypothetical) 
CB4_10 
_ CB3_11 
(hypothetical) 
CB4_11 
_ CB3_17 
(hypothetical) 
CB4_17 CB3/CB4_17 homolog not 
present in CB1 
CB1_21 
(hypothetical) 
CB3_22 
(hypothetical) 
CB4_22 ORF of CB1 are not shared 
with CB3+CB4 
_ CB3_23 
(hypothetical) 
CB4_23 
CB1_24 (HNH) CB3_26 
(hypothetical) 
CB4_26 ORFs of CB1 are not shared 
with CB3+CB4 
_ CB3_27 
(hypothetical) 
CB4_27 
CB1_26 
(hypothetical) 
CB3_29 
(hypothetical) 
CB4_29 ORF of CB1 different in part to 
CB3+CB4 
CB1_39 (HNH) _   CB1 has no homolog in 
CB3+CB4 
CB1_42 (N4 
gp32-like) 
CB3_45 (N4 gp32-
like) 
CB4_44 (N4 gp32-
like) 
N4 gp32-like gene of CB3 
different to CB1+CB4 
CB1_45 (rIIB) CB3_49 (rIIB) CB4_48 (rIIB) Difference of CB1 ORF length 
compared to CB1+CB4 
CB1_61 (tail 
spike) 
CB3_66 (tail spike) CB4_64, 65 (tail 
spike) 
CB4 homolog split into two 
ORFs 
CB1_63 
(thymidylate 
synthase) 
CB3_68 
(thymidylate 
synthase) 
CB4_67 
(thymidylate 
synthase) 
ORF of CB1 and CB3 different 
to CB4 
    2 tRNA genes 
(tRNA1 and tRNA2) 
CB4 has tRNA genes not 
present in CB1+CB3 
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Table S3.6. Homologs of the eighteen core proteins described by Li et al. 2016 found present in 
the genomes of Pectobacterium phages CB1, CB3 and CB4. 
No. N4-like Core genes CB1 homolog CB3 homolog CB4 homolog 
1 RNA P1 CB1_22 CB3_24 CB4_24 
2 RNA P2 CB1_23 CB3_25 CB4_25 
3 gp24 N4 CB1_35 CB3_38 CB4_38 
4 gp25 N4 CB1_38 CB3_41 CB4_41 
5 DNA P/ gp39 N4 CB1_46 CB3_50 CB4_49 
6 gp42 N4 CB1_66 CB3_71 CB4_70 
7 DNA primase CB1_67 CB3_72 CB4_71 
8 gp44 N4 CB1_70 CB3_75 CB4_74 
9 SSB/gp45 N4 CB1_72 CB3_77 CB4_76 
10 vRNAP CB1_77 CB3_82 CB4_81 
11 gp53 N4 CB1_80 CB3_85 CB4_84 
12 gp54 N4 CB1_81 CB3_86 CB4_85 
13 gp55 N4 CB1_82 CB3_87 CB4_86 
14 MCP/ gp56 N4 CB1_83 CB3_88 CB4_87 
15 gp57 N4 CB1_84 CB3_89 CB4_88 
16 94kDa protein/ gp59 N4 CB1_86 CB3_91 CB4_90 
17 terminase A CB1_91 CB3_97 CB4_95 
18 gp69 CB1_93 CB3_99 CB4_97 
 
 
Table S3.7. Putative single-stranded hairpin promoters predicted in the genomes of 
Pectobacterium phages CB1, CB3 and CB4 identified assisted with QuikFold.  
Phage Promotor Coordinates Sequence 
CB1 Porf1_1 76 - 105 bp GTGTTGAACCGGTATCCGGTACAGTACCGT 
Porf1_2 823 - 852 bp ATGGCATCCATGCATCATGGCATCCATATG 
Porf1_5 2085 - 2114 bp TTGGACCGAGCGTATCGCTCAGCCCACTTA 
CB3 Porf3_1 130 - 159 bp GTGTTGAACCGGTATCCGGTACAGTACCGT 
Porf3_ 2 919 - 948 bp ATGGCATCCATGCATCATGGCATCCATATG 
Porf3_4 1850 - 1879 bp TCGGACCGCACGTATCGTGCAGCCCACTTA 
CB4 Porf4_1 76 - 105 bp GTGTTGAACCGGTATCCGGTACAGTACCGT 
Porf4_2 866 - 895 bp ATGGCATCCATGCATCATGGCATCCATATG 
Porf4_4 1797 - 1826 bp TCGGACCGCACGTATCGTGCAGCCCACTTA 
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Table S3.8. High ΔG rho-independent terminators predicted in the genome Pectobacterium 
phage vB_PatP_CB1 identified using ARNold and QuikFold. 
Terminator Coordinates Sequence ΔG 
kcal/mol 
Torf1_1 397 - 428 GCCTACTCTTCGGAGTAGGCTTATTCTTTTCT -17.2 
Torf1_7 2,906 - 2,935 TAACCCCTTCGGGGGTTATCTTATTTTTTA -13.6 
Torf1_20 7,127 - 7,158 GCCATCCCTTCGGGGATGGCTGTTTTATTGAG -19.3 
Torf1_26 11,034 - 11,070 CGGACTCCCTAAGATGGGGAGTCCGTATTTTTTCA
TA 
-19 
Torf1_45 25,131 - 25,163 GCCAGCCCTTCGGGGCTGGTTTTTTAATATCAT -18.8 
Torf1_47 28,088 - 28,113 GCCCCTTCGGGGGCTTTTTTGAGGCT -13.7 
Torf1_51 29,497 - 29,525 AGCCCCTAACGGGGCTTTTTTATTGAGGT -12.8 
Torf1_56 31,765 - 31,793 GCCCACCTAGTGTGGGCTTATATTAATCT -10.7 
Torf1_57 31,751 - 
31,782, 
complement 
AGCCCACACTAGGTGGGCTTTTTTATAGCATC -11.8 
Torf1_61 33,531 - 
33,561, 
complement 
GGGAGCCTAATGGCTCCCTTTTTAATCTGGA -15.4 
Torf1_72 45,051 - 45,078 GCCCACTTCGGTGGGCTTTTTTATCTAT -14.7 
Torf1_76 46,958 - 46,987 GCCCCTCGATTGAGGGGCTTTATTTTTTAG -14.5 
Torf1_77 46,944 - 
46,976, 
complement 
AGCCCCTCAATCGAGGGGCTTTTTATTACGGTA -15.4 
Torf1_81 62,438 - 
62,467, 
complement 
GGGAGCTTAAGGCTCCCTTTTCATTGTGAG -11.9 
Torf1_83 63,896 - 
63,928, 
complement 
GCCGGGGATAATTCCCCGGCTTTTTTATATCTA -18.1 
Torf1_87 69,766 - 69,796 CTCCCTCTTCAGAGGGAGcTTTTAAACCTGA -12.1 
Torf1_88 70,620 - 70,649 GCCCCACTTCGGTGGGGCTTTTTCCGTTAT -18 
Torf1_89 71,047 - 71,076 GCCCCCGATTAAGGGGGCTTTTTTATTACA -14.6 
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Table S3.9. High ΔG rho-independent terminators predicted in the genome Pectobacterium 
phage vB_PatP_CB3 identified using ARNold and QuikFold. 
Terminator Coordinates Sequence ΔG 
kcal/mol 
Torf3_1 451 -  482 GCCTACTCTTCGGAGTAGGCTTATTCTTTTCT -17.2 
Torf3_7 2,670 - 2,699 TAACCCCTTCGGGGGTTATCTTATTTTTTA -13.6 
Torf3_21 7,283 - 7,314 GCCATCCCTTCGGGGATGGCTGTTTTATTGAG -19.3 
Torf3_29 11,386 - 11,422 CGGACTCCCCATCTTAGGGAGTCCGTATTTTTTCATA -17.1 
Torf3_57 20,329 - 20,357 GCCAGATTTAATCTGGCTTTTTCTTTTTA -9.4 
Torf3_49 25,440 - 25,472 GCCAGCCCTTCGGGGCTGGTTTTTTAATATCAT -18.8 
Torf3_51 28,397 - 28, 422 GCCCCTTCGGGGGCTTTTTTGAGGCT -13.7 
Torf3_55 29,806 - 29, 834 AGCCCCTAACGGGGCTTTTTTATTGAGGT -12.8 
Torf3_60 32,074 - 32,102 GCCCACCTAGTGTGGGCTTATATTAATCT -10.7 
Torf3_65 33,840 - 33,870, 
complement 
GGGAGCCTAATGGCTCCCTTTTTAATCTGGA -15.4 
Torf3_77 45,360 - 45, 387 GCCCACTTCGGTGGGCTTTTTTATCTAT -14.7 
Torf3_81 47,267 - 47,296 GCCCCTCGATTGAGGGGCTTTATTTTTTAG -14.5 
Torf3_82 47, 253 - 47, 285, 
complement 
AGCCCCTCAATCGAGGGGCTTTTTATTACGGTA -15.4 
Torf3_86 62,747 - 62,776, 
complement 
GGGAGCTTAAGGCTCCCTTTTCATTGTGAG -11.9 
Torf3_88 64,205 - 64,237, 
complement 
GCCGGGGATAATTCCCCGGCTTTTTTATATCTA -18.4 
Torf3_92 69,948 - 69,978 CTCCCTCTTCAGAGGGAGcTTTTAAACCTGA -12.1 
Torf3_94 70,802 - 70,831 GCCCCACTTCGGTGGGGCTTTTTCCGTTAT -18 
Torf3_95 71,229 - 71,258 GCCCCCGATTAAGGGGGCTTTTTTATTACA -14.6 
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Table S3.10. High ΔG rho-independent terminators predicted in the genome Pectobacterium 
phage vB_PatP_CB4 identified using ARNold and QuikFold. 
Terminato
r 
Coordinates Sequence ΔG 
kcal/mo
l 
Torf4_1 396 - 429 GCCTCATCCTTCGGGATGGGGCTATCTCTTTTC
T 
-19.6 
Torf4_7 2,617 - 2,646 TAACCCCTTCGGGGGTTATCTTATTTTTTA -13.6 
Torf4_21 7,230 - 7,261 GCCATCCCTTCGGGGATGGCTGTTTTATTGAG -19.3 
Torf4_29 11,333 - 11,369 CGGACTCCCCATCTTAGGGAGTCCGTATTTTTT
CATA 
-17.1 
Torf4_45 20,116 - 20,144 GCCAGATTTAATCTGGCTTTTCTTTTTAA -9.4 
Torf4_48 25,226 - 25,258 GCCAGCCCTTCGGGGCTGGTTTTTTAATATCAT -18.8 
Torf4_50 28,183 - 28,208 GCCCCTTCGGGGGCTTTTTTGAGGCT -13.7 
Torf4_54 29,592 - 29,620 AGCCCCTAACGGGGCTTTTTTATTGAGGT -12.8 
Torf4_59 31,860 - 31,888 GCCCACCTAGTGTGGGCTTATATTAATCT -10.7 
Torf4_64 33,826 - 33,656, 
complement 
GGGAGCCTAATGGCTCCCTTTTTAATCTGGA -15.4 
Torf4_76 45,615 - 45,642 GCCCACTTCGGTGGGCTTTTTTATCTAT -14.7 
Torf4_81 47,508 - 47,540, 
complement 
AGCCCCTCAATCGAGGGGCTTTTTATTACGGTA -15.4 
Torf4_80 47,522 - 47,551 GCCCCTCGATTGAGGGGCTTTATTTTTTAG -14.5 
Torf4_85 63,002 - 63,031, 
complement 
GGGAGCTTAAGGCTCCCTTTTCATTGTGAG -18.1 
Torf4_91 70,203 - 70,233 CTCCCTCTTCGGAGGGAGcTTTTAAACCTGA -15.2 
Torf4_92 71,175 - 71,204 GCCCCACTTCGGTGGGGCTTTTTCCGTTAT -18 
Torf4_93 71,602 - 71,631 GCCCCCGATTAAGGGGGCTTTTTTATTACA -14.6 
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Table S3.11. Shared high ΔG putative rho-independent terminators among Pectobacterium 
phages CB1, CB3 and CB4 
no. CB1 CB3 CB4 
1 Torf1_01 Torf3_01 Torf4_01 
2 Torf1_07 Torf3_07 Torf4_07 
3 Torf1_20 Torf3_21 Torf4_21 
4 Torf1_26 Torf3_29 Torf4_29 
5 Torf1_45 Torf3_49 Torf4_48 
6 Torf1_47 Torf3_51 Torf4_50 
7 Torf1_51 Torf3_55 Torf4_54 
8 Torf1_56 Torf3_60 Torf4_59 
9 Torf1_61 Torf3_65 Torf4_64 
10 Torf1_72 Torf3_77 Torf4_76 
11 Torf1_76 Torf3_81 Torf4_80 
12 Torf1_77 Torf3_82 Torf4_81 
13 Torf1_81 Torf3_86 Torf4_85 
14 Torf1_87 Torf3_92 Torf4_91 
15 Torf1_88 Torf3_94 Torf4_92 
16 Torf1_89 Torf3_95 Torf4_93 
 
 
Figure S3.4. (A) Genomic DNA of Pectobacterium phage vB_PatP_CB1, which had been 
digested with restriction enzyme ClaI (lane 1), with DNA marker (Hyperladder 1kb, Bioline) 
(lane MW).  (B) In silico digest of CB1 redundant genomic DNA with ClaI with Dam methylation 
(lane 2); non-Dam methylation (lane 3); DNA marker (Hyperladder 1kb, Bioline) (lane MW). Gel 
concentration 1 % w/v agarose. Image B was generated using Snapgene.  
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Figure S3.5. (A) Genomic DNA of Pectobacterium phage vB_PatP_CB3, which had been 
digested with restriction enzyme ClaI (lane 1), with DNA marker (Hyperladder 1kb, Bioline) 
(lane MW).  (B) In silico digest of CB3 redundant genomic DNA with ClaI with Dam methylation 
(lane 2); non-Dam methylation (lane 3); DNA marker (Hyperladder 1kb, Bioline) (lane MW). Gel 
concentration 1 % w/v agarose. Image B was generated using Snapgene.  
 
Figure S3.6. (A) Genomic DNA of Pectobacterium phage vB_PatP_CB4, which had been 
digested with restriction enzyme ClaI (lane 1), with DNA marker (Hyperladder 1kb, Bioline) 
(lane MW).  (B) In silico digest of CB4 redundant genomic DNA with ClaI with Dam methylation 
(lane 2); non-Dam methylation (lane 3); DNA marker (Hyperladder 1kb, Bioline) (lane MW). Gel 
concentration 1 % w/v agarose. Image B was generated using Snapgene.  
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Figure S3.7. Pictures of the typically observed outcomes for the tuber rot assays. A: tuber 
treated with bacterial strains DSM 18077 + DSM 30186 and SM buffer. B: tuber treated with 
bacterial strains DSM 18077 + DSM 30186 and phage mixture (CB1 + CB3 + CB4). C: tuber 
treated with water and SM buffer.  
 
Figure S4.1. Pectobacterium phage CB5 plaque morphology on 0.4% w/v LB overlay using host 
strain P. atrosepticum DSM 30186 (12 hr incubation). 
 
Figure S4.2. Coverage map showing the distribution of reads when mapped back to the contig 
representing the genome of Pectobacterium phage CB5 obtained from genome assembly. Map 
created with CLC Genomics Workbench. 
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Table S4.1. Genomic annotation of Pectobacterium phage CB5 
ORF Start 
(bp) 
Stop 
(bp) 
Length 
(aa) 
Molecular 
weight (kDa) 
Function 
CB5_1 617 450 55 6.67 hypothetical protein 
CB5_2 786 944 52 6.02 hypothetical protein 
CB5_3 1172 1474 100 11.15 hypothetical protein 
CB5_4 1461 1652 63 7.14 hypothetical protein 
CB5_5 1652 1780 42 5.25 hypothetical protein 
CB5_6 1829 2398 189 20.38 hypothetical protein 
CB5_7 2462 2725 87 9.67 hypothetical protein 
CB5_8 2802 3050 82 9.87 hypothetical protein 
CB5_9 3047 3325 92 10.72 hypothetical protein 
CB5_10 3408 3584 58 6.6 hypothetical protein 
CB5_11 3581 3760 59 7.07 hypothetical protein 
CB5_12 3757 4101 114 13.2 hypothetical protein 
CB5_13 4107 4982 291 32.6 hypothetical protein 
CB5_14 4995 5852 285 5.81 hypothetical protein 
CB5_15 5842 6813 323 35.83 Putative peptidase 
CB5_16 6800 7234 144 15.81 hypothetical protein 
CB5_17 7227 7664 145 16.92 HNH endonuclease 
CB5_18 7661 8464 267 30.25 putative DNA primase 
CB5_19 8645 8782 45 5.09 hypothetical protein 
CB5_20 8784 8927 47 5.14 hypothetical protein 
CB5_21 8927 9088 53 5.77 hypothetical protein 
CB5_22 9088 10350 420 46.64 putative DNA helicase  
CB5_23 10337 10792 151 17.61 HNH endonuclease 
CB5_24 10792 11322 176 19.57 putative nucleotidyl 
transferase 
CB5_25 11366 11596 76 8.69 hypothetical protein 
CB5_26 11586 11768 60 6.91 hypothetical protein 
CB5_27 11761 11943 60 6.55 hypothetical protein 
CB5_28 11997 14339 780 88.55 putative DNA polymerase 
CB5_29 14329 14805 158 18.26 HNH endonuclease 
CB5_30 14817 15656 279 29.7 hypothetical protein 
CB5_31 15670 16716 348 39.15 putative 5' exonuclease 
CB5_32 16673 16840 55 6.46 hypothetical protein 
CB5_33 16837 17082 81 9.01 hypothetical protein 
CB5_34 17075 17500 141 15.97 DNA endonuclease VI 
CB5_35 17481 17702 73 8.12 hypothetical protein 
CB5_36 17695 18669 324 36.18 putative 
metallophosphoesterase 
CB5_37 18779 19102 107 12.02 hypothetical protein 
CB5_38 19213 19395 60 6.83 hypothetical protein 
CB5_39 19402 21846 814 91.61 DNA-dependent RNA 
polymerase 
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CB5_40 21939 22136 65 7.54 hypothetical protein 
CB5_41 22133 22585 150 16.67 HNH endonuclease 
CB5_42 22578 22997 139 15.85 hypothetical protein 
CB5_43 22990 23316 108 11.2 putative structural protein 
CB5_44 23319 24830 503 55.63 putative head-tail connector 
protein 
CB5_45 24830 25699 289 30.47 putative scaffolding protein 
CB5_46 25717 26700 327 36.28 putative capsid protein 
CB5_47 26760 27317 185 21.13 putative tubular protein A 
CB5_48 27327 27809 160 18.47 HNH endonuclease 
CB5_49 27829 30129 766 83.39 putative tubular protein B 
CB5_50 30126 30740 204 21.53 putative internal virion protein 
A 
CB5_51 30750 33464 904 97.96 putative internal virion protein 
B 
CB5_52 33474 37265 1263 135.4 putative internal virion protein 
C 
CB5_53 37275 38879 534 55.84 tail fiber protein 
CB5_54 38888 39175 95 10.38 putative DNA maturase B 
CB5_55 39184 41001 605 68.34 putative DNA maturase B 
CB5_56 41010 41198 62 6.34 hypothetical protein 
CB5_57 41208 41597 129 13.24 putative Rz1A protein 
CB5_58 41587 41856 89 10.16 putative holin 
CB5_59 41840 42445 201 21.93 putative lysozyme 
CB5_60 42460 44217 586 61.92 putative tail spike protein 
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Figure S4.3. Phylogenetic analyses of amino sequences of the head-tail connecting protein (A), 
terminase (B), tail tube protein A (C) and tail tube protein B (D) of Pectobacterium phage CB5 
and 52 members of the Autographivirinae subfamily, using maximum likelihood (Whelan and 
Goldman substitution model), with 100 bootstrap replicates.  
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Table S4.2. Taxonomy output from VICTOR analysis of 52 phages from the subfamily 
Autographivirinae and Pectobacterium phage CB5, OPTSIL clustering of taxon boundaries 
based on the D4 formula at genus and subfamily level. Numbers represent the genus and 
subfamily which phages have been allocated.  
Phage genus subfamily 
Enterobacteria phage SP6 (NC_004831) 1 1 
Escherichia virus K1E (NC_007637) 1 1 
Escherichia virus K1-5 (NC_008152) 1 1 
Erwinia amylovora phage Era103 (NC_009014) 1 1 
Pseudomonad phage gh-1 (AF493143) 3 2 
Kluyvera phage Kvp1 (FJ194439) 3 2 
Enterobacteria phage T7 (NC_001604) 3 2 
Klebsiella phage K11 (NC_011043) 3 2 
Klebsiella phage KP32 (NC_013647) 3 2 
Escherichia phage K30 (NC_015719) 3 2 
Ralstonia phage RSB1 (NC_011201) 2 3 
Pseudomonas phage Bf7 (NC_016764) 4 3 
Escherichia phage phiKT (NC_019520) 5 3 
Yersinia phage phiR8-01 (HE956707) 6 3 
Yersinia phage phi80-18 (HE956710) 6 3 
Aeromonas phage phiAS7 (NC_019528) 6 3 
Cronobacter phage vB_CskP_GAP227 (NC_020078) 6 3 
Xanthomonas phage f20-Xaj (KU595432) 9 3 
Xanthomonas phage f30-Xaj (KU595433) 9 3 
Xylella phage Prado (NC_022987) 9 3 
Pseudomonas phage PT5 (EU056923) 7 4 
Pseudomonas phage phiKMV (NC_005045) 7 4 
Pseudomonas phage LKD16 (NC_009935) 7 4 
Pseudomonas phage LKA1 (NC_009936) 7 4 
Pseudomonas phage LUZ19 (NC_010326) 7 4 
Pseudomonas phage PT2 (NC_011107) 7 4 
Pseudomonas phage phikF77 (NC_012418) 7 4 
Pseudomonas phage phi-2 (NC_013638) 7 4 
Pseudomonas phage MPK7 (NC_022091) 7 4 
Pseudomonas phage MPK6 (NC_022746) 7 4 
Ralstonia virus phiAp1 (KY117485) 8 4 
Ralstonia phage RSB3 (NC_022917) 8 4 
Pantoea phage LIMEzero (NC_015585) 10 4 
Enterobacteria phage J8-65 (NC_025445) 10 4 
Acinetobacter phage vB_ApiP_P2 (MF033351) 11 4 
Acinetobacter phage Abp1 (NC_021316) 11 4 
Acinetobacter phage Petty (NC_023570) 11 4 
Acinetobacter phage phiAB1 (NC_028675) 11 4 
Acinetobacter phage Fri1 (NC_028848) 11 4 
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Vibrio phage VP93 (NC_012662) 12 4 
Klebsiella phage KP34 (NC_013649) 12 4 
Pantoea phage LIMElight (NC_019454) 12 4 
Klebsiella phage F19 (NC_023567) 12 4 
Klebsiella phage NTUH-K2044-K1-1 (NC_025418) 12 4 
Klebsiella phage vB_KpnP_SU503 (NC_028816) 12 4 
Klebsiella phage vB_KpnP_SU552A (NC_028870) 12 4 
Pectobacterium phage PhiM1 (JX290549) 13 4 
Dickeya phage BF25/12 (KT240186) 13 4 
Pectobacterium phage PPWS1 (LC063634) 13 4 
Pectobacterium phage Peat1 (NC_029081) 13 4 
Pectobacterium phage PP16 (NC_031068) 13 4 
Pectobacterium phage PP90 (NC_031096) 13 4 
Pectobacterium phage CB5 (KY953156) 13 4 
 
 
Table S4.3. Shared early region ORFs between PhiM1-like phages as determined by Coregenes 
no. Early gene region Peat1 CB5 phiM1 PP90 
1 hypothetical protein AXI77_gp61 CB5_3 PhiM1_03 PP90_2 
2 hypothetical protein AXI77_gp01 CB5_6 PhiM1_04 PP90_3 
3 hypothetical protein AXI77_gp07 CB5_12 PhiM1_08 PP90_7 
4 hypothetical protein AXI77_gp08 CB5_13 PhiM1_09 PP90_8 
5 peptidase AXI77_gp09 CB5_15 PhiM1_10 PP90_9 
6 hypothetical protein AXI77_gp10 CB5_16 PhiM1_11 PP90_10 
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Table S4.4.  Proteins of PhiM1-like phage involved in DNA replication, repair and related 
metabolism 
no. 
DNA replication & nucleotide 
metabolism Peat1 CB5 phiM1 PP90 
1 
DNA primase 
AXI77_gp12 + 
AXI77_gp13 CB5_18 
PhiM1_1
2 
PP90_1
2 
2 
DNA helicase AXI77_gp17 CB5_22 
PhiM1_1
4 
PP90_1
5 
3 
DNA polymerase AXI77_gp21 CB5_28 
PhiM1_1
4 
PP90_2
1 
4 
5' exonuclease AXI77_gp23 CB5_31 
PhiM1_2
2 
PP90_2
4 
5 
endonuclease VII AXI77_gp25 CB5_34 
PhiM1_2
5 
PP90_2
7 
6 
DNA dependent RNA polymerase AXI77_gp30 CB5_39 
PhiM1_3
1 
PP90_3
2 
7 
5' kinase / 3'phosphatase  _ _ 
PhiM1_2
8 
PP90_2
9 
8 nucleatidyl transferase  _ CB5_24 _ _ 
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Table S4.5. Structural proteins of the PhiM1-like phages 
no. Structural protein Peat1 CB5 phiM1 PP90 
1 head tail connector AXI77_gp34 CB5_44 PhiM1_35 PP90_38 
2 
scaffolding protein 
AXI77_gp37 CB5_45 PhiM1_36 
PP90_40 
+PP90_41 
3 major capsid AXI77_gp38+AXI77_gp39 CB5_46 PhiM1_38 PP90_43 
4 tubular protein A AXI77_gp41+AXI77_gp42 CB5_47 PhiM1_39 PP90_44 
5 tubular protein B AXI77_gp43 CB5_49 PhiM1_40 PP90_45 
6 internal virion protein A AXI77_gp44 CB5_50 PhiM1_41 PP90_46 
7 internal virion protein B AXI77_gp45 CB5_51 PhiM1_42 PP90_47 
8 internal virion protein C AXI77_gp46+AXI77_gp47 CB5_52 PhiM1_43 PP90_48 
9 tail fibre AXI77_gp48 CB5_53 PhiM1_44 PP90_49 
10 large terminase AXI77_gp50 CB5_54 PhiM1_45 PP90_50 
11 small terminase AXI77_gp51 CB5_55 PhiM1_46 PP90_51 
12 tail spike AXI77_gp57 CB5_60 PhiM1_52 PP90_56 
 
Table S4.6. Proteins of lysis cassette of the PhiM1-like phages 
no. Lysis protein Peat1 CB5 phiM1 PP90 
1 U-spanin AXI77_gp54 CB5_57 PhiM1_49 PP90_53 
2 Holin AXI77_gp55 CB5_58 PhiM1_50 PP90_54 
3 Endolsyin AXI77_gp56 CB5_59 PhiM1_51 PP90_55 
 
 
Figure S5.1. Pectobacterium phage CB7 plaque morphology on 0.4% w/v LB overlay using host 
strain P. atrosepticum DSM 30186 (12 hr incubation). 
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Table S5.1. Genome annotation of Pectobacterium phage CB7 
ORF Start Stop Length 
(aa) 
Molecular 
weight (kDa) 
Predicted function 
CB7_1 1 384 127 14.12 large terminase (Part 2) 
CB7_2 678 1178 166 18.59 HNH homing endonuclease 
CB7_3 1348 2457 369 41.94 large terminase (Part 1) 
CB7_4 2476 3999 507 55.37 putative portal protein 
CB7_5 4069 4644 191 21.35 putative prohead core protein 
protease  
CB7_6 4641 5750 369 40.57 structural protein 
CB7_7 5768 6217 149 15.6 putative head 
stabilization/decoration protein 
CB7_8 6237 7235 332 37.6 putative major head protein 
CB7_9 7356 7970 204 22.67 Conserved hypothetical protein 
CB7_10 8031 11330 1099 111.95 virion structural protein 
CB7_11 11369 12019 216 24.54 structural protein 
CB7_12 12021 12515 164 17.19 structural protein 
CB7_13 12614 13141 175 20.14 structural protein 
CB7_14 13204 13665 153 17.4 Conserved hypothetical protein 
CB7_15 13676 14116 146 16.58 structural protein 
CB7_16 14116 14841 241 26.47 structural protein 
CB7_17 14902 16323 473 50.69 structural protein 
CB7_18 16327 16806 159 17.2 putative tail tuber protein 
CB7_19 16878 17354 158 17.21 conserved hypothetical protein 
CB7_20 17441 17623 60 6.95 conserved hypothetical protein 
CB7_21 17701 17817 38 4.33 conserved hypothetical protein 
CB7_22 17821 18771 316 34.88 conserved hypothetical protein 
CB7_23 18771 21203 810 87.72 putative tape measure protein 
CB7_24 21272 22126 284 31.67 structural protein 
CB7_25 22129 22503 124 14.38 structural protein 
CB7_26 22503 23495 330 36.5 putative tail protein 
CB7_27 23505 24248 247 26.42 putative baseplate assembly protein 
CB7_28 24257 24790 177 20.45 putative tail lysozyme 
CB7_29 24880 26364 494 54.37 putative baseplate assembly protein 
CB7_30 26374 27018 214 24.2 putative baseplate protein 
CB7_31 27029 28693 554 59.21 phage Tail Collar Domain containing 
protein 
CB7_32 28699 29214 171 19.4 tail fiber assembly protein  
CB7_33 29256 29594 112 13.09 conserved hypothetical membrane 
protein 
CB7_34 29581 30049 152 17.41 conserved hypothetical membrane 
protein 
CB7_35 30073 30333 86 9.89 conserved hypothetical protein 
CB7_36 30346 32727 793 81.89 putative tail fiber protein 
CB7_37 32766 34007 413 43.48 structural protein 
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CB7_38 34544 34041 167 19.02 HNH homing endonuclease 
CB7_39 35770 34544 408 43.15 conserved hypothetical protein 
CB7_40 36320 35946 124 14.68 conserved hypothetical protein 
CB7_41 37133 36441 230 24.64 conserved hypothetical protein 
CB7_42 37519 37130 129 14.07 hypothetical protein 
CB7_43 37850 37521 109 12.77 conserved hypothetical protein 
CB7_44 38239 37853 128 14.68 hypothetical membrane protein 
CB7_45 38445 38236 69 8.16 conserved hypothetical protein 
CB7_46 38426 38707 93 11.03 conserved hypothetical protein 
CB7_47 38707 38910 67 7.72 conserved hypothetical protein 
CB7_48 39006 39491 161 17.95 HNH homing endonuclease 
CB7_49 39493 39843 116 12.89 DNA polymerase (part 3) 
CB7_50 40327 39944 127 14.91 HNH homing endonuclease 
CB7_51 40809 40474 111 12.78 DNA polymerase (part 2) 
CB7_52 41393 40944 149 17.72 HNH homing endonuclease 
CB7_53 43520 41523 665 75.98 DNA polymerase (part 1) 
CB7_54 44064 43498 188 21.95 HNH homing endonuclease 
CB7_55 44848 44132 238 26.53 structural protein 
CB7_56 45027 44848 59 6.59 conserved hypothetical protein 
CB7_57 45277 45020 85 9.6 conserved hypothetical protein 
CB7_58 45741 45277 154 18 conserved hypothetical protein 
CB7_59 46120 45719 133 15.04 restriction alleviation protein Lar  
CB7_60 46479 46117 120 13.63 conserved hypothetical protein 
CB7_61 47814 47176 212 23.88 conserved hypothetical protein 
CB7_62 47980 47801 59 6.43 HNH homing endonuclease 
CB7_63 48778 48077 233 26.1 putative DNA methylase 
CB7_64 48771 49034 87 9.77 conserved hypothetical protein 
CB7_65 49031 49210 59 6.65 conserved hypothetical protein 
CB7_66 49383 49207 58 6.4 hypothetical membrane protein 
CB7_67 49989 49717 90 10.42 conserved hypothetical protein 
CB7_68 50179 49982 65 7.35 conserved hypothetical protein 
CB7_69 50388 50176 70 8.65 conserved hypothetical protein 
CB7_70 50550 50407 47 5.25 hypothetical membrane protein 
CB7_71 50846 50547 99 11.11 conserved hypothetical protein 
CB7_72 50843 51127 94 10.88 hypothetical protein 
CB7_73 53328 51214 704 79.27 putative primase/helicase 
CB7_74 53767 53492 91 10.29 conserved hypothetical protein 
CB7_75 53994 53803 63 7.37 conserved hypothetical protein 
CB7_76 54206 53991 71 8.48 conserved hypothetical protein 
CB7_77 54348 54184 54 6.23 conserved hypothetical protein 
CB7_78 54571 54341 76 8.24 conserved hypothetical protein 
CB7_79 54782 54564 72 7.74 conserved hypothetical protein 
CB7_80 57250 54779 823 92.19 putative helicase (with intein) 
CB7_81 57435 57250 61 6.56 conserved hypothetical protein 
CB7_82 57643 57446 65 7.16 hypothetical membrane protein 
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CB7_83 58170 57640 176 19.88 SleB 
CB7_84 58600 58220 126 14.05 conserved hypothetical protein 
CB7_85 59135 58593 180 19.79 putative phosphatase 
CB7_86 59125 59337 70 8.12 conserved hypothetical protein 
CB7_87 59566 59396 56 6.31 conserved hypothetical protein 
CB7_88 59793 59563 76 9.07 conserved hypothetical protein 
CB7_89 59969 59871 32 3.79 conserved hypothetical protein 
CB7_90 60105 59959 48 5.28 conserved hypothetical protein 
CB7_91 60332 60162 56 6.7 conserved hypothetical protein 
CB7_92 60774 60325 149 17.08 conserved hypothetical protein 
CB7_93 61006 60818 62 7.25 conserved hypothetical protein 
CB7_94 61329 61006 107 11.67 conserved hypothetical protein 
CB7_95 61534 61316 72 7.71 conserved hypothetical protein 
CB7_96 61878 61534 114 13.31 conserved hypothetical protein 
CB7_97 62117 61875 80 9.16 hypothetical protein 
CB7_98 62438 62175 87 10.08 hypothetical membrane protein 
CB7_99 62703 62422 93 10.68 conserved hypothetical protein 
CB7_100 62962 62693 89 9.94 putative lipoprotein 
CB7_101 63192 62959 77 8.81 conserved hypothetical protein 
CB7_102 63371 63189 60 6.83 conserved hypothetical protein 
CB7_103 64002 63475 175 20.5 conserved hypothetical protein 
CB7_104 64126 65367 413 48.03 conserved hypothetical protein 
CB7_105 65357 65527 56 6.63 conserved hypothetical protein 
CB7_106 65517 65720 67 7.78 conserved hypothetical protein 
CB7_107 65717 66247 176 20.32 conserved hypothetical protein 
CB7_108 66313 67551 412 46.86 MoxR  
CB7_109 67583 68095 170 19.49 HNH homing endonuclease 
CB7_110 68097 69647 516 58.39 conserved hypothetical protein 
CB7_111 69656 70036 126 14.39 conserved hypothetical protein 
CB7_112 70033 70546 167 19.44 hypothetical protein 
CB7_113 70768 71010 80 8.93 conserved hypothetical protein 
CB7_114 71198 71320 40 4.49 conserved hypothetical protein 
CB7_115 71320 71670 116 13.72 hypothetical membrane protein 
CB7_116 71784 71981 65 7.16 conserved hypothetical protein 
CB7_117 71971 72510 179 20.87 conserved hypothetical protein 
CB7_118 72503 72712 69 8.02 conserved hypothetical protein 
CB7_119 72790 73020 76 8.49 conserved hypothetical protein 
CB7_120 73208 73438 76 8.8 conserved hypothetical protein 
CB7_121 73440 73721 93 10.58 conserved hypothetical protein 
CB7_122 73718 73975 85 9.45 conserved hypothetical protein 
CB7_123 74035 74871 278 31.59 conserved hypothetical protein 
CB7_124 76170 75748 140 16.32 conserved hypothetical protein 
CB7_125 76169 76495 108 11.96 conserved hypothetical protein 
CB7_126 76575 76796 73 7.82 conserved hypothetical protein 
CB7_127 76843 77190 115 12.82 conserved hypothetical protein 
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CB7_128 77290 77559 89 10.1 conserved hypothetical protein 
CB7_129 77846 78076 76 8.19 hypothetical membrane protein 
CB7_130 78087 78539 17 16.98 conserved hypothetical protein 
CB7_131 78903 79289 128 14.09 conserved hypothetical protein 
CB7_132 79299 79610 103 12 hypothetical membrane protein 
CB7_133 79613 79747 44 5.5 hypothetical protein 
CB7_134 79824 80063 79 8.56 conserved hypothetical protein 
CB7_135 80159 80596 145 16.43 conserved hypothetical protein 
CB7_136 80661 80840 59 6.91 hypothetical protein 
CB7_137 80892 81149 85 9.54 conserved hypothetical protein 
CB7_138 81363 81542 59 6.6 putative lipoprotein 
CB7_139 81605 81901 98 10.73 conserved hypothetical protein 
CB7_140 82114 82320 68 7.54 conserved hypothetical protein 
CB7_141 82770 83315 181 20.69 conserved hypothetical protein 
CB7_142 83415 83615 66 7.47 conserved hypothetical protein 
CB7_143 85143 85628 161 18.35 HNH homing endonuclease 
CB7_144 86073 85861 70 8 conserved hypothetical protein 
CB7_145 86386 86066 106 12.17 conserved hypothetical protein 
CB7_146 86702 86379 107 12.2 conserved hypothetical protein 
CB7_147 87047 86712 111 12.48 conserved hypothetical protein 
CB7_148 87220 87044 58 6.44 conserved hypothetical protein 
CB7_149 87567 87343 74 8.51 conserved hypothetical protein 
CB7_150 87713 87567 48 5.55 conserved hypothetical protein 
CB7_151 87964 87713 83 9.35 conserved hypothetical protein 
CB7_152 88438 87968 156 18.17 conserved hypothetical protein 
CB7_153 88638 88438 66 7.45 conserved hypothetical protein 
CB7_154 88868 88638 76 8.61 hypothetical protein 
CB7_155 89147 88881 88 10.69 conserved hypothetical protein 
CB7_156 89503 89144 119 13.93 conserved hypothetical protein 
CB7_157 89853 89626 75 8.83 conserved hypothetical protein 
CB7_158 90395 89850 181 20.58 conserved hypothetical protein 
CB7_159 90564 90376 62 6.71 conserved hypothetical protein 
CB7_160 90853 90524 109 12.51 conserved hypothetical protein 
CB7_161 91080 90853 75 8.78 conserved hypothetical protein 
CB7_162 88438 87968 79 8.92 conserved hypothetical protein 
CB7_163 91510 91397 37 4.01 conserved hypothetical protein 
CB7_164 92010 91510 166 19.08 conserved hypothetical protein 
CB7_165 92361 92023 112 13.06 conserved hypothetical protein 
CB7_166 92706 92497 69 7.28 conserved hypothetical protein 
CB7_167 93005 92685 106 11.57 conserved hypothetical protein 
CB7_168 93453 92992 153 17.69 conserved hypothetical protein 
CB7_169 93971 93456 171 19.93 conserved hypothetical protein 
CB7_170 94176 94027 49 5.67 conserved hypothetical protein 
CB7_171 94860 94417 147 16.45 hypothetical membrane protein 
CB7_172 95659 95066 197 22.54 conserved hypothetical protein 
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CB7_173 95921 95661 86 9.93 conserved hypothetical protein 
CB7_174 96430 95930 166 18.69 conserved hypothetical protein 
CB7_175 97542 96434 372 42.96 putative nucleotidyltransferase 
CB7_176 98030 97629 133 14.6 hypothetical membrane protein 
CB7_177 98428 98030 132 15.33 conserved hypothetical protein 
CB7_178 98724 98425 99 10.7 hypothetical membrane protein 
CB7_179 100178 98853 441 50.54 tRNA nucleotidyl transferase 
CB7_180 100681 100172 169 19.86 HNH homing endonuclease 
CB7_181 101010 100678 110 13.22 conserved hypothetical protein 
CB7_182 101439 101095 114 12.72 putative HNH endonuclease 
CB7_183 102106 101567 179 20.5 putative DNA methylase, N-6 
adenine-specific 
CB7_184 103008 102106 300 33.97 ClpP ATP-dependent protease 
subunit 
CB7_185 103484 103008 158 18.38 conserved hypothetical protein 
CB7_186 103812 103495 105 12.08 conserved hypothetical protein 
CB7_187 104282 103812 156 17.88 putative NrdG 
CB7_188 106381 104279 700 78.38 putatice NrdD 
CB7_189 107127 106378 249 28.36 phosphate starvation-inducible 
phoH-like protein  
CB7_190 107526 107143 127 14.48 endolysin 
CB7_191 107948 107535 137 15.62 conserved hypothetical protein 
CB7_192 108246 107959 95 10.96 glutaredoxin 
CB7_193 108470 108246 74 8.37 conserved hypothetical protein 
CB7_194 108691 108470 73 8.16 conserved hypothetical protein 
CB7_195 109088 108702 128 14.27 ribonucleotide reductase small 
subunit, NrdB (part 2) 
CB7_196 109953 109246 235 27.18 HNH homing endonuclease 
CB7_197 111732 110083 549 63.26 ribonucleotide reductase small 
subunit, NrdB (part 1) 
CB7_198 112000 111830 56 7.12 conserved hypothetical protein 
CB7_199 112107 111997 36 4.22 hypothetical protein 
CB7_200 112339 112109 76 8.87 hypothetical protein 
CB7_201 114789 112375 804 90.46 ribonucleotide reductase large 
subunit, NrdA (part 2) 
CB7_202 115425 114934 163 18.61 HNH homing endonuclease 
CB7_203 116424 115543 293 33.04 ribonucleotide reductase large 
subunit, NrdA (part 1)  
CB7_204 116445 116675 76 8.84 conserved hypothetical protein 
CB7_205 116678 117172 164 18.61 conserved hypothetical protein 
CB7_206 117939 117259 226 25.68 thymidylate synthase 
CB7_207 118235 117942 97 10.8 conserved hypothetical protein 
CB7_208 118822 118640 60 7.16 conserved hypothetical protein 
CB7_209 119433 118822 203 23.35 putative 5'(3')-
deoxyribonucleotidase 
CB7_210 120079 119423 218 24.76 conserved hypothetical protein 
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CB7_211 121247 120165 360 41.45 putative DNA 
polymerase/exonuclease 
CB7_212 121799 121263 178 20.66 HNH homing endonuclease 
CB7_213 122029 121799 76 9.13 conserved hypothetical protein 
CB7_214 122534 122022 170 19.34 endoVII packaging and 
recombination endonuclease 
CB7_215 123171 122536 211 24.48 conserved hypothetical protein 
CB7_216 123751 123128 207 22.88 conserved hypothetical protein 
CB7_217 124064 123732 110 12.82 conserved hypothetical protein 
CB7_218 125179 124064 371 42.43 exonuclease 
CB7_219 125676 125179 165 19.48 HNH homing endonuclease 
CB7_220 126179 125676 167 19.58 HNH homing endonuclease 
CB7_221 126681 126169 170 19.59 HNH homing endonuclease 
CB7_222 127216 126665 183 21.28 conserved hypothetical protein 
CB7_223 127628 127290 112 12.51 conserved hypothetical protein 
CB7_224 127993 127628 121 13.76 conserved hypothetical protein 
CB7_225 128205 127993 70 8.42 conserved hypothetical protein 
CB7_226 128422 128213 69 7.35 conserved hypothetical membrane 
protein 
CB7_227 128940 128419 173 20.49 conserved hypothetical protein 
CB7_228 129323 129039 94 10.79 conserved hypothetical protein 
CB7_229 129705 129397 102 11.64 conserved hypothetical protein 
CB7_230 130088 129717 123 14.64 HNH homing endonuclease 
CB7_231 130393 130217 58 6.48 conserved hypothetical protein 
CB7_232 130755 130393 120 13.84 pyrophosphatase 
CB7_233 131250 130810 146 17.42 hypothetical membrane protein 
CB7_234 132626 131247 459 52.12 DNA ligase 
CB7_235 132817 132623 64 7.49 conserved hypothetical protein 
CB7_236 133299 132904 131 14.6 conserved hypothetical protein 
CB7_237 133622 133296 108 12.22 conserved hypothetical protein 
CB7_238 133918 133619 99 11.73 conserved hypothetical protein 
CB7_239 134025 133909 38 4.57 conserved hypothetical protein 
CB7_240 134348 134025 107 12.56 conserved hypothetical protein 
CB7_241 134670 135041 123 14.37 conserved hypothetical protein 
CB7_242 135096 135986 296 32.89 ribose-phosphate 
pyrophosphokinase  
CB7_243 135970 136527 185 20.73 HNH homing endonuclease 
CB7_244 136538 137374 278 31.7 nicotinamide phosphoribosyl 
transferase (part 2) 
CB7_245 134356 137937 193 21.56 HNH homing endonuclease 
CB7_246 137934 138932 332 37.41 nicotinamide phosphoribosyl 
transferase (part 1) 
CB7_247 138978 139169 63 7 conserved hypothetical protein 
CB7_248 139229 139480 83 9.64 conserved hypothetical protein 
CB7_249 139638 140030 130 14.8 HNH homing endonuclease 
CB7_250 140312 140686 124 13.54 conserved hypothetical protein 
 
 
238 
 
CB7_251 141337 141891 184 19.68 structural protein 
CB7_252 141988 142359 123 14.11 conserved hypothetical membrane 
protein 
CB7_253 142359 142673 104 11.7 putative lipoprotein 
 
 
 
Table S5.2. Sigma 70 – like putative promoter sequence detected in the genome of 
Pectobacterium phage CB7 
 
 
Promoter Start Stop Sequence 
Porf56 45103 45065 TACAACATTGTTGTCGCCAAAGGCGGGGACCGCAATAAC  
Porf79 54853 54815 GACATTATTGTTGACCAAGGTGTCCGTAAGTTCTATCAT 
Porf97 62188 62188 TAAAATTCGGTTGACAGTAGAGATCGGGGCCTGTAATAT 
Porf125 76101 76139 AAATCATTTGTTGACAACCTGGCCGGGCCGGGCCACAAT 
Porf126 76489 76527 TAAATAGTTGTTGACACCGGGGCCACGTGGCCCCATACT  
Porf128 77200 77238 GTTTTAGGGGTTGACGCCCGGCGGCGTTACCCCCATAAT 
Porf129 77,776 77814 AAAATAATTGTTGACGCCGGGCACCGTCCCGGCATACAA  
Porf131 78811 78849 AAAATAGTTGTTGACTCTTGCCCCGTCCCGCTGGCATAA 
Porf135 80067 80105 AAAAAGGGGCTTGACGTTGTGAAACGTTAGGCCCTATAA  
Porf136 80590 80628 AAAATAAAAGTTGACACCGGGGCCACCTGGCCCCATAAT 
Porf138 81288 81326 GAAAATAAACTTGACGCCGGGACGGTTCCCGGCTTATAA  
Porf139 81536 81574 AAAATAAATGTTGACGCCGGGCACCGTCCCGGCTATACT  
Porf140 82045 82083 AAAAATTAGTTTGACACCCGGCCCGGAGGGGCCGATAAT 
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Table S5.3. Sigma 70-like promoters detected in the genome of Cronobacter phage CR3 
(accession no. JQ691612) 
 
Promoter Start Stop Sequence 
pcr3_53 41845 41810 AAAATTGTTGACTTCCTTCCTGATTTCCCGCATAAT  
pcr3_54 42349 42314 TTTTTAATTGACAGCGGGGCCGAAAGGCCCCATAAT 
pcr3_59 45981 45946 AAAATTCTTGTATTCCGGGGGCTTCGGCCCCTTTTC 
pcr3_128 80533 80568 ATTTTTCTTGACCTGCCAGGCAAGCCGGGCCACAAT 
pcr3_129 80932 80967 ATAATGCTTGACGGGGCCAGCGATAGGCCCCATAAT  
pcr3_130 81471 81506 AAGAGTATTGACACCGGGGCCACCTGGCCCCATACT 
pcr3_132 82181 82216 TTTGGGGTTGACGCCCGGCCAGGATGGGTCCATAAT  
pcr3_133 82513 82548 ATAATTGTTGACCGGGGCCGGGTTAGGCCCCATAAT 
pcr3_135 91606 91571 TCTTTTGTTGACACCGGGGCCGATAGGCCCCATAAT 
pcr3_135 83275 83310 ATTTTGGTTGACACGGGGCCGGGTTAGGCCCCATAA 
pcr3_139 84806 84841 AAGGGGCTTGACGTCGTGAAACGTTAGGCCCTATAA 
pcr3_141 85882 85917 AAAGCGCTTGACGCCGGGACGGTTCCCGGCTTATAA 
pcr3_143 86335 86370 ATAATTCTTGACGCCGGGCACCGTCCCGGCTTACAA 
pcr3_144 87078 87113 TAAATGATTGACATCCGGCCCGAAAGGGCCGATAAT 
pcr3_145 87356 87391 AAAGTAGTTGACGGCGGGGCCGATAGGCCCCATAAT 
pcr3_147 87898 87933 ACTATTGTTGACGCCGGGCACCGTCCCGGCCTATAA 
pcr3_150 89365 89400 TCCGGGGTTGACACCCGGCGCAATAGGGCCGATAAT  
pcr3_157 91952 91987 AATAATATTGACTCAGGGGCCGAAAGGCCCCATAAT 
pcr3_242 133519 133484 AAAGTTGTTGACACACTGAGTTAAAACGAGCATAAT  
pcr3_243 133519 133484 AAACCGCTTGACGTTGGTTTCTGCCGGGTCCATAAT 
pcr3_248 136375 136340 AAGTGGCTTGACGCCGGGATCGATAAGTGCCTTAAT 
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Figure S5.2. Genome map of Cronobacter phage CR3 (accession no. JQ691612) showing 
locations of Sigma 70-like. The map comprises of arrows indicating the location of ORFs. 
Genome map created with Snapgene.   
 
Table S5.4. Sigma 70-like promoters detected in the genome of Cronobacter phage CR8 
(accession no. KC954774).  
Promoter Start Stop Sequence 
pcr8_54 42743 42706 ACAAAATTGTTGACTTCCTTCCTGATTTCCCGCATAAT  
pcr8_55 43247 43210 ATTTTTTAATTGACAGCGGGGCCGAAAGGCCCCATAAT 
pcr8_86 59955 59918 ACATTATTGTTGACCAAGGTGTCCGTAAGTTCTATCAT  
pcr8_132 81405 81442 AAATTTTTCTTGACCTGCCAGGCAAGCCGGGCCACAAT 
pcr8_133 81,804 81841 AAATAGTGCTTGACGGGGCCGATGATAGGCCCCATAAT  
pcr8_134 82342 82379 AAAAGACTATTGACATCGGGGCCACCTGGCCCCATACT  
pcr8_136 83054 83091 TTTTAGGGGTTGACGCCCGGCGGCGTTACCCTCATAAT 
pcr8_137 83414 83451 AAATAATTGTTGACGCCGGGAACCGTCCCGGCTTATAA  
pcr8_138 83740 83777 AAATAATTGTTGACCGGGGCCGGGTTAGGCCCCATAAT  
pcr8_140 84503 84540 TAATTTTGGTTGACACGGGGCCGGGTTAGGCCCCATAA  
pcr8_144 86044 86081 TCCCGGGGCTTGACGTCCGGCCCCGGTTCCTCCATAAT  
pcr8_146 87117 87154 TAAAAGCGCTTGACGCCGGGACGGTTCCCGGCTTATAA  
pcr8_148 87570 87607 AAATAATTGTTGACGCCGGGCACCGTCCCGGCTTACAA  
pcr8_149 88313 88350 TTTAAATGATTGACATCCGGCCCAAAAGGGCCGATAAT  
pcr8_150 88587 88624 AAAAAGTAGTTGACGGCGGGGCCGATAGGCCCCATAAT 
pcr8_151 88906 88943 AAATAATGCTTGACGGGGCCAACGTTAGGCCCCATAAT  
pcr8_154 90372 90409 GATCCGGGGTTGACACCCGGCGCAATAGGGCCGATAAT 
pcr8_160 92418 92455 AATCTTTTGTTGACACCGGGGCCGATAGGCCCCATAAT 
pcr8_161 92798 92835 AAAATAATATTGACTCAGGGGCCGAAAGGCCCCATAAT 
pcr8_246 134079 134042 AAAAAGTTGTTGACACACTGAGTTAAAACGAGCATAAT 
pcr8_250 136935 136898 AAAAGTGGCTTGACGCCGGGATCGGTAAGTGCCTTAAT 
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Figure S5.3. Genome map of Cronobacter phage CR8 (accession no. KC954774) showing 
locations of Sigma 70-like. The map comprises of arrows indicating the location of ORFs. 
Genome map created with Snapgene. 
Table S5.5. Sigma 70-like promoters detected in the genome of Cronobacter phage CR9 
(accession no. JQ691611).  
 
Promoter Start Stop  Sequence 
54 39759 39722 ACAAAAGTATTGACTTCCCTCCCAAGTTCCCTCATAAT 
55 40262 40225 TTTTCTGATTGACAACCGGGGCCGGAAGGCCCCATAAT 
146 83055 83092 AAATTTTTCTTGACCTGCCAGGCAAGCCGGGCCACAAT  
148 83952 83989 AAATATTGCTTGACGGGGCCGATGATAGGCCCCATAAT 
149 84490 84527 AAAAGACTATTGACATCGGGGCCACCTGGCCCCATACT 
151 85201 85238 TTTTAGGGGTTGACGCCCAGCGGCGTTACCCTCATAAT 
152 85532 85569 AAATAATTGTTGACCGGGGGCCGGATAGGCCCCATAAT  
155 86296 86333 AATTTAGGTTGACACGGGGCCGGGTTAGGCCCCATAAT 
158 87840 87877 TTCCGGGGCTTGACGCCCGGCCCCGGTTCCCCCATAAT 
160 88865 88902 AAATAATTGTTGACCGGGGCCGGGTTAGGCCCCATAAT 
164 90355 90392 AAAAGTAGTTGACGCCGGGGCCGCTTAGGCCCCATAAT 
165 90676 90713 AAATAAATCTTGACGGGGCCGACGATAGGCCCCATAAT 
168 92144 92181 TGTGAAGGGTTGACACCTGCCGCGATAGGGCCGATAAT 
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Figure S5.4. Genome map of Cronobacter phage CR9 (accession no. JQ691611) showing 
locations of sigma 70-like. The map comprises of arrows indicating the location of ORFs. 
Genome map created with Snapgene.   
Table S5.6. High ΔG rho-independent terminators predicted in the genome Pectobacterium 
phage CB7 identified using ARNold and QuikFold. 
 
Terminator Start Stop Sequence ΔG (kcal/mol)
Torf8 7244 7274 GGTCACCTTCGGGTGGCCTTTTTTATTGACC -15.30
Torf12 12521 12551 AGCCGCCTCCGGGCGGCTTTCTTTTTGTCTG -13.70
Torf20 17625 17660 GGCTGGAGTCGAAAGACTCTGGCCTTTTCTTTTTTG -20.80
Torf23 21209 21235 GGGGCTTCGGCCCCcTTTTTTATTGCC -13.30
Torf28 24794 24825 AGGGAGCCTCTGGCTCCCTTTTCTTTTAATTC -13.80
Torf37 34032 34003 GGCACCCGACTGGGTGCCTTTTTTATTACT -14.30
Torf40 35813 35784 GGCCTCAATACTGGGGCCTTGTTTATCCTC -11.80
Torf48 39005 38978 CCGCCCTTCGGGGCGGTTTTTTATTATC -15.50
Torf73 51208 51178 AGGTCCCTTCTGGGGCCTTTTTTCGTTTGAC -12.00
Torf84 58211 58179 GGCTCAGTGATAAACTGGGCCTTTCTTATTTAG -13.70
Torf108 67570 67603 GGATCATCTTCGGATGGTCCtTTTTGCATTTGGG -14.60
Torf118 72718 72718 GGGGTTGACTTCGGTCAACCCCTTTTGCTATTCTT -20.10
Torf126 76806 76834 GGCCCCCGCCGGGGGCCTTTCGTGTGGAG -15.40
Torf133 79794 79822 GGGGCCGCTTAGGCCCCTTATTTTTGATC -14.40
Torf141 83315 83346 GCCCGCCACCCCGGCGGGCTTTTTGTTGCATC -16.20
Torf142 83634 83663 GCCCGGCATAGTCCGGGCTTTTTGTTGCCT -12.00
Torf144 85824 85795 GACCTCCTTCGGGAGGTCTTTTTGTATCTT -16.10
Torf149 87342 87313 ACCGCCCTCTGGGCGGTTTTCATGTTTAAG -11.80
Torf163 91391 91365 CCGCCTTCGGGCGGgTTTTTTTTTTAT -12.90
Torf171 94413 94413 GGTCGATCGTCGAAAGGCGGTCGGCCTTTCTTTTTGGA -22.20
Torf182 101088 101059 GGCCACCTTCGGGTGGCCTTTTTTATTGCA -18.00
Torf198 111826 111796 ACCGCCCTTCGGGGCGGTTTTTCTATCTTGA -16.70
Torf211 120158 120127 GCCGCCCTTCGGGGCGGTtTTCTTTTTGACTT -17.00
Torf228 129035 129003 AACCGCCCTTCGGGGCGGTTTTTCTTTATCTGC -17.60
Torf241 135032 135060 GGCCCCTTGACGGGGCCTTTTTCTTTTTG -13.60
Torf246 138939 138967 CCGCCCTTCGGGGCGGTTTTCTTCTCTCA -15.50
Torf253 142685 142719 GGCTCTCCATTCGTGGAGGGCCTTTTCTTTTAGGG -16.40
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Table S5.7. Comparison of potential gene products of CB7 identified in DNA replication, methylation and nucleotide metabolism with other members 
of Cr3virus using ACT (TBLASTX) 
Phages CB7 ΦTE  DU_PP_I  DU_PP_IV CR3  CR8  CR9  PEB02  
Accession no.   JQ015307 MF979569 MF979563 JQ691612 KC954774 JQ691611 KT353109 
DNA polymerase CB7_49,51,5
3 
phiTE_6, 8, 
10 
P1A145kb_p52 P12B145kb_p52 CR3_gp060 HL10_gp06
1 
CL97_gp063
, 65 
ADU18_17
4 
cytosine methylase CB7_63  _ _ _ CR3_gp067  HL10_gp06
8  
CL97_gp073  ADU18_18
3  
putative 
primase/helicase 
CB7_73 phiTE_23 P1A145kb_p70 P12B145kb_p71 CR3_gp077 HL10_gp07
8 
CL97_gp084 ADU18_19
4 
putative helicase CB7_80 phiTE_30 P1A145kb_p79 P12B145kb_p80 CR3_gp084 HL10_gp08
7 
CL97_gp093 ADU18_20
3 
putative nucleotidyl 
transferase 
CB7_175 phiTE_132 P1A145kb_p18
5 
P12B145kb_p18
6 
CR3_gp195 HL10_gp19
8 
CL97_gp211 ADU18_34 
tRNA nucleotidyl 
transferase 
CB7_179 phiTE_136 P1A145kb_p19
1 
P12B145kb_p19
2 
CR3_gp201 HL10_gp20
4 
CL97_gp217 ADU18_40 
adenine methylase CB7_183 phiTE_140 P1A145kb_p19
4 
P12B145kb_p19
5 
CR3_gp204 HL10_gp20
7 
CL97_gp022
0 
ADU18_43 
NrdG CB7_187 phiTE_144 _ _ _ _ _ _ 
NrdD CB7_188 phiTE_145 _ _ _ _ _ _ 
NrdB CB7_195, 
197 
phiTE_152 P1A145kb_p20
6 
P12B145kb_p20
7 
CR3_gp215 HL10_gp21
8 
CL97_gp230 ADU18_55 
NrdA CB7_201, 
203 
phiTE_154 P1A145kb_p20
9 
P12B145kb_p21
0 
CR3_gp216 HL10_gp22
0 
CL97_gp231 ADU18_56 
thymidylate synthase CB7_206 phiTE_159  P1A145kb_p21
2 (poor 
homologyl) 
P12B145kb_p21
3 (poor 
homology) 
CR3_gp219 
(poor 
homology) 
HL10_gp22
3 (poor 
homology 
protein 
level) 
CL97_gp235 
(poor 
homology) 
ADU18_59 
(poor 
homology) 
5'(3') 
deoxyribonuclease 
CB7_209 phiTE_162 P1A145kb_p21
4 
P12B145kb_p21
5 
CR3_gp221 HL10_gp22
5 
CL97_gp237 ADU18_61 
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DNA 
polymerase/exonuclea
se 
CB7_211 phiTE_164 P1A145kb_p21
8 
P12B145kb_p21
9 
CR3_gp224 HL10_gp22
8 
CL97_gp240 ADU18_64 
EndoVII CB7_214 phiTE_167 P1A145kb_p22
1 
P12B145kb_p22
2 
CR3_gp226 HL10_gp23
0 
CL97_gp242 ADU18_66 
endonuclease CB7_218 phiTE_171 P1A145kb_p22
5 
P12B145kb_p22
6 
CR3_gp230 HL10_gp23
4 
CL97_gp246 ADU18_70 
pyrophophatase CB7_232 phiTE_185 P1A145kb_p24
2 
P12B145kb_p24
3 
CR3_gp245 HL10_gp24
7 
CL97_gp262 ADU18_84 
DNA ligase CB7_234 phiTE_187 P1A145kb_p24
4 
P12B145kb_p24
5 
CR3_gp247 HL10_gp24
9 
CL97_gp264 ADU18_86 
ribose phosphate 
pyrophosphokinase 
CB7_242 phiTE_193 P1A145kb_p25
2 
P12B145kb_p25
3 
CR3_gp256 HL10_gp25
8 
CL97_gp272 ADU18_97 
nicotinamide 
phosphoribosyl 
transferase 
CB7_244, 
246 
phiTE_195, 
197 
P1A145kb_p25
4, 256 
P12B145kb_p25
5, 257 
CR3_gp257 HL10_gp25
9 
CL97_gp273 ADU18_98 
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Table S5.8. Comparison of potential gene products of CB7 identified in DNA replication, methylation and nucleotide metabolism with that of 
Escherichia phage rv5 and Salmonella phage PVP-SE1 using ACT (TBLASTX) 
Phages CB7 rV5 PVP-SE1 
Accession no. KY514263 DQ832317 GU070616 
DNA polymerase CB7_49,51,53 ORF228 16 
cytosine methylase CB7_63 ORF231 9 
putative primase/helicase CB7_73 ORF230 13 
putative helicase CB7_80 ORF237 3 
putative nucleotidyl transferase CB7_175 _ 166 
tRNA nucleotidyl transferase CB7_179 _ 159 
adenine methylase CB7_183 ORF123 152 
NrdG CB7_187 ORF117 143 
NrdD CB7_188 ORF112 142 
NrdB CB7_195, 197 ORF110 139 
NrdA CB7_201, 203 ORF109 138 
thymidylate synthase CB7_206 ORF106 (little homology at 
protein level) 
134 (little homology at 
protein level) 
5'(3') deoxyribonuclease CB7_209 ORF104 131 
DNA polymerase/exonuclease CB7_211 ORF99 128 
EndoVII CB7_214 ORF97 126 
endonuclease CB7_218 ORF94 123 
pyrophosphatase CB7_232 _ _ 
DNA ligase CB7_234 _ _ 
ribose phosphate pyrophosphokinase CB7_242 ORF80 97 
nicotinamide phosphoribosyl 
transferase 
CB7_244, 246 _ 96 
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Table S5.9.  Shared structural proteins of phages of Cr3virus determined using ACT (TBLASTX). 
Phages CB7 ΦTE DU_PP_I DU_PP_IV CR3 CR8 CR9 PBES 02 
Accession no. KY514263 JQ015307 MF979560 MF979563 JQ691612 KC954774 JQ691611 KT353109 
putative portal protein CB7_4 phiTE_209 P1A145kb_p2 P12B145kb_p2 CR3_gp2 HL10_gp2 CL97_gp2 ADU18_109 
prohead core protein protease CB7_5 phiTE_210 P1A145kb_p3 P12B145kb_p3 CR3_gp3 HL10_gp3 CL97_gp3 ADU18_110 
unknown structural protein CB7_6 phiTE_211 P1A145kb_p4 P12B145kb_p4 CR3_gp4 HL10_gp4 CL97_gp4 ADU18_111 
head stabilization/decoration 
protein CB7_7 phiTE_212 P1A145kb_p5 P12B145kb_p5 CR3_gp5 HL10_gp5 CL97_gp5 ADU18_112 
putative major head protein CB7_8 phiTE_213 P1A145kb_p6 P12B145kb_p6 CR3_gp6 HL10_gp6 CL97_gp6 ADU18_113 
putative tail fibre protein CB7_10 phiTE_215 P1A145kb_p8 P12B145kb_p8 CR3_gp8 HL10_gp8 CL97_gp8 ADU18_115 
unknown structural protein CB7_11 phiTE_210 P1A145kb_p9 P12B145kb_p9 CR3_gp9 HL10_gp9 CL97_gp9 ADU18_116 
unknown structural protein CB7_12 phiTE_217 P1A145kb_p10 P12B145kb_p10 CR3_gp10 HL10_gp10 CL97_gp10 ADU18_117 
unknown structural protein CB7_13 phiTE_218 P1A145kb_p11 P12B145kb_p11 CR3_gp12 HL10_gp12 CL97_gp11 ADU18_119 
unknown structural protein CB7_15 phiTE_220 P1A145kb_p13 P12B145kb_p13 CR3_gp14 HL10_gp14 CL97_gp13 ADU18_121 
unknown structural protein CB7_16 phiTE_211 P1A145kb_p14 P12B145kb_p14 CR3_gp15 HL10_gp15 CL97_gp14 ADU18_122 
putative tail sheath protein CB7_17 phiTE_222 P1A145kb_p15 P12B145kb_p15 CR3_gp16 HL10_gp16 CL97_gp15 ADU18_123 
putative tail tube protein  CB7_18 phiTE_223 P1A145kb_p16 P12B145kb_p16 CR3_gp17 HL10_gp17 CL97_gp16 ADU18_124 
putative tape measure protein  CB7_23 phiTE_228 P1A145kb_p21 P12B145kb_p21 CR3_gp20 HL10_gp20 CL97_gp19 ADU18_127 
unknown structural protein CB7_24 phiTE_229 P1A145kb_p22 P12B145kb_p22 CR3_gp21 HL10_gp21 CL97_gp20 ADU18_128 
unknown structural protein CB7_25 phiTE_230 P1A145kb_p23 P12B145kb_p23 CR3_gp22 HL10_gp22 CL97_gp21 ADU18_129 
putative tail protein CB7_26 phiTE_231 P1A145kb_p24 P12B145kb_p24 CR3_gp23 HL10_gp23 CL97_gp22 ADU18_130 
putative baseplate protein  CB7_27 phiTE_232 P1A145kb_p25 P12B145kb_p25 CR3_gp24 HL10_gp24 CL97_gp23 ADU18_131 
putative tail lysozyme CB7_28 phiTE_233 P1A145kb_p26 P12B145kb_p26 CR3_gp25 HL10_gp25 CL97_gp24 ADU18_132 
putative baseplate wedge 
protein CB7_29 phiTE_234 P1A145kb_p27 P12B145kb_p27 CR3_gp26 HL10_gp26 CL97_gp25 ADU18_133 
putative baseplate protein CB7_30 phiTE_235 P1A145kb_p28 P12B145kb_p28 CR3_gp27 HL10_gp27 CL97_gp26 ADU18_134 
putative tail collar protein CB7_31 phiTE_236 P1A145kb_p29 P12B145kb_p29 CR3_gp28 HL10_gp28 CL97_gp27 ADU18_135 
putative tail fibre protein CB7_32 phiTE_237 P1A145kb_p30 P12B145kb_p30 CR3_gp29 HL10_gp29 CL97_gp28 ADU18_136 
 
 
247 
 
tail chaparone protein CB7_36 phiTE_241 P1A145kb_p34 P12B145kb_p34 CR3_gp33 HL10_gp33 CL97_gp32 ADU18_140 
unknown structural protein CB7_37 phiTE_237 P1A145kb_p35 P12B145kb_p35 CR3_gp34 HL10_gp34 CL97_gp33 ADU18_141 
unknown structural protein CB7_55 - - - - - - - 
unknown structural protein CB7_251 phiTE_203 - - - - - - 
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Table S5.10. Shared structural proteins (using currently available annotation) of phages of 
Vequintavirinae (Pectobacterium phage CB7, Escherichia phage rv5 and Salmonella phage PVP-
SE1) determined using ACT (TBLASTX). Proteins in bold and italics are those with have been 
determined to be presence in mature virion of phage in question by ESI-MS/MS analysis as 
determined by Santos et al 2011 and Kropinski et al 2013 
Pectobacterium phage CB7 
Accession no. KY514263 
Escherichia phage rV5 
Accession no. DQ832317 
Salmonella phage PVP-SE1 
Accession no. NC_016071 
CB7_4, putative portal 
protein 
gp64, portal protein PVP-SE1_gp75, conserved 
hypothetical protein 
CB7_5, putative prohead core 
protein protease 
gp63, conserved 
hypothetical protein 
PVP-SE1_gp74, hypothetical 
protein 
CB7_6, unknown structural 
protein 
gp62, conserved 
hypothetical protein 
PVP-SE1_gp73, hypothetical 
protein 
CB7_7, putative head 
stabilization/decoration 
protein,  
gp61, putative head 
stabilization/decoration 
protein 
PVP-SE1_gp72, head 
stablization/ decorative 
protein 
CB7_8, putative major head 
protein 
gp60, major capsid protein PVP-SE1_gp71, putative major 
head protein 
CB7_10, putative tail fibre 
protein 
_ PVP-SE1_gp69, hypothetical 
protein 
CB7_11, unknown structural 
protein 
_ PVP-SE1_gp68, hypothetical 
protein 
_ _ PVP-SE1_gp67, hypothetical 
protein 
CB7_12, unknown structural 
protein 
_ _ 
CB7_13, unknown structural 
protein 
gp57, hypothetical protein PVP-SE1_gp65, conserved 
hypothetical protein 
CB7_15, unknown structural 
protein 
gp55, conserved 
hypothetical protein 
PVP-SE1_gp63, conserved 
hypothetical protein 
CB7_16, unknown structural 
protein 
gp54, hypothetical protein PVP-SE1_gp62, hypothetical 
protein 
CB7_17, putative tail sheath 
protein 
gp53, tail sheath protein PVP-SE1_gp61, structural 
protein 
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CB7_18, putative tail tube 
protein 
gp52, tail tube protein PVP-SE1_gp60, structural 
protein 
CB7_23, putative tape 
measure protein 
gp49, putative tail protein PVP-SE1_gp57, hypothetical 
protein 
CB7_24, unknown structural 
protein 
gp48, hypothetical protein PVP-SE1_gp56, conserved 
hypothetical protein 
CB7_25, unknown structural 
protein 
gp47, hypothetical protein PVP-SE1_gp55, conserved 
hypothetical protein 
CB7_26, putative tail protein gp46, conserved 
hypothetical protein 
PVP-SE1_gp54, conserved 
hypothetical protein 
CB7_27, putative baseplate 
protein 
gp45, tail baseplate protein PVP-SE1_gp53, putative 
baseplate assembly protein 
CB7_28, putative tail 
lysozyme 
gp44, conserved 
hypothetical protein 
PVP-SE1_gp52, conserved 
hypothetical protein 
_ gp43, tail fibre protein PVP-SE1_gp51, possible tail 
fibre protein 
_ gp42, putative tail protein PVP-SE1_gp50, conserved 
hypothetical protein 
_ _ PVP-SE1_gp49, conserved 
hypothetical protein 
_ gp41, tail fibre protein  _ 
_ gp37, putative tail protein _ 
CB7_29, putative baseplate 
wedge protein 
gp36, tail baseplate protein PVP-SE1_gp48, baseplate 
component 
CB7_30, putative baseplate 
protein 
gp35, hypothetical protein PVP-SE1_gp47, conserved 
hypothetical protein 
CB7_31, putative tail collar 
protein (N-terminus only) 
gp33, putative tail fibre 
protein 
PVP-SE1_gp46, putative tail 
fibre protein 
_ gp32, tail fibre protein PVP-SE1_gp45, putative tail 
fibre assembly protein 
_ gp30, tail fibre protein PVP-SE1_gp46, hypothetical 
protein 
putative tail fibre protein, gp28, putative tail fibre PVP-SE1_gp41, putative tail 
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CB7_36 protein (weakening 
homology towards C 
terminus) 
fibre protein 
unknown structural protein, 
CB7_37 
_ PVP-SE1_gp40, hypothetical 
with Ig-like domain (weak 
homology) 
_ gp27, hypothetical protein    
unknown structural protein, 
CB7_55 
_   
unknown structural protein, 
CB7_251 
_   
_ gp133, unknown structural 
protein 
  
_ _ PVP-SE1_gp19, hypothetical 
protein 
_ _ PVP-SE1_gp10, conserved 
hypothetical protein 
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Table S5.11.  Putative cell wall degrading and cell lysis proteins of phages in the subfamily Vequintavirinae. Determined using ACT (TBLASTX). 
Phage rV5 PVP-SE1 CB7 ΦTE DU_PP_I DU_PP_IV CR3 CR8 CR9 PBES 02 
Accession 
no. 
DQ83231
7 
NC_01607
1 
KY51426
3 
NC_02020
1 
MF979560 MF979563 NC_01797
4 
NC_024354 NC_02371
7 
KT353109 
Rz gp67 gp78 CB7_252 phiTE_20
4 
P1A145kb_p2
66 
P12B145kb_p2
67 
CR3_264 CR8_268 CL97_gp28
0 
ADU18_01
06 
Rz1 Gp66 Gp79 CB7_253 phiTE_20
5 
P1A145kb_p2
67 
P12B145kb_p2
68 
CR3_265 CR8_269 CL97_gp28
1 
ADU18_01
07 
SleB Gp2 Gp243 CB7_83 phiTE_33 P1A145kb_p0
83 
P12B145kb_p0
84 
CR3_87 CR8_90 CL97_gp95 ADU18_02
06 
putative 
class II 
holin 
_ _ CB7_82 phiTE_03
2 
P1A145kb_p0
81 
P12B145kb_p0
82 
CR3_086 CR8_089 CL97_gp09
4 
ADU18_02
05 
T4 gp25 - 
like 
Gp44 Gp52 CB7_28 phiTE_23
3 
P1A145kb_p0
26 
P12B145kb_p0
26 
CR3_25 CL97_gp_0
24 
CL97_gp02
4 
ADU18_01
32 
CB7_ 190 
- like 
    CB7_190 phiTE_14
7 
_ _ _ _ _ _ 
CR3_ 210 
- like 
    _ _ P1A145kb_p2
01 
P12B145kb_p2
02 
CR3_210 CL97_gp22
6 
CL97_gp22
6 
ADU18_00
50 
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Table S6.1. Proteins in the genome of Pectobacterium phage CBB that share homology 
(Detected using BLASTP). 
Proteins that share homology 
CBB_47 (CBB_600) to CBB_50 (CBB_603) 
CBB_147 to CBB_148 to CBB_149 
CBB_160 to CBB_161 
CBB_438 to CBB_439 
CBB_480 to CBB_481 to CBB_482 
CBB_536 to CBB_537 
CBB_539 to CBB_540 to CBB_541 to CBB_543 
CBB_549 to CBB_553 
CBB_356 to CBB_10 (CBB_563) 
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Table S6.2. Genome annotation of Pectobacterium phage CBB 
ORF  Start Stop Length 
(aa) 
Molecular 
weigth 
(KDa) 
Function 
CBB_1 20 197 55 6.65 hypothetical protein 
CBB_2 1427 1615 62 7.00 hypothetical protein 
CBB_3 1800 2477 225 25.17 conserved hypothetical protein 
CBB_4 2627 2896 89 10.13 conserved hypothetical protein 
CBB_5 3032 3316 94 10.83 conserved hypothetical protein 
CBB_6 3352 3741 129 14.96 conserved hypothetical protein 
CBB_7 3906 3793 57 6.30 hypothetical protein 
CBB_8 3965 4117 50 5.58 hypothetical protein 
CBB_9 4165 4437 90 10.08 conserved hypothetical protein 
CBB_10 4501 4947 148 16.80 conserved hypothetical protein 
CBB_11 5024 5479 151 17.13 conserved hypothetical protein 
CBB_12 5560 5685 41 4.54 hypothetical protein 
CBB_13 5758 5985 75 8.43 hypothetical protein 
CBB_14 6059 6481 140 16.39 conserved hypothetical protein 
CBB_15 6663 6998 111 12.23 conserved hypothetical protein 
CBB_16 7068 7235 55 6.68 conserved hypothetical protein 
CBB_17 7319 7498 59 6.51 conserved hypothetical protein 
CBB_18 7989 8243 123 14.45 conserved hypothetical protein 
CBB_19 7989 8243 84 9.99 conserved hypothetical protein 
CBB_20 8248 8406 52 5.88 hypothetical protein 
CBB_21 8696 8929 77 8.56 conserved hypothetical protein 
CBB_22 8953 9111 52 6.06 putative membrane protein 
CBB_23 9123 9326 67 7.51 conserved hypothetical protein 
CBB_24 9326 9502 58 6.86 conserved hypothetical protein 
CBB_25 9581 9784 67 7.56 conserved hypothetical protein 
CBB_26 9814 10164 116 13.40 conserved hypothetical protein 
CBB_27 10391 10642 83 9.44 putative membrane protein  
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CBB_28 10674 10832 52 5.87 hypothetical protein 
CBB_29 10841 11716 291 31.54 structural protein 
CBB_30 11856 12053 65 8.04 conserved hypothetical protein 
CBB_31 12017 12142 41 4.86 conserved hypothetical protein 
CBB_32 12132 12326 64 8.12 hypothetical protein 
CBB_33 12370 12723 117 13.52 putative membrane protein  
CBB_34 12720 13109 129 14.27 hypothetical protein 
CBB_35 13181 13372 63 7.27 conserved hypothetical protein 
CBB_36 13435 13821 128 14.27 conserved hypothetical protein 
CBB_37 13941 14183 80 9.53 conserved hypothetical protein 
CBB_38 14240 14758 172 18.82 structural protein 
CBB_39 14822 15160 112 12.64 conserved hypothetical protein 
CBB_40 15403 15750 115 12.92 hypothetical protein 
CBB_41 15841 16059 72 8.27 conserved hypothetical protein 
CBB_42 16235 16837 200 23.42 conserved hypothetical protein 
CBB_43 17042 17374 110 12.84 conserved hypothetical protein 
CBB_44 17584 17826 80 9.16 conserved hypothetical protein 
CBB_45 17906 18793 295 33.78 conserved hypothetical protein 
CBB_46 18869 19207 112 13.26 conserved hypothetical protein 
CBB_47 19411 19641 76 8.64 conserved hypothetical protein 
CBB_48 19725 20072 115 13.49 conserved hypothetical protein 
CBB_49 20272 20463 63 7.18 hypothetical protein 
CBB_50 20533 20709 58 6.43 conserved hypothetical protein 
CBB_51 21113 21382 89 10.35 conserved hypothetical protein 
CBB_52 21452 22009 185 20.69 hypothetical protein 
CBB_53 22520 23107 195 23.35 conserved hypothetical protein 
CBB_54 23110 23721 203 23.78 conserved hypothetical protein 
CBB_55 23696 24328 210 25.13 conserved hypothetical protein 
CBB_56 24459 25058 199 23.04 conserved hypothetical protein 
CBB_57 25055 25576 173 20.85 conserved hypothetical protein 
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CBB_58 25537 26139 200 23.71 conserved hypothetical protein 
CBB_59 26146 26559 137 15.94 conserved hypothetical protein 
CBB_60 26573 27016 147 17.35 conserved hypothetical protein 
CBB_61 27096 27572 158 18.37 conserved hypothetical protein 
CBB_62 27576 27746 56 6.48 Conserved hypothetical protein 
CBB_63 27751 28359 202 23.72 conserved hypothetical protein 
CBB_64 28360 29247 295 35.49 conserved hypothetical protein 
CBB_65 29231 29551 105 12.91 conserved hypothetical protein 
CBB_66 29595 29993 132 14.79 conserved hypothetical protein 
CBB_67 30018 30368 116 13.41 conserved hypothetical protein 
CBB_68 30409 30729 106 12.54 putative membrane protein  
CBB_69 30733 31506 257 29.85 conserved hypothetical protein 
CBB_70 31506 32300 264 30.72 conserved hypothetical protein 
CBB_71 32990 33514 174 21.26 conserved hypothetical protein 
CBB_72 33527 34069 180 20.59 DNA N-6-adenine-methyltransferase 
CBB_73 34091 34630 179 20.43 cytitidyltransferase 
CBB_74 34614 34895 93 10.90 conserved hypothetical protein 
CBB_75 34942 35490 182 21.01 conserved hypothetical protein 
CBB_76 35528 35686 52 6.20 conserved hypothetical protein 
CBB_77 35673 36374 233 27.34 conserved hypothetical protein 
CBB_78 36371 36574 67 7.65 putative membrane protein 
CBB_79 36555 37667 370 42.67 conserved hypothetical protein 
CBB_80 37709 38440 243 28.09 conserved hypothetical protein 
CBB_81 38485 38784 99 11.32 conserved hypothetical protein 
CBB_82 38781 39077 98 11.45 conserved hypothetical protein 
CBB_83 39142 40290 382 44.10 RNA ligase 1 and tail fiber attachment 
catalyst  
CBB_84 40325 40561 78 9.27 conserved hypothetical protein 
CBB_85 40554 40774 74 8.71 conserved hypothetical protein 
CBB_86 40791 41015 74 8.52 conserved hypothetical protein 
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CBB_87 41003 41935 310 35.99 polynucleotide 5'-kinase and 3'-
phosphatase 
CBB_88 41991 42200 69 7.71 conserved hypothetical protein 
CBB_89 42213 42380 55 6.47 putative membrane protein 
CBB_90 42370 42642 90 10.90 conserved hypothetical protein 
CBB_91 42639 42977 112 12.94 conserved hypothetical protein 
CBB_92 42979 43206 75 8.47 putative membrane protein 
CBB_93 43187 43435 82 9.58 conserved hypothetical protein 
CBB_94 43432 43788 118 14.06 conserved hypothetical protein 
CBB_95 43788 44033 81 9.78 conserved hypothetical protein 
CBB_96 44077 44715 212 24.93 conserved hypothetical protein 
CBB_97 44715 45494 259 30.02 putative serine/threonine protein 
phosphatase  
CBB_98 45494 45952 152 17.25 conserved hypothetical protein 
CBB_99 45963 47201 412 47.48 conserved hypothetical protein 
CBB_100 47228 48643 471 53.23 DNA ligase 
CBB_101 48640 49065 141 16.67 conserved hypothetical protein 
CBB_102 49043 49834 263 30.56 metallophosphoesterase 
CBB_103 49836 50264 142 14.64 conserved hypothetical protein 
CBB_104 50278 50970 230 25.46 ATP-dependent Clp protease 
proteolytic subunit  
CBB_105 50987 51274 95 10.46 conserved hypothetical protein 
CBB_106 51280 51735 151 17.75 conserved hypothetical protein 
CBB_107 51781 52335 184 22.46 conserved hypothetical protein 
CBB_108 52320 52847 175 20.60 conserved hypothetical protein 
CBB_109 52837 53319 160 19.09 conserved hypothetical protein 
CBB_110 53306 53761 151 16.85 CMP/dCMP deaminase 
CBB_111 53763 54032 89 10.40 putative membrane protein 
CBB_112 54740 54084 218 21.75 major tail protein 
CBB_113 54982 56079 365 42.17 bifunctional nicotinamide 
mononucleotide 
adenylyltransferase/ADP-ribose 
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pyrophosphatase  
CBB_114 56123 56641 172 20.20 conserved hypothetical protein 
CBB_115 56702 58189 495 55.68 nicotinamide 
phosphoribosyltransferase 
CBB_116 58232 58453 73 8.39 putative membrane protein  
CBB_117 58455 59402 315 37.08 conserved hypothetical protein 
CBB_118 59615 60061 148 16.64 structural protein 
CBB_119 60073 60315 80 9.60 conserved hypothetical protein 
CBB_120 60328 61119 263 29.72 putative Sir2-like protein  
CBB_121 61135 62034 299 34.45 conserved hypothetical protein 
CBB_122 62034 62336 100 11.13 putative membrane protein 
CBB_123 62407 63846 479 53.57 PhoH family protein  
CBB_124 63894 64076 60 7.03 conserved hypothetical protein 
CBB_125 64251 64943 230 27.02 conserved hypothetical protein 
CBB_126 64940 65146 68 7.26 putative membrane protein 
CBB_127 65153 65302 49 5.62 putative membrane protein 
CBB_128 65377 65922 181 22.37 conserved hypothetical protein 
CBB_129 65949 66791 200 31.87 conserved hypothetical protein 
CBB_130 66793 67407 204 22.68 conserved hypothetical protein 
CBB_131 67407 67688 93 10.26 co-chaperonin GroES 
CBB_132 67698 6893 421 47.60 tyrosyl-tRNA synthetase 
CBB_133 68985 69171 68 7.80 putative lipoprotein 
CBB_134 69317 69958 213 25.45 conserved hypothetical protein 
CBB_135 69948 70313 121 13.72 dCMP deaminase 
CBB_136 70300 70620 106 12.88 hypothetical protein 
CBB_137 70613 71239 208 24.62 hypothetical protein 
CBB_138 71229 71486 85 10.21 conserved hypothetical protein 
CBB_139 71483 71683 66 7.74 hypothetical protein 
CBB_140 71696 72247 183 21.16 conserved hypothetical protein 
CBB_141 72380 74217 611 69.42 anaerobic NTP reductase large subunit 
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CBB_142 74304 74621 105 12.19 hypothetical protein 
CBB_143 74628 75074 148 18.00 conserved hypothetical protein 
CBB_144 75120 75884 254 25.22 hypothetical protein 
CBB_145 75881 76354 157 17.91 anaerobic ribonucleoside-triphosphate 
reductase activating protein  
CBB_146 76347 76523 58 6.57 conserved hypothetical protein 
CBB_147 76602 79310 902 98.07 conserved hypothetical protein 
CBB_148 79320 82070 916 98.70 structural protein 
CBB_149 82083 84833 916 100.67 structural protein 
CBB_150 84966 85526 186 22.00 conserved hypothetical protein 
CBB_151 85483 85752 89 10.61 hypothetical protein 
CBB_152 85749 86528 259 29.85 putative tRNA-His guanylyltransferase 
CBB_153 87000 87302 154 19.59 conserved hypothetical protein 
CBB_154 87000 87302 100 11.23 conserved hypothetical protein 
CBB_155 87310 87789 159 18.38 conserved hypothetical protein 
CBB_156 87786 88418 210 25.22 conserved hypothetical protein 
CBB_157 88427 89287 286 33.21 putative N-4 cytosine-specific 
methyltransferase  
CBB_158 89284 89619 111 12.97 conserved hypothetical protein 
CBB_159 89628 90878 416 48.92 nucleotidyltransferase 
CBB_160 90878 91294 138 16.13 conserved hypothetical protein 
CBB_161 91298 91801 167 19.46 conserved hypothetical protein 
CBB_162 91791 92360 189 21.48 conserved hypothetical protein 
CBB_163 92332 92748 138 15.80 acyl carrier protein 
CBB_164 92821 93189 122 14.09 structural protein 
CBB_165 93186 93500 104 11.90 structural protein 
CBB_166 93574 93963 129 15.24 conserved hypothetical protein 
CBB_167 93974 94228 84 10.36 conserved hypothetical protein 
CBB_168 94890 95255 121 14.61 conserved hypothetical protein 
CBB_169 95287 95727 146 17.18 structural protein 
CBB_170 95771 96202 143 16.86 conserved hypothetical protein 
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CBB_171 96192 96695 167 19.77 GTP cyclohydrolase 
CBB_172 96676 96963 95 11.16 conserved hypothetical protein 
CBB_173 96976 97545 189 21.41 thymidine kinase 
CBB_174 97599 98108 169 19.78 putative membrane protein 
CBB_175 98105 98713 202 23.04 putative membrane protein 
CBB_176 98710 99069 119 13.58 conserved hypothetical protein 
CBB_177 99071 99205 44 4.71 putative membrane protein 
CBB_178 99207 99806 199 23.57 hypothetical protein 
CBB_179 99808 100128 106 12.32 hypothetical protein 
CBB_180 100131 100678 182 21.27 conserved hypothetical protein 
CBB_181 100759 101995 418 47.45 RNA ligase 
CBB_182 101998 102606 202 24.17 conserved hypothetical protein 
CBB_183 102737 104251 504 55.82 structural protein 
CBB_184 104304 104444 46 5.03 putative membrane protein 
CBB_185 104498 104920 140 17.28 conserved hypothetical protein 
CBB_186 104913 105488 191 21.94 conserved hypothetical protein 
CBB_187 105603 106538 311 35.38 lysozyme 
CBB_188 106561 106899 112 12.88 sigma 54 modulation 
protein/ribosomal protein S30EA  
CBB_189 106983 107384 133 16.15 conserved hypothetical protein 
CBB_190 107371 107514 47 5.63 hypothetical protein 
CBB_191 107501 107716 71 8.66 conserved hypothetical protein 
CBB_192 107713 108828 371 42.75 multifunctional tRNA nucleotidyl 
transferase/2'3'-cyclic 
phosphodiesterase/2'nucleotidase/ph
osphatase 
CBB_193 108894 109316 140 16.50 nudix hydrolase 
CBB_194 109342 109578 140 8.70 glutaredoxin 
CBB_195 109580 109993 137 15.18 conserved hypothetical protein 
CBB_196 109996 110340 114 13.50 conserved hypothetical protein 
CBB_197 110388 110630 80 9.39 conserved hypothetical protein 
CBB_198 110675 111175 166 18.85 conserved hypothetical protein 
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CBB_199 111202 111531 109 11.97 conserved hypothetical protein 
CBB_200 111541 111903 120 13.48 conserved hypothetical protein 
CBB_201 111951 112736 261 29.62 neck protein 
CBB_202 112774 113028 84 9.77 conserved hypothetical protein 
CBB_203 113067 113708 213 24.82 putative deoxynucleoside 
monophosphate kinase  
CBB_204 113797 116451 884 95.91 tail sheath monomer 
CBB_205 116558 117247 229 25.39 structural protein 
CBB_206 117331 118107 258 29.03 structural protein 
CBB_207 118118 119212 364 39.83 structural protein 
CBB_208 119212 119670 152 17.69 head completion protein 
CBB_209 119672 120235 187 21.53 conserved hypothetical protein 
CBB_210 120263 120808 181 20.95 structural protein 
CBB_211 120811 121371 186 20.24 structural protein 
CBB_212 121384 122820 478 53.17 structural protein 
CBB_213 122838 123767 309 33.36 structural protein 
CBB_214 123767 124177 136 14.86 structural protein 
CBB_215 124181 124555 124 14.33 conserved hypothetical protein 
CBB_216 124693 126036 447 50.67 ATPase 
CBB_217 126078 127430 450 51.29 putative membrane protein 
CBB_218 127539 127775 218 8.64 conserved hypothetical protein 
CBB_219 127777 128469 230 26.15 conserved hypothetical protein 
CBB_220 128469 128777 102 11.58 conserved hypothetical protein 
CBB_221 128764 129351 195 22.36 conserved hypothetical protein 
CBB_222 129358 129687 109 12.86 conserved hypothetical protein 
CBB_223 129650 130579 309 35.33 thymidylate synthase  
CBB_224 132533 130611 640 68.10 structural protein 
CBB_225 133259 132621 212 24.19 structural protein 
CBB_226 138084 137934 1553 153.27 long tail fiber proximal subunit 
CBB_227 138944 138084 286 30.02 structural protein 
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CBB_228 140166 139024 380 41.68 structural protein 
CBB_229 140272 140769 165 19.05 structural protein 
CBB_230 140780 141388 202 21.80 structural protein 
CBB_231 141399 142505 368 40.39 structural protein 
CBB_232 142976 142509 148 17.72 MutT/NUDIX hydrolase family protein 
CBB_233 144323 142986 445 51.35 tail sheath stabilizer and completion 
protein 
CBB_234 145816 144320 498 57.00 structural protein 
CBB_235 144320 145816 765 84.34 ATP-dependent Clp protease ATP-
binding subunit clpA  
CBB_236 158274 148252 3340 379.94 structural protein 
CBB_237 161820 158356 1154 131.71 baseplate wedge 
CBB_238 162285 161896 129 14.83 base plate protein 
CBB_239 162784 162296 162 18.49 baseplate hub subunit and tail 
lysozyme 
CBB_240 165504 162820 894 97.09 baseplate hub subunit and tail 
lysozyme 
CBB_241 167891 165504 795 88.83 structural protein 
CBB_242 168217 167903 104 12.23 baseplate wedge protein 
CBB_243 169931 169071 245 27.69 structural protein 
CBB_244 169071 169931 286 33.56 sigma factor for late transcription  
CBB_245 169918 170949 343 39.92 recombination endonuclease subunit 
CBB_246 170962 173103 713 82.05 recombination endonuclease subunit 
CBB_247 173132 173866 244 27.28 structural protein 
CBB_248 174344 173868 158 18.15 DNA endonuclease VII  
CBB_249 175307 175131 58 6.93 conserved hypothetical protein 
CBB_250 176185 175328 285 32.55 structural protein 
CBB_251 176250 178418 722 78.41 structural protein 
CBB_252 178435 180171 578 65.18 portal vertex protein of head  
CBB_253 180229 180459 76 8.63 conserved hypothetical protein 
CBB_254 181414 182043 274 30.25 structural protein 
CBB_255 181414 182043 209 23.24 prohead core scaffold and protease 
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CBB_256 182112 183236 274 42.55 structural protein 
CBB_257 183315 184490 391 42.11 precursor of major head subunit 
CBB_258 184644 185060 138 15.98 conserved hypothetical protein 
CBB_259 185089 185400 103 12.02 conserved hypothetical protein 
CBB_260 185445 187064 539 56.65 putative tail fiber protein 
CBB_261 187057 187470 137 16.06 tail fiber assembly protein 
CBB_262 187916 190948 100 11.31 conserved hypothetical protein 
CBB_263 187916 190948 1010 115.94 DNA polymerase 
CBB_264 190964 191476 170 19.32 conserved hypothetical protein 
CBB_265 191541 192272 243 26.74 conserved hypothetical protein 
CBB_266 192319 192933 204 23.92 putative phosphoesterase or 
phosphohydrolase  
CBB_267 192945 193154 69 8.22 conserved hypothetical protein 
CBB_268 193160 193459 90 10.74 co-chaperonin GroES  
CBB_269 193452 194171 239 28.50 structural protein 
CBB_270 194219 194875 218 22.43 structural protein 
CBB_271 194891 195451 186 19.23 structural protein 
CBB_272 195646 196632 328 38.17 RNaseH ribonuclease 
CBB_273 196632 197132 166 19.04 conserved hypothetical protein 
CBB_274 197176 197883 235 27.52 terminase DNA packaging enzyme 
large subunit  
CBB_275 197870 199519 549 62.89 DNA terminase packaging enzyme 
large subunit  
CBB_276 199556 200845 429 48.67 structural protein 
CBB_277 201073 202116 347 38.62 ssDNA binding protein 
CBB_278 202175 203305 376 41.44 recA-like protein  
CBB_279 203307 203771 154 17.96 conserved hypothetical protein 
CBB_280 203817 204662 281 32.53 putative DNA polymerase III epsilon 
subunit  
CBB_281 204685 206169 494 56.09 NA-DNA + DNA-DNA helicase 
CBB_282 204685 206169 145 17.16 conserved hypothetical protein 
CBB_283 206670 207173 167 19.15 conserved hypothetical protein 
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CBB_284 207173 208018 281 32.25 conserved hypothetical protein 
CBB_285 208005 208724 239 28.82 conserved hypothetical protein 
CBB_286 208721 209068 115 13.30 structural protein 
CBB_287 209034 209684 216 25.11 putative membrane protein 
CBB_288 209668 210021 117 14.23 conserved hypothetical protein 
CBB_289 210079 211050 323 36.68 structural protein 
CBB_290 211113 212159 348 40.38 putative DNA primase  
CBB_291 212167 213663 498 55.75 DNA primase-helicase 
CBB_292 213666 213935 89 10.37 structural protein 
CBB_293 213937 214095 52 5.60 conserved hypothetical protein 
CBB_294 214097 214495 132 14.70 structural protein 
CBB_295 214541 215485 314 34.25 conserved hypothetical protein 
CBB_296 215485 215703 72 8.36 conserved hypothetical protein 
CBB_297 215700 216503 267 30.22 conserved hypothetical protein 
CBB_298 216536 217180 214 23.65 structural protein 
CBB_299 217193 217528 111 12.15 structural protein 
CBB_300 217568 218269 233 26.64 restriction endonuclease type II-like  
CBB_301 218274 218825 183 20.26 conserved hypothetical protein 
CBB_302 218854 219432 192 20.83 structural protein 
CBB_303 219508 221838 776 87.79 ribonucleotide-diphosphate reductase 
alpha subunit  
CBB_304 221881 222054 257 30.80 conserved hypothetical protein 
CBB_305 222664 223785 373 43.37 ribonucleotide-diphosphate reductase 
subunit beta  
CBB_306 223824 224012 62 7.09 putative membrane protein 
CBB_307 224073 224306 77 9.14 conserved hypothetical protein 
CBB_308 224318 224698 126 14.78 structural protein 
CBB_309 224698 225414 238 26.30 conserved hypothetical protein 
CBB_310 225436 226089 217 24.21 structural protein 
CBB_311 226101 226811 236 26.33 putative membrane protein 
CBB_312 226944 227318 124 13.97 putative membrane protein 
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CBB_313 227315 227833 172 19.68 dihydrofolate reductase 
CBB_314 227833 228267 144 16.20 ribonuclease H 
CBB_315 228264 229604 446 51.65 DNA helicase Dda  
CBB_316 229672 230217 181 19.94 structural protein 
CBB_317 230236 230430 64 7.30 conserved hypothetical protein 
CBB_318 230504 231010 168 18.74 translation initiation factor IF-3 
CBB_319 231071 231604 177 20.09 ATP-dependent Clp protease  
CBB_320 231666 232199 177 20.64 structural protein 
CBB_321 231189 233799 536 61.65 structural protein 
CBB_322 233799 236342 847 96.34 structural protein 
CBB_323 236433 236717 94 10.58 putative membrane protein 
CBB_324 236813 238786 657 74.42 DNA gyrase subunit B 
CBB_325 238837 240243 468 53.17 DNA topoisomerase II 
CBB_326 240331 243014 789 87.98 structural protein 
CBB_327 242709 243014 101 11.84 conserved hypothetical protein 
CBB_328 242974 243492 172 20.57 DNA polymerase III alpha subunit 
CBB_329 243539 243913 124 13.94 conserved hypothetical protein 
CBB_330 243924 244244 106 11.70 conserved hypothetical protein 
CBB_331 244288 244578 96 11.15 conserved hypothetical protein 
CBB_332 244581 245534 317 36.15 sliding clamp loader subunit 
CBB_333 245543 246163 206 24.06 conserved hypothetical protein 
CBB_334 246221 246790 189 21.94 structural protein 
CBB_335 246790 247473 227 25.70 structural protein 
CBB_336 247473 248267 264 30.76 conserved hypothetical protein 
CBB_337 248404 248943 179 19.20 conserved hypothetical protein 
CBB_338 248977 249177 66 7.02 conserved hypothetical protein 
CBB_339 249236 250432 398 45.96 conserved hypothetical protein 
CBB_340 250525 251667 380 42.63 toxic ion resistance protein 
CBB_341 251734 252066 110 13.01 conserved hypothetical protein 
CBB_342 252066 252740 224 25.57 putative metallopeptidase  
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CBB_343 252797 253894 365 42.11 putative membrane protein 
CBB_344 253891 254445 184 20.71 structural protein 
CBB_345 254558 254737 59 6.44 conserved hypothetical protein 
CBB_346 254749 255096 115 13.26 putative membrane protein  
CBB_347 255145 255777 210 25.48 conserved hypothetical protein 
CBB_348 255777 256262 161 18.99 conserved hypothetical protein 
CBB_349 256322 256046 574 64.97 conserved hypothetical protein 
CBB_350 258785 259024 79 9.26 hypothetical protein 
CBB_351 259027 259467 146 17.29 conserved hypothetical protein 
CBB_352 259469 259672 67 7.74 conserved hypothetical protein 
CBB_353 259672 260019 115 13.81 conserved hypothetical protein 
CBB_354 260021 260335 104 12.35 conserved hypothetical protein 
CBB_355 260322 260672 116 13.29 hypothetical protein 
CBB_356 260659 261378 239 27.60 conserved hypothetical protein 
CBB_357 361368 261616 82 9.91 conserved hypothetical protein 
CBB_358 361621 261815 64 7.65 conserved hypothetical protein 
CBB_359 261832 262851 339 39.69 conserved hypothetical protein 
CBB_360 262861 263232 123 14.27 conserved hypothetical protein 
CBB_361 263250 264299 349 40.33 nicotinamide-nucleotide 
adenylyltransferase  
CBB_362 264296 265099 267 30.12 nicotinamide mononucleotide 
transporter PnuC  
CBB_363 365101 265212 103 11.83 hypothetical protein 
CBB_364 265432 265674 80 9.22 conserved hypothetical protein 
CBB_365 265721 265924 67 8.38 conserved hypothetical protein 
CBB_366 265921 266358 145 17.42 conserved hypothetical protein 
CBB_367 266355 266660 101 11.61 hypothetical protein 
CBB_368 266657 266968 103 11.70 conserved hypothetical protein 
CBB_369 266977 267321 114 13.01 conserved hypothetical protein 
CBB_370 267305 267658 117 13.82 structural protein 
CBB_371 267658 268017 119 13.97 conserved hypothetical protein 
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CBB_372 268028 268333 101 11.83 conserved hypothetical protein 
CBB_373 268330 268779 149 17.30 conserved hypothetical protein 
CBB_374 268895 269311 138 15.96 conserved hypothetical protein 
CBB_375 269337 270125 275 29.73 conserved hypothetical protein 
CBB_376 270125 271390 421 49.56 conserved hypothetical protein 
CBB_377 271430 272620 396 45.37 conserved hypothetical protein 
CBB_378 272817 273290 157 18.24 conserved hypothetical protein 
CBB_379 273314 273646 110 12.84 conserved hypothetical protein 
CBB_380 273650 274237 195 21.98 putative 5'3'-deoxyribonucleotidase 
CBB_381 274231 274755 184 21.05 conserved hypothetical protein 
CBB_382 274908 275486 192 21.86 conserved hypothetical protein 
CBB_383 276036 276362 108 12.90 conserved hypothetical protein 
CBB_384 276721 276870 49 5.31 conserved hypothetical protein 
CBB_385 276870 277124 84 9.80 conserved hypothetical protein 
CBB_386 277124 277815 263 30.18 conserved hypothetical protein 
CBB_387 277908 278285 125 15.24 conserved hypothetical protein 
CBB_388 278242 278703 153 17.78 conserved hypothetical protein 
CBB_389 278703 278972 89 10.60 conserved hypothetical protein 
CBB_390 278969 279484 171 20.33 conserved hypothetical protein 
CBB_391 279438 279893 151 17.79 hypothetical protein 
CBB_392 279874 280302 142 16.92 peptidyl-tRNA hydrolase 
CBB_393 280575 280934 119 13.85 putative membrane protein  
CBB_394 280924 281157 77 8.75 conserved hypothetical protein 
CBB_395 281139 281300 53 6.27 hypothetical protein 
CBB_396 281303 281557 84 10.07 conserved hypothetical protein 
CBB_397 281564 281926 120 13.63 conserved hypothetical protein 
CBB_398 281910 282374 154 18.72 conserved hypothetical protein 
CBB_399 282396 283256 286 32.94 DNA-cytosine methyltransferase 
CBB_400 283249 283560 103 11.73 conserved hypothetical protein 
CBB_401 283563 283904 113 13.37 conserved hypothetical protein 
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CBB_402 283901 284605 234 27.62 conserved hypothetical protein 
CBB_403 284616 284972 118 14.28 conserved hypothetical protein 
CBB_404 284976 285500 174 20.74 hypothetical protein 
CBB_405 285502 285699 65 7.88 conserved hypothetical protein 
CBB_406 286108 286341 77 8.78 conserved hypothetical protein 
CBB_407 286338 286478 46 5.33 conserved hypothetical protein 
CBB_408 286581 286904 107 12.32 conserved hypothetical protein 
CBB_409 286950 287381 143 16.39 conserved hypothetical protein 
CBB_410 287391 287585 64 7.45 conserved hypothetical protein 
CBB_411 287587 287937 116 13.34 conserved hypothetical protein 
CBB_412 287948 288283 111 13.02 conserved hypothetical protein 
CBB_413 288587 288790 67 7.68 hypothetical protein 
CBB_414 288793 288909 38 4.50 hypothetical protein 
CBB_415 288912 289204 97 11.07 putative membrane protein  
CBB_416 289202 289468 88 10.43 hypothetical protein 
CBB_417 289425 289715 96 11.02 conserved hypothetical protein 
CBB_418 289786 289986 66 7.38 conserved hypothetical protein 
CBB_419 290507 290740 77 8.78 conserved hypothetical protein 
CBB_420 290851 291255 134 15.88 HNH 
CBB_421 291456 291608 50 5.85 putative membrane protein  
CBB_422 291615 291815 66 7.92 conserved hypothetical protein 
CBB_423 291815 292030 71 7.79 putative membrane protein  
CBB_424 292027 292224 65 7.46 putative membrane protein  
CBB_425 292224 292664 146 16.95 conserved hypothetical protein 
CBB_426 292771 292983 70 7.96 hypothetical protein 
CBB_427 292983 293228 81 9.06 hypothetical protein 
CBB_428 293231 293458 75 8.91 hypothetical protein 
CBB_429 293458 293718 86 9.76 hypothetical protein 
CBB_430 293781 293984 67 7.37 hypothetical protein 
CBB_431 293985 294785 266 31.18 conserved hypothetical protein 
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CBB_432 294787 295089 100 11.17 hypothetical protein 
CBB_433 295082 295489 135 16.01 conserved hypothetical protein 
CBB_434 295486 295713 75 8.65 hypothetical protein 
CBB_435 295860 296153 97 11.65 conserved hypothetical protein 
CBB_436 296228 296510 93 10.10 conserved hypothetical protein 
CBB_437 296513 296710 65 7.77 conserved hypothetical protein 
CBB_438 296694 297059 121 14.35 conserved hypothetical protein 
CBB_439 297059 297415 118 13.86 conserved hypothetical protein 
CBB_440 297566 297799 77 8.77 conserved hypothetical protein 
CBB_441 287796 298419 207 22.95 hypothetical protein 
CBB_442 298580 298416 54 6.21 putative membrane protein 
CBB_443 298638 299012 124 13.92 putative membrane protein  
CBB_444 299204 299788 194 22.99 conserved hypothetical protein 
CBB_445 299807 300313 168 19.31 conserved hypothetical protein 
CBB_446 300462 300677 71 8.28 conserved hypothetical protein 
CBB_447 300741 300983 80 9.42 conserved hypothetical protein 
CBB_448 300996 301466 156 17.67 putative membrane protein 
CBB_449 301822 301499 107 12.97 hypothetical protein 
CBB_450 301908 302054 48 5.50 conserved hypothetical protein 
CBB_451 302871 303272 133 15.96 conserved hypothetical protein 
CBB_452 303296 303505 69 8.15 conserved hypothetical protein 
CBB_453 303601 303825 74 8.40 conserved hypothetical protein 
CBB_454 303825 304223 132 15.67 conserved hypothetical protein 
CBB_455 304960 305559 199 22.79 conserved hypothetical protein 
CBB_456 305594 305947 117 13.68 conserved hypothetical protein 
CBB_457 306246 306680 144 16.17 conserved hypothetical protein 
CBB_458 306761 307072 103 12.15 conserved hypothetical protein 
CBB_459 307418 307648 76 9.02 conserved hypothetical protein 
CBB_460 307810 308058 82 9.86 hypothetical protein 
CBB_461 308384 308710 108 12.71 conserved hypothetical protein 
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CBB_462 308798 309034 78 9.29 conserved hypothetical protein 
CBB_463 309027 309512 161 19.18 conserved hypothetical protein 
CBB_464 309514 309717 67 8.19 conserved hypothetical protein 
CBB_465 309819 310202 127 15.22 hypothetical protein 
CBB_466 310195 310458 87 10.19 conserved hypothetical protein 
CBB_467 310740 310958 72 8.66 conserved hypothetical protein 
CBB_468 310951 311301 116 14.25 conserved hypothetical protein 
CBB_469 311332 311727 131 15.68 conserved hypothetical protein 
CBB_470 311949 312266 105 12.42 conserved hypothetical protein 
CBB_471 312370 312621 83 9.83 conserved hypothetical protein 
CBB_472 312784 313227 147 17.05 conserved hypothetical protein 
CBB_473 313316 313441 41 4.56 conserved hypothetical protein 
CBB_474 313431 313574 47 5.31 conserved hypothetical protein 
CBB_475 313561 313809 82 9.26 conserved hypothetical protein 
CBB_476 313917 314393 158 18.14 PrlF antitoxin like protein 
CBB_477 314383 314901 172 19.72 conserved hypothetical protein 
CBB_478 314891 315019 42 5.11 conserved hypothetical protein 
CBB_479 315019 315333 104 11.86 putative membrane protein 
CBB_480 315333 315671 112 12.40 putative membrane protein 
CBB_481 315671 315988 105 11.60 putative lipoprotein 
CBB_482 315998 316297 99 10.85 putative membrane protein 
CBB_483 316356 316493 45 5.33 conserved hypothetical protein 
CBB_484 316468 316671 67 7.91 conserved hypothetical protein 
CBB_485 316707 317192 161 18.55 conserved hypothetical protein 
CBB_486 317245 317511 88 10.26 hypothetical protein 
CBB_487 317511 317957 148 16.31 putative lipoprotein 
CBB_488 318005 318136 43 4.84 conserved hypothetical protein 
CBB_489 318191 318814 207 24.12 conserved hypothetical protein 
CBB_490 318898 319257 119 14.22 conserved hypothetical protein 
CBB_491 319369 319557 62 7.20 conserved hypothetical protein 
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CBB_492 319565 319762 65 7.44 conserved hypothetical protein 
CBB_493 319847 320068 73 8.43 hypothetical protein 
CBB_494 320745 321431 228 24.72 structural protein 
CBB_495 321487 322026 179 20.99 S-adenosyl-L-methionine-dependent 
methyltransferase 
CBB_496 323175 322042 377 40.94 structural protein 
CBB_497 323350 323925 191 21.62 conserved hypothetical protein 
CBB_498 323937 324242 101 11.57 putative membrane protein 
CBB_499 324246 324728 160 18.21 putative membrane protein 
CBB_500 324788 325309 173 19.65 conserved hypothetical protein 
CBB_501 325354 325824 156 18.63 putative membrane protein 
CBB_502 325834 326283 149 16.81 putative membrane protein 
CBB_503 326355 326600 81 9.24 conserved hypothetical protein 
CBB_504 326593 327318 241 28.55 putative membrane protein 
CBB_505 327311 327430 39 3.96 conserved hypothetical protein 
CBB_506 327433 327867 144 16.72 putative membrane protein 
CBB_507 327921 328448 175 20.65 conserved hypothetical protein 
CBB_508 328450 328773 107 12.01 conserved hypothetical protein 
CBB_509 328773 329156 125 14.78 conserved hypothetical protein 
CBB_510 329214 329405 63 6.99 conserved hypothetical protein 
CBB_511 330631 330861 76 8.77 transcriptional regulator  
CBB_512 330858 331007 49 5.55 conserved hypothetical protein 
CBB_513 331103 332091 330 37.92 subfamily RNA polymerase sigma-70 
subunit  
CBB_514 332108 312818 236 26.63 conserved hypothetical protein 
CBB_515 332827 333018 63 7.20 conserved hypothetical protein 
CBB_516 333073 334047 324 37.22 conserved hypothetical protein 
CBB_517 334461 334634 98 11.47 hypothetical protein 
CBB_518 334461 334634 57 6.57 hypothetical protein 
CBB_519 334700 335134 144 16.95 endonuclease V N-glycosylase UV 
repair enzyme 
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CBB_520 335198 335383 61 6.99 conserved hypothetical protein 
CBB_521 335458 335853 131 15.54 conserved hypothetical protein 
CBB_522 335850 336044 64 7.15 putative membrane protein 
CBB_523 336041 336274 77 8.82 conserved hypothetical protein 
CBB_524 336949 337752 267 31.25 conserved hypothetical protein 
CBB_525 337822 338832 336 39.56 conserved hypothetical protein 
CBB_526 338899 339423 174 19.85 conserved hypothetical protein 
CBB_527 339433 340227 264 30.74 conserved hypothetical protein 
CBB_528 340294 340860 188 21.78 HNH 
CBB_529 340862 341182 106 12.48 putative membrane protein 
CBB_530 341299 342369 356 40.50 conserved hypothetical protein 
CBB_531 342424 342612 62 7.21 conserved hypothetical protein 
CBB_532 342609 342866 85 10.40 conserved hypothetical protein 
CBB_533 342863 342030 55 6.23 conserved hypothetical protein 
CBB_534 343063 343335 90 10.45 structural protein 
CBB_535 343417 344337 306 35.70 conserved hypothetical protein 
CBB_536 344368 345027 219 24.75 structural protein 
CBB_537 345042 345689 215 24.14 structural protein 
CBB_538 345789 346571 260 29.12 conserved hypothetical protein 
CBB_539 345789 346571 107 12.12 putative membrane protein 
CBB_540 346911 347099 62 7.10 putative membrane protein 
CBB_541 347102 347263 53 5.89 putative membrane protein 
CBB_542 347277 348047 256 29.98 conserved hypothetical protein 
CBB_543 348094 348444 116 13.14 putative membrane protein 
CBB_544 348444 348782 112 13.12 putative membrane protein 
CBB_545 348782 349132 116 13.29 putative membrane protein 
CBB_546 349199 349495 98 10.86 putative membrane protein 
CBB_547 349547 350170 207 22.41 putative lipoprotein 
CBB_548 350849 350196 217 23.81 structural protein 
CBB_549 351530 350859 223 24.84 structural protein 
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CBB_550 352396 351539 285 31.83 kelch-like protein  
CBB_551 353100 352396 234 25.38 structural protein 
CBB_552 353952 353119 280 31.25 structural protein 
CBB_553 354701 354030 223 25.40 structural protein 
CBB_554 355464 354667 265 29.91 kelch-like protein  
CBB_555 357350 357538 62 7.00 hypothetical protein 
CBB_556 357723 358400 225 25.17 conserved hypothetical protein 
CBB_557 358550 358819 89 10.13 conserved hypothetical protein 
CBB_558 358955 359239 94 10.83 conserved hypothetical protein 
CBB_559 359275 359664 129 14.96 conserved hypothetical protein 
CBB_560 359889 359716 57 6.30 hypothetical protein 
CBB_561 359888 360040 50 5.58 hypothetical protein 
CBB_562 360088 360360 90 10.08 conserved hypothetical protein 
CBB_563 360424 360870 148 16.80 conserved hypothetical protein 
CBB_564 360947 361402 151 17.13 conserved hypothetical protein 
CBB_565 361483 361608 41 4.54 hypothetical protein 
CBB_566 361681 361908 75 8.43 hypothetical protein 
CBB_567 361982 362404 140 16.39 conserved hypothetical protein 
CBB_568 362586 362921 111 12.23 conserved hypothetical protein 
CBB_569 362991 363158 55 6.68 conserved hypothetical protein 
CBB_570 363242 363421 59 6.51 conserved hypothetical protein 
CBB_571 363494 363865 123 14.45 conserved hypothetical protein 
CBB_572 363912 364166 84 9.99 conserved hypothetical protein 
CBB_573 365171 365329 52 5.88 hypothetical protein 
CBB_574 364619 364852 77 8.56 conserved hypothetical protein 
CBB_575 364876 365034 52 6.06 putative membrane protein 
CBB_576 365046 365249 67 7.51 conserved hypothetical protein 
CBB_577 365282 365425 47 6.86 conserved hypothetical protein 
CBB_578 365504 365707 67 7.56 conserved hypothetical protein 
CBB_579 365737 366087 116 13.40 conserved hypothetical protein 
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CBB_580 366314 366565 83 9.44 putative membrane protein 
CBB_581 366597 366755 52 5.87 hypothetical protein 
CBB_582 366764 367639 291 31.54 structural protein 
CBB_583 367779 367976 65 8.04 conserved hypothetical protein 
CBB_584 367940 368065 41 4.86 conserved hypothetical protein 
CBB_585 368055 368249 64 8.12 hypothetical protein 
CBB_586 368293 368646 117 13.52 putative membrane protein 
CBB_587 368643 369032 129 14.27 hypothetical protein 
CBB_588 369104 369295 63 7.27 conserved hypothetical protein 
CBB_589 369358 369744 128 14.27 conserved hypothetical protein 
CBB_590 369864 370106 80 9.53 conserved hypothetical protein 
CBB_591 370163 370681 172 18.82 conserved hypothetical protein 
CBB_592 370745 371083 112 12.64 conserved hypothetical protein 
CBB_593 371326 371673 115 12.92 hypothetical protein 
CBB_594 371764 371982 72 8.27 conserved hypothetical protein 
CBB_595 372158 372760 200 23.42 conserved hypothetical protein 
CBB_596 372965 373297 110 12.84 conserved hypothetical protein 
CBB_597 373507 373749 80 9.16 conserved hypothetical protein 
CBB_598 373829 374716 295 33.78 conserved hypothetical protein 
CBB_599 374792 375130 112 13.26 conserved hypothetical protein 
CBB_600 375334 375564 76 8.64 conserved hypothetical protein 
CBB_601 375648 375995 115 13.49 conserved hypothetical protein 
CBB_602 376195 376386 63 7.18 hypothetical protein 
CBB_603 376456 376632 58 6.43 conserved hypothetical protein 
CBB_604 377036 377305 89 10.35 conserved hypothetical protein 
CBB_605 377375 377932 185 20.69 hypothetical protein 
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Table S6.3. tRNA genes in the genome of Pectobacterium phage CBB (Detected using tRNAscan 
–SE and ARAGORN). 
Feature Location Function Predection program 
tRNA gene 1 268,792 bp - 
268,878 bp 
Ser, anticodon GCT tRNAscan-SE 
tRNA gene 1A 272,675 bp - 
272,749 bp 
 tRNA-Trp(cca) ARAGORN 
tRNA gene 1B 275,819 bp - 
275,892 bp 
tRNA-Thr(tgt) ARAGORN 
tRNA gene 2 276,549 bp - 
276,669 bp 
Val, anticodon AAC (intron 
present 276,585 bp – 
276,634 bp) 
tRNAscan-SE 
tRNA gene 3 280,358 bp - 
280,440 bp 
Leu, anticodon TAG tRNAscan-SE 
tRNA gene 4 288,346 bp – 
288,417 bp 
Arg, anticodon TCT tRNAscan-SE 
tRNA gene 5 289,995 bp -
290,067 bp 
Sup, anticodon CTA or 
tRNA-Pyl(cta)  
TRNAscan -SE 
ARAGORN 
tRNA gene 6 290,284 bp – 
290,367 bp 
Leu, anticodon TAA tRNAscan-SE 
tRNA gene 7 290,373 bp – 
290,482 bp 
Val, anticodon GAC (intron 
present 290,373 bp – 
290,482 bp) 
tRNAscan-SE 
tRNA gene 7A 290,748 bp -
290,824 bp 
tRNA-Met(cat) ARAGORN 
tRNA gene 8 292,673 bp -
292,754 bp 
Leu, anticodon TAA tRNAscan-SE 
tRNA gene 9 295,724 bp – 
295,837 bp 
Pseudo tRNA tRNAscan-SE 
tRNA gene 10 297,425 bp -
297,546 bp 
Phe, anticodon GAA, 
(intron present 297,459 bp 
– 297,510 bp) 
tRNAscan-SE 
tRNA gene 11 299,090 bp -
299,176 bp 
Leu, anticodon CAA tRNAscan-SE 
tRNA gene 12 302,062 bp – 
302,132 bp 
Glu, anticodon TTC tRNAscan-SE 
tRNA gene 13 302,143 bp -
302,231 bp 
tRNA-Tyr(gta) ARAGORN 
tRNA gene 14 302,564 bp - 
302,654 bp 
 tRNA-Ser(tga) ARAGORN 
tRNA gene 15 302,662 bp - 
302,780 bp 
Ser, anticodon AGA (intron 
present 302,696 bp – 
302,744 bp) 
tRNAscan-SE 
tRNA gene 16 304, 228 bp – 
304,298 bp 
Ile, anticodon GAT tRNAscan-SE 
tRNA gene 16A 307,123 bp -
307,195 bp 
 tRNA-Asn(gtt) ARAGORN 
tRNA gene 17 307,717 bp – 
307,789 bp 
Gln, anticodon TTG tRNAscan-SE 
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tRNA gene 17A 308,195 bp -    
308,267 bp 
tRNA-Gly(tcc) ARAGORN 
tRNA gene 18 309,726 bp -
309,787 bp 
Asp, anticodon GTC tRNAscan-SE 
tRNA gene 19 310, 643 bp – 
310,718 bp 
Arg, anticodon ACG tRNAscan-SE 
tRNA gene 20 311,782 bp – 
311,853 bp 
Pro, anticodon TGG tRNAscan-SE 
tRNA gene 21 311,859 bp - 
311,931 bp 
Pro, anticodon TGG tRNAscan-SE 
tRNA gene 22 312,275 bp – 
312,348 bp 
His, anticodon GTG tRNAscan-SE 
tRNA gene 23 312, 637 bp – 
312,710 bp 
Phe, anticodon GAA tRNAscan-SE 
tRNA gene 24 313,823 bp – 
313,895 bp 
Lys, anticodon TTT tRNAscan-SE 
tRNA gene 25 318,802 bp – 
318,876 bp 
Cys, anticodon GCA tRNAscan-SE 
tRNA gene 26 319,754 bp – 
319,826 bp 
Met, anticodon CAT tRNAscan-SE 
tRNA gene 26A 320,334 bp-
320,411 bp 
tRNA-Met(cat) ARAGORN 
tRNA gene 27 320, 479 bp – 
320,511 bp 
Ala, anticondon TGC tRNAscan-SE 
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Table S6.4. Pectobacterium phage CBB tRNA genes and codon usage (CBB_1 - CBB_554)  
aa  Frequency Codon Occurrence Codon Freq. Freq./aa 
tRNA gene 
occurrence 
Ala 5.83% GCA 3058 2.86% 49.06% 1 
    GCC 313 0.29% 5.02%   
    GCG 584 0.55% 9.37%   
    GCT 2278 2.13% 36.55%   
Arg 4.09% CGA 380 0.36% 8.69%   
    CGC 432 0.40% 9.88%   
    CGG 130 0.12% 2.97%   
    CGT 2587 2.42% 59.17% 1 
    AGA 684 0.64% 15.65% 1 
    AGG 159 0.15% 3.64%   
Asm 6.16% AAC 2506 2.34% 38.06% 1 
    AAT 4079 3.81% 61.94%   
Asp 6.65% GAC 1525 1.43% 21.44% 1 
    GAT 5588 5.22% 78.56%   
Cys 1.14% TGC 287 0.27% 23.62% 1 
    TGT 928 0.87% 76.38%   
Gln 3.60% CAA 2750 2.57% 71.39% 1 
    CAG 1102 1.03% 28.61%   
Glu 7.35% GAA 6766 6.33% 86.13% 1 
    GAG 1090 1.02% 13.87%   
Gly 5.83% GGA 1316 1.23% 21.12% 1 
    GGC 565 0.53% 9.07%   
    GGG 336 0.31% 5.39%   
    GGT 4015 3.75% 64.43%   
His 1.97% CAC 593 0.55% 28.13% 1 
    CAT 1515 1.42% 71.87%   
Ile 6.88% ATA 1017 0.95% 13.83%   
    ATC 1620 1.51% 22.02% 1 
    ATT 4719 4.41% 64.15%   
Leu 7.75% CTA 1751 1.64% 21.13% 1 
    CTC 264 0.25% 3.19%   
    CTG 715 0.67% 8.63%   
    CTT 1750 1.64% 21.12%   
    TTA 2521 2.36% 30.43% 2 
    TTG 1284 1.20% 15.50% 1 
Lys 6.58% AAA 5314 4.97% 75.47% 1 
    AAG 1727 1.61% 24.53%   
Met 2.35% ATG 2512 2.35% 100.00% 3 
Phe 4.58% TTC 2109 1.97% 43.08% 2 
    TTT 2786 2.60% 56.92%   
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Pro 3.28% CCA 1951 1.82% 55.70% 2 
    CCC 86 0.08% 2.46%   
    CCG 329 0.31% 9.39%   
    CCT 1137 1.06% 32.46%   
Ser 6.63% TCA 1883 1.76% 26.54% 1 
    TCC 329 0.31% 4.64%   
    TCG 313 0.29% 4.41%   
    TCT 1836 1.72% 25.88% 1 
    AGC 544 0.51% 7.67% 1 
    AGT 2189 2.05% 30.86%   
Thr 6.41% ACA 2141 2.00% 31.23% 1 
    ACC 677 0.63% 9.87%   
    ACG 477 0.45% 6.96%   
    ACT 3561 3.33% 51.94%   
Trp 1.21% TGG 1289 1.21% 100.00% 1 
Tyr 4.89% TAC 1752 1.64% 33.53% 1 
    TAT 3473 3.25% 66.47%   
Val 6.85% GTA 3095 2.89% 42.22%   
    GTC 365 0.34% 4.98% 1 
    GTG 666 0.62% 9.08%   
    GTT 3205 3.00% 43.72% 1 
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Table S6.5. Quasicore proteins of the T4 like phage identified within the genome of Pectobacterium phage CBB with sequence comparison to homologs in 
Enterobacter phage T4 and Vibrio phage KVP40 (reference strains of T4virus and Schizot4virus, respectively) using BLASTP. 
Function T4 like core 
protein 
CBB homolog Accession no. 
of T4 protein 
Identity E-value Accession no. 
of KVP40 
Identity E-value 
DNA 
replication, 
repair and 
recombination 
gp49-
Endonclease 
VII 
CBB_288 NP_049692.1 30 3.01E-06 NP_899379.1 32 1.00E-11 
gp30 - DNA 
ligase 
CBB_100 NP_049813.1 30 1.00E-47 NP_899305.1 33 2.00E-63 
RNaseH CBB_172 NP_049859.1 29 1.00E-13 NP_899249.1 24 1.00E-13 
gp52- Type II 
DNA 
toppisomeras
e subunit 
CBB_325 NP_049875.1 27 1.00E-33 NP_899529.1 30 4.00E-42 
Dda- short 
range DNA 
helicase 
CBB_315 NP_049632.1 30 4.00E-30 NP_899402.1 28 1.18E+04 
Auxillary 
metabolism 
NrdG - subunit 
of anaerobic 
ribonucleotide 
reductase 
complex 
CBB_145 NP_049688.1 48 4.00E-51 NP_899263.1 43 3.00E-47 
cd - dCMP 
deaminase 
CBB_110 NP_049828.1 41 3.00E-38 NP_899367.1 39 1.00E-33 
Frd - 
Dihydrofolate 
reductase 
CBB_313 NP_049850.1 30 2.00E-13 NP_899254.1 36 6.00E-18 
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Td - 
thymidylate 
synthtase 
CBB_233 NP_049848.1 43 4.00E-18 NP_899279.1 34 2.00E-57 
Tk - thymidine 
kinase 
CBB_173 NP_049819.1 44 2.00E-51 NP_899436.1 46 3.00E-46 
gp1 - dDMP 
kinase 
CBB_203 NP_049852.1 29 3.00E-04 NP_899338.1 67 0.59 
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Table S6.6. Phage portal vertex proteins used for phylogenetic study of CBB and the GAP32-
like phage. 
The conserved region of CBB portal vertex protein used to construct the phylogenetic tree. 
 Sequence – 
DMQPHQAMAYVERVKNDIHQRRIPSNKGGSTSLMDAAYNPLSILEDYFFPQTAEGRGSSVETLPGGDNLG
QIDDLRYFNNKLIRGLQIPASYLPMGPDDGGVALFGDGATQAMASELRFNNECMRYQRIISRIFDEEFKRYM
IKNGYNISASSFEVTFNPPMNFAANRKAEMDAKLIQTYM 
Phage 
Portal vertex protein -  
Accession no. 
Enterobacteria_phage_IME08 YP_003734309.1 
Escherichia_phage_slur07 YP_009197287.1 
uncultured_Mediterranean_phage_uvMED BAR36277.1 
uncultured_Mediterranean_phage_uvMED(2) BAR31405.1 
uncultured_Mediterranean_phage_uvMED(3) BAR29473.1 
Synechococcus_phage_S-IOM18 YP_008126421.1 
Synechococcus_phage_S-RIM2_R1_1999 YP_007675582.1 
uncultured_Mediterranean_phage ANS04762.1 
Enterobacteria phage RB14 YP_002854503.1 
Aeromonas_phage_25 YP_656382.1 
Synechococcus_phage_metaG-MbCM1 YP_007001618.1 
Enterobacteria_phage_RB16 YP_003858509.1 
Aeromonas_phage_65  YP_004300925.1 
Aeromonas_phage_Aeh1 NP_944108.1 
Aeromonas_phage_PX29 YP_009011644.1 
Enterobacteria_phage_JS10 YP_002922513.1 
Aeromonas_phage_Aes508 YP_007010833.1 
uncultured Mediterranean phage ANS05306.1 
Cyanophage_P-RSM6 YP_007675137.1 
Escherichia_phage_ECML-134 YP_009102640.1 
Prochlorococcus_phage_P-SSM3 YP_008129949.1 
Shigella_phage_pSs-1  YP_009110988.1 
Enterobacteria_phage_QL01 YP_009202903.1 
Ralstonia_phage_RSP15 BAU39992.1 
uncultured_Mediterranean_phage ANS05306.1 
uncultured_Mediterranean_phage(2) ANS05306.1 
uncultured_Mediterranean_phage_uvMED BAR34134.1 
Cyanophage_P-RSM1  YP_007877738.1 
Cyanophage_Syn30 YP_007877943.1 
Escherichia_phage_121Q YP_009102185.1 
Synechococcus_phage_S-CAM8 YP_008125640.1 
Synechococcus_phage_S-RIM8_A.HR1 YP_007518198.1 
Synechococcus_phage_syn9 YP_717798.1 
Synechococcus_phage_S-CRM01  YP_004508471.1 
Synechococcus_phage_S-RSM4 YP_003097343.1 
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Cyanophage_S-RIM50 AMO42907.1 
Enterobacteria_phage_RB27 YP_009102372.1 
Enterobacteria_phage_RB3 YP_009102372.1 
Enterobacteria_phage_RB32 YP_803110.1 
Escherichia_phage_vB_EcoM-UFV13 ANA50202.1 
Salmonella_phage_STML-198 YP_009148150.1 
Shigella_phage_SHFML-11 ANN86599.1 
Aeromonas_phage_44RR2.8t NP_932511.1 
Cyanophage_P-TIM40 YP_009188207.1 
Cyanophage_S-RIM32 AMO43137.1 
Enterobacteria_phage_RB69 NP_861872.1 
Enterobacteria_phage_vB_EcoM_VR20 YP_009207360.1 
Enterobacteria_phage_vB_EcoM_VR5 YP_009205862.1 
Enterobacteria_phage_vB_KleM-RaK2 YP_007007244.1 
Escherichia_phage_APCEc01 YP_009225085.1 
Escherichia_phage_PBECO_4 SCA80472.1 
Escherichia_phage_vB_EcoM_JS09 YP_009030623.1 
Aeromonas_phage_CC2 YP_007010339.1 
Cronobacter_phage_vB_CsaM_GAP32 YP_006987350.1 
Edwardsiella_phage_PEi20 YP_009190346.1 
Enterobacteria_phage_Bp7 YP_007004276.1 
Enterobacteria_phage_JSE YP_002922232.1 
Escherichia_phage_e11/2 YP_009030776.1 
Escherichia_phage_UFV-AREG1 ANH50304.1 
Escherichia_phage_vB_EcoM_PhAPEC2 YP_009056756.1 
Pelagibacter_phage_HTVC008M YP_007517949.1 
Prochlorococcus_phage_P-HM1  YP_004322541.1 
Prochlorococcus_phage_P-HM2 YP_004323487.1 
Prochlorococcus_phage_P-RSM4 YP_004323264.1 
Prochlorococcus_phage_P-SSM2 YP_214363.1 
Prochlorococcus_phage_P-SSM4 YP_214665.1 
Prochlorococcus_phage_P-SSM7 YP_004324951.1 
Prochlorococcus_phage_Syn33 YP_004323727.1 
Sinorhizobium_phage_phiM12 YP_009142980.1 
Sinorhizobium_phage_phiN3  YP_009212309.1 
Synechococcus_phage_S-PM2  YP_195138.1 
Synechococcus_phage_S-ShM2 YP_004322786.1 
Synechococcus_phage_S-SM1 YP_004323020.1 
Synechococcus_phage_S-SSM5 YP_004324725.1 
Synechococcus_phage_S-SSM7 YP_004324197.1 
Vibrio_phage_KVP40 BAA77377.1 
Vibrio_phage_nt-1 YP_008125180.1 
Yersinia_phage_PST YP_009153767.1 
Prochlorococcus_phage_MED4-213 YP_007673752.1 
Salmonella_phage_S16 YP_007501199.1 
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Salmonella_phage_vB_SnwM_CGG4-1 ANA49508.1 
Synechococcus_phage_ACG-2014a  AIX28031.1 
Synechococcus_phage_ACG-2014b YP_009140680.1 
Synechococcus_phage_ACG-2014d AIX21202.1 
Synechococcus_phage_ACG-2014e YP_009134611.1 
Synechococcus_phage_ACG-2014f AIX42351.1 
Synechococcus_phage_ACG-2014g YP_009133666.1 
Synechococcus_phage_ACG-2014h YP_009008243.1 
Synechococcus_phage_ACG-2014i YP_009140894.1 
Synechococcus_phage_ACG-2014j  YP_009134101.1 
Synechococcus_phage_S-MbCM100 YP_009007965.1 
Shigella_phage_Shfl2 YP_004415062.1 
Escherichia_phage_HY03 AKJ72700.1 
Vibrio_phage_VH7D YP_009006286.1 
uncultured_phage_MedDCM-OCT-S09-C7 ADD95604.1 
Aeromonas_phage_phiAS4 YP_003969129.1 
Aeromonas_phage_phiAS5 YP_003969303.1 
Klebsiella phage vB_KpnM_KpV477 ANT40618.1 
Klebsiella phage JD18 YP_009190743.1 
Enterobacteria phage T4 NP_049782.1 
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Figure S6.1. Maximum likelihood tree created from the alignment of the major capsid protein 
of 100 homologous sequences from different T4-like phages to that of the major capsid 
protein of phage CBB found using a BLASTP search. 100 bootstrap replicates were conducted. 
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Table S6.7. Promoter 1 of Phage CBB found using MEME 
 
 
 
 
 
 
 
 
 
Promoter location Sequence 
Porf_36 13,365-13,402 AAAAATAGCTTGCATCACTCGTAATTATGAAGTATAAT 
Porf_41 15,759-15,796 AAAAAGGAGTTGACAACAGTTGGCTCCTTTGCTATACT 
Porf_44 17,515-17,552 AAAAATTCCCTTGCTTTCTTTCTTTCGTGTGGTATACT 
Porf_83 39,070-39,107 AATACTGACTTGACACGAGGCAGCAAGAGTGTTACAAT 
Porf_166 93,493-93,530 AAAAATAGCTTGATTTTGAGCTACATAATTGATATAAT 
Porf_181 100,667`-100,704 ACAAATTGCTTGACATGGCAGTGAGTATCATATATCAT 
Porf_189 106,894-106,931 GAATAAACCTTGACAGTACGATAAAAAAGTGCTACATT 
Porf_360 262,781-262,818 AAATTTACCTTGACAAAATCAACTCCATCCCTGATAAT 
Porf_395 281,079-281,116 AAAAATGACTTGGCAGGAGATTAATATTCCTGTACAAT 
Porf_436 296,151-296,188 TAAAAATCCTTGACTTGCGTCGGTTGACCTGATAGAAT 
Porf_491 319,303-319,340 CAAAACACCTTGACAGTGGCATCCTCTCATGGCAAAAT 
Porf_497 323,285-323,322 AGATTTTGCTTGACAAGACGGCATTTTTTGTTTATAAT 
Porf_503 326,287-326,324 AAATACCAGTTGACTCAACGTGGGTTAACTGGTATACT 
Porf_510 329,125-329,162 AATTTGGCCTTGCAATCAGCGAACGCATGTGATATATT 
Porf_524 336,865-336,902 AGAAAATCCTTGACTTGCTTCAGCAAGGCGAGTACACT 
Porf_525 337,752-337,789 AAAAATACATTGACGTGGCACATTTTTTGTGCCATAAT 
Porf_538 345,724-345,761 TATTTAGGCTTGACACGATGTTAAATCTTTGATATAAT 
Porf_546 349,130-349,167 TAATTTGGCTTGACTTAGGCTTTCGAACTCCGTATAAT 
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Table S6.8. Promoter 2 of Phage CBB found using MEME 
 
 
 
 
 
 
 
 
Promoter Location Sequence 
Porf_66 29,539-29,567 TGAAACAGAATAATTTTTTATGGTATAAT 
Porf_113 54,897-54,925 TGAAACGTAAGGAATTTTTCTGCTATAAT 
Porf_193 108,832-108,860 TGAAACAGCTTTAAAAATTATGGTATAGT 
Porf_218 127,475-127,503 TGAAACGTACCAAAATTTTATGGTATAAT 
Porf_235 145,858-145,886 TGGAACGACCTAAAAAAATGTGCTATAAT 
Porf_244 168,994-169,022 TGGAACGTTTTTTAAAATTGTGGTATAAT 
Porf_258 184,600-184,628 TGAAACGTATACATTTATTATGGTATAAT 
Porf_262 187,472-187,500 TGAAACGAAAATAAAACGTATGATATAAT 
Porf_265 191,483-191,511 TGAAACGGGTACATTTTTTATGATATAAT 
Porf_272 195,587-195,615 TGAAACTGCACATAAAAATGTGGTATAAT 
Porf_282 206,162-206,190 TGGAATGAGTTAAATTTTTGTGATATAAT 
Porf_290 211,052-211,080 TGGAATGCATTAAAAAAATGTGGTATAAT 
Porf_300 217,526-217,554 TGAAACAATAAAAAAACATGTGCTATAAT 
Porf_307 224,015-224,043 TGAAACGCCAAAATAAAATATGGTATAAT 
Porf_312 226,886-226,914 TGAAACAGCTTGGAATATTATGATATAAT 
Porf_324 236,752-236,780 TGAAACAAAGAAACAAATTATGCTATAAT 
Porf_329 243,482-243,510 TGAAATGGTAAAAAAAATTATGGTATAAT 
Porf_418 289,731-289,759 TGAAACGGCGATAAAAACTGTGGTATAAT 
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Table S6.9. Promoter 3 of Phage CBB found using MEME based on analysis of 100bps upstream 
regions of structural genes 
 
Promoter Location  Sequence 
Porf_112 54,769-54,782 ATAAATATTAATAT 
Porf_165 93,137-93,150 ATGAATACCGCAAA 
Porf_169 95,252-95,265 CTAAATACGGTATC 
Porf_201 111,914-111,927 CTAAATATGATATA 
Porf_204 133,744-113,757 ATAAATAACATTAT 
Porf_205 116,515-116528 ATAAATACATTAAA 
Porf_206 177,288-117,301 CTAAATATAATATA 
Porf_210 120,228-120,241 ATAAATAAAATAAA 
Porf_213 122,794-122,807 CTAAATTCATTAAA 
Porf_224 132,558-132,571 ATAAATACTGGATA  
Porf_226 137,986-137,999  ATAAATACTTGAAA 
Porf_227 138,970-138,983 ATAAATATAAGAAA 
Porf_228 140,195-140,208 ATAAATATTTGTAA 
Porf_229 140,234-140,247 ATAAATAAGTAAAA  
Porf_234 145,841-145,854 ATAAATACGGTATA 
Porf_236 158,306-158,319 ATAAATAAAACAAA 
Porf_237 161,845-161,858 ATAAATATTTCTAT 
Porf_239 162,810-162,823 ATAAATACTTATAC  
Porf_243 168,976-168,989 ATAAATACTTGATA 
Porf_250 176,224-176,237 ATAAATAACTAATA 
Porf_251 176,198-176211 ATAAATACGACTAT 
Porf_256 182,056-182,069 ATAAATATCTTTAC 
Porf_260 185,404-185,417 ATAAATATTTCTAT 
Porf_271 195,498-195,511 ATAAATAACATTAA 
Porf_276 199,519-199,532 ATAAATATATCTAT 
Porf_289 210,031-210,044 ATAAATATTGTATA 
Porf_298 216,496-216,509 CTAAATAAGGATAT 
Porf_302 218,818-218,831 CTAAATAATTCTAT 
Porf_320 231,630-231,643 ATAAATACTCAAAA  
Porf_496 323,194-323,207 ATAAATACTTTATA  
Porf_534 343,023-343,036 ATAAATAAATGAAA 
Porf_537 345,717-345,730 CTAAATAATTAATA 
Porf_551 353,119-353,132 CTAAATTTTACAAA 
Porf_552 353,975-353,988 GTAAATACATAATA 
Porf_553 354,727-354,740 GTAAATACAGGATA 
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Table S7.10. Terminators of Phage CBB detected using ARNold and confirmed using Mfold Quikfold 
Terminator Coordinates Sequence ΔG kcal/mol 
Torf8  3,939-3,974 GGGGGAACATGAAAGTTCCCCTgTTTTTTTCCTTGA -13.8 
Torf18  7,952 - 7,980  GGGGAACATTGTTCCCCTTTTTAAGTGAG -10.9 
Torf26  10,171 - 10,208 AGTACTGGTGAAATATCCAGTACTgTTTTTATGTACAG -11.4 
Torf39 15,175 - 15,205 AGGTTGACTTCGGTCGGCCTtTTTTGTTATACTT -11.8 
Torf47  19,234 - 19,268  GGGCAACCAAATAACGGTTGCCCTTTTTTGTATTC -15.3 
Torf52  22,047 - 22, 081  GCCGCTGTCATAATGACGGCGGCTTACTTTATGGG -18 
Torf67 30,374 - 30,401 GGGGCTTAATTGCCCCTTTTCTATAGGA -11.1 
Torf70 32,322 - 32, 354 GGACGGTACAGTGTATCGTCCTTTTTTAATTGA -12.2 
Torf80 38,447 - 38,475 GCCCCGAAATTCGGGGCTTTCTTTTTAAA -13.4 
Torf87 41,945 - 41,972 GGGATACTTCGGTATCCCTTCTTTTTTAAT -14 
Torf106 51,742- 51,774 AGGCCACTTAGTTGTGGCCTTTTTCTTTTAAGG -12.6 
Torf111 54,040 - 54,067 GGAGCCATATGGCTCCTTTTTTATTTTA -11.9 
Torf113 56,086 - 56, 116 GGAGTACTTCGGTACTCCaTTTTAAGTAAGA -14.4 
Torf123 63,856 - 63, 887 GGGGATACTTAGGTATCCCCTTTTTAATTGGA -14.3 
Torf124 64,214 - 64,242 GGCCACGCAATGTGGCCTTTTTTATTGGA -11 
Torf146 76-523 - 76,553 AGCACCTGCAAGGGTGCTTTTTTTGTTTATA -10 
Torf149 84,839 - 84, 869  AGCGGTCACTTGACCGCTTTTTTCTTTTGTG -11.6 
Torf152 86,569 - 86,596 GGGAGTGTTAGCTCCCTTTTACATTTCA -10 
Torf163 92,758 - 92, 787 CCCGTCATAAATGGCGGGTTTTCTATTAAA -10.4 
Torf165 93,533 - 93,565 AGGAAATCGTGAGATTTCCTTTTTTCGTTTGGA -12.3 
Torf173 97,558 - 97,590 TGGGCTGATATAATCAGTCCATATTTTTATGGG -11 
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Torf183 104,263 - 104, 292 GCCTCACTCCGGTGGGGCTTTTTCATTTAA -12 
Torf188 106,936 - 106, 971 GGACAGGCAGCGATGCTCTGTCCTTTTTTATTTTAA -13.8 
Torf197 110,637 - 110, 666 GGGCATCTTAGGATGCCCTTTTTTCAATTG -13 
Torf202 113,016 - 113,052 GGAAGAATCTTAATAGGGTTCTTCCTTTTTTCGTTTA -13.2 
Torf204 116,418 - 116,485 GGAGCCATATGGCTCCTTTTTTGTTTTC -11.9 
Torf205 117,258 - 117, 289 GCCCTGGACTTGTCTAGGGCTTTTTTATTGCT -14.7 
Torf215 124,614 - 124, 647 AGCACTGAAAACTCAGTGCTtTTCTTTTTATCAA -10.9 
Torf216 126, 042 - 126, 072 AGGGGCATTATGCCCCTtTTGTTTTATGAGG -11.2 
Torf224 
130,573 - 130,603 
(complement) AGGGAGCTTTTGCTCCCTTTCTTTTTACACC -12.6 
Torf223 130,586 - 130, 616 AGGGAGCAAAAGCTCCCTTTTTTTGTTATTG -12.1 
Torf225 132,578 - 132, 611 AGGTCAACTTATGTTGGCCTtTTGTTTTTTGTAG -10.6 
Torf228 
138, 985 - 139, 017 
(complement) AGGGAGATACTTATCTCCCTTTTTTCATTGTGA -11.2 
Torf236 
148, 214 - 148, 255 
(complement) GGGAGCCATATGGCTCCCTTTTTCTTTATTT -15.2 
Torf235 148,227 - 148, 256 GGGAGCCATATGGCTCCCTTTTTTGTTATA -15.2 
Torf237 
158,318 - 158, 348 
(complement) GGGCATCTTCGGATGCCCTTTATTCTTGCAT -16 
Torf246 173, 110 - 173, 140 AGGAGCCATTAGGCTCCTTTTTTTATGATAT 12.1 
Torf247 
173, 095 - 173, 128 
(complement) AAGGAGCCTAATGGCTCCTTtTTGTTTATAGGTC 13.5 
Torf257 184, 538 - 184, 566 GGACGCTTTATGCGTCCTTTTCGCATTTC -11.3 
Torf261 187,504 - 187, 543 GGCATCCTAGCGGAGAGTTAGGATGCTTTTTTTATACATG -17.1 
Torf262 187,863 - 187, 892 TGCCCCAGGATTGGGGCGTTTTGTTTTAAG -11.6 
Torf265 192,281 - 192, 313 AGGGAGCGTAATGCTCCCTcTTTTTATTTGGAT -11.7 
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Torf269 194, 180 - 194, 209 GGAGAACATATGTTCTCCTTTTTCTTTTTT -10.7 
Torf270 
174, 166 - 194, 198 
(complement) AGGAGAACATATGTTCTCCTTTTTTTATTACTC  -11.2 
Torf277 202, 130 - 202, 164 TTGGGGCAACGGATTTGCCCCGATTTCATTTCATG -13.7 
Torf279 203, 777 - 203, 808 AGGACGCTTATTGCGTCCTTTTTGTTTTTTAG -11.8 
Torf303 221, 845 - 221, 873 TCCCGTCTATGACGGGATTTTTTATCAGG -10.4 
Torf305 223,790 - 223, 816 GGAGGCTTTGCCTCCTTTTTCATGGAT -10 
Torf310 
225,406 - 225, 434 
(complement) GGGAGCTTACGCTCCCTTTTTTATGCATT -11.5 
Torf323 236,722 - 236, 757 TAACGACGCTCCAGAGCGTCGTTATTTTTTTGAAAC -15 
Torf325 240,252 - 240,279 GGACGCATAAAGCGTCCTTTATTTTTAAT -10.8 
Torf330 244,250 - 244, 279 GCCCTGCATTGTCAGGGCTTTCTTTTTGTC -10.5 
Torf333 246,154 - 246, 182 AGGGGAGTAATCCCCTTTTCCGTTTAGTA -11 
Torf338 249,187 - 249, 219 TGGGGAATGAAAGTTCCCCGcTTTTTAATTTAA -13.5 
Torf340 251, 689 - 251, 720 AGCTCCCAACACTTGGGGGCTTTTTTCATATG -12.1 
Torf344 254, 455 - 254, 489 AGCTGGCCTTAGTTGGTCAGCTTTTTTAAGTAAGA -13.2 
Torf364 265, 682 - 265, 712 CCCTGTACTAAGTACAGGGTTTTTAATTGAG -11.4 
Torf446 300, 688 - 300, 723 TGCCGCCAACATTGTTGGCGGTAcTTTTAAGTTAGA -15.4 
Torf448 301, 467 - 301, 490 GGGCGAAAGCCCTTTTTTAATTGA -10.8 
Torf468 311, 288 - 311, 323 GGGATTTTCCGTAAGGGAAATCCCTTTTTTCGTTTA -17.8 
Torf488 318, 141 - 318, 173 AGGGAGCGGATTGCTCCCTgTTTTATAATGCAT -12.3 
Torf494 321, 450 - 321, 478 GGCAGCCATTGGCTGCCTTTTTTCGTTTA -13.1 
Torf495 322, 016 - 322, 046  GGCACTCATAAAGAGTGCCTTTTGTTTTACG -12.6 
Torf496 
322,001 - 322, 035 
(complement) AGGCACTCTTTATGAGTGCCTtTTTTTCTTGTATA -13.6 
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Torf500 325, 314 - 325, 350 TTCGGGGATTAACTATCCCCGAAacTTTTAATGGTGA -14.6 
Torf515 333, 025 - 333, 050 GGGTTGACTTCGGTCAGCCCTTTATTTTAATT -16.8 
Torf518 334,640 - 334, 671 GGGTTGACTTCGGTCAGCCCTTTTTTGTATAA -16.8 
Torf520 335, 395 - 335, 426 GGGTTGACTTCGGTCAGCCCTTTTTGCTATAC -16.8 
Torf525 338, 856 - 338, 888 TGCCAAACATCGTGTTTGGCATTTTTTATTAAA -11.2 
Torf542 348,061 - 348, 089 ACTCCCTACGGGGAGTTTTTTATTGAGGC -11.6 
Torf546 349, 505 - 349, 535 CCGCCAGCATTGTTGGCGGTTTTTTAATTGC -12.5 
Torf547 350, 176 - 350, 206 AAGCCCCAAAAGGGGCTTTTTTAATTTGTGA -11.8 
Torf548 350,166 - 350, 191 GCCCCAAAAGGGGCTTTTTTAATTTG -10.4 
Torf553 
353, 992 - 354, 024 
(complement) AGCTCAACTTAGGTTGGGCTTTTTCTGTTTTTG -10.1 
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Table S7.11. Comparison of identified structural proteins of phages CBB, to those identified for Gap32 (Abbasifar, et al. 2014) and RaK2 (Šimoliūnas 
et al 2014) 
CBB ORFs GAP32 ORFs Rak2 ORFs CBB-MS 
detected 
GAP32-MS 
detected 
Rak2-MS 
detected 
_ hypothetical protein 
GAP32_001  
_   yes   
structural protein 
CBB_029/ CBB_582 
hypothetical protein 
GAP32_025  
_ yes yes   
structural protein 
CBB_038/CBB_591 
hypothetical protein 
GAP32_032  
hypothetical protein 
ORF275 
yes yes yes 
ATP-dependent Clp 
protease proteolytic 
subunit CBB_104 
ATP-dependent Clp 
protease proteolytic 
subunit GAP32_103 
putative ATP-dependent 
Clp protease proteolytic 
subunit RaK2_00489 
yes     
_   hypothetical protein 
ORF493  
    yes 
major tail protein 
CBB_112 
Ig domain-containing 
protein GAP32_111 
putative structural protein 
ORF496 
yes yes yes 
putative membrane 
protein CBB_118 
hypothetical protein 
GAP32_118  
_ yes yes   
PhoH family protein 
CBB_123 
PhoH family protein 
GAP32_122 
hypothetical protein 
ORF506 
    yes 
_   hypothetical protein 
ORF526w 
    yes 
_   putative tail fibre protein 
ORF527w 
    yes 
_   tail fibre fragment 
ORF528w 
    yes 
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_   hypothetical protein 
ORF529 
    yes 
_   hypothetical 
protein, ORF530w 
    yes 
_   hypothetical protein, 
ORF531w 
    yes 
_   tail spike protein ORF532     yes 
_   hypothetical protein 
ORF533 
    yes 
_   hypothetical protein 
ORF534 
    yes 
hypothetical protein 
CBB_144 
_ _ yes     
hypothetical protein 
CBB_148 
putative membrane 
protein GAP32_144  
_   yes   
structural protein 
CBB_149 
hypothetical protein 
GAP32_145  
_   yes   
putative membrane 
protein CBB_164 
putative membrane 
protein GAP32_160 
hypothetical protein 
ORF010 
    yes 
hypothetical protein 
CBB_165 
hypothetical protein 
GAP32_161  
hypothetical protein 
ORF011 
    yes 
conserved hypothetical 
protein CBB_169 
hypothetical protein 
GAP32_165  
hypothetical protein 
RaK2_00015  
yes     
conserved hypothetical 
protein CBB_183 
hypothetical protein 
GAP32_176  
_ yes     
neck protein CBB_201 neck protein 
GAP32_195 
hypothetical protein 
ORF038 
yes   yes 
tail sheath monomer tail sheath monomer hypothetical protein   yes yes 
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CBB_204 GAP32_198 ORF041 
structural protein 
CBB_205 
hypothetical protein 
GAP32_199  
hypothetical protein 
ORF042 
yes yes yes 
structural protein 
CBB_206 
hypothetical protein 
GAP32_200  
hypothetical protein 
ORF043 
  yes yes 
conserved hypothetical 
protein CBB_207 
hypothetical protein 
GAP32_201  
RaK2_00044  yes     
head completion 
protein CBB_208 
head completion 
protein GAP32_202 
head completion protein 
RaK2_0004 
      
structural protein 
CBB_210 
hypothetical protein 
GAP32_204  
hypothetical protein 
ORF047 
yes yes yes 
structural protein 
CBB_211 
hypothetical protein 
GAP32_205  
hypothetical protein 
ORF048 
  yes yes 
structural protein 
CBB_212 
hypothetical protein 
GAP32_206  
hypothetical protein 
ORF049 
  yes yes 
conserved hypothetical 
protein CBB_213 
hypothetical protein 
GAP32_207  
hypothetical protein 
ORF050 
yes   yes 
conserved hypothetical 
protein CBB_214 
hypothetical protein 
GAP32_208  
hypothetical protein 
ORF051 
yes   yes 
structural protein 
CBB_224 
hypothetical protein 
GAP32_218  
hypothetical protein 
ORF060w 
yes yes yes 
structural protein 
CBB_225 
hypothetical protein 
GAP32_219  
_ yes yes   
long tail fibre proximal 
subunit CBB_226 
long tail fibre proximal 
subunit  
GAP32_220 
_ yes yes   
structural protein 
CBB_227 
hypothetical protein 
GAP32_221  
hypothetical protein 
ORF061w 
yes yes yes 
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structural protein 
CBB_228 
hypothetical protein 
GAP32_222  
hypothetical protein 
RaK2_00062  
yes yes   
structural protein 
CBB_229 
hypothetical protein 
GAP32_223  
hypothetical protein 
ORF063 
  yes yes 
structural protein 
CBB_230 
hypothetical protein 
GAP32_224  
hypothetical protein 
RaK2_00064  
yes yes   
structural protein 
CBB_231 
hypothetical protein 
GAP32_225  
hypothetical protein 
ORF065 
yes yes yes 
tail sheath stabilizer 
and completion protein 
CBB_233 
tail sheath stabilizer and 
completion protein 
GAP32_227 
hypothetical protein 
RaK2_00067  
yes yes   
structural protein 
CBB_234 
hypothetical protein 
GAP32_228  
hypothetical protein 
ORF068w 
yes yes yes 
structural protein 
CBB_236 
hypothetical protein 
GAP32_230  
hypothetical protein 
ORF070w 
yes yes yes 
baseplate wedge 
CBB_237 
baseplate wedge 
GAP32_232 
hypothetical protein 
ORF071w 
yes yes yes 
base plate protein 
CBB_238 
base plate protein 
GAP32_232 
hypothetical protein 
ORF072w 
  yes yes 
baseplate hub subunit 
and tail lysozyme 
CBB_239 
subunit and tail 
lysozyme GAP32_233 
T4-like lysozyme ORF073w       
baseplate hub subunit 
and tail lysozyme 
CBB_240 
baseplate hub subunit 
and tail lysozyme 
GAP32_234 
putative virion protein and 
lysozyme murein 
RaK2_00078  
yes yes   
conserved hypothetical 
protein CBB_241 
hypothetical protein 
GAP32_235  
hypothetical protein 
ORF079w 
yes   yes 
baseplate wedge hypothetical protein hypothetical protein yes     
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protein CBB_242 GAP32_236  ORF080w 
conserved hypothetical 
protein CBB_243 
hypothetical protein 
GAP32_237  
hypothetical protein 
ORF081 
yes yes yes 
hypothetical protein 
CBB_247 
_ _ yes     
hypothetical protein 
CBB_250 
hypothetical protein 
GAP32_243  
baseplate hub subunit 
ORF087 
    yes 
structural protein 
CBB_251 
hypothetical protein 
GAP32_244  
hypothetical protein 
ORF088 
yes yes   
portal vertex protein of 
head CBB_252 
portal vertex protein of 
head GAP32_245 
portal vertex protein 
ORF089 
  yes yes 
conserved hypothetical 
protein CBB_254 
hypothetical protein 
GAP32_247  
hypothetical protein 
ORF091 
yes   yes 
prohead core scaffold 
and protease CBB_255 
prohead core scaffold 
and protease 
GAP32_248 
prohead core scaffolding 
protein and protease 
ORF092 
  yes yes 
conserved hypothetical 
protein CBB_256 
hypothetical protein 
GAP32_249  
hypothetical protein 
ORF093 
yes     
precursor of major 
head subunit CBB_257 
precursor of major head 
subunit GAP32_250 
major capsid protein 
ORF094 
yes yes yes 
putative tail fibre 
protein CBB_260 
putative tail fibre 
protein GAP32_254 
hypothetical protein 
ORF098 
yes yes yes 
tail fibre assembly 
protein CBB_261 
tail fibre assembly 
protein GAP32_255 
_       
hypothetical protein 
CBB_269 
hypothetical protein 
GAP32_263  
hypothetical protein 
ORF105 
    yes 
structural protein 
CBB_270 
hypothetical protein 
GAP32_264  
hypothetical protein 
ORF106w 
yes yes yes 
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structural protein 
CBB_271 
hypothetical protein 
GAP32_265  
hypothetical protein 
ORF107w 
yes yes yes 
conserved hypothetical 
protein CBB_276 
hypothetical protein 
GAP32_270  
hypothetical protein 
ORF112 
yes     
ssDNA binding protein 
CBB_277 
ssDNA binding protein 
GAP32_271 
hypothetical protein 
ORF113 
    yes 
S-adenosyl-L-
methionine-dependent 
methyltransferase 
CBB_286 
hypothetical protein 
GAP32_281  
hypothetical protein 
ORF123 
yes     
structural protein 
CBB_289 
hypothetical protein 
GAP32_284  
hypothetical protein 
ORF126 
  yes   
conserved hypothetical 
protein CBB_292 
hypothetical protein 
GAP32_287  
hypothetical protein 
ORF129 
yes     
conserved hypothetical 
protein CBB_294 
hypothetical protein 
GAP32_289 
hypothetical protein 
ORF131 
yes     
structural protein 
CBB_298 
hypothetical protein 
GAP32_293  
hypothetical protein 
ORF135 
yes yes yes 
conserved hypothetical 
protein CBB_299 
hypothetical protein 
GAP32_294  
 hypothetical protein 
ORF136 
yes     
structural protein 
CBB_302 
hypothetical protein 
GAP32_297  
hypothetical protein 
ORF139 
  yes yes 
hypothetical protein 
CBB_308 
hypothetical protein 
GAP32_303  
hypothetical protein 
ORF143 
    yes 
putative membrane 
protein CBB_310 
hypothetical protein 
GAP32_305  
hypothetical protein 
ORF145w 
    yes 
structural protein 
CBB_316 
hypothetical protein 
GAP32_311  
hypothetical protein 
ORF151 
  yes yes 
 
 
297 
 
conserved hypothetical 
protein CBB_320 
hypothetical protein 
GAP32_315  
hypothetical protein 
RaK2_00155  
yes yes   
structural protein 
CBB_321 
hypothetical protein 
GAP32_316  
_   yes   
structural protein 
CBB_322 
hypothetical protein 
GAP32_317  
hypothetical protein 
ORF156 
yes yes yes 
structural protein 
CBB_326 
hypothetical protein 
GAP32_321  
hypothetical protein 
ORF160 
  yes yes 
conserved hypothetical 
protein CBB_334 
hypothetical protein 
GAP32_329  
hypothetical protein 
ORF168 
yes     
structural protein 
CBB_335 
hypothetical protein 
GAP32_330  
hypothetical protein 
ORF169 
  yes   
structural protein 
CBB_344 
hypothetical protein 
GAP32_339  
hypothetical protein 
ORF175 
  yes yes 
hypothetical protein 
CBB_370 
_ hypothetical protein 
ORF182 
    yes 
conserved hypothetical 
protein CBB_494 
hypothetical protein 
GAP32_473  
hypothetical protein 
ORF233 
yes   yes 
structural protein 
CBB_496 
hypothetical protein 
GAP32_475  
putative structural protein 
RaK2_00496 
yes yes   
structural protein 
CBB_534 
hypothetical protein 
GAP32_515  
_   yes   
hypothetical protein 
CBB_536 
_ _ yes     
hypothetical protein 
CBB_537 
_ _ yes     
structural protein 
CBB_548 
hypothetical protein 
GAP32_530  
_ yes yes   
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structural protein 
CBB_549 
hypothetical protein 
GAP32_531  
_ yes yes   
laminin_G_3 family 
protein CBB_551 
_ _ yes     
kelch-like protein 
CBB_552 
_ _ yes     
conserved hypothetical 
protein CBB_553 
hypothetical protein 
GAP32_002  
_ yes     
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Table S7.1. Genomic annotation of Erwinia phage Y3 
ORF  Start 
(bp) 
End 
(bp) 
Length 
(aa) 
Molecular 
weight (kDa) 
Function 
Y3_001 1 1497 498 56.32 replicative DNA helicase (DnaB) 
Y3_002 1507 1767 86 10 hypothetical protein 
Y3_003 1748 2551 267 30.28 hypothetical protein 
Y3_004 2538 5369 943 105.71 putative terminase 
Y3_005 5416 5628 70 7.65 hypothetical protein 
Y3_006 5636 7576 646 72.53 putative portal protein 
Y3_007 7621 7914 97 10.75 hypothetical protein 
Y3_008 7911 8294 127 13.92 hypothetical protein 
Y3_009 8338 8460 40 4.52 hypothetical protein 
Y3_010 8457 8945 162 18.33 hypothetical protein 
Y3_011 9002 9973 323 36.76 DNA polymerase I  
Y3_012 9983 10498 171 19.38 hypothetical protein 
Y3_013 10498 11082 194 21.81 ADP-ribose-binding protein 
Y3_014 11098 11430 110 12.36 hypothetical protein 
Y3_015 11437 12189 250 28.48 putative membrane protein 
Y3_016 12201 12590 129 14.77 hypothetical protein 
Y3_017 12641 13411 256 28.9 carboxy-S-adenosyl-L-methionine 
synthase 
Y3_018 13437 14309 290 32.85 asparagine synthase  
Y3_019 14376 14525 49 5.19 hypothetical protein 
Y3_020 14594 15232 212 24.2 oxygenase 
Y3_021 15324 15932 202 22.34 hypothetical protein 
Y3_022 15943 16206 87 9.71 hypothetical protein 
Y3_023 16215 16670 151 17.1 hypothetical protein 
Y3_024 16685 16936 83 9.81 putative DNA primase 
Y3_025 16902 17183 93 10.23 hypothetical protein 
Y3_026 17186 17608 140 15.78 hypothetical protein 
Y3_027 17605 17997 130 14.6 hypothetical protein 
Y3_028 18007 18426 139 15.87 hypothetical protein 
Y3_029 18608 19450 280 32.39 DNA adenine methylase 
Y3_030 19460 20170 236 27.14 hypothetical protein 
Y3_031 20178 20549 123 13.85 AntA/AntB antirepressor domain-
containing protein 
Y3_032 20551 21201 216 24.87 hypothetical protein 
Y3_033 21203 21718 171 19.52 hypothetical protein 
Y3_034 21687 22103 138 16.29 hypothetical protein 
Y3_035 22088 22606 172 18.98 CMP deaminase 
Y3_036 22713 23390 225 25.08 hypothetical protein 
Y3_037 23399 23878 159 17.31 hypothetical protein 
Y3_038 23878 24033 51 5.46 hypothetical protein 
Y3_039 24082 24543 153 17.31 hypothetical protein 
Y3_040 24521 25051 176 19.9 hypothetical protein 
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Y3_041 25032 25706 224 25.91 putative membrane protein 
Y3_042 25699 26013 104 12.17 hypothetical protein 
Y3_043 25997 26332 111 12.92 hypothetical protein 
Y3_044 26329 26634 101 11.38 hypothetical protein 
Y3_045 26646 27746 366 42.02 Thymidylate synthase 
Y3_046 27743 28390 215 24.63 hypothetical protein 
Y3_047 28390 29271 293 33.81 hypothetical protein 
Y3_048 29321 29656 111 12.82 hypothetical protein 
Y3_049 29703 30407 234 25.35 putative transcriptional repressor 
protein 
Y3_050 30409 32538 709 79.84 C-5 cytosine methyltransferase 
Y3_051 32684 33256 190 21.71 hypothetical protein 
Y3_052 33256 33453 65 7.38 putative membrane protein 
Y3_053 33696 33574 40 4.54 hypothetical protein 
Y3_054 33753 34154 133 15.12 hypothetical protein 
Y3_055 34215 34952 245 27.39 hypothetical protein 
Y3_056 35021 35359 112 12.73 hypothetical protein 
Y3_057 35310 35759 149 16.04 hypothetical protein 
Y3_058 35780 36064 94 11.32 hypothetical protein 
Y3_059 36201 36725 174 20.32 hypothetical protein 
Y3_060 36722 37123 133 15 ASCH domain-containing protein  
Y3_061 37120 37755 211 23.89 hypothetical protein 
Y3_062 38306 38716 136 15.69 hypothetical protein 
Y3_063 38732 38962 76 8.38 putative membrane protein 
Y3_064 38959 39078 39 4.22 putative membrane protein 
Y3_065 39075 39587 170 19.5 hypothetical protein 
Y3_066 39577 40257 226 25.11 GTP pyrophosphokinase 
Y3_067 40229 40579 116 13.46 hypothetical protein 
Y3_068 40548 40934 128 14.88 hypothetical protein 
Y3_069 40897 41514 205 23.36 hypothetical protein 
Y3_070 41511 41849 112 13.24 hypothetical protein 
Y3_071 42000 42338 112 12.87 hypothetical protein 
Y3_072 42355 43011 218 24.83 hypothetical protein 
Y3_073 43072 43767 231 24.67 hypothetical protein 
Y3_074 43767 44588 273 30.34 hypothetical protein 
Y3_075 45113 44649 154 17.24 putative lipoprotein 
Y3_076 45403 45110 97 10.87 hypothetical protein 
Y3_077 45721 45416 101 11.3 putative membrane protein 
Y3_078 46017 45778 79 9.17 hypothetical protein 
Y3_079 46650 46051 199 20.94 hypothetical protein 
Y3_080 47516 46650 288 31.12 hypothetical protein 
Y3_081 48062 47526 178 18.7 hypothetical protein 
Y3_082 49054 48062 330 35.24 hypothetical protein 
Y3_083 49701 49180 173 18.03 hypothetical protein 
Y3_084 50792 49698 364 40.31 hypothetical protein 
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Y3_085 51383 50802 193 20.72 hypothetical protein 
Y3_086 52186 51383 267 28.61 hypothetical protein 
Y3_087 52754 52296 152 16.19 hypothetical protein 
Y3_088 53839 52754 361 38.55 hypothetical protein 
Y3_089 54785 53841 314 33.35 hypothetical protein 
Y3_090 55282 54785 165 17.4 putative membrane protein 
Y3_091 56367 55360 335 36.53 hypothetical protein 
Y3_092 57401 56379 340 36.01 hypothetical protein 
Y3_093 58471 57413 352 38.25 hypothetical protein 
Y3_094 59133 58552 193 20.28 hypothetical protein 
Y3_095 59365 59144 73 8.06 hypothetical protein 
Y3_096 60307 59378 309 33.34 hypothetical protein 
Y3_097 60917 60321 198 21.67 hypothetical protein 
Y3_098 62610 60997 537 54.92 putative virion protein 
Y3_099 63377 62634 247 28.88 hypothetical protein 
Y3_100 63880 63374 168 18.49 putative membrane protein 
Y3_101 65055 64234 273 30.57 hypothetical protein 
Y3_102 65957 65130 275 29.95 hypothetical protein 
Y3_103 66417 65941 158 17.11 hypothetical protein 
Y3_104 67238 66420 272 28.02 putative tail fibre protein 
Y3_105 67452 67249 67 7.45 hypothetical protein 
Y3_106 70346 67470 958 106.02 putative tail fiber hinge protein 
Y3_107 72409 70391 672 74.33 hypothetical protein 
Y3_108 72912 72421 163 16.07 putative tail fiber protein 
Y3_109 73554 72922 210 20.26 phage tail fiber protein 
Y3_110 74991 73555 478 50.11 putative phage tail protein, 
containing intein domain 
Y3_111 77315 74988 775 83.33 putative phage tail-collar fibre 
protein 
Y3_112 81929 77403 1508 166.89 hypothetical protein 
Y3_113 83392 81926 488 54.34 putative baseplate wedget subunit 
protein 
Y3_114 83811 83392 139 16.01 baseplate protein 
Y3_115 84101 83811 96 9.81 putative baseplate spike protein 
Y3_116 87129 85369 586 64.59 hypothetical protein 
Y3_117 87572 87138 144 16.54 hypothetical protein 
Y3_118 88183 87569 204 23.02 dTMP kinase  
Y3_119 88686 88195 163 19.11 DNA repair protein MmcB-like  
Y3_120 89134 88676 152 17.34 NUDIX hydrolase 
Y3_121 89643 89131 170 18.45 hypothetical protein 
Y3_122 89970 89686 94 10.38 hypothetical protein 
Y3_123 90668 89973 231 26.34 hypothetical protein 
Y3_124 91466 90678 262 28.65 putative baseplate protein 
Y3_125 93358 91463 631 69.24 hypothetical protein 
Y3_126 93795 93361 144 16.13 hypothetical protein 
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Y3_127 94085 93795 96 10.49 hypothetical protein 
Y3_128 94876 94064 270 28.14 hypothetical protein 
Y3_129 97565 94887 892 94.13 putative chitosanase 
Y3_130 98380 97565 271 31.93 hypothetical protein 
Y3_131 99099 98416 227 25.85 hypothetical protein 
Y3_132 99621 99109 170 18.78 putative tail tube protein  
Y3_133 100297 99626 223 25.23 hypothetical protein 
Y3_134 100853 100344 169 18.94 putative tail tube protein  
Y3_135 102549 100864 561 61.62 phage tail sheath protein 
Y3_136 102950 102606 114 12.7 hypothetical protein 
Y3_137 103624 102950 224 24.93 hypothetical protein 
Y3_138 104104 103691 137 14.86 hypothetical protein 
Y3_139 105260 104160 366 39.84 putative major capsid protein 
Y3_140 106028 105321 235 24.79 structural protein 
Y3_141 108157 106082 691 73.94 hypothetical protein 
Y3_142 109347 108235 370 41.12 hypothetical protein 
Y3_143 110128 109349 259 29.14 putative prohead core protein 
protease 
Y3_144 110555 110139 138 15.62 hypothetical protein 
Y3_145 111337 110558 259 28.14 hypothetical protein 
Y3_146 112475 111303 390 44.39 glycosyl transferase family 2 
Y3_147 113451 112534 305 35.5 hypothetical protein 
Y3_148 115400 113454 648 71.07 DNA ligase 
Y3_149 117322 115442 626 70.97 hypothetical protein 
Y3_150 121573 117389 1394 153.9 hypothetical protein 
Y3_151 122802 121633 389 41.77 hypothetical protein 
Y3_152 123800 122823 325 34.35 hypothetical protein 
Y3_153 124588 123803 261 29.15 hypothetical protein 
Y3_154 128607 124600 1335 141.4 putative major tail protein 
Y3_155 129236 128604 210 23.16 hypothetical protein 
Y3_156 129885 129247 212 24.38 hypothetical protein 
Y3_157 130628 129933 231 25.84 hypothetical protein 
Y3_158 132357 130678 559 62.16 tail sheath protein 
Y3_159 133488 132445 347 38.49 hypothetical protein 
Y3_160 134333 133485 282 32.3 hypothetical protein 
Y3_161 134542 134333 69 7.75 hypothetical protein 
Y3_162 135167 134553 204 22.94 hypothetical protein 
Y3_163 135626 135255 123 14.47 hypothetical protein 
Y3_164 135922 135632 96 10.35 hypothetical protein 
Y3_165 136387 135962 141 15.63 hypothetical protein 
Y3_166 136910 136395 171 19.51 hypothetical protein 
Y3_167 137194 136910 94 10.54 hypothetical protein 
Y3_168 138792 137194 532 60.92 DNA repair helicase 
Y3_169 139340 138795 181 21.37 hypothetical protein 
Y3_170 139774 139340 144 16.21 hypothetical protein 
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Y3_171 140949 139771 392 43.9 hypothetical protein 
Y3_172 141145 140927 72 7.97 hypothetical protein 
Y3_173 144375 141211 1054 121.34 DNA polymerase A 
Y3_174 145684 144458 408 43.8 hypothetical protein 
Y3_175 146242 145694 182 20.63 putative lysozyme 
Y3_176 152139 146284 1951 217.11 putative ATP-dependent DNA 
helicase 
Y3_177 152636 152139 165 18.37 hypothetical protein 
Y3_178 153429 152647 260 29.77 hypothetical protein 
Y3_179 153791 153426 121 13.54 HNH family endonuclease 
Y3_180 154658 153828 276 30.38 hypothetical protein 
Y3_181 155525 154719 268 28.94 hypothetical protein 
Y3_182 156738 155578 386 42.73 putative head to tail joining 
protein 
Y3_183 157846 156740 368 41.61 hypothetical protein 
Y3_184 159129 157846 427 46.7 hypothetical protein 
Y3_185 159998 159321 225 23.88 hypothetical protein 
Y3_186 161195 160119 358 40.94 phage recombination related 
endonuclease 
Y3_187 162263 161268 331 34.79 hypothetical protein 
Y3_188 162837 162310 175 20.3 putative ssDNA binding protein  
Y3_189 163698 162856 280 29.91 hypothetical protein 
Y3_190 164702 163767 311 34.69 hypothetical protein 
Y3_191 165107 164742 121 13.1 DUF2778 domain-containing 
protein 
Y3_192 165312 165172 46 5.64 hypothetical protein 
Y3_193 165824 165312 170 19.92 hypothetical protein 
Y3_194 166879 165824 351 36.98 hypothetical protein 
Y3_195 167490 166888 200 21.83 hypothetical protein 
Y3_196 167822 167490 110 11.98 hypothetical protein 
Y3_197 168394 167825 189 21.17 putative glycosyl hydrolase 
Y3_198 168804 168469 111 12.96 putative membrane protein 
Y3_199 169517 168804 237 26.76 hypothetical protein 
Y3_200 169756 169508 82 9.18 hypothetical protein 
Y3_201 170067 169759 102 12.03 hypothetical protein 
Y3_202 172400 170067 777 89.06 putative ATPase 
Y3_203 172600 172400 66 7.75 hypothetical protein 
Y3_204 172809 172600 69 8.11 hypothetical protein 
Y3_205 173344 172907 145 16.54 hypothetical protein 
Y3_206 174127 173357 256 27.83 hypothetical protein 
Y3_207 174084 174221 45 5.03 hypothetical protein 
Y3_208 174802 174269 177 19.44 hypothetical protein 
Y3_209 176195 174903 430 47.66 putative DNA polymerase III  
Y3_210 176547 176350 65 7.61 hypothetical protein 
Y3_211 177605 177018 195 22.71 hypothetical protein 
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Y3_212 177937 177605 110 12.85 hypothetical protein 
Y3_213 178513 177941 190 21.57 hypothetical protein 
Y3_214 179486 178515 323 36.32 hypothetical protein 
Y3_215 179971 179495 158 17.25 hypothetical protein 
Y3_216 180207 179983 74 8.76 hypothetical protein 
Y3_217 180709 180212 165 19.78 hypothetical protein 
Y3_218 181279 180755 174 20.47 hypothetical protein 
Y3_219 182899 181283 538 62.27 hypothetical protein 
Y3_220 183944 183288 218 24.15 hypothetical protein 
Y3_221 185064 183955 369 41.36 hypothetical protein 
Y3_222 185163 185711 182 20.97 putative Holliday junction 
resolvase 
Y3_223 185721 186110 129 14.32 hypothetical protein 
Y3_224 186145 186816 223 25.93 hypothetical protein 
Y3_225 186809 188575 588 60.82 putative surface adhesion protein 
Y3_226 188632 189291 219 24.47 hypothetical protein 
Y3_227 190437 189346 363 39.78 phage-associated DNA primase 
Y3_228 190503 190844 113 13.51 hypothetical protein 
Y3_229 190810 191895 361 41.35 putative exonuclease 
Y3_230 191934 192302 122 14.24 hypothetical protein 
Y3_231 192311 192817 168 17.48 hypothetical protein 
Y3_232 192801 193331 176 20.47 hypothetical protein 
Y3_233 193345 193890 181 20.28 hypothetical protein 
Y3_234 193894 194118 74 8.2 hypothetical protein 
Y3_235 194115 194450 111 12.62 hypothetical protein 
Y3_236 194440 194658 72 7.88 hypothetical protein 
Y3_237 194664 195347 227 26.21 hypothetical protein 
Y3_238 195347 195871 174 19.27 hypothetical protein 
Y3_239 195864 196331 155 17.53 putative cyclic phosphodiesterase 
Y3_240 196387 196704 105 12 hypothetical protein 
Y3_241 196750 197787 345 40.23 hypothetical protein 
Y3_242 197832 199094 420 48.28 putative single stranded DNA 
binding protein 
Y3_243 199160 201652 830 92.86 RecA protein 
Y3_244 201708 202085 125 13.56 hypothetical protein 
Y3_245 202160 202879 239 26.69 hypothetical protein 
Y3_246 202986 204005 339 39.28 hypothetical protein 
Y3_247 204051 204812 253 29.09 hypothetical protein 
Y3_248 204984 205106 40 4.74 hypothetical protein 
Y3_249 205256 206188 310 33.92 hypothetical protein 
Y3_250 206329 206889 186 20.6 hypothetical protein 
Y3_251 207116 207754 212 23.13 hypothetical protein 
Y3_252 207860 208111 83 9.23 hypothetical protein 
Y3_253 208179 208835 218 24.07 hypothetical protein 
Y3_254 208887 209414 175 20.57 hypothetical protein 
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Y3_255 209471 209740 89 10.05 hypothetical protein 
Y3_256 209785 210126 113 12.85 hypothetical protein 
Y3_257 210203 210562 119 13.81 hypothetical protein 
Y3_258 210563 210832 89 9.74 hypothetical protein 
Y3_259 210829 211194 121 14.49 hypothetical protein 
Y3_260 211277 211762 161 19.28 hypothetical protein 
Y3_261 211750 212124 124 14.45 hypothetical protein 
Y3_262 212128 212442 104 12.22 hypothetical protein 
Y3_263 212534 212977 147 16.79 hypothetical protein 
Y3_264 213043 213369 108 12.05 hypothetical protein 
Y3_265 213436 213792 118 13.07 hypothetical protein 
Y3_266 213857 214276 139 16.31 hypothetical protein 
Y3_267 214337 214846 169 19.66 hypothetical protein 
Y3_268 214981 215181 66 7.72 hypothetical protein 
Y3_269 215184 215624 146 17.05 hypothetical protein 
Y3_270 215692 216732 346 39.06 hypothetical protein 
Y3_271 216707 216928 73 8.29 putative membrane protein 
Y3_272 216921 217466 181 20.65 RNA 2'-phosphotransferase 
Y3_273 217459 217857 132 15.52 hypothetical protein 
Y3_274 217933 219276 447 51.67 GTP 3',8-cyclase MoaA 
Y3_275 219288 219842 184 20.99 hypothetical protein 
Y3_276 219842 220174 110 12.99 putative membrane protein 
Y3_277 220174 220500 108 12.13 hypothetical protein 
Y3_278 220504 220980 158 18.13 hypothetical protein 
Y3_279 220985 221242 85 9.3 C4-type zinc finger domain-
containing protein 
Y3_280 221245 221610 121 14.59 hypothetical protein 
Y3_281 221585 221944 119 13.77 hypothetical protein 
Y3_282 221952 222287 111 13.04 hypothetical protein 
Y3_283 222339 222704 121 13.57 hypothetical protein 
Y3_284 222714 223430 238 26.94 hypothetical protein 
Y3_285 223405 223602 65 7.27 putative membrane protein 
Y3_286 223599 224159 186 21.09 hypothetical protein 
Y3_287 224216 225190 324 37.76 UV damage endonuclease UvsE 
Y3_288 225282 225575 97 11.05 hypothetical protein 
Y3_289 225577 225840 87 10.09 hypothetical protein 
Y3_290 226002 226295 97 11.12 hypothetical protein 
Y3_291 226273 226521 82 9.34 hypothetical protein 
Y3_292 226592 227101 169 18.45 hypothetical protein 
Y3_293 227101 227403 100 11.7 hypothetical protein 
Y3_294 227390 228460 356 40.29 hypothetical protein 
Y3_295 228572 228874 100 11.58 hypothetical protein 
Y3_296 228883 229443 186 20.77 hypothetical protein 
Y3_297 229458 229904 148 16.5 hypothetical protein 
Y3_298 229901 230083 60 6.6 putative lipoprotein 
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Y3_299 230097 230360 87 9.68 hypothetical protein 
Y3_300 230360 230896 178 19.53 putative dUTPase 
Y3_301 231516 232193 225 25.11 lytic transglycosylase 
Y3_302 232208 232882 224 25.25 hypothetical protein 
Y3_303 232954 233895 313 36.76 hypothetical protein 
Y3_304 233970 234662 230 25.91 putative membrane protein 
Y3_305 234665 234883 72 8.57 putative membrane protein 
Y3_306 234888 235220 110 12.6 hypothetical protein 
Y3_307 235207 235749 180 20.81 hypothetical protein 
Y3_308 235787 237085 432 49.85 hypothetical protein 
Y3_309 237135 237566 143 15.52 hypothetical protein 
Y3_310 237576 237875 99 11.52 hypothetical protein 
Y3_311 237993 238457 154 17.4 hypothetical protein 
Y3_312 238458 239090 210 24.86 hypothetical protein 
Y3_313 239102 239293 63 7.32 hypothetical protein 
Y3_314 239418 239756 112 12.48 hypothetical protein 
Y3_315 240074 241612 512 55.71 hypothetical protein 
Y3_316 241698 242933 411 45.3 hypothetical protein 
Y3_317 242990 243319 109 12.79 hypothetical protein 
Y3_318 243316 243795 159 17.38 hypothetical protein 
Y3_319 243785 245065 426 49.51 hypothetical protein 
Y3_320 245088 248105 1005 109.22 hypothetical protein 
Y3_321 248161 249009 282 32.09 hypothetical protein 
Y3_322 249105 249665 186 19.33 hypothetical protein 
Y3_323 249818 250597 259 28.56 hypothetical protein 
Y3_324 250812 251375 187 19.14 hypothetical protein 
Y3_325 251476 251973 165 18.01 hypothetical protein 
Y3_326 251954 252718 254 28.7 hypothetical protein 
Y3_327 252846 254885 679 75.4 DNA topoisomerase 4 subunit B  
Y3_328 254887 255189 100 10.83 hypothetical protein 
Y3_329 255189 256841 550 60.07 DNA topoisomerase 4 subunit A 
Y3_330 257187 258455 422 47.57 hypothetical protein 
Y3_331 258935 259780 281 31.04 hypothetical protein 
Y3_332 259838 260968 376 43.38 hypothetical protein 
Y3_333 260986 261357 123 14.14 hypothetical protein 
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Figure S7.1. Genome map of Erwinia phage Y3 showing locations of predicted promotors with 
the consensus sequence of CTGTAAATA in the genome. Arrows indicate locations of ORFs with 
colours indicating the following. Purple: hypothetical protein, green: nucleotide metabolism 
and DNA replication-related, blue: virion structural related, pink: miscellaneous. 
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Figure S7.2. Predicted promotor in Erwinia amylovora phage vB_PcaM_ Y3 shared with 
Pseudomonas phage Lu11 
 
Promoter Location  Sequence 
Porf_008 7816-7828 AATTCTGTAAATA 
Porf_014 10448-10460 AATACTGTAAATA 
Porf_018 13410-13422 AAATCTGTAAACA 
Porf_019 14296-14308 GAATCTGTAAATA 
Porf_021 15281-15293 AAGTCTGTAAATA 
Porf_029 18577-18589 AAATCTGTAAATA 
Porf_042 25623-25635 TATTCTGTAAATG 
Porf_049 29646-29678 ATAACTGTAAATA 
Porf_056 34950-34962 TAATCTGTAAATA 
Porf_063 38678-38690 GAATCTGTAAATA 
Porf_073 43002-43014 AAATCTGTAAATA 
Porf_123 90713-90701 GTTACTGTAAATG 
Porf_148 115443-115431 AATGCTGTAAATA 
Porf_162 135206-135194 AAAACTGTAAATA 
Porf_171 140998-140986 AAGGCTGTAAATG 
Porf_173 144417-144405 AAATCTGTAAATA 
Porf_179 153829-153817 AGAACTGTAAATA 
Porf_188 162856-162844 GTATCTGTAAATA 
Porf_204 172861-172849 AAAACTGTAAATA 
Porf_209 176243-176231 AATACTGTAAATA 
Porf_210 176601-176589 TTAACTGTAAATA 
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Porf_217 180756-180744 GATTCTGTAAACT 
Porf_219 182939-182927 ATATCTGTAAATA 
Porf_224 186101-186113 GGATCTGTAAATA 
Porf_228 190479-190491 TTATCTGTAAATA 
Porf_241 14296-14308 GAATCTGTAAATA 
Porf_242 197786-197798 AAAACTGTAAACA 
Porf_245 202076-202088 TAATCTGTAAATA 
Porf_291 226504-226516 GAGTCTGTAAATA 
Porf_293 222295-222307 GATTCTGTAAATC 
Porf_322 249032-249044 TAATCTGTAAACA 
Porf_323 259759-249771 GAATCTGTAAATC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
310 
 
Table S7.3. High ΔG rho-independent terminators predicted in the genome Erwinia amylovora 
phage vB_EamM_Y3 identified using ARNold and QuikFold. 
Terminator Coordinates Sequence ΔG 
kcal/
mol 
Torf019 14,545 - 14577 GGGGCTGCTCATTGCAGTCCCTTTTTACTTTCC -15.8 
Torf028 18433 - 18465 AGGGTGCCTTAGGGTGCCCTTTTCTGATCGTAT -12.7 
Torf038 24040 - 24074 TGGGGTGGCTGTGTGCTGCCCCATTTTTGTTTGGA -16.3 
Torf055 34975 - 35007 TGGGTGGCCTTGTGCTGCCCATTTTTGTTTCTA -11.8 
Torf061 37762 - 37793 TGGGTGGCTTCGGCTGCCCATTTTGCATTTGG -15.8 
Torf061a 38232 - 38265 GCTGGGAAGTATTTCTCAGCaaTTTTAGTGGCAG -10.4 
Torf075 44598 - 44638 
(complement) 
GGGCGACTCTCTTGATTGAGGGCCGCCCTTTTTCGATCTTG -17.9 
Torf074 44610 - 44652 AGGGCGGCCCTCAATCAAGAGAGTCGCCCTTTTTATTTGCT
AC 
-18.4 
Torf078 45738 - 45770 
(compl ement) 
AGGGTGGCTTCGGCTGCCCTTTCTTTTTGTCCA -15.3 
Torf083 49134 - 49173 
(complement) 
ACAGTGGTGCTCATTCAGGCCACTGTcTTTAATTTAAATT -10.4 
Torf094 58504 - 58545 
(complement) 
GGGGCATGTATCTTCTGAGGTACTGCCCCTTTCGCATTTCC
A 
-18.3 
Torf098 60928 - 60960 
(complement) 
GGGTGGGCCTGTGCTCACCCTTTTTACTATTCA -14.3 
Torf107 70356 - 70385 
(complement) 
AGGGGCTTCGGCCCCTcTTCTCGATCTTAA -14.2 
Torf112 77354 - 77388 
(complement) 
GGAGCTAGATGTTCCTGGCTCCcTTTTGACTTTCA -13.3 
Torf116 84142 - 84176 
(complement) 
CGGGTGGCCATTAGGCTGCCCGTTTTTGTTTCTCG -16.6 
Torf134 100306 - 
100337 
(complement) 
GGGCCAGATGTTTTGGCCCTTTTTCGTTTCTG -12.3 
Torf138 103634 - 
103667 
(complement) 
AGGGTGGCTTCGGCTGCCCTtTTTTGTATCTGGA -15.3 
Torf150 117370 - 
117399 
(complement) 
GCGGGGGTTAAATCCCGCTTTTCCTTTTCG -12.8 
Torf158 130637 - 
130667 
(complement) 
GGAGGGCTTCGGTCCTCCTTTTTCGTATTGT -15.5 
Torf159 132404 - 
132436 
(complement) 
AGGGTGCCTGCGGGTGCCCTTTTTACGTTTTGG -12.7 
Torf163 135211 - 
135245 
(complement) 
GAGCTGGGCTTCGGTCCGGCTCTTTTACCTTCTGC -19.1 
Torf174 144417 - 
144448 
(complement) 
TGGGTGGCTTCGGCTGCCCATTTTCATTTCTA -15.8 
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Torf181 154674 - 
154705 
(complement) 
GGGAGCCTCGCGGGGTTCCCTTTTTCGTTTCT -14.8 
Torf185 159253 - 
159285 
(complement) 
AGGGTGGCTTCGGCTGCCCTTTTTGTTTTTCTA -15.3 
Torf187 161228 - 
161261 
(complement) 
TGGGCGGCCTTCGGGTTGCCCATTTTTCTGTAAA -17.7 
Torf192 165128 - 
165166 
(complement) 
GGGCTTGCATCGAGAGGTGTAGGCCCTTTTGTTTTTTAT -21 
Torf198 168431 - 
168463 
(complement) 
AGGGTGGCTTCGGCTGCCCTTTTTGTTTCTGAC -15.3 
Torf205 172871 - 
172902 
(complement) 
GGGCTGCCTAATGGTGGCCCTTCTTTCTATCT -15.3 
Torf209 174860 - 
174894 
(complement) 
TGGGTGGCCAATGAGCTGCCCATTTTTATTTCAGA -12.2 
Torf227 189302 - 
189340 
(complement) 
TGGGAGACTCCTTTCGGGGCCTCCCATTTTTTTGTCTAA -15.6 
Torf226 189315 - 
189352 
TGGGAGGCCCCGAAAGGAGTCTCCCATTTTACTATGCC -19.9 
Torf239 196342 - 
196375 
GCGGTGGCCATTGTGCTGCCGCTTTTGTCATTTG -13.5 
Torf242 199108 - 
199141 
TGGGGTGGCATAAGCTGCCCCATTCTTTTCTCTA -15.8 
Torf243 201667 - 
201697 
GGCGGGCTTCGGCTCGCCcTTTCTTTAACAG -16.1 
Torf245 202919 - 
202952 
GGGAGATCATGATGGTCTCCCaTTTTTTTTATTT -14.3 
Torf248 205154 - 
205194 
GGGCTGTCAGAAATCAATCTGATGGCCCTTTCTCTTTTATA -18.2 
Torf250 206912 - 
206943 
GGGGTGCCTTCGGGTGCCCCTTTTGCGTCTCT -18.5 
Torf252 208127 - 
208156 
GAGACGTTACGGCGTCTCTTTTCTTTTATA -10.2 
Torf254 209432 - 
209461 
GCCTTGCGCAAGCGGGGCTTTTCTGATCTG -13.5 
Torf256 210134 - 
210165 
GGGCTGCCTAACGGTGGCCCTTTTTCGTTTCT -16.7 
Torf259 211224 - 
211252 
GGGGCTCGCTGAGTCCCTTTCATTTAGGA -10.6 
Torf266 214284 - 
214322 
GGGATGCTCACAAAGGTGGGTGTCCCcTTTTACTTTCTG -17 
Torf269 215643 - 
215678 
GCACTGGTCTGAAAAGGTCAGTGCTTTTCCTACATT -16.6 
Torf302 232894 - CGGGAGACCTTAACTGGTTTCCCGTTTTTCATTCTT -16 
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232929 
Torf310 237944 - 
237973 
GCGTAGCAGATGCTGCGCTTTTTTACTTTA -12.2 
 
 
Table S7.4. List of jumbo Erwinia amylovora phage with genome sequences deposited in 
Genbank to date. 
Phage Genome 
accession no. 
Terminase 
accession no. 
Portal vertex 
accession no 
Reference 
vB_EamM_Deimos-Minion KU886225  ANH52287.1 ANH52104.1 (Esplin et al., 
2017) 
vB_EamM_RAY KU886224 ANH51964.1 ANH51787.1 (Esplin et al., 
2017) 
vB_EamM_Special G KU886222  ANJ64995.1 ANJ64816.1 (Esplin et al., 
2017) 
Ea35-70 KF806589 AHI60333.1 AHI60156.1 (Yagubi et 
al., 2014) 
vB_EamM_Simmy50 KU886223  ANH51648.1 ANH51468.1 (Esplin et al., 
2017) 
vB_EamM_Caitlin KX397365  ANZ48565.1 YP_009292163.1 (Esplin et al., 
2017) 
vB_EamM_ChrisDB KX397366  ANZ48843.1 YP_009292784.1 (Esplin et al., 
2017) 
vB_EamM_EarlPhillipIV KX397367  ANZ49082.1 YP_009278390.1 (Esplin et al., 
2017) 
vB_EamM_Huxley KX397368  ANZ49353.1 YP_009293062.1 (Esplin et al., 
2017) 
vB_EamM_Kwan KX397369  ANZ49636.1 YP_009278705.1 (Esplin et al., 
2017) 
vB_EamM_Machina KX397370  ANZ49910.1 ANZ49731.1 (Esplin et al., 
2017) 
vB_EamM_Parshik KX397371  ANZ50181.1 ANZ50004.1 (Esplin et al., 
2017) 
vB_EamM_Phobos KX397372  ANZ50429.1 ANZ50268.1 (Esplin et al., 
2017) 
vB_EamM_Stratton KX397373  ANZ50705.1 ANZ50524.1 (Esplin et al., 
2017) 
vB_EamM_RisingSun MF459646  ASU03430.1 ASU03582.1 (Esplin et al., 
2017) 
vB_EamM_Joad MF459647  ASU03673.1 ASU03827.1 (Esplin et al., 
2017) 
vB_EamM_Asesino NC_031107.1 YP_009290899.1 YP_009290715.1 unpublished 
vB_EamM_Yoloswag KY448244  AQT28491.1 AQT28493.1 (Esplin et al., 
2017) 
vB_EamM_Y3 KY984068 ARW58644 ARW58646 This work 
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Abstract: The increase in antibiotic resistance in pathogenic bacteria is a public health danger
requiring alternative treatment options, and this has led to renewed interest in phage therapy. In this
respect, we describe the distinct host ranges of Staphylococcus phage K, and two other K-like phages
against 23 isolates, including 21 methicillin-resistant S. aureus (MRSA) representative sequence types
representing the Irish National MRSA Reference Laboratory collection. The two K-like phages were
isolated from the Fersisi therapeutic phage mix from the Tbilisi Eliava Institute, and were designated
B1 (vB_SauM_B1) and JA1 (vB_SauM_JA1). The sequence relatedness of B1 and JA1 to phage K was
observed to be 95% and 94% respectively. In terms of host range on the 23 Staphylococcus isolates,
B1 and JA1 infected 73.9% and 78.2% respectively, whereas K infected only 43.5%. Eleven open
reading frames (ORFs) present in both phages B1 and JA1 but absent in phage K were identified
by comparative genomic analysis. These ORFs were also found to be present in the genomes of
phages (Team 1, vB_SauM-fRuSau02, Sb_1 and ISP) that are components of several commercial
phage mixtures with reported wide host ranges. This is the first comparative study of therapeutic
staphylococcal phages within the recently described genus Kayvirus.
Keywords: phage isolation; bacteriophage; phage resistance; MRSA; Staphylococcus; Kayvirus
1. Introduction
Staphylococcus aureus (S. aureus) is an opportunistic and important pathogen in clinical and
health-care settings causing a wide variety of diseases commonly involving the skin, soft tissue,
bone, and joints [1]. It is also a well-known causative agent of prosthetic joint infections (PJI),
cardiac device infections, and intravascular catheter infections [1]. S. aureus pathogenicity is due,
in part, to its ability to acquire and express a wide array of virulence factors, as well as antimicrobial
resistance determinants [2], an example of which involves the acquisition of the staphylococcal
cassette chromosome (SCCmec) leading to the development of methicillin resistance in S. aureus [3].
Methicillin-resistant S. aureus (MRSA) was first reported in 1961 [4], and has since been observed to
cause serious infections in hospitals worldwide. Reports of MRSA clones resistant to the majority of
antibiotics are a growing concern [5]. As such, new treatment options are needed.
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Bacteriophages (phages) are biological entities composed of either DNA or RNA enclosed within a
protein coat [6]. They are highly specific, with most phages capable of infecting only a single bacterial
species [6,7], and studies on these viruses have been performed since the late 19th century [8]. The phage
infection process usually begins with the recognition of the receptor on the bacterial cell surface by its
receptor binding protein [9]. In natural environments bacterial hosts have evolved many mechanisms
to protect themselves from phage attack to include; adsorption blocking, DNA injection blocking,
restriction-modification system (R/M), abortive infection, and the clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas systems [10,11]. In turn, phages have evolved several strategies for
overcoming these systems to ensure their survival in the phage-host co-evolutionary race [12–14].
The use of phages as therapeutics to eliminate pathogenic bacteria dates back to experiments
conducted by Felix d'Herelle in 1919 at a French hospital to treat dysentery [15]. Since then, a wide
range of phage therapy trials have been undertaken, many with very promising results [15,16].
Pyophage and Intesti-phage are among the commercial phage mixtures currently produced at the
Eliava Institute. Metagenomic studies on these phage mixtures have been reported [17,18] and
the staphylococcal phages Sb-1 and ISP are key components of Pyophage [19,20]. Other phages
isolated from these commercial phages mixes have also been reported [21–24]. Phages like
vB_SauM-fRuSau02 was isolated from a phage mix produced by Microgen (Moscow, Russia) [21] and
Team 1 was isolated from PhageBioDerm, a wound healing preparation consisting of a biodegradable
polymer impregnated with an antibiotic and lytic phages [22–24]. These phages all possess a wide
host range against a number of clinically relevant S. aureus isolates, demonstrating the efficacy of such
commercial phage mixtures in treating a range of bacterial infections [19–24].
In this paper, we employed another phage mixture from the Eliava Institute, namely the Fersisi
phage mix. Fersisi is a relatively new combination developed approximately 15–20 years ago on the
basis of Pyophage, although with fewer phage components. Two phages from this mix were designated
B1 (vB_SauM_B1) and JA1 (vB_SauM_JA1). Phage K, on the other hand, is a well-known phage being
the type phage of the recently designated genus Kayvirus of the subfamily Spounavirinae [25]. The exact
origin of phage K is unknown, but descriptions of the phage are made as far back as 1949 [26,27].
An initial host range study involving this phage reported it to be ineffective against many MRSA
strains [26]. Thus, phages B1 and JA1 were compared (on the basis of their host range) to phage K to
explore possible host range differences and it was observed that both phages had broader host ranges.
A comparative study was performed on their genomes and the genomes of similar phages from other
commercial phage mixtures (Team 1, vB_SauM-fRuSau02, Sb_1 and ISP) with reported wide host
ranges, to provide molecular insight into the differences in host range encountered in this study.
2. Results and Discussion
2.1. Origin of Phages B1 and JA1
Phages B1 and JA1 were isolated from the Fersisi commercial phage mixtures; batch 010112 (B1)
and F-062015 (JA1). This product is used in the treatment of staphylococcal and streptococcal infections.
For the isolation of B1, phage enrichment was carried out using staphylococcal host cultured from the
sonicate fluid of a hospital patient suffering from PJI. DPC5246 was subsequently used as propagating
host for B1, as a prophage was encountered in the PJI strain. Phage enrichment in the isolation of
JA1 was done using the Cork Institute of Technology (CIT) collection strain S. aureus CIT281189.
Both the PJI strain and CIT281189 were insensitive to phage K.
2.2. Morphology and Host Range of Phages K, B1 and JA1
Phages B1 and JA1 exhibited typical characteristics of phages belonging to the Myoviridae family,
similar to the reported morphology of phage K [26]. All three phages possessed an A1 morphology [28],
displaying an icosahedral head as well as a long contractile tail. They also contained a structure previously
described as knob-like appendages by O'Flaherty et al. [26], extending from their base plates (likely
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“clumped/aggregated” base plate appendices) and clearly visible in Figure 1. Estimations were made on the
dimensions of these phages (Table 1). Capsid heights were estimated as 92.9± 4.0 nm (B1), 87.0± 2.1 nm
(JA1) and 92.9± 3.8 nm (K). Tail dimension were also estimated as 233.0± 4.4× 23.4± 1.2 nm (B1),
231.5 ± 4.7 × 22.7 ± 0.9 nm (JA1), and 227.5± 5.5× 23.8± 1.0 nm (K), and base plates/knobs
complexes were estimated as 30.1± 1.8× 47.2± 3.7 nm (B1), 32.5± 7.9× 45.8± 1.4 nm (JA1),
and 36.6± 5.1× 41.7± 2.6 nm (K). Owing to the similar morphology of all three phages, a host range
study was conducted to explore possible differences in host spectra across a number of hospital isolates.
Twenty-one of these isolates represented the entire collection of MRSA sequence-types identified in
Ireland by the National MRSA Reference Laboratory (Dublin, Ireland), and includes the commonly
encountered ST22-MRSA-IV, which has been predominant in Irish hospitals since the late 1990s [29].
The other two S. aureus strains used in this study were included as additional phage propagation
strains. Host range was assessed by plaque assay technique on lawns of various MRSA strains listed
in Table 2. The efficiency of plaquing (EOP) was used to represent the degree to which each of the
phages studied infected all 23 staphylococcal strains. Phage JA1 had the broadest host range, forming
plaques on 18 out of the 23 staphylococcal strains examined. B1 also had a broad host range and
was capable of forming plaques on 17 isolates (with some in common with the 18 lysed by phage
JA1). Phage K had the narrowest host range, forming plaques on only 10 of the isolates (including its
propagating strain DPC5246). All 23 staphylococcal strains were effectively lysed by at least one of the
three phages, with the exception of E1139 (IV) ST45 and E1185 (IV) ST12, whose EOP were significantly
low at 3.88 × 10−6 and 1.16 × 10−6 respectively; as well as 3488 (VV) ST8, which was resistant to all
three phages. Plaque size ranged from 0.5 mm to 1.5 mm, with a halo occurring in some instances
(Table 3 and Supplementary Materials, Figure S1). The wide host range encountered in this study is
common among K-like phages and has been reported for other staphylococcal K-like phages, such as
JD007, which infected 95% of S. aureus isolates obtained from several hospitals in Shanghai, China [30].
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Table 1. Dimensions of staphylococcal phages B1, JA1, and K derived from micrographs obtained from
transmission electron microscopy.
Phages Head (nm) Tail Length (nm)(incl. “knob”)
Tail Width
(nm)
Baseplate “knob”
Length (nm)
Baseplate “knob”
Width (nm)
B1 92.9 ± 4.0(n = 11)
233.0 ± 4.4
(n = 12)
23.4 ± 1.2
(n = 12)
30.1 ± 1.8
(n = 12)
47.2 ± 3.7
(n = 10)
JA1 87.0 ± 2.1(n = 9)
231.5 ± 4.7
(n = 9)
22.7 ± 0.9
(n = 9)
32.5 ± 7.9
(n = 9)
45.8 ± 1.4
(n = 9)
K 92.9 ± 3.8(n = 16)
227.5 ± 5.5
(n = 16)
23.8 ± 1.0
(n = 16)
36.6 ± 5.1
(n = 16)
41.7 ± 2.6
(n = 16)
Table 2. Host ranges of staphylococcal phages B1, JA1, and K against methicillin-resistant
Staphylococcus aureus (MRSA) strains from the Irish National Reference Laboratory (St. James’s Hospital
Dublin, Ireland) including the efficiency of plaquing (EOP) of these strains.
S. aureus Strain Phage K Phage B1 Phage JA1
DPC5246* 1.00 ± 0.0 1.00 ± 0.0 8.98 × 10−1 ± 0.8
CIT281189* No infection No infection 1.00 ± 0.0
0.0066 (IIIV) ST239 No infection No infection 2.59 ± 2.5
0.1206 (IV) ST250 No infection 3.89 × 10−1 ± 0.3 1.35 ± 1.2
0.1239 (III) ST239 No infection 1.46 × 10−1 ± 0.1 4.17 × 10−2 ± 0.0
0.1345 (II) ST5 No infection No infection 2.08 × 10−1 ± 0.1
0073 (III) ST239 No infection 3.21 × 10−1 ± 0.2 No infection
0104 (III) ST239 No infection 3.95 × 10−1 ± 0.2 1.82 ± 1.6
0220 (II) ST5 3.03 × 10−1 ± 0.1 2.17 × 10−1 ± 0.2 2.38 × 10−1 ± 0.2
0242 (IV) ST30 4.43 × 10−1 ± 0.1 5.23 × 10−1 ± 0.5 4.90 × 10−1 ± 0.3
0308 (IA) ST247 1.40 ± 0.2 1.36 ± 1.3 1.71 ± 1.6
3045 (IIV) ST8 No infection 4.93 × 10−2 ± 0.0 1.69 ± 0.7
3144 (IIV) ST8 No infection 1.21 ± 1.0 2.17 ± 1.2
3488 (VV) ST8 No infection No infection No infection
3581 (IA) ST247 No infection No infection 9.26 × 10−1 ± 0.7
3594 (II) ST36 4.38 × 10−1 ± 0.1 8.67 × 10−1 ± 0.4 1.06 ± 0.7
3596 (IIV) ST8 2.49 × 10−4 ± 0.0 1.29 ± 0.9 3.59 ± 2.7
E1038 (IIV) ST8 1.27 × 10−4 ± 0.0 2.02 × 10−1 ± 0.2 1.89 ± 1.4
E1139 (IV) ST45 No infection 3.88 × 10−6 ± 0.0 No infection
E1174 (IV) ST22 7.03 × 10−1 ± 0.7 3.11 × 10−1 ± 0.2 No infection
E1185 (IV) ST12 1.16 × 10−6 ± 0.0 No infection No infection
E1202 (II) ST496 No infection 4.79 × 10−1 ± 0.2 9.49 × 10−1 ± 0.8
M03/0073 (III) ST239 1.76 ± 0.5 1.51 ± 0.8 2.30 ± 0.7
* S. aureus strains for phage propagation; data is represented as means ± standard deviations based on
triplicate measurements.
Table 3. Zone sizes and morphologies of B1, JA1, and K plaques formed on MRSA strains collected
from the Irish National MRSA Reference Laboratory (St. James’s Hospital Dublin, Ireland).
S. aureus Strain Phage K Phage B1 Phage JA1
DPC5246 2 mm 1 mm with halo to 2 mm 1 mm with halo to 2 mm
CIT281189 No plaques No plaques 1.5 mm
0.0066 (IIV) ST239 No plaques No plaques 1 mm
0.1206 (IV) ST250 No plaques 2 mm 0.5 mm with halo to 1 mm
0.1239 (III) ST239 No plaques 0.5 mm, faint plaques 1 mm
0.1345 (II) ST5 No plaques No plaques 1 mm
0073 (III) ST239 No plaques 0.5 mm No plaques
0104 (III) ST239 No plaques 0.5 mm 1 mm
0220 (II) ST5 0.5 mm 1 mm 1 mm
0242 (IV) ST30 1 mm 1.5 mm 1.5 mm
0308 (IA) ST247 1 mm 1 mm 0.5 mm, faint plaques
3045 (IIV) ST8 No plaques 1 mm 1 mm
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Table 3. Cont.
S. aureus Strain Phage K Phage B1 Phage JA1
3144 (IIV) ST8 No plaques 1.5 mm, faint plaques 1 mm
3488 (VV) ST8 No plaques 0.5 mm, faint plaques 0.5 mm with halo to 1 mm
3581 (IA) ST247 No plaques No plaques 1 mm
3594 (II) ST36 1.5 mm 1 mm 1.5 mm
3596 (IIV) ST8 0.5 mm 0.5 mm with halo to 1.5 mm 0.5 mm with halo to 1.5 mm
E1038 (IIV) ST8 0.5 mm, faint plaques 0.5 mm, faint plaques 1.5 mm
E1139 (IV) ST45 No plaques 0.5 mm, faint plaques No plaques
E1174 (IV) ST22 0.5 mm, faint plaques 0.5 mm No plaques
E1185 (IV) ST12 0.5 mm, faint plaques No plaques No plaques
E1202 (II) ST496 No plaques 1 mm 0.5 mm
M03/0073 (III) ST239 2 mm 0.5 mm with halo to 1.5 mm 0.5 mm with halo to 1.5 mm
2.3. Phage Adsorption on Phage Resistant Isolates
While some level of phage insensitivity was encountered against all three phages, phage K was the
frequently insensitive virion to the S. aureus strains tested, and thus, was chosen to evaluate whether or not
adsorption inhibition played a role in its insensitivity. Phage K was able to adsorb to all phage-insensitive
strains to approximately the same extent as the propagating strain DPC5246. This rules out the possibility
of adsorption inhibition playing a role in the narrow host range encountered with phage K in comparison
to both phages B1 and JA1 (Supplementary Materials, Figure S2). Additionally, adsorption studies with
phages B1 and JA1 indicated that adsorption did not play a role in the differences observed.
2.4. Genome Comparison between Phages B1, JA1, and K
The genome of phage K is 139,831 bp in size with long terminal repeats (LTRs) of 8486 bp [31].
Genomes of similar sizes were obtained for phages B1 and JA1, these being 140,808 bp and 139,484 bp,
respectively. Examination of sequence reads allowed the identification of LTRs for these phages, due to
the identification of a region within their genomes with roughly double the average number of reads,
these regions being 8076 bp and 7651 bp in size for phages B1 and JA1, respectively. This approach to
the determination of terminal repeats has been utilized for a number of phages [32–34]. The sequences of
all three phages, when analyzed, contained the 12 bp inverted repeat sequences 5′-TAAGTACCTGGG-3′
and 5′-CCCAGGTACTTA-3′, which separates the LTRs from the non-redundant part of the phage DNA,
and are characteristic of K-like phages [22,35]. Thus, the entire packaged genome sizes are 148,884 bp (B1),
147,135 bp (JA1), and 148,317 bp (K). Phage K possessed 212 ORFs in its genome [31,36], whereas phages
B1 and JA1 possessed 219 (Supplementary Materials, Table S1) and 215 ORFs (Supplementary Materials,
Table S2) respectively.
Nucleotide pairwise sequence alignment based on BLASTN revealed phages B1 and JA1
(including their LTRs) to be 99% identical to each other, thus can be considered different isolates
of the same phage species [37]. On the other hand, phages B1 and JA1 (including their LTRs) showed
95% and 94% identity (respectively) to phage K, placing these phages on the boundary of speciation.
The examination of 100 bp sequences upstream of each ORFs on the non-redundant genome of
these phages, using MEME [38], identified 44 and 43 RpoD-like promoters for phages B1 and JA1,
respectively. It was observed that these promoters where heavily concentrated in regions with ORFs
encoding short hypothetical proteins and those with functions associated with nucleotide metabolism
and DNA replication, rather than those associated with virion structure (Supplementary Materials,
Tables S3 and S4). A similar finding was also reported with K-like phage vB_SauM-fRuSau02 [21].
Additionally, 30 Rho-independent terminators were identified on the non-redundant genomes for both
B1 and JA1 (Supplementary Materials, Tables S5 and S6).
Four ORFs present in phage B1 were observed to be absent in JA1 (Table 4). These ORFs encoded
two putative terminal repeat-encoded proteins (PhageB1_009, 016) and two proteins of unknown function
(phageB1_202, 203). Although both B1 and JA1 had similar content of ORFs with 1% difference between
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their genomes, both phages varied in their host range on the S. aureus strains they infected. This variation
is likely attributed to the difference encountered in their genome. Additionally, multiple ORFs present in
phage K but absent in both B1 and JA1 were encountered (Figure 2, Table 5). Furthermore, ORFs present
in both phages B1 and JA1 but absent in K were also encountered (Figure 2, Table 6). These ORFs are
discussed below.
Table 4. List of missing ORFs present in phage B1 but absent in phage JA1.
ORFs Amino Acid Numbers Protein Size (kDa) Predicted Function
PhageB1_009 112 13.5 Terminal repeat encoded protein
PhageB1_016 107 12.4 Terminal repeat encoded protein
PhageB1_202 32 3.5 Unknown
PhageB1_203 104 11.6 Unknown
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Figure 2. G nome comparison f phages B1, JA1, and K (i ing their long terminal repeat ) using
currently available annotations employing BLASTN and vis alize ith Easyfig. Regions of sequence
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Table 5. List of missing ORFs and their predicted putative functions absent in both phages B1 and
JA1 but present in phage K.
ORFs Amino Acid Number Protein Size (kDa) Predicted Function
PhageK_004 108 12.7 Unknown
PhageK_016* 107 12.4 Unknown
PhageK_019 57 4.7 Unkno n
PhageK_020 89 10.2 Unknown
PhageK_168 185 21.7 Predicted to contain a transmembrane region based on InterProScan
PhageK_187 101 11.7 Unknown
PhageK_188 123 13.8 Predicted to contain a transmembrane region based on InterProScan
PhageK_189 78 9.2 Unknown
PhageK_190 175 20.6 Predicted as a putati oshatase
PhageK_191 106 12.9 Unk
PhageK_192 76 8.9 Predicted to contain a transmembrane region based on InterProScan
PhageK_196 226 25.8 Unknown
PhageK_205 83 9.7 Unknown
PhageK_206 98 11.2 Unkno n
PhageK_208 99 1.6 Unkn
PhageK_209 75 8.9 Unkno n
PhageK_211 117 13.9 Predicted to possess a transmembrane region based on InterProScan
PhageK_212 128 15.6 Unknown
* ORF that phage JA1 does not share with phage K.
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Table 6. List of missing ORFs and their predicted function absent in phage K but present in phages
B1 and JA1.
ORFs Amino Acid Number Protein Size (kDa) Predicted Function
PhageJA1_003
(PhageB1_003) 96 11.3 Unknown
PhageJA1_020
(PhageB1_022) 161 19.1 Unknown
PhageJA1_021
(PhageB1_023) 135 16.5 Unknown
PhageJA1_084
(PhageB1_087) 323 39.6
Predicted as a putative endonuclease interrupting the terminase large
subunit [PhageJA1_083 (PhageB1_086) and PhageJA1_085
(PhageB1_088)]
PhageJA1_152
(PhageB1_155) 322 38.3
Predicted as a putative endonuclease containing a LAGLIDADG-like
domain and an Intein splicing domain and interrupts the DNA repair
protein [PhageJA1_151 (PhageB1_154) and PhageJA1_153 (PhageB1_156)]
PhageJA1_206
(PhageB1_212) 73 8.9 Unknown
PhageJA1_208
(PhageB1_214) 169 20.3 HHpred indicates homology to cell wall hydrolases
PhageJA1_209
(PhageB1_215) 109 12.6 Unknown
PhageJA1_211
(PhageB1_217) 104 12.0 Unknown
PhageJA1_212
(PhageB1_218) 55 6.5 Unknown
PhageJA1_213
(PhageB1_219) 33 3.7 Predicted to possess a transmembrane region based on InterProScan
2.4.1. Characteristic Features of Phage K ORFs Absent in Both JA1 and B1
Seventeen ORFs present in phage K were absent in both phages B1 and JA1, with one additional
ORF found not to be shared between JA1 and K. These ORFs are listed in Table 5. No function could be
assigned to these with the exception of phageK_190, which based on NCBI conserved domain search
possessed a metallophosphatase-like domain (cd07390; E value; 3.94 × 10−30) and is a member of the
metallophosphatase (MPP) superfamily. Families within this superfamily of enzymes are functionally
diverse, involved in the cleavage of phosphoester bonds, and include Mre11/SbcD-like exonucleases,
Dbr1-like RNA lariat debranching enzymes, YfcE-like phosphodiesterases, purple acid phosphatases
(PAPs), YbbF-like UDP-2,3-diacylglucosamine hydrolases, and acid sphingomyelinases (ASMases) [39].
2.4.2. Characteristic Features of Phages B1 and JA1 ORFs Absent in Phage K
Eleven ORFs present in both phages B1 and JA1 were absent in phage K (Table 6). No putative
function could be assigned to the majority of these ORFs based on BLASTP, InterProScan or HHpred
analysis, with the exception of phageJA1_084 (phageB1_087) and phageJA1_152 (phageB1_155), which
encoded homing endonucleases interrupting both the terminase large subunit and the DNA repair
protein, respectively. These homing endonucleases are site-specific DNA endonucleases capable of
initiating DNA breaks leading to repair and recombination event that results in the integration of
this endonuclease ORF into a gene that was previously lacking it [40]. The presence of these mobile
genetic elements is common among known staphylococcal phages of the subfamily Spounavirinae,
and these endonucleases ORFs are known to insert themselves into essential phage genes [21,41].
Additionally, HHpred analysis indicated ORFs PhageJA1_208 and PhageB1_214 to possess remote
homology to cell-degrading proteins. The majority of these ORFs were found to be located next to the
genome termini of JA1 and B1, with genes located in this region having been previously reported in
similar phages to be expressed early in phage development [35]. Such proteins are usually involved in
subversion of the host’s machinery to aid phage takeover [42,43].
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2.4.3. Comparison of Phages K, B1, and JA1 with other Similar Therapeutic Phages (Team1,
vB_SauM-fRuSau02, Sb-1 and ISP)
Four additional staphylococcal phages that originate in commercial phage therapeutic mixtures
are Team1, vB_SauM-fRuSau02, Sb-1 and ISP, as discussed earlier [19–24]. These phages were
also reported to possess wide host ranges towards a number of clinically relevant S. aureus strains.
Although similar, these phages have several feature differences from each other and from phages B1 and
JA1. Comparison of nucleotide identities (BLASTN) with phage K shows that they belong to the genus
Kayvirus (Supplementary Materials, Table S7) possessing genomes of similar sizes, apart from Sb-1,
being smaller than would be expected, suggesting the genome submission may have been incomplete
(Figure 3). Additionally, the arrangement of ORFs is quite similar. Furthermore, tRNA genes of these
phages were also examined. All seven phages were found to possess the same four tRNA genes
for methionine, tryptophan, phenylalanine, and aspartic acid (Supplementary Materials, Table S8).
The eleven ORFs which were present in B1 and JA1 but absent in K (Table 6, Supplementary Materials,
Figure S3) were similarly present in Team 1, vB_SauM-fRuSau02, Sb-1 and ISP. And likewise,
the ORFs present in K, but absent in both B1 and JA1, were also missing in these phages. However,
vB_SauM-fRuSau02 possesses a much shorter putative tail protein (RS_159) of 73 amino acids compared
to the phage K counterpart (PhageK_151) of 170 amino acids. Non-hypothetical proteins that differed
between these phages were a membrane protein (Phage B1_180, PhageJA1_177, and Phage_170) and
an ATPase-like protein (Protein id: CCA65911.1 for phage ISP). Other ORFs that differed among these
phages were mostly hypothetical proteins.
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Figure 3. Genome comparison of phage K with the six staphylococcal phages employed in commercial
phages mixture (B1, JA1, Team 1 [22–24], vB_Sau -fRuSau02 [21], Sb-1 [19] and ISP [20]) using
currently available annotations e ploying BLASTN and visualized with Easyfig.
S. aureus employ several defense strategies against viral attack [10,44] and these, such as restriction
modification systems [45] and CRISPR-Cas systems [46], may vary from strain to strain. These defenses
along with several variations encountered at the genetic level across phages B1, JA1, and K may explain
the differences in host ranges observed in this study.
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3. Materials and Methods
3.1. Bacterial Strains, Phage and Growth Requirement
Phages B1 and JA1 were isolated from a commercial phage cocktail purchased from the George
Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. The MRSA strains
utilized in this study were all acquired from the Irish National MRSA Reference Laboratory, Dublin,
Ireland [2] with the exception of DPC5246 and CIT281189, which are routine propagation strains
utilized in our laboratory [26,36]. These strains were routinely cultured in Brain Heart Infusion broth
(BHI; Sigma, St. Louis, MO, USA) at 37 ◦C with shaking or on BHI plates containing 1.5% (w/v)
bacteriological agar (Sigma). All strains were stocked in BHI containing 40% glycerol and stored at
−80 ◦C.
3.2. CsCl Gradient Purification
Isopycnic centrifugation through CsCl gradients was performed as previously described [47],
with a number of modifications. A high titer phage lysate (>1× 109 plaque forming units [PFU] mL−1),
was precipitated using polyethylene glycol (15% w/v PEG8000, 1 M NaCl) at 4 ◦C overnight and
centrifuged, after which the pellet was resuspended in TMN buffer (10 mM Tris-HCl pH 7.4, 10 mM
MgSO4·7H2O, 0.5 M NaCl). The resulting phage preparation was placed onto a CsCl step gradient
composed of 1.3, 1.5, and 1.7 g/mL layers and spun in a 100 Ti rotor (Beckman Coulter, Brea, CA, USA)
at 200,480 g for 3 h at 4 ◦C. The resulting phage preparations were dialyzed in Tris-HCl buffer (10 mM,
pH 7.5) at 4 ◦C.
3.3. Phage Host Range and Adsorption Study
Host range assay was performed for phages B1, JA1, and K using the plaque assay plating
technique (Tables 2 and 3). This was done in triplicate for three independent experiments. The efficiency
of plaquing (EOP) was determined by dividing the phage titer on each test strain by the phage titer of
the reference strain (S. aureus DPC5246, in the case of phages B1 and K, and S. aureus CIT281189 for
phage JA1) [48]. An adsorption assay was performed according to the protocol previously described
elsewhere with some modification [49]. Briefly, MRSA strains were grown to an optical density (OD)
of 0.2 at 600 nm (estimated cell count at 108 colony forming unit (cfu) mL−1) and 100 µL of cells were
mixed with 100 µL of respective phage titered at approximately 1 × 107 PFU/mL for a multiplicity
of infection (MOI) of 0.1. The resulting mixtures were incubated at room temperature for 5 min to
allow for phage adsorption. The bound phages were separated from the free phages by centrifugation
at 14,000 rpm for 5 min. Adsorption of the phage on each strain was determined by subtracting
the number of unbound phage (per mL) from the total input PFU/mL. Adsorption efficiency was
expressed as a percentage relative to the propagating strain DPC5246.
3.4. Transmission Electron Microscopy
Electron microscopic analysis was performed following negative staining of the CsCl gradient
prepared phages on freshly prepared carbon films with 2% (w/v) uranyl acetate. Electron micrographs
were taken using a Tecnai 10 transmission electron microscope (FEI Thermo Fisher, Eindhoven,
the Netherlands) at an acceleration voltage of 80 kV with a MegaView G2 CDD camera (EMSIS,
Muenster, Germany).
3.5. Phage DNA Isolation
Phage DNA extraction was performed on CsCl purified high titer phages. These were initially treated
with MgCl2 followed by pre-treatment with DNase and RNase for 60 min at 37 ◦C. Following that
subsequent treatment with SDS, EDTA and proteinase K with further incubation for 60 min at 55 ◦C.
DNA extractions were then performed on the pre-treated samples with phenol/chloroform/isoamyl
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alcohol (25:24:1 v/v/v) and chloroform/isoamyl alcohol (24:1 v/v). DNA precipitation was achieved
using sodium acetate and 95% ethanol. DNA quality and quantity were estimated using a Nanodrop
(ND-1000) and visualized following agarose gel electrophoresis
3.6. Phage DNA Sequencing
DNA sequencing was performed with a high throughput Illumina HiSeq system sequencing
(GATC Biotech, Konstanz, Germany). Library preparation was performed by DNA fragmentation
together with adapter ligation. The libraries were then measured and quantified on a Fragment
Analyzer and then sequenced to generate 2 × 300 bp paired-end reads. De novo assembly was
performed using CLC Bio Genomics Workbench v8.0 (Aarhus, Denmark).
3.7. Bioinformatic Analysis
Open reading frames (ORFs) for the sequenced phages were predicted with Glimmer [50] and
GenemarkS [51]. Putative functions were assigned to these ORFs using BLASTP (https://blast.ncbi.nlm.
nih.gov/Blast.cgi?PAGE=Proteins), HHpred (https://toolkit.tuebingen.mpg.de/#/tools/hhpred; [52])
and InterProscan (http://www.ebi.ac.uk/interpro/search/sequence-search; [53]). Transfer RNA
was predicted using tRNAscan-SE (http://lowelab.ucsc.edu/tRNAscan-SE/; [54]) and ARAGORN
(http://130.235.46.10/ARAGORN/; [55]). Potential promoters were predicted using MEME (Multiple
Em for Motif Elicitation) (http://meme-suite.org/tools/meme; [38]), followed by manual curation.
Potential Rho-independent terminators were identified using ARNold (http://rna.igmors.u-psud.
fr/toolbox/arnold; [56]) with Mfold QuikFold (http://unafold.rna.albany.edu/?q=DINAMelt/
Quickfold; [57]) using RNA energy rules 3.0 to verify predictions. Artemis Comparison Tool (ACT)
was used for the identification of feature variations between the genomes of phages, with homology
being assessed with BLASTN [58] Genome comparison maps between phages were visualized using
the Easyfig visualization tool [59]. K-like Staphylococcus phages used in comparative studies were K
(KF766114), Team 1 (KC012913), vB_SauM-fRuSau02 (MF398190), Sb-1 (HQ163896) and ISP (FR852584).
3.8. Nucleotide Sequence Accession Number
The genome sequence for phages B1 and JA1 were deposited into GenBank under the accession
numbers MG656408 and MF405094, respectively.
4. Conclusions
Host range of three highly similar phages was performed in this study, and it was identified
that phages B1 and JA1 from the Fersisi commercial phage mix had a much broader host range
in comparison to phage K on a representative Irish bank of clinical MRSA sequence type isolates.
Comparisons of their genomes lead to the identification of several ORFs absent in phage K, but present
in both phages B1 and JA1. These ORFs were also identified in several other staphylococcal phages
sourced from commercial phage mixtures (B1, JA1, Team 1 [22–24], vB_SauM-fRuSau02 [21], Sb-1 [19]
and ISP [20]), also with a reported wide host range. The exact role of these ORFs is currently unknown.
However, these ORFs along with several variations encountered at the genetic level between these
phages may, in part, explain their different host range. Unfortunately, information is lacking on
the influences of various phage resistance systems, which may be active in Staphylococcus aureus.
Phage research also needs to focus more on elucidation of the functions of hypothetical proteins to
allow greater understanding of how phages overcome such systems.
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A B S T R A C T
In recent years, the microbiological safety of powdered infant formula has gained increasing attention due to the
identification of contaminating C. sakazakii and its epidemiological link with life-threatening neonatal
infections. Current intervention strategies have fallen short of ensuring the production of infant formula that
is free from C. sakazakii. In this study, we describe the isolation and characterisation of three bacteriophages
(phages) and their application as a phage cocktail to inhibit the growth of C. sakazakii in different brands of
infant formula, while also assessing the phages ability to prevent biofilm formation. All three phages, isolated
from slurry, possess a relatively broad host range, verified by their ability to infect across genera and species.
When all three phages were combined and used as part of a phage cocktail, 73% coverage was obtained across all
Cronobacter strains tested. Optimum thermo-tolerance and pH stability were determined between 4 °C–37 °C,
and pH 6–8, respectively, well within the normal range of application of infant formula. Genome sequencing and
analysis revealed all the phages to be free from lysogenic properties, a trait which renders each favourable for
phage therapy applications. As such, the combined-phage preparation (3 × 108 pfu/mL) was found to possess a
strong bactericidal effect on C. sakazakii/C. sakazakii LUX cells (≤104 cfu/mL), resulting in a significant
reduction in cell numbers, to below the limit of detection (< 10 cfu/mL). This was observed following a 20 h
challenge in different brands of infant formula, where samples in the absence of the phage cocktail reached
concentrations of ~109 cfu/mL. The phage cocktail also demonstrated promise in preventing the establishment
of biofilm, as biofilm formation could not be detected for up to 48 h post treatment. These results highlight the
potential application of this phage preparation for biocontrol of C. sakazakii contamination in reconstituted
infant formula and also as a preventative agent against biofilm formation.
1. Introduction
Cronobacter spp. (formally Enterobacter sakazakii) consists of a
diverse group of Gram-negative, facultatively anaerobic, motile bacilli
belonging to the Enterobacteriaceae family (Iversen et al., 2007). The
genus comprises seven species: Cronobacter sakazakii, Cronobacter
malonaticus, Cronobacter turicensis, Cronobacter universalis, Cronobacter
muytjensi, Cronobacter dublinensis and Cronobacter condiment (Brady
et al., 2013; Joseph et al., 2012). In recent years, C. sakazakii has
gained significant attention as an emerging food-borne pathogen due to
the associated link between infectious disease and the consumption of
contaminated foods, in particular, reconstituted infant milk formula.
While C. sakazakii is responsible for causing severe clinical infections in
immunocompromised individuals of all ages, it is pre-term, low-birth
weight infants who are most at risk (FAO/WHO 2008; Healy et al.,
2010). Clinical symptoms of infection in infants include meningitis,
bacteraemia and severe forms of necrotising enterocolitis, with case
fatality rates ranging between 40 and 80% (Friedemann, 2009). These
high mortality rates and the fact that many survivors are very often left
with chronic neurological and developmental disorders, highlights the
damaging effect this organism has on infant health (Forsythe, 2005; Lai,
2001). Accordingly, The International Commission for Microbiological
Specifications for Foods has ranked C. sakazakii as a “Severe hazard for
restricted populations, life threatening or substantial chronic sequelae
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of long duration”, placing the organism in the same category as
Clostridium botulinum, Cryptosporidium parvum and Listeria monocyto-
genes (types A and B) (ICMSF, 2002).
C. sakazakii is ubiquitous in nature with many studies indicating
that plant material is its primary niche (in particular vegetables, fruits,
cereals, wheat, rice, herbs and spices). However, other more pertinent
sources also found to harbour this pathogen include powdered infant
formula (PIF) and milk powder manufacturing environments
(Friedemann, 2007; Kandhai et al., 2004).
C. sakazakii possess physiological traits which affords its ability to
survive in such environments and thus permit PIF to serve as a prime
vehicle for transmission to the immunocompromised infant. These traits
include, (1) resistance to desiccation and osmotic stress (Breeuwer
et al., 2003), (2) an extended temperature growth range (Iversen and
Forsythe, 2004), (3) thermo-tolerance compared to other Enterobacter-
iaceae found in PIF (Nazarowec-White and Farber, 1997a, 1997b), and
(4) the ability to form biofilms on a range of different materials
including polycarbonate which is often used to make babies bottles
(Iversen and Forsythe, 2004).
PIF is not manufactured as a sterile preparation and hence can
become contaminated with C. sakazakii during production. Although
the organism is effectively inactivated during pasteurisation
(Nazarowec-White and Farber, 1997a, 1997b), contamination is likely
to occur from the addition of non-sterile ingredients during manufac-
ture. Indeed, it has been suggested that PIF ingredients originating from
plant material, which have not been heat treated are a potential source
of C. sakazakii contamination (Healy et al., 2010). Other possible
sources of contamination include the use of non-sterile equipment
during processing or reconstitution, and from temperature abuse of the
reconstituted formula itself (Al-Nabulsi et al., 2009).
Capsular polysaccharides on the outer surface of C. sakazakii cells
play a central role in biofilm formation, giving the organism the ability
to attach and colonise a variety of surfaces including stainless steel,
glass, latex, polycarbonate, silicon and polyvinyl chloride (PVC)
(Iversen et al., 2004). The bacterial cells embedded in a matrix of
exopolymeric substances, are physiologically distinct from their plank-
tonic counterparts. These cells demonstrate changes in growth rate and
gene transcription and often exhibit a significantly higher tolerance to
antibiotics (≤1000 times higher) and other sanitising agents. The
presence of persister cells, the reduced metabolic activity present in the
inner layers of the biofilm and the decreased penetration of antibiotics
through the exopolymeric matrix, all contribute to this increased
resistance (Donlan and Costerton, 2002; Keren et al., 2004). As a
result, complete elimination is very often compromised and re-infection
commonly occurs.
Consequently, the microbiological safety of PIF is under continuous
scrutiny as a result of contaminating C. sakazakii and its epidemiolo-
gical link with life-threatening neonatal infections (Forsythe, 2005;
Himelright, 2002; Hunter and Bean, 2013). The destructive economic
impact the pathogen has on healthcare systems and PIF production
facilities due to contaminated product recalls is also apparent (Chenu
and Cox, 2009). Indeed, there is a growing requirement for the
development of new and effective mechanisms to further prevent C.
sakazakii contamination in both food, and the food processing environ-
ment.
Bacteriophages (phages) and their derivatives are well recognised
for their antibacterial properties, demonstrating promise as natural,
safe and effective alternatives for the prevention, treatment and/or
eradication of foodborne pathogens in a range of different foods and
food processing environments. These include, decontamination of live-
stock, sanitation of contact surfaces and equipment, in addition to
biocontrol of raw meats, fresh foods and vegetables (Endersen et al.,
2014; Goodridge and Bisha, 2011), cheese (Carlton et al., 2005), ready-
to-eat (RTE) foods (Bigot et al., 2011), skim milk (Ellis et al., 1973;
Endersen et al., 2013), and reconstituted infant formula (Kim et al.,
2007), all of which demonstrate their applicability for use at each stage
of the food production process. ListShield™, approved for use in the US
in 2006 as a processing aid to control Listeria monocytogenes in meat and
poultry products, marked the arrival of the first phage-based product to
the commercial marketplace in the Western world (Bren, 2006).
Following this significant development, several phage related products
have been approved for use in the US, including preparations active
against the prominent foodborne pathogens, E. coli O157:H7, Salmo-
nella, and additional preparations against L. monocytogenes (Endersen
et al., 2014; Goodridge and Bisha, 2011). The pioneering anti-listeria
phage-based preparation is now registered in Europe as an organic food
additive and has also been approved for use as a food processing aid by
the Food Standards Australia & New Zealand, highlighting the fact that
phage-based preparations are continuing to gain global acceptance as
safe and effective alternatives for the biocontrol of harmful foodborne
pathogens (Fsanz, 2012; Hodgson, 2013).
Here we report the isolation and characterisation of three phages
against the opportunistic, foodborne, infant formula pathogen, C.
sakazakii. In addition, we demonstrate the efficacy of the phages, used
as part of a phage cocktail, at inhibiting the growth of C. sakazakii in
four different brands of reconstituted infant milk formula while also
assessing the phages ability to prevent biofilm formation.
2. Materials and methods
2.1. Bacterial strains and growth media
The following strains were used in this study: C. sakazakii ATCC
BAA 894, C. sakazakii ATCC BAA 894 LUX, C. sakazakii DPC 6258, C.
muytjensi ATCC 51329, C. sakazakii ATCC 29004, and C. sakazakii DPC
8155. These were sourced from the Dairy Products Research Centre,
DPC, Moorepark, Fermoy, Co. Cork, Ireland. Strains were stored at
−80 °C and routinely grown on Luria-Bertani (LB) agar, in LB broth
and in some cases supplemented with 1% or 2.5% D-(+)-glucose at
37 °C. HiChrome™ Cronobacter spp. Agar, Modified (14,763, Sigma
Aldrich) was used for selective growth of C. sakazakii when necessary.
Selective growth of C. sakazakii ATCC BAA 894 LUX was achieved by
the addition of 500 μg/mL erythromycin to LB broth/agar.
2.2. Isolation of phages
Phages were isolated from slurry, sourced from a cattle farmer in
Clonakilty, West Cork, Ireland, using methods described previously
(Carlson, 2005). Briefly, each sample (5 mL) was added to equal
volumes of LB broth (Sigma Aldrich, UK), supplemented with 10 mM
CaCl2 (Sigma Aldrich) and inoculated with a mid-log phase C. sakazakii
ATCC BAA 894 culture. Samples were incubated overnight at 37 °C with
shaking. Samples were centrifuged at 4000g for 15 min to pellet cells
and debris. The supernatant was filtered through a 0.45 μM filter and
the filtrate was re-enriched with mid-log phage C. sakazakii culture two
more times. The supernatant obtained from the final enrichment step
was filter-sterilised and tested for the presence of viable infective
phages by adding 100 μL of the filtrate to 100 μL of early log phase C.
sakazakii cells in a 5 mL LB 0.4% w/v overlay agar tube tempered to
50 °C and subsequently poured onto the surface of a LB 1.5% w/v agar
plate. Plates were incubated at 37 °C overnight and then examined for
phage plaques.
2.3. Phage purification and amplification
Presumptive phages were purified by successive single plaque
isolation and were routinely propagated on C. sakazakii ATCC BAA
894 as previously described (O'Flaherty et al., 2005). Briefly, a single
isolated plaque was aseptically picked from a lawn of C. sakazakii ATCC
BAA 894 on LB agar using a sterile capillary tube and added to 100 μL
of early-log phase culture. The sample was incubated at 37 °C over-
night. The resulting lysate was centrifuged, filter sterilised and serially
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diluted followed by standard plaque assay on C. sakazakii, as described
previously. Single plaque purification was repeated twice, after which
purified phage was recovered. The phage titre was assessed using a spot
plaque assay method, where 10 μL of serial dilutions of each phage
suspension were spotted onto C. sakazakii seeded indicator plates.
Plates were incubated at 37 °C overnight and spot dilutions were
subsequently examined for the presence of plaques. High titre phage
suspensions were obtained by adding 5 mL of phage buffer (50 mM Tris
pH 8, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2) to a standard plaque
assay plate revealing confluent lysis. Phages were recovered by
aseptically running sterile hockey sticks across the surface of the agar
plate to physically recover the phages, incubating for 2 h at 37 °C with
shaking. The buffer was then recovered from the plate, centrifuged to
pellet debris and filter sterilised using a 0.45 μm filter. Again, phage
titres were assessed using a spot plaque assay technique as described
previously. The purified high-titre phage solutions were stored at 4 °C.
2.4. Phage DNA preparation
Phage DNA isolation and restriction analysis were carried out as
previously described (Kropinski and Clokie, 2009). Briefly, 18 μL of
1 mg/mL DNAse I (Fischer Scientific, 11873795) and 8 μL of 12.5 mg/
mL RNase A (Sigma-Aldrich) were added to 1.8 mL aliquots of phage
lysate. Samples were mixed and incubated at 37 °C for 30 min in order
to remove host genomic contaminants. Subsequently, 92 μL of 10% SDS
and 18 μL of 10 mg/mL proteinase K (Roche) were added. Following
further 30 min incubation at 65 °C, proteins were removed by two
chloroform steps. Equal volumes of chloroform: isoamyl alcohol: phenol
(24:24:1) (Sigma-Aldrich, Dublin, Ireland) was added, mixed thor-
oughly and centrifuged at 1500g for 5 min (repeated twice). The upper
layer was carefully removed and transferred to a new sterile tube. This
step was repeated using equal volumes of chloroform: isoamyl alcohol
(24:1), centrifuged for 5 min at 6000g. DNA was precipitated from the
sample using 0.3 M Sodium Acetate solution pH 5.2 and 100% ethanol
(2/3 volume of extract) following incubation at room temperature for
20 min. Samples were centrifuged for 20 min at 14000g. The DNA was
washed twice with 70% ethanol. DNA pellets were dried in a Rotovap
(DNA speed Vac, DNA 110, Savant, Instruments. Inc. Holbrook, NY) on
low power for 2–3 min to remove existing ethanol. DNA was re-
suspended in TE buffer pH 7.4 and dissolved at 55 °C for 1–2 h. The
quality and quantity of DNA was assessed by use of Nanodrop spectro-
photometer (Nanodrop ND 1000) and running DNA on an agarose gel
by electrophoresis followed by visualisation.
2.5. Genome sequencing and annotation
Phage DNA was sequenced with the Illumina MiSeq system at VIB
Nucleomics Core, Belgium for phages vB_CsaM_leB and vB_CsaM_leN
and at the University of Liverpool, Centre for Genomic Research, UK for
phage vB_CsaM_leE (herein referred to as leB, leN, and leE, respec-
tively). Libraries for phage leB and leN were created with a custom
NEBNext® Ultra™ DNA Kit and for phage leE the TruSeq DNA Nano LT
library Sample Preparation Kit was used. The quality of each library
preparation was assessed using the Agilent Bioanalyzer and Qubit
measurements before being sequenced with paired end reads of
2 × 250 bp for phage leE and 2 × 150 bp for phage leB and leN.
Reads were assembled for phage leB and leN with the CLC Bio
Genomics Workbench v7.0 (Aarhus, Denmark) and for phage leE with
the Spades genome assembler v.3.10 (St. Petersburg, Russia). Contigs
were resolved with average coverage of 964×, 2,182× and 2030× for
phages leB, leN and leE, respectively. Open reading frames (ORFs)
encoding potential proteins were predicted with Glimmer (http://www.
ncbi.nlm.nih.gov/genomes/MICROBES/glimmer_3.cgi) (Delcher et al.,
1999) and GenemarkS (http://exon.gatech.edu/genemark/genemarks.
cgi) (Besemer et al., 2001). Possible functions of these proteins were
predicted with BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.
cgi?PAGE=Proteins) with tRNA genes being predicted with ARAGORN
(http://130.235.46.10/ARAGORN/) (Laslett and Canback, 2004). Lin-
ear genome map comparison of the phages was created using Easyfig
(Sullivan et al., 2011) with comparison of genome sequences utilising
TBLASTX. Coregenes (Turner et al., 2013) was used for total proteome
comparisons between phages leB, leE, and leN to Enterobacteria phage
T4 (BLASTP threshold was set at 75%) with PHACTs being used to
predict the lifestyles of phages (http://www.phantome.org/PHACTS/
index.php) (McNair et al., 2012).
2.6. Accession numbers
The genomes of all three phages were submitted to Genbank under
accession numbers KX443552, KX431559 B and KX431560 for phage
leE, leB and leN, respectively.
2.7. Electron microscopy
Transmission electron microscopy (TEM) was performed as de-
scribed previously (Kelly et al., 2012b, Sambrook and Russell, 2006).
Briefly, a purified phage stock was prepared using CsCl2 gradient to
achieve a titre in excess of 108 pfu/mL. The sample was negatively
stained with 2% (w/v) uranyl acetate on freshly prepared carbon films.
Grids were analysed using a Tecnai 10 transmission electron micro-
scope (FEI Company, Eindhoven, the Netherlands) at an acceleration
voltage of 80 kV. Micrographs were taken with a MegaView G2 CCD-
camera (EMSIS, Münster, Germany).
2.8. Host range profiles of phages leB, leE, and leN
The host range of each phage was examined against 21 different
Cronobacter/Enterobacter strains, many of clinical origin, which were
sourced from the Dairy Products Research Centre, DPC, Moorepark,
Fermoy, Co. Cork, Ireland. Host range was determined by standard
plaque assay technique as described previously (O'Flaherty et al.,
2005).
2.9. Effect of thermal treatment on phage infectivity
For each phage, 3 × 250 μL phage suspensions (~1.0 × 108 pfu/
mL) were each placed either in the fridge at 4 °C or in water baths set to
37 °C, 45 °C, 55 °C, 60 °C, 72 °C and 90 °C respectively. Following 1 h
incubation, 10 μL volumes of serially diluted samples were spotted on
C. sakazakii ATCC BAA 894 seeded agar. Plates were left to dry and
placed in the incubator at 37 °C overnight. A thermocouple (Kane-May
KM330, Inlec, UK) was placed in a control tube containing 250 μL of
phage buffer to ensure the desired temperature of the phage suspension
was achieved for each experiment.
2.10. Effect of pH on phage infectivity
For each phage, 3 × 250 μL aliquots of each phage suspension
(~1.0 × 108 pfu/mL) were exposed to different pH values ranging
from pH 2.0 to pH 10.0. Phages were suspended in MP buffer [50 mM
Tris pH 8, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2], which had been
adjusted to desired pH values of 2.0, 4.0, 6.0, 7.0, 8.0, and 10.0,
respectively. The samples was incubated at 37 °C for 1 h, serially
diluted and spotted (10 μL) onto C. sakazakii ATCC BAA 894 seeded
agar. Plates were left to dry and the plates were incubated at 37 °C
overnight.
2.11. Preparation of phage cocktail
The phage cocktail was prepared by combining equal volumes of
each individual purified phage solution at ~109 pfu/mL. The high titre
phage preparation was stored at 4 °C until needed.
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2.12. Investigation of the antibacterial potential of the three phage cocktail
against C. Sakazakii ATCC BAA 894 in four different brands of
reconstituted infant milk formula
The three phage cocktail (~3 × 108 pfu/mL) was inoculated into
each of the four reconstituted infant milk formulae containing
~1 × 104 cfu/mL of C. sakazakii ATCC BAA 894 to a final volume of
10 mL, and incubated with shaking at 37 °C for 20 h. Standard plate
counts were performed on HiChrome™ Cronobacter spp. agar every 2 h
over the 20 h period to quantify surviving cells. This was achieved by
setting up a staggered experiment 12 h apart to account for the hours
that could not be monitored during the night. PIF was prepared
aseptically using sterile water (10% w/v) and mixed to ensure homo-
geneity. Positive controls were represented as samples containing the
inoculated culture at ~1 × 104 cfu/mL +MP buffer only. Negative
controls were represented as samples containing reconstituted infant
formula only. All experiments were performed in triplicate and
bacterial concentrations were expressed as mean cfu/mL counts and
standard deviation. In addition, parallel experiments were performed
using a LUX labelled C. sakazakii ATCC BAA 894 strain supplemented
with 500 μg/mL erythromycin in a microtitre plate assay and lumines-
cence was monitored using the in vivo IVIS Imaging System (Xenogen
Inc).
2.13. Biofilm formation
Static microtitre plate assays based on previous studies (Cerca et al.,
2007) were used to investigate biofilm formation but with modifica-
tions. Briefly, an overnight pure culture of the following strains (C.
sakazakii ATCC BAA 894, C. sakazakii ATCC 29004, C. sakazakii DPC
6528, C. sakazakii DPC 8155 and C. muytjensi ATCC 51329) were each
suspended in LB broth to an optical density equivalent of 0.5 McFarland
units. A selection of different broths (TSB, BHI and LB) supplemented
with 1% and 2.5% D-(+)-glucose and four different brands of infant
formula were tested for their ability to aid in biofilm formation. Cells
were subsequently diluted into the appropriate solution to give a
starting inoculum of ~1 × 104 cfu/mL. 200 μL of the test sample
(BHIglucose(g), LBg, TSBg or PIF) containing the culture was added
to a sterile 96 well plate. 200 μL of test media alone was added as a
negative control. All wells were seeded in triplicate. Microtitre plates
were incubated at 37 °C for 48 h to allow biofilm formation. Following
incubation, media was removed and wells were washed three times
with 200 μL of saline (Ringer's) solution using a multichannel pipette
(Gilson) to remove media and planktonic cells. Microtitre plates were
placed in a 50 °C incubator in an inverted position and allowed to dry
for 1 h. Formed biofilms were stained with 200 μL of 1% crystal violet
solution (Sigma Aldrich, UK) for 10 min at room temperature. The wells
were washed to remove excess dye and left to dry before visually
comparing the intensity of staining in the wells.
2.14. Biofilm prevention with phage cocktail
Following the identification of two C. sakazakii strains (C. sakazakii
ATCC BAA 894, and C. sakazakii DPC 6528) that were capable of
forming strong biofilms when grown in different types of infant formula
(outlined above, 2.13.), the ability of the phage cocktail to prevent
biofilm formation by these strains was investigated using a plate
staining and live cell count assay.
2.14.1. Plate staining assay
The plate staining assay was performed as per the biofilm formation
method described above with the following adjustments. At the start of
the assay, 50 μL of the phage cocktail (~3 × 108 pfu/mL) was added to
200 μL of C. sakazakii culture in one set of wells in the microtitre plate,
while 50 μL of MP buffer was added to a second set of wells also
containing 200 μL of C. sakazakii culture. PIF alone was used as a
negative control. The plates were incubated at 37 °C for 48 h, after
which the media was poured off and biofilms were stained as described
above. The stain was removed and the wells were washed gently. The
plates were left to dry, after which 30% glacial acetic acid was added to
solubilise the stain. The biofilm prevention ability of the phage cocktail
was assessed by examining the optical density of the wells spectro-
photometrically at OD590nm.
2.14.2. Live cell count assay
The live cell count assay was performed as per the plate staining
method with the following modifications. At the end of the 48 h
incubation period, the media was removed and biofilms were washed
three times with ringers to remove media and planktonic cells. Biofilms
were resuspended by mechanical scraping in 100 μL of saline solution
(Ringer's) and immediately diluted and plated on to HiChrome™
Cronobacter spp. agar plates to determine cfu/mL counts.
3. Results
3.1. Phage isolation and morphology
Following routine enrichments with the host bacterial strain C.
sakazakii ATCC BAA 894, phage leB, leE and leN were isolated from
slurry samples obtained from a cattle farmer in Clonakilty, Co. Cork,
Ireland. All three phages formed clear plaques on the host strain
following overnight incubation at 37 °C. Plaque size ranged from
2.0 mm to 4.5 mm in diameter on 0.4% semi-solid agar. Each phage
was purified by successive single plaque isolation and propagation on
the host strain. High titre phage suspensions of ~109 pfu/mL, were
recovered from LB agar plates using 5 ml of MP buffer and stored at 4 °C
until needed. Morphological characterisation of phages using TEM
indicated that each belonged to the family Myoviridae (Fig. 1). The
micrographs revealed phage leB, leE, and leN, to have moderately
Fig. 1. Electron micrographs of leB (a), leN (b), and of four phage particles of leE (c), with either extended or contracted (right) tail sheaths. Structural details: collar ( ), tail fibers folded
upwards along the tail sheath ( ), extended tail fibers with typical knee-like hinges (↑), baseplates (►). Uranyl acetate (2%) was used to stain the phages for transmission electron
microscopy.
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elongated heads accompanied by contractile tails, indicating that each
belongs to the family Myoviridae, subtype A2 (Ackermann, 2001).
Phage dimensions are represented in Table 1.
3.2. Results from genome sequencing and annotation
Through sequencing, genomes with sizes of 177,907 bp, 181,570 bp
and 179,516 bp were obtained for phages leB, leE and leN, respectively,
with a G + C% content of 45%. Following bioinformatic annotation a
total number of 281 ORFs, 284 ORFs and 286 ORFs were predicted for
phages leB, leE and leN, respectively, with it being possible to annotate
about 40% (107 ORFs, 111 ORFs and 109 ORFs for leB, leE and leN,
respectively) of their ORFs with a possible function (Supplementary
Table 1). Additionally, one tRNA gene for glycine was predicted to be
present in the genomes of all three phages (see supplemental data).
The genomes of these phage were found to be highly similar to each
other (99% identity with 94–99% coverage) with their closest known
relatives at the nucleotide level being found to be T4 like phages
Cronobacter phage GAP161 [JN882287.1] and Citrobacter phage
Margaery [KT381880.1] (98–99% identity with 92–97% coverage).
At the proteomic level phages leB, leE and leN were found to have
strong homology with Enterobacteria phage T4 [NC_00866] (Fig. 2),
with phage leB sharing 116 homologs and phages leE and leN sharing
117 homologs with that of T4..It has been suggested that phages which
share more> 40% of their proteins fall within phage genus boundaries
(Lavigne et al., 2009). As these phages were found to share> 40% of
their gene products they could be placed within the genus T4 virus.
PHACTs software confidently predicted that all these phages had
lytic lifestyles, with average probability values exceeded 0.5 for phages
leB (0.658), leE(0.663) and leN(0.659). Consistent with this prediction
was that genes for integrases, excisionases or phage repressors were not
identified in their genomes. Furthermore, no genes for toxins were
detected.
3.3. Phage host range
Host range results revealed that our phages infected 12 (leB), 12
(leE) and 13 (leN) of the 21 strains tested. All phages appeared to
predominantly infect strains within the C. sakazakii species possessing
the ability to plaque and lyse 10 (leB), 10 (leE) and 11 (leN) of 15C.
sakazakii strains tested. In addition, as evidenced by the presence of
plaques, all three phages were capable of infecting across genera and
species, lysing C. muytjensi strain ATCC 51329 and E. cloacae strain
NCTC 11933. However, when tested against other Enterobacter/
Cronobacter species (E. gergorviae NCTC 11431, E. cloacae NCTC
11590, C. malonaticus DPC 6531 and E. aerogenes NCTC 10006), lysis
was not evident. The combination of all three phages resulted in 73%
coverage across the Cronobacter strains tested (Table 2).
3.4. Effect of temperature and pH on phage infectivity
All phages were tested for their ability to retain infectivity following
exposure to a range of different temperature extremes. In general, it was
observed that all phage retained infectivity between 4 and 50 °C. While
a ~2.5 log reduction in titre was observed for phage leN following 1 h
exposure to 50 °C, the titres of phage leB and leE were reduced by ≤6
logs during this temperature challenge. No viable phages could be
recovered from the lysates exposed for 1 h to 60 °C, 72 °C or 90 °C
(Fig. 3A).
The effect of pH on phage infectivity was investigated by exposing
phage leB, leE and leN to a range of acidic, neutral and basic
environments for 1 h. In general, all three phages retained activity
over pH 6 to pH 10. However, when exposed pH 10 for 1 h, a 5 log, 3.5
log and 6 log reduction in phage titre was observed for phages leB, leE,
and leN, respectively. No viable phages could be recovered from lysates
following exposure to both pH 2 and pH 4 for 1 h (Fig. 3B).
Table 1
Phage dimensions.
Phage Head (nm) Tail length (nm) incl. collar and baseplate Free tail fibers (nm)
leB 119.4 ± 3.6 × 89.7 ± 3.6 (n= 6) 116.0 ± 1.5 (n= 5) Not visible on micrographs
leE 115.1 ± 3.5 × 90.3 ± 6.9 (n= 15) 113.8 ± 2.0 (n= 11) 111.5 ± 7.4 (n= 15)
leN 113.0 ± 4.1 × 91.9 ± 2.5 (n= 16) 114.6 ± 2.4 (n= 18) 114.0 ± 7.9 (n= 15)
Fig. 2. Linear map comparison of the genomes of Enterobacteria phage T4 and of Cronobacter sakazakii phage leB, leE and leN, created using EasyFig, utilising tBLASTx to make
comparison between genomes. The genome maps are comprised of blue arrows indicating locations of genes among the different phage genomes and lines between genome maps indicate
level of homology. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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3.5. Investigation of the antibacterial potential of the three phage cocktail
against C. sakazakii ATCC BAA 894 in four different brands of reconstituted
infant milk formula
Cronobacter phages leB, leE, and leN were combined as part of a
phage cocktail (~3 × 108 pfu/mL) to assess their ability to inhibit the
growth of Cronobacter sakazakii ATCC BAA 894 in four different brands
of infant formula. Bacterial counts of ~1 × 104 cfu/mL were used for
each biocontrol experiment, as this bacteria:phage concentration ratio
was determined as the maximum inhibitory limit to successfully
prevent outgrowth of C. sakazakii following the 20 h challenge. This
contaminating concentration of cells is well in excess of the expected
levels of C. sakazakii contamination typically found in reconstituted
powdered infant formula (< 1 cell/100 g of PIF) (van Acker et al.,
2001) and hence represents a clear indication of phage biocontrol
potential. Following a 5 h incubation period, C. sakazakii concentra-
tions were reduced to below the detection limit (< 10 cfu/mL) in
samples challenged with the phage cocktail. This level of inactivation
was maintained over the 20 h challenge, where samples in the absence
of the phage cocktail had reached bacterial concentrations in excess of
109 cfu/mL (Fig. 4). Parallel experiments, where the LUX labelled C.
sakazakii ATCC BAA 894 strain was employed to monitor cell viability,
gave a similar result. Luminescence could not be detected from the
wells challenged with the phage cocktail over the 20 h period, where
significant relative light units (RLUs) were detected in the wells
containing C. sakazakii LUX cells + MP buffer only (Fig. 5). At the
end of the assay all wells were serially diluted and plated to determine
the number of viable cells present in the sample. While the wells
containing C. sakazakii LUX strain alone had reached a concentration of
~109 cfu/mL, bacterial concentrations were reduced below the limit of
detection (< 10 cfu/mL) in the wells challenged with the phage
cocktail.
3.6. Biofilm formation
Static microtitre plate assays were used to investigate biofilm
formation by selected Cronobacter strains. Strain selection was depen-
dant on individual phage infection profiles when tested against the 21
Cronobacter strains. Based on phage susceptibility testing (Table 2), five
strains were selected for biofilm formation assessment. Biofilm forma-
tion experiments were performed in BHI, TSB and LB broths, supple-
mented with 1% and 2.5% glucose and also in four different brands of
Table 2
Host range of Cronobacter phages leB, leE, and leN, where phage lysis is represented in cfu/mL. (−) denotes – no lytic activity. Strains were obtained from the Dairy Products Research
Centre, DPC, Moorepark, Fermoy, Co. Cork, Ireland.
Strain name Origin Phage lysis (cfu/mL)
leB leE leN
C. sakazakii ATCC BAA 894 Powdered infant formula 1.35E + 08 1.20E + 08 1.01E + 08
C. sakazakii DPC 6529 Tracheal aspirate − − 5.10E + 02
C. sakazakii DPC 6522 Blood 8.00E + 01 1.19E + 02 2.10E + 02
C. sakazakii DPC 6523 Cerebral spinal fluid − − −
C. sakazakii NCT 8155 Tin of dried powdered milk 1.20E + 08 1.17E + 09 1.05E + 09
C. muytjensi ATCC 51329 − 2.20E + 09 1.20E + 08 1.90E + 07
C. sakazakii DPC 6524 Stool − − −
C. sakazakii DSM 4485 Child's throat 7.50E + 05 5.00E + 01 1.70E + 02
C. malonaticus DPC 6531 Brain tumour − − −
C. sakazakii ATCC 29004 − 1.89E + 07 2.70E + 08 4.50E + 08
C. sakazakii DPC 6530 Bronchial alveolar lavage 4.20E + 02 3.30E + 04 6.80E + 04
E. cloacae NCTC 11933 Human/clinical isolate 1.00E + 01 1.57E + 08 1.00E + 02
C. sakazakii DPC 6527 Blood 4.00E + 01 3.10E + 02 2.00E + 01
E. gergorviae NCTC 11431 Human urinary tract − − −
E. cloacae NCTC 11590 − − − −
E. aerogenes NCTC 10006 Sputum − − −
C. sakazakii DPC 6526 Blood 1.10E + 02 1.98E + 09 4.00E + 01
C. sakazakii ATCC 12868 − − − −
C. sakazakii DPC 6528 Cerebral spinal fluid 7.80E + 07 6.50E + 08 8.70E + 07
C. sakazakii DPC6525 Urine − − −
C. sakazakii NCTC 11467 Human throat 1.76E + 08 3.10E + 02 2.00E + 01
Fig. 3. (A) Effect of temperature on phage viability following 1 h exposure to 4 °C, 37 °C, 45 °C, 50 °C, 60 °C, 72 °C, and 90 °C. (■) represent an average of initial phage titres for all three
phages tested. ( ), ( ), and ( ) columns represent phage leB, leE, leN 1 h temperature challenge experiments, respectively. Assays were performed in triplicate and phage titres were
expressed as the mean ± standard deviation. (B) Effect of pH on phage viability following 1 h exposure to acidic and alkaline environments. (■) represent an average of initial phage
titres for all three phages tested. ( ), ( ), and ( ) represent leB, leE, and leN, 1 h pH challenge experiments. Assays were performed in triplicate and phage titres were expressed as the
mean ± standard deviation.
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Fig. 4. Growth inhibition of C. sakazakii ATCC BAA 894 using the phage cocktail in four different brands of reconstituted infant milk formula (PIF1, PIF2, PIF3, and PIF4). Dark grey lines
represent C. sakazakii grown in the absence of the phage cocktail. Light grey lines represent C. sakazakii grown in the presence of the phage cocktail (~3 × 108 pfu/mL). Growth
inhibition of C. sakazakii was determined by cfu/mL counts. Assays were performed in triplicate and bacterial concentrations were expressed as the mean ± standard deviation.
Fig. 5. Bioluminescence assay demonstrating the biocontrol potential of the phage cocktail following a 20 h challenge against C. sakazakii ATCC BAA 894 LUX in PIF1 brand of
reconstituted infant milk formula. PIF1 is representative of PIF2, PIF3, and PIF4. Lane 1 contains PIF alone. Lane 2 contains C. sakazakii LUX +MP buffer. Lane 3 contains C. sakazakii
LUX + the phage cocktail at ~3 × 108 pfu/mL.
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reconstituted infant milk formulae. Wells were inoculated with the
selected Cronobacter strains and incubated at 37 °C for 48 h, followed by
the addition of a 1% crystal violet stain to allow for direct visualisation
of biofilms. It was found that the five Cronobacter strains were incapable
of forming biofilms in BHI, TSB and LB alone and when supplemented
with different concentrations of glucose (results not shown). However,
C. sakazakii ATCC BAA 894 and C. sakazakii DPC 6528 were found to be
strong biofilm producers when grown in each of the four different
brands of PIF tested (Fig. 6).
3.7. Biofilm prevention - plate staining and live cell count assay
The first step of biofilm formation is initial attachment of bacteria to
a solid surface. Accordingly, the effect of a high-titre, three-phage
preparation (~3 × 108 pfu/mL) was assessed for its ability to prevent
biofilm formation by C. sakazakii ATCC BAA 894 and C. sakazakii DPC
6528 in different brands of infant formula. Static microtitre plate assays
were used and monitored by plate staining and live cell count assays.
Plates were stained following the 48 h biofilm prevention challenge.
The stain was subsequently solubilised and measured at OD590nm to
further assess the ability of the phage cocktail to prevent biofilm
formation. This data is presented in Fig. 7. Results revealed the phage
cocktail to be very effective at preventing biofilm formation, which was
evident when compared to the control wells where strong biofilm
formation was observed. In addition, parallel plate count experiments
were performed in conjunction with the plate staining and solubilisa-
tion assays. Following the 48 h biofilm prevention challenge, bacterial
concentrations were reduced to below the limit of detection (< 10 cfu/
mL) in the wells containing the phage cocktail, when compared to the
control wells, where bacterial growth had reached levels of ~109 cfu/
mL, again confirming the strong anti-biofilm potential of the phage
cocktail against C. sakazakii in different brands of infant formula.
Fig. 6. Biofilm formation by Cronobacter spp. after 48 h incubation at 37 °C in different brands of reconstituted infant formulae. Confirmation of strong biofilm formation by C. sakazakii
ATCC BAA 894 and C. sakazakii DPC 6528 is indicated by intense crystal violet staining in wells. (For interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
Fig. 7. Biofilm plate staining and solubilisation assays demonstrating the efficacy of the phage cocktail at preventing biofilm formation by C. sakazakii ATCC BAA 894 and C. sakazakii
DPC 6528 following a 48 h challenge. () PIF only, () PIF containing C. sakazakii cells and MP buffer, and () PIF containing C. sakazakii cells and the three phage cocktail.
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4. Discussion
Consumption of contaminated reconstituted infant milk formula
and concomitant C. sakazakii infections in infants and neonates has
resulted in international efforts to improve existing pathogen control
processes. Current intervention strategies have fallen short of providing
powdered infant formula that is free from C. sakazakii contamination.
Many novel technologies have been proposed in an effort to address this
problem, some of which include, the use of hot water, gamma
irradiation and high pressure processing to inactivate the pathogen
prior to ingestion (Edelson-Mammel and Buchanan, 2004; Gonzalez
et al., 2006; Lee et al., 2006). The natural biotherapeutic properties of
phages are well recognised throughout the world, with many studies
providing promising evidence of their biocontrol potential against
several leading and emerging foodborne pathogens, while also demon-
strating their suitability for use at each stage of the farm-to-fork
continuum (Endersen et al., 2014; Goodridge and Bisha, 2011).
The rationale and motivation for performing the current study
relates to the aforementioned reconstituted infant milk formula dilem-
ma, and its associated health risks, in addition to the possibility of
employing naturally occurring phages to alleviate this problem. We
describe the isolation and characterisation of three novel Cronobacter
phages and subsequent utilisation of a three phage preparation for
biocontrol of C. sakazakii in different brands of infant formula. In
addition to the activity and stability of the phages in infant formula, the
anti-biofilm potential of the phage cocktail was also demonstrated.
Three Cronobacter phages were isolated following routine enrichments
of a variety of different environmental samples, including soil, slurry,
activated sludge, river water, moss, grass, and wheat. While multiple
phages were isolated from these sources, three phages which demon-
strated particular promise for use as biocontrol agents against C.
sakazakii were selected for further characterisation. Sewage has been
recognised as a primary niche for many Enterobacteriaceae, so it is not
uncommon that these and other Cronobacter phages were isolated from
effluent environments (Kim et al., 2007; Zuber et al., 2008).
It is well documented that temperate phages from Enterobacteriaceae
are known to harbour important bacterial virulence genes that can be
readily transferred between bacteria. Determining phages to be absent
of lysogenic capabilities is a primary consideration that must be taken
into account if they are to be used in food related applications (Brüssow
et al., 2004; Faruque and Mekalanos, 2012). As these phages have been
determined to have lytic lifestyles and do not possess genes for toxic
proteins they meet the required properties of phage intended for phage
therapy applications. In addition, these phages have been determined to
belong to the phage genus of.T4 virus,.phages from this genus have
been deemed safe for phage therapy applications (Bruttin and Brüssow,
2005; Denou et al., 2009).
Phage susceptibility was assessed using 21 strains from Cronobacter/
Enterobacter genera. The broad host range attributed to phages leB, leE,
and leN correlates well with previous findings. Loessner et al. (1993),
demonstrated the broad host range of Enterobacter cloncae isolated
phages, which were capable of cross infecting Panteo agglomerans, C.
sakazakii, E. coli and Serratia marcescens (Loessner et al., 1993). In
addition Zuber and co-authors also observed the broad host range
capabilities of five combined E. sakazakii phages with an infection
profile extending across several genera (Zuber et al., 2008).
Determining the environmental stability of phages considered for
biocontrol in food and the food processing environment is essential.
Common environmental extremes often associated with the food and
food industry include low pH and high temperature pressures.
Establishing the stress limits of each phage, permits appropriate and
optimal application, and more effective biocontrol results overall. Each
of the three phages were challenged for their ability to initiate host
infection following exposure to a range of pH and temperature
extremes. In general, all three phages retained maximum infectivity
between pH 6 and pH 8. These findings compare well with those
previously demonstrated, where the researchers found that E. coli
phage T7 demonstrated optimum pH stability between pH 6 and pH 8
(Kerby et al., 1949). Similarly, in another study, phage T4 demon-
strated optimum pH stability from pH 6–7.4 (Kłak et al., 2010), whereas
coliphage λ demonstrated very high stability across a wide pH range,
where no significant decrease in titre was observed from pH 3–11
(Jepson and March, 2004). Temperature plays a fundamental role in the
survival of phages. Optimal attachment, penetration, multiplication and
the length of the latent period (in the case of temperate phages) are
often dictated by temperature (Nasser and Oman, 1999; Olson et al.,
2004; Yates et al., 1985). Higher than optimal temperatures are thought
to extend the latent period, while lower than optimal temperatures are
often thought to result in a reduced multiplication rate (Tey et al.,
2009). In this current study, phages leB, leE, and leN were found to
retain infectivity from 4 to 50 °C, with optimum infectivity occurring
between 4 and 37 °C. Yang et al. (2010) evaluated the temperature
stability of Acinetobacter phage AB1 which showed a higher tolerance to
extreme temperatures, compared to phage leB, leE, and leN. Phage AB1
was very heat stable at 50 °C and 60 °C, as only a slight drop in phage
titre was observed following a 1 h challenge. At 70 °C a significant
number of the phages were inactivated, with only 0.52% of viable
phages remained in the sample following 1 h incubation. Similarly, at
90 °C,> 99% of the phages had lost their infective ability following
15 min exposure to this temperature (Yang et al., 2010). In another
study, the thermo-tolerance of staphylococcal phages was evaluated in
milk. Researchers found that these phages were most stable when
maintained at 4 °C for 8 h, while observing a 20–30% increase in phage
inactivation when challenged at 22 °C and 37 °C, respectively. While
both phages survived very short exposure to high temperature extremes
(72 °C for 15 s), phage titres were reduced below the limit of detection
after 1 min (Garcia et al., 2009).
In recent years, the application of phages for biocontrol of harmful
pathogens in both pre- and postharvest food environments has become
a noteworthy treatment alternative due to the increasing worldwide
problem of antibiotic resistance and the reduction in the development
of novel technologies for pathogen control. In this study, phage
mediated killing and growth inhibition was demonstrated using a
three-phage cocktail against C. sakazakii in four different brands of
infant formula. Overall, it was found that the phage cocktail was
effective at reducing contaminating C. sakazakii cells below the limit of
detection (< 10 cfu/mL) when bacterial concentration were used at a
starting concentration of ≤1 × 104 cfu/mL. This bacteria to phage
concentration ratio was the maximum inhibitory limit to successfully
prevent outgrowth of C. sakazakii over the 20 h challenge. It is
interesting to note that despite slight differences in formula constitu-
tion, the growth rate of C. sakazakii was not affected for all formulas
tested, nor did it impede phage infection. Our biocontrol results were
similar to those outline by Zuber et al. (2008), who found that a high
dose of 108 pfu/mL of phage could effectively sterilise broth contami-
nated with both high (106 cfu/mL) and low (102 cfu/mL) pathogen
counts (Zuber et al., 2008). In addition, Kim et al., 2007 reported
inhibition of C. sakazakii at a range of different incubating temperatures
when high titre 109 pfu/mL single phage suspensions were used (Kim
et al., 2007). Both Zuber et al. (2008), and Kim et al. (2007) also
reported that when challenging low numbers of the contaminating
pathogen with a reduced dose of the phage preparation, a delay in
phage replication was evident up until bacterial counts had reached
~104 cfu/mL. Only after crossing this threshold did phage replication
occur but overall did not result in complete sterilisation of the sample.
This would suggest that high concentrations of phage-based prepara-
tions are needed for complete sterilisation of a low quantity of target
cells (Kasman et al., 2002; Weld et al., 2004). It is reported that the
level of C. sakazakii contamination in PIF is very low (< 1 bacterial
cell/100 g) (Holý and Forsythe, 2014), therefore improper handling is
thought to contribute to bacterial growth and subsequent development
of infection among low birth weight infants and neonates. The
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contaminating levels of C. sakazakii used in this study were much
higher than levels typically found in PIF which demonstrates the
efficacy of this phage cocktail for biocontrol of C. sakazakii in
reconstituted infant formula.
Many phage-based intervention strategies have been documented
against biofilm formation (Doolittle et al., 1995; Kelly et al., 2012a).
Biofilms are a significant source of repeat contamination in dairy
manufacturing plants, threatening the quality and safety of the
manufactured produce, in addition to causing extensive economic
losses to the food manufacturing industry due to produce recalls and
corrosion of equipment (Gram et al., 2007). In addition, the persistence
of foodborne pathogens, like C. sakazakii, on feeding areas, on the
surfaces of equipment used in formula preparation, and within enteral
feeding tubes, are also thought to contribute to neonatal outbreaks (Kim
et al., 2007). Due to the high fatality rate associated with C. sakazakii
infection among infants and neonates (up to 80%), the destructive
nature of the organism towards survivors, the ability of C. sakazakii to
form biofilms and because of the problems associated with biofilm
treatment and removal, it is clear that biofilm prevention is the
preferable biocontrol option. We evaluated the biocontrol potential of
the phage cocktail for its ability to prevent biofilm formation. Results
indicated that the phage cocktail was very effective in preventing the
establishment of biofilm where biofilm formation could not be detected
for both strains tested for up to 2 days post-treatment. These results
were similar to those outlined by Kelly et al. (2012a, 2012b), who
demonstrated the efficacy of a modified phage cocktail for the preven-
tion of Staphylococcus aureus biofilm formation. These researchers
observed complete inhibition of biofilm formation over a 48 h time
period (Kelly et al., 2012a). In addition, other studies have described
the use of phages in an attempt to reduce biofilm formation. Hydrogel-
coated catheters were impregnated with phage preparations and
resulted in an approximate 90% reduction in both Proteus mirabilis
and Escherichia coli formed biofilms when compared with un-treated
controls (Carson et al., 2010). The anti-biofilm formation potential
demonstrated by the phage cocktail in this study is promising and may
have potential in future applications as perhaps a stand-alone treatment
or used in conjunction with alternative antibacterials for the control
and/or eradication of C. sakazakii contamination in food and the food
production environment.
5. Conclusion
International efforts to develop novel strategies to improve the
microbiological safety of PIF are ongoing. Although many advances in
pathogen control have been made in recent years, cost and efficiency as
well as the safety of preparation and nutritional stability are a problem.
C. sakazakii contamination of PIF still remains an issue for public health
concern. Phages have long been recognised for their inherent ability to
control pathogens in food and food related environments, where other
treatments have failed to do so. More and more, these non-destructive
particles are continually gaining acceptance around the world as a
viable alternative to antibiotics, and other treatment methods following
the rise of multi-drug resistant bacteria. Accordingly, this study has
presented three phages active against the infant formula associated
pathogen, C. sakazakii. The phages were characterised in terms of
temperature and pH stability and were combined to demonstrate the
efficacy of using a three phage cocktail for biocontrol of C. sakazakii in
four different brands of infant formula. In addition, their ability to
effectively inhibit biofilm formation was also established. Our results
highlight the promising potential of these phages for biocontrol of C.
sakazakii contamination in infant formula and also as preventative
biotherapeutic agents against biofilm formation. It should be noted that
the isolation of additional phages capable of inactivating more resistant
strains of C. sakazakii is a worthwhile endeavour. While 73% coverage
is impressive, it could certainly be improved upon. Additional studies
are now required in order to further this concept into practical use.
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Abstract
Bacteriophages (phages) are viruses that infect bacterial hosts, and since their
discovery over a century ago they have been primarily exploited to control
bacterial populations and to serve as tools in molecular biology. In this
commentary, we highlight recent diverse advances in the field of phage
research, going beyond bacterial control using whole phage, to areas including
biocontrol using phage-derived enzybiotics, diagnostics, drug discovery, novel
drug delivery systems and bionanotechnology.
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Introduction
Bacteriophages (phages) are viruses that specifically infect 
bacteria. After their discovery in 1915 by Twort and 1917 by 
d’Herelle, these agents were initially used to treat bacterial infec-
tions, although widespread acceptance was limited owing to 
lack of understanding of phage biology and the development of 
antibiotic therapy in the 1940s1. With antibiotic resistance becom-
ing problematic in the late twentieth century2, there was a renewed 
interest in phage therapy research. Alongside this application, 
and indeed the fundamental role that phage research played in 
the understanding of molecular biology, phage research has led 
to the development of new technologies not only for therapy and 
biocontrol but also for bacterial detection, drug delivery, drug 
discovery, and nanotechnology.
Antibacterials and biocontrol
In addition to the well-documented cases of using wild-type 
phages as tools to eliminate pathogenic bacteria in infected 
humans3 and in foods4, the phage-encoded peptidoglycan hydro-
lases called endolysins have also been exploited in purified 
form to rapidly lyse bacterial cells5. The Gram-positive phage 
endolysins generally contain at least one enzymatic domain and a 
cell-wall-binding domain. Chimeric endolysins have recently been 
developed by fusing enzymatic domains to alternative cell-wall-
binding determinants, thus altering endolysin behaviour and host 
range6. In the case of Gram-negative bacteria, the outer membrane 
is a barrier to exogenously added endolysin reaching the pepti-
doglycan target. Thus, the fusion of polycationic peptides to the 
Gram-negative endolysin facilitates outer membrane penetration 
allowing these new so-called Artilysin®s access to the Gram-
negative peptidoglycan7. Recent research has also reported a 
phage endolysin (from a Streptococcus pyogenes phage) with the 
ability to cross mammalian cell membranes. Its endolysin, PlyC, 
was found to consist of two subunits, one of which is proposed 
to bind to the eukaryotic cell membrane, facilitating entry by 
endocytosis8. These are major breakthroughs in endolysin 
research, and, with further investigation and testing, similar 
enzymes may be discovered/engineered and used in the future to, 
respectively, treat infections caused by Gram-negative bacteria 
and intracellular bacterial infections.
A recent advance in the area of antibiotic therapy has been the 
exploitation of phages to control antibiotic-resistant bacteria. 
Phages have been engineered to deliver CRISPR-Cas nucleases 
into antibiotic-resistant bacterial cells, and, in doing so, researchers 
have been able to harness the specific DNA-cleaving capacity 
of CRISPRs to knock out antibiotic resistance sequences, render-
ing resistant organisms antibiotic sensitive9. The use of phages 
as delivery vehicles ensures the specificity required in biocontrol. 
The wider exploitation of phages as delivery systems is discussed 
below.
Bacterial diagnostics
Phage virions and their encoded proteins can also be useful for 
the detection and specific identification of bacteria. The sim-
plest of these is where a standard number of specific phages are 
incubated with a food material or some other test sample. If the 
bacterial target is present and viable, detectable phage numbers will 
increase through amplification on the pathogen. Modifications of 
this method can generate results more rapidly, and in the case of 
Yersinia pestis, Sergueev et al., for example, developed a quantita-
tive real-time PCR to detect the increase in phage DNA instead of 
traditional plaque assays10. Reporter phages can also detect bacteria 
through infection without needing cell lysis and progeny phages. 
In this case, the phage genomes are modified to carry a biolumi-
nescence or fluorescence gene that the phage alone cannot express. 
Upon injection of the phage DNA into its host, active biolumi-
nescent or fluorescent proteins are synthesized, facilitating visual 
detection. Recently, Zhang et al. engineered an Escherichia coli 
0157:H7 reporter phage containing Luciferase NanoLuc (Nluc)11 
and with it detected as few as five CFU of the E. coli by biolumines-
cence in a complex food matrix within nine hours12.
Reporter phage assays have also been adapted to assess drug 
sensitivity in the target bacterium. A Mycobacterium tuberculosis 
(TB) fluorophage, ϕ2GFP10, has been shown to detect TB in the 
complex matrix of a sputum sample, but also when rifampin or 
kanamycin are included in the assay, fluorescence was shown to 
be detectably diminished in sensitive cells in comparison with 
antibiotic-resistant variants13. Advantages of using whole phages 
for the detection of bacteria are that only viable bacterial cells 
are detected, bacterial host specificity is excellent, and phage 
cultivation is relatively inexpensive (however, lytic activity of 
a reporter phage should ideally be inactivated to ensure that the 
bacterial targets are not prematurely destroyed).
Phage receptor-binding proteins (RBPs) have also been used 
successfully in bacterial detection and identification. The 
receptor-binding domain of the RBP in Campylobacter phage 
NCTC12673 was used to create a simple glass slide agglutina-
tion test for Campylobacter, and when fused to green fluorescent 
protein, the receptor-binding domain allowed the detection of 
Campylobacter jejuni and Campylobacter coli isolates through 
fluorescent microscopy14. Phages, because of their vast diver-
sity, provide a plentiful source of host-specific proteins to create 
simple identification tests such as the agglutination assay men-
tioned above specifically for Campylobacter. In this regard, whole 
phage and phage RBPs have been successfully attached to biosens-
ing surfaces for bacterial detection, allowing for high specificity. 
Of the two, the RBPs are simpler and easier to attach. In addi-
tion, they can be recombinantly produced and are reported to have 
better stability than antibodies15. Optimization of phage densities 
and attachment to biosensing surfaces is still ongoing16.
In the context of detection, the phage endolysins (discussed 
earlier) can also have a role when used instead of traditional 
DNA extraction reagents. It was shown that the peptidoglycan of 
Staphylococcus aureus is degraded more rapidly by staphylococ-
cal endolysin ClyH than by lysostaphin, thus shortening the DNA 
sample preparation for real-time PCR when the endolysin was 
employed17. Phage display, which involves genetically modifying 
a phage virion so that a foreign peptide is displayed on the surface 
(discussed further below), can also be exploited in bacterial 
detection systems. Lee et al. created a phage that displayed two 
different peptides, one with an affinity to gold nanoparticles and 
another with specificity to a target protein. By measuring the 
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ultraviolet absorbance of this phage, they could detect as little as 
25 femtomoles of their target antigen18. These modified phages 
have also been incorporated into systems capable of in-the-field 
real-time detection using engineered phage displaying peptides 
capable of binding to a magnetoelastic resonator as well as the 
target analytes, such as bacteria and endospores19–21.
Drug discovery and phage-based drug delivery systems
Since phage display was first described in 1985 by Smith22, it has 
seen numerous applications in the identification of receptor and 
ligand interactions of infectious diseases and cancers23,24, with these 
developments allowing for drug discovery25 and vaccine design26. 
Phage display is now allowing the modification of phages into 
vehicles (nanocarriers) for chemotherapeutic drug delivery by 
the attachment of a drug to the phage surface and presentation of 
peptides on the surface of that phage with specificity to a ligand 
of interest. Such constructs have even been designed to target 
non-host bacteria, including mammalian cells27. These phages, 
displaying therapeutic peptides, can even be designed to pass 
the blood–brain barrier28, and such constructs could thus have 
potential in the treatment of diseases such as Alzheimer’s and 
Parkinson’s. Phages with an affinity to specific cell receptors, such 
as those overexpressed in cancer cells, may be exploited beyond 
drug delivery to allow for simultaneous target detection by 
displaying diagnostic reporter molecules or by detection of bound 
phage DNA by real-time PCR29,30.
Empty phage capsids are also being employed as carriers, with 
studies demonstrating the potential to encapsulate RNA mol-
ecules, peptides, and therapeutic compounds31–33. Phage capsids 
or virus-like particles (VLPs) have also been modified to present 
ligands on their surface to allow the delivery of encapsulated RNA-
guided endonucleases to specific cell types for in situ genome 
editing34. When phages are used as nanocarriers to deliver chemo-
therapeutic drugs for cancer treatment, drug half-life is extended 
and toxicity is focused only on the site of interest, lessening 
damage to body tissues35. Capsid-based carriers have also been 
developed by fusing drug-loaded liposomes to capsid proteins dis-
playing peptides with binding specificity to a particular target36.
Biotechnology
Genetically modified filamentous phages have been used in 
material synthesis to construct nanowires and films for semi-
conductor applications37, piezoelectric energy generation38, and 
photo-response properties39. These materials have been used to 
create devices such as ion batteries and catalysts40,41, with phage 
M13-based nanowires also being constructed into scaffolding to 
allow guided cell growth for human tissue formation42.
Phage-derived enzymes, which have formed part of a core 
toolbox in traditional molecular biology, are now being applied 
to novel concepts. Phage RNA polymerase and ribonuclease 
H are being used to create in vitro genetic circuits that have 
potential future applications in nanodevices and the regulation of 
processes within artificial cells43. Recombinases are seeing use 
in these constructions by extending memory capabilities to these 
circuits44. These enzymes are also being used to create novel tools 
for bacterial genome editing and accelerated evolution45,46. It is 
noteworthy that many past phage-dedicated reviews have not sat-
isfactorily encompassed the recent advances of phage applications 
in nanomedicine; a recent excellent article comments in a 
comprehensive way on the many roles and opportunities of phages 
as nano-therapeutics, bioimaging probes, biomimetic biomateri-
als, tissue regenerative scaffolds, matrices for directing stem cell 
fate, and probes for detecting disease biomarkers, among numerous 
others47.
Summary
This commentary provides a snapshot of the increasing diversity 
of phage research in recent years and shows that it is advancing 
rapidly and that new applications are being reported frequently. 
Since the discovery of phages a century ago, their research focus 
has diversified from applying these agents to simply treat bacterial 
infections to a broad range of useful functions including biocontrol, 
diagnostics, drug discovery, and drug delivery as well as several 
applications in nanomedicine.
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Genome Sequence of Jumbo Phage vB_AbaM_ME3 of Acinetobacter
baumanni
Colin Buttimer,a Lisa O’Sullivan,a Mohamed Elbreki,a Horst Neve,b Olivia McAuliffe,c R. Paul Ross,c Colin Hill,d Jim O’Mahony,a
Aidan Coffeya
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Bacteriophage (phage) vB_AbaM_ME3 was previously isolated fromwastewater effluent using the propagating host Acinetobac-
ter baumanniiDSM 30007. The full genome was sequenced, revealing it to be the largest Acinetobacter bacteriophage sequenced
to date with a size of 234,900 bp and containing 326 open reading frames (ORFs).
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Acinetobacter baumannii has emerged in recent times as an im-portant nosocomial pathogen. Health care-acquired A. bau-
mannii infections include pneumonia and urinary tract and
bloodstream infections (1). There is only a small number of bac-
teriophages (phages) with genomes greater than 200 kbp (termed
“jumbo” phages) that have had their genomes sequenced to date.
Most of their encoded proteins do not have any homologues in
current sequence databases, and the diversity of these phages has
been great enough that it has limited comparative genomics stud-
ies (2).
A phage with the ability to lyseA. baumannii strain DSM 30007
was isolated from effluent obtained from a wastewater treatment
plant in Cork, Ireland. Transmission electron microscopy re-
vealed that the phage belonged to the Myoviridae family, and ac-
cording to nomenclature proposed by Kropinski et al. was named
vB_AbaM_ME3 (ME3) (3). A high titer phage suspension was
concentrated by ultracentrifugation, and DNA extraction was
performed as previously described (4). DNA was sequenced using
the 454 FLX Titanium PLUS Sequencing approach (LGC Genom-
ics, Mannheim, Germany). Open reading frames (ORFs) were
identified using GLIMMER and GenemarkS (5, 6), with possible
function of these ORFs’ proteins being predicted with BLASTp,
pFam, InterProScan, THMHMM v.2.0, LipoP v1.0 (7–11), with
tRNAscan.SE 1.21 being used to locate any tRNA present in the
genome (12).
To date, this is the largest Acinetobacter phage genome se-
quenced, with a size of 234,900 bp (the genome ends of ME3 are
not known). The overall %GC is 40%, similar to that of its host
(13). The genome was predicted to have 326 ORFs with four tRNA
genes.
On the basis of homology, putative functions were assigned to
77 ORFs, with 19 ORFs annotated as putative membrane proteins,
two ORFs annotated as putative lipoproteins, and the remaining
228 ORFs being annotated as hypothetical proteins.
Phage ME3 is an orphan phage, however, it has eight ORFs
encoding structural proteins that share homology to those of the
novel Bacillus phage 0305phi8-36 (GenBank accession number
NC_009760.1), although showing high levels of divergence (per-
centage identity of 26% to 34%). The major head protein
(ME3_22), portal protein (ME3_19), and tail sheath subunit
(ME3_29) are examples of such proteins. Until now, these pro-
teins of 0305phi8-36 have only been found to share homology
with those of phage-like elements found in the genomes of B. thu-
ringiensis serovar israelensis and B. weihenstephanensis (14). With
regard to these structural proteins and the large terminase subunit
(ME3_13), phages ME3 and 0305phi8-36 may share a distant an-
cestor.
Phage ME3 appears to encode its own DNA replication ma-
chinery including DNA polymerase subunits (ME3_60 and 61),
thymidylate synthase enzymes (ME3_107 and 108), helicases, and
enzymes involved in DNA degradation and repair. ME3 also pos-
sesses two cell wall degrading enzymes, ME3_8, a lysozyme with
proven lytic activity against A. baumannii and ME3_113, a puta-
tive cell wall hydrolase. Phage ME3 also has a curiously large num-
ber of genes associated with Ter-stress response (ME3_286, 284,
289, 290, and 291) and a massive protein of 5,419 amino acids
(ME3_104) possessing domains relating to host specificity and
binding (IPR015406, IPR008979).
Accession number(s). The full genome sequence of A. bau-
mannii phage vB_AbaM_ME3 was deposited in GenBank under
the accession number KU935715.
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